USAID/Madagascar
Outcome Monitoring Survey in the MAHEFA Areas
April 2015 This publication was produced at the request of the United States Agency for International Development. It was prepared independently by Agence CAPSULE.
PERFORMANCE EVALUATION:
USAID/MADAGASCAR OUTCOME MONITORING SURVEY IN THE MAHEFA AREAS
PREPARED BY AGENCE CAPSULE
[APRIL 7, 2015]
DISCLAIMER The author’s views expressed in this publication do not necessarily reflect the views of the United States Agency for International Development or the United States Government.
ACKNOWLEGMENTS
Our grateful thanks go to:
• Vololontsoa Raharimalala and Jean-Claude Randrianarisoa for their continued support and assistance to Agence CAPSULE‘s team in conducting the study, • Dr Onja Rahamefy for her technical and expertise assistance, • Daniel Andriatsimba for his contribution to geographical mapping, • All the local authorities and health responsibles in the MAHEFA intervention zones: DIANA, SAVA, SOFIA, Boeny, Melaky and Menabe.
Last and not the least, our many thanks go to the administrative team led by Eugenio Raniriharinosy and all the surveyors and supervisors who provided us great assistance, enabling us to successfully carry out the survey.
In short, we would like to express our most sincere and deepest gratitude to all those who, directly or indirectly, contributed to the accomplishment of this survey.
―This report is made possible by the generous support of United States Agency for International Development (USAID), under terms of Cooperative Agreement No. SOL-687-14-000005. The contents are the responsibility of Agence CAPSULE and do not necessarily reflect the views of USAID or the United States Government.‖
ACRONYM LIST
ANC: Antenatal Care BCC: Behaviour Change Communication CALC: Calculation CHV: Community Health Volunteer COR: Contracting Officer‘s Representative COSAN: Comité de Santé CPR: Contraceptive Prevalence Rate CSB: Basic Health Center (Public) CU0-6: Child between 0 - 6 months CU1: Children under one year of age CU5: Children under 5 years of age CU6-23: Child between 6 - 23 months of age CU6-59: Child between 6 - 59 months of age DEF: DEFINITION OR CLUES FP/RH: Family Planning / Reproductive Health GPS: Global Positioning System GMP: Growth Monitoring and Promotion HH: Household HPN: Health, Population and Nutrition IPC: Interpersonal communication IPTP: Intermittent Preventive Therapy for Pregnant IRS: Indoor Residual Spraying ITN: Insecticide-Treated Net JSI: John Snow, Inc KMS: Kaominina Mendrika Salama LAPM: Long-Acting Permanent Method MCPR: Modern Contraceptive Prevalence Rate MDG: Millennium Development Goals MM: Measurement Method MUAC: Mid-Upper Arm Circumference (MUAC) tapes NGO: Non-Governmental Organization OMS: Outcome Monitoring Survey POS: Point of Sales PPS: Probability Proportional to Size RS: Random Start SI: Sample Interval STI: Sexually Transmitted Infection VIP: Ventilated Improved Pit latrine WRA: Woman of Reproductive Age
TABLE OF CONTENT
EXECUTIVE SUMMARY……………………………………………………………………..1
INTRODUCTION…………………………………………………………………………...….3
PROJECT BACKGROUND …………………………………………………………………..3
PURPOSE-OBJECTIVES OF THE SURVEY…………………………………….…………3
METHODOLOGY –LIMITATION ………………….…………………………………….....4
GLOBAL RESULTS…………………………………………………………………………...8
TABLE 1: HOUSEHOLD INDICATORS………………………………………………..8 TABLE 2: WRA INDICATORS…………………………………………………………..17 TABLE 3: CARETAKER INDICATORS ……………………………………………….24 TABLE 4: CHV INDICATORS ………………………………….……………………….34 TABLE 5: POS INDICATORS……………………………………………………………39
ANNEX …………………………………………………………………...………………….. 44
A. RESULTS OF THE MAIN KEY INDICATORS ………...…………..…………...…...... 45 B. ANNEX B : Location and map of sites visited during the survey……………………….65 C. ANNEX C : Detailed methodologies and limitations…………………………...……….70 D. ANNEX D - INDICATOR LEVEL IN REGIONS AND DISTRICTS ….………...... 93 D.1. HH INDICATORS……………………………………………………….…………….93 D.2. WRA INDICATORS…………………………...………………………………….....105 D.3. CARETAKERS INDICATORS………………………...…………………………..113 D.4. CHV INDICATORS………………………………………………………………….144 D.5. POS INDICATORS………………………………………………………………….151 E. ANNEX E: Data collection instruments………………………………………...……….166 E.1. HH Questionnaire……………………………………………………………..…….166 E.2. WRA Questionnaire …………………………………………………………..…. . 192 E.3. CARETAKER Questionnaire ……………………………………………………….213 E.4. CHV Questionnaire………………………………………………….………………237 E.5. POS Questionnaire……………………………………………………………….….246
1. EXECUTIVE SUMMARY
This report provides key results of the FY 2014 outcome monitoring survey (OMS) conducted in the USAID-funded community health care project that is being implemented by the MAHEFA project in the following regions: DIANA, SAVA, SOFIA, Boeny, Melaky and Menabe. A baseline survey of the MAHEFA project on key health outcome indicators was carried out in 2012. The results of that survey showed a low level of critical child health indicators such as the percentage of fully immunized children before age one (19%), the percentage of children between 6-59 months of age receiving vitamine A during the last six months (11.4%) and poor access to improved drinking water source and sanitation. Although a low percentage of women were exposed to family planning messages (12.9%), contraceptive rate was 26.9%. A proportion of 33.2% of women were seen at Antenatal Care (ANC) at least four times during their pregnancy, and a higher percentage, almost the half of birth was attended by skilled healthcare providers such as a doctor, a nurse or a midwife.
Summary of findings of the 2014 OMS: I.A. MATERNAL HEALTH AND FAMILY PLANNING From the onset of the project to the end of September 20141, the proportion of women seen at ANC at least four times during their pregnancy has significantly increased, from 33.2% to 67.3%. The percentage of birth attended by skilled health providers has also increased, from 49.9% to 77.7%.
Modern contraceptive prevalence rate (MCPR) has increased from 26.9% to 41.3%. The percentage of Women of Reproductive Age (WRA) who were exposed to family planning Information-Education-Communication/Behavioral Communication Change Communication (IEC/BCC) messages also increased from 12.9% to 80.3%. Among them, 48.4% received the messages from Community Health Volunteers (CHVs), the remaining has heard messages through other channels such as other healthcare providers (56.3%), television (10.9%), newspapers, posters and books (1.1%). The above data indicated evidences of effective mass and Interpersonal Communication (IPC) through CHVs that rose general awareness of Family Planning (FP) among women. However, there is a need to strength IPC through CHVs in order to individually identify and satisfy the unmet need for FP, reported by 30.6% of women (DHS 2008: 19%).
I.B. WATER, SANITATION AND DIARRHEAL DISEASE The results showed a significant increase of the percentage of households having access to improved drinking water source, from 46.8% to 65.2%. Although 24.8% of the interviewed
1 USAID Fiscal Year is from October 01 to September 30. Outcome Monitoring Survey in the MAHEFA Areas - 1 -
households reported practice of effective water treatment, it was observed that only 1.6% did it correctly for water boiling; the correct use is close to zero for other techniques such as Sur‘eau. The proportion of households having access to private and improved sanitation facilities has increased from 3.1% in 2012, to 9.8% in 2014. But open defecation was still reported by 39.9% of the households in 2014. An increase in the diarrhea prevalence was reported among children under five of age (CU5), from 5.5% at baseline to 10.3% in 2014. I. C. NUTRITION The percentage of children under six months of age (CU6) exclusively breastfed in the past 24 hours was high: 95.9%. About 39% of Children under two of age (CU2) were weighted during Growth Monitoring and Promotion (GMP) in the last two months. Respectively, 0.5%, 1.7% and 97.8% of the measured children were in the red, yellow, green Mid-Upper Arm Circumference (MUAC) zones. However, moderate and severe hunger was experienced by 6.7% of the surveyed households. I.D. MALARIA The percentage of households with at least one Insecticide Treated Net (ITN) was at 82.9%. At baseline, the overall ITN coverage was significantly higher, 91.8%. However, the percentages of women and CU5 who slept under ITN and/or in a house sprayed with IRS the previous night were of 52.5% and 67.9%, respectively. Malaria prevalence was low, 0.3%. A proportion of 8.2% of children with fever were treated by CHVs.
I.E. HEALTH SYSTEM There were 4.5% of households that reported having access to the MAHEFA innovative transportation system, but only 0.3% has used it. Besides, 0.1% reported membership of health mutual promoted by MAHEFA. I. F. COMMUNITY HEALTH VOLUNTEERS
A proportion of 36.1% of CHVs are certified on Family Planning 4 and 22.9% are polyvalent, with three or more qualifications (PF4, IEC/Counseling, and Sexually Transmitted Infections, Child Health or others). The percentage of CHVs providing counseling on Family Planning/Reproductive Health (FP/RH) and Sexually Transmitted Infections (STIs) was 46.9%. Although the majority of CHVs (91.5%) reported no stock-out of injectable contraceptives, it was found that 42.2% experienced stock-outs of Oral Rehydration Solution (ORS) and/or Zinc supplements.
Although an increase in diarrhea prevalence among CU5 was found.
Overall, the results of this survey highlight better status for several maternal and child health indicators.
Outcome Monitoring Survey in the MAHEFA Areas - 2 -
INTRODUCTION From September 18th to October 30th 2014, Agence CAPSULE conducted the OMS field data collection in the six regions of the MAHEFA intervention zones. OMS is a population-based survey, representative of the population of households having at least one woman of reproductive age (WRA) or one child under five (CU5) within the districts or regions of MAHEFA implementation areas. This report summarizes the main results of the fieldwork as it is required in the section C.7.3 and C.7.4 of the Terms of Reference of the RFP No.: SOL-687-14-000005.
2. PROJECT BACKGROUND
To help communities in remote hard to reach areas who are greatly affected by the socioeconomic degradation and the decline of the health system, USAID/Madagascar awarded a five-year community-based healthcare cooperative agreement, known as MAHEFA, to JSI Research & Training Institute, Inc. (JSI) (Award Number 687-A-11-00013-00). This five-year project that will run from May 23, 2011 to May 22, 2016, is targeting 275 Communes within 24 districts in the six regions of Madagascar (DIANA, SAVA, SOFIA, Boeny, Melaky, and Menabe).
The main objective of this project is to increase the use of proven community-based interventions and of essential selected products among underserved populations in the six northern and western regions of Madagascar. To pursue this objective, the project has strived to achieve three intermediate results:
IR 1: Increase demand of high-quality health services and products IR 2: Increase availability of high-impact services and products IR 3: Improve the quality of care delivered by community-based health practitioners
3. PURPOSE AND OBJECTIVES OF THE SURVEY
4.1. PURPOSE
USAID/Madagascar needs a year-to-year comparable health status of the population in the intervention zones of the USAID-funded projects in Madagascar. The purpose of this OMS is to measure the current status of the USAID key selected health indicators in the MAHEFA project intervention zones. The main findings of this survey include indicators related to the MAHEFA activities and outcome indicators at higher level of the USAID/Madagascar Health, Nutrition, and Population (HPN) Results Framework.
The results of the survey will help the Mission to identify and understand the successes of the project, under-performing interventions and problems that need to be addressed for better results that will contribute to the achievement of the MAHEFA health programs. Specifically for the MAHEFA project, findings will help set the course for the remaining duration of the project.
Outcome Monitoring Survey in the MAHEFA Areas - 3 -
4.2. OBJECTIVES OF THE SURVEY
A baseline survey of the MAHEFA project was conducted in FY 2012, one year after the implementation of the project. The status of the key indicators on hygiene, water and sanitation and health financing was assessed at the household and/or individual levels. To this end, data on maternal and child health, nutrition, malaria, family planning, water, hygiene and sanitation, transportation means and quality of CHV services were collected from various respondents such as women of reproductive age including pregnant women, caregivers of CU5, CHVs and health product Supply Points (POS).
The MAHEFA project has been running for three years. It is then crucial to document the magnitude of changes of the selected outcome indicators in order to better understand the outcome of the project interventions on its beneficiaries as well as to get regular data to monitor its performance.
Indicators and corresponding questions are presented in tables 1-5: Table 1: Household indicators Table 2: Woman of Reproductive Age indicators Table 3: Caretaker of CU5 indicators Table 4: CHV indicators Table 5: POS indicators
5. METHODOLOGY – LIMITATION
The 2014 OMS used a quantitative cross-sectional design that mainly targeted WRA, caretakers of CU5 in approximately 2,400 households from randomly selected Fokontany. In addition, structured interviews were conducted with CHVs and POS in the Fokontany and Communes related to the sampled households.
Two-stage cluster sampling techniques were used for selecting the household members to be interviewed. However, to ensure better comparability with the 2012 baseline, this survey prioritizes the selection of the Fokontany already used for the MAHEFA baseline survey, which itself was randomly sampled.
Five (5) Fokontany were randomly selected within each of the 24 districts of intervention. After that, a systematic random sampling was performed to select 20 households to be interviewed in each selected Fokontany. A total number of households, N=2400 (24 districts x 5 Fokontany x 20 households) was obtained. With each sampled household, the consultant interviewed household heads, all WRA, including pregnant women and all caretakers of CU5. In addition, data on households environment related to the surveyed outcomes such as possession and use of Insecticide Treated Nets (ITNs), sanitation facilities, and perception on CHV performance were also collected.
Two (2) CHVs and one (1) POS at the commune level were also interviewed. Additional information related to household socioeconomic characteristics, in the sampled Commune and Fokontany were also gathered.
Outcome Monitoring Survey in the MAHEFA Areas - 4 -
Five structured questionnaires were used to collect the data. The questionnaires were pre-tested, adapted to prior implementation. Enumerators were trained to select the households using systematic random techniques, to collect the needed data and to measure the Mid-upper arm circonference (MUAC) of children. Supervisors were trained on data collection supervision techniques and supervised the enumerators during fieldwork. Any interview could not be administered without the informed consent of the respondents.
Two separate components were explored. The first component focused on the population, beneficiaries of health services from the MAHEFA project, and the second on supported-CHVs and POS who provided IEC/BCC services and commodities to the project‘s beneficiaries.
Of the 2,400 households planned for this survey, 2,391 interviews have been achieved. The results were obtained from 2,529 WRA, and 2,134 CU5, among whom MUACs were measured. In addition, 200 CHVs and 51 POS have been interviewed.
Type Sample size Households 2391 Women in Reproductive Age (WRA) 2529 WRA in union 1686 WRA following SP treatment 165 WRA doing antenatal consultation 565 WRA with live birth in the past five years 1600 WRA with live birth in the past two years 921 Mother of CU1 420 Children under five years old (CU5) 2134 Children under 2 years old (CU2) 917 Children under 12 months (CU1) 493 CU six months breastfed 204 Children under six months 282 Children under one month (28 days) 10 Children between 6-8.9 months 150 Children between 6-59.9 months 1845 Children between 9-23.9 months 466 Children between 12-23.9 months 414 CU5 with diarrhea in the past 2 weeks 225 CU5 with fever in the past 2 weeks 319 CU5 testing RDT 21 CU5 with cough/pneumonia in the past 2 weeks 103 CU5 living in areas targeted by ITN distribution or IRS spraying 2188 CHVs 200 POS 51
Tablet computers have been used during the interview and STATA software has been used to perform data analysis.
Outcome Monitoring Survey in the MAHEFA Areas - 5 -
5.1. WEIGHTING THE SAMPLE
The number of sampled households is the same within each district though the total number of the population varies. Therefore, samples were weighted for frequency calculations:
• The strata are 24 districts (1 24) • Clusters are Fokontany (1 5) within each stratum
To calculate weighting, the following information must be available in the data files: - the total number of Fokontany in each district - the number total number of households in each Fokontany - the weights: they were calculated based upon the above information
We calculated: - the probability of drawing each Fokontany : P1 = 5/ total number of Fokontany - the probability of selection for each household: P2 = 20 / total number of HH
For the production of tables, the following weights have been used: - Tables for households and WRA: Weighting = 1 / (P1 x P2)
5.2. CALCULATION METHOD
Frequencies were calculated for the majority of the indicators. Scales were used for indicators on Gender Empowerment (Indicator 1.08), Hunger (Indicator 1.18) [Ballard et al., 2011], WRA self-efficacy (Indicator 2.13), and satisfaction of CHV‘s quality care (Indicators 2.06 and 3.16). For each participant, the sum of the obtained scores from client satisfaction questions was computed and multiplied by 3.125 in order to obtain a score from 25 to 100. ―Satisfied WRA or caretakers‖ obtained a score of 75 or more.
In order to detect the differences between percentages, the Pearson Khi-2 test or the Fisher‘s exact test was performed if applicable. Differences were considered statistically significant when the p-values did not exceed five percent (5%).
5.3. LIMITATION • The methodology used for both, MAHEFA 2012 baseline and the 2014 OMS, is the same. However, the period differs as the MAHEFA baseline was conducted between June – July 2012. Whereas the the OMS took place in September – October, 2014. These differences limit the comparison between the two surveys, especially for seasonal illnesses. • Some indicators of the 2014 OMS were not collected in the MAHEFA baseline. Therefore, their comparison with this OMS could not be determined at this point. • Under or over reporting has biased some indicators‘ level. Assurance of confidentiality was assured in order to minimize biased information. • Memory biases have influenced information on prior events. Their importance was minimal for events that occurred in the past two weeks such as fever. However, it remains unknown
Outcome Monitoring Survey in the MAHEFA Areas - 6 -
for the number of CHVs re-supplying from the POS (indicators 5.03, 5.04), and for the CHV visits in households. • Although the questionnaires were pretested and adapted prior to the implementation of this survey, question about hearing nutrition messages (question 107G, annex E2) might not have been understood by some participants. Therefore, the related indicator was under reported. • History biases are inavoidable. Other events might have determined or contributed to changes in the magnitude of the indicators‘ level. • As the household samples were from the Fokontany selected during the 2012 baseline, some of the participants might have already been interviewed in 2012. Thus, they might have been accostumed to the questionnaire, which led to over or under reported information. • Exclusion criteria for OMS 2014 (HH with at least one WRA or one CU5)
Outcome Monitoring Survey in the MAHEFA Areas - 7 -
6. GLOBAL RESULTS
6.1. TABLE 1: HOUSEHOLD INDICATORS
INDICATORS MAHEFA 2014 OMS Definition 2012 Baseline 1.01: % of households using improved sanitation 3.1% 9.8%
Latrines with slab or Improved sanitation facilities with sewer connections, septic system connections, pour-flush latrines, covered pit: 6.8% ventilated improved pit latrines (VIPs), composting Septic system: 1.4% toilets and pit latrines with a slab or covered pit. Using public or shared sanitation facilities was not VIPs: 1% considered as having improved sanitation. Sewer connections: 0.6%
Numerator n=175 Denominator N=2,391 1.02: % of households with improved drinking water 46.8% 65.2% source Public standpipe or public
Improved drinking water sources are household borehole: 26.8% connection, public standpipe, borehole, protected dug Protected dug well: 25.1% well, protected spring, and rainwater collection. On premises piped drinking water connections – running Protected spring: 0.2% water in dwelling, yard or plot. Dug well with pump: 3.2%
Numerator n=1,351 Household water Denominator N=2,391 connection: 1.5% 1.03: % of households with at least one ITN 91.8% 82.9% Households with at least one ITN All districts were subject to
Numerator n=2,008 ITN mass distribution in Denominator N=2,391 2013 - 2014 1.04: % of houses sprayed with IRS in the last 12 N/A 0%* months by USG-funded programs
Homes and barns sprayed with IRS in the last 12 months by USG-funded programs Numerator n=0 Denominator N= 2,391 * 9.2% of households reported IRS spray in the past 12 months (funded by other program than USG)
Outcome Monitoring Survey in the MAHEFA Areas - 8 -
1.05: % of households with soap and water at hand 11% 15.6% washing station commonly used by family members
Households with soap and water at hand washing station commonly used by family members Numerator n=327 Denominator N=2,391 1.06: % of households practicing open defecation N/A 39.9%
Household heads who reported members of their household practiced open defecation. Numerator n=1,244 Denominator N=2,391 1.07: % of households that are practicing effective 23% 24.8% household water treatment Water boiling: 19.1%
Effective household water treatment includes boiling, Sur‘eau: 8.4% chlorine disinfection, solar disinfection, water Other chlorine solution: 0.4% filtration and combined flocculation/chlorination systems. Water filtration: 0.3% Numerator n=506 Solar disinfection: 0.1% Denominator N=2,391 1.08: % of household head reporting increased N/A 2014 baseline scores are agreement with the concept that males and females available should have equal access to social, economic, and political opportunities Average score: 0.039
A test using a Likert five point scale was run. The household heads should be tested again at the end of the program. Obtained scores are to be compared to determine any increase Respondents N=2389 Males n=1808 Females n=581 Missing =2 (See figure 1)
Outcome Monitoring Survey in the MAHEFA Areas - 9 -
1.09: % of households practicing correct use of N/A 1.8% recommended water treatment technologies Water boiling (boiled water put
- Water boiling (boiled water kept covered or put in a in a clean and covered recipient clean and covered recipient for storage) for storage): 1.6% - Water boiling and kept covered Correct water filtration: 0.2% - Correct water filtration - Correct use of Sur‘eau Correct use of Sur‘eau: 0% - Correct water chlorination Correct water chlorination: 0% - Correct solar disinfection. Correct solar disinfection: 0% Numerator n=46 Denominator N=2,391 1.10: % of households covered by USG-supported N/A 0.1% health insurance or subsidies
Percentage of households reporting coverage by MAHEFA health insurance or subsidies (in order to avoid double counting, households receiving both insurance and subsidies were counted only once. Numerator n=3 Denominator N=2,391 1.11: % of households having access to USG- N/A 4.5% supported emergency transportation system
Household heads who mentioned MAHEFA ambulances as emergency transportation for pregnant women and CU5 Numerator n=103 Denominator N=2,391 1.12: % of households having used USG-supported N/A 0.3% emergency transportation system
Households having used MAHEFA emergency transportation system Numerator n=15 Denominator N=2,391 1.13: % of households visited by CHVs for health- N/A 18.3% related IPC in the past 3 months WRA reporting one or more visits by CHVs for health-related IPC in the past thres months preceding the survey (proxy) Numerator n=461 Denominator N=2,529 WRA
Outcome Monitoring Survey in the MAHEFA Areas - 10 -
1.40: % of households who know the three message N/A 13.5% of DIORANO ―Wash your hands with soap‖: Households who know the following three messages Wash your hands with soap 28.7% Use hygienic latrines ―Use hygienic latrines‖: 19.0% Transport and store water safely. Numerator n=217 ―Transport and store water Denominator N=2,391 safely‖: 22.3% 1.15: % of households having a cell phone 26.3% 32.4% Households having a cell phone. Only those phones that are working will be counted for this indicator. Numerator n=643 Denominator N=2,391 1.16: % of households willing to participate in a N/A 62.2% phone interview
The household head is willing to participate in a phone interview Numerator n=1,352 Denominator N=2,391 1.17: % of households having access to electricity at 17% 37.7% home (DHS Households having an electricity connection at home 2008) Numerator n=683 Denominator N=2,391 1.18: % of households with moderate or severe N/A 6.5% hunger
The household hunger scale* was used. Households that had scores ranging from two to six were considered to be with moderate or severe hunger. Numerator n=174 Denominator N=2,389 Missing=2 * Terri Ballard & al.Household Hunger Scale: Indicator Definition and Measurement Guide. FANTA project August 2011
The results indicated an increase in the use of improved sanitation facilities (Indicator 1.01) in the studied households, from 3.1% to 9.8%. Compared to the 2012 baseline data, the percentages of households using improved sanitation increased significantly in all regions, except in Sava: from 2.4% to 10.7% in Sofia; from 0.3% to 5.9% in Boeny, from 1.3% to 7.9% in Menabe, from one percent (1%) to 4.7% in Melaky, and from 7.7% to 11.9% in Diana.
Outcome Monitoring Survey in the MAHEFA Areas - 11 -
A significant difference of percentage was found with regard to the use of improved sanitation facilities in districts, ranging from zero percent (0%) in Morafenobe to 27% in Antsiranana I (p<0.001) (See table 20, annex D). The lowest rates were found in Ambatomainty (0%), Antsalova (0%), Morafenobe (0%), and Mahabo (1.2%).
Findings showed an increase of the percentage of households with access to improved drinking water source (Indicator 1.02), from 46.8% to 65.2%. Household heads from Diana reported the highest level, close to 74%, and the lowest was found in Melaky, 39.1%. The percentages also differed significantly between the districts (p=0.000). The highest rate was reported in Antsiranana I (94.6%), and the lowest were found in Soalala (9.5%) and Ambatomainty (11.1%).
Female household heads were more likely to have a household with improved drinking water source compared to male household heads (p=0.002)
The percentage of households with soap and water at hand washing station (Indicator 1.05) has increased from 11% to 15.6%. Approximately, half of households with water connection (49.5%), experienced water-cut at the moment of the survey. About the same proportion (44.9%) of households fetching water did not have water available at their hand washing station. Moreover, when water was available at hand washing station, in 46.8% of the visited households, no soap was found around to appropriately wash hands.
The percentages of households with soap and water at hand washing station significantly differed among regions (p<0.01). The highest percentages were seen in Menabe, 21.6%, and Diana, 20.1%; while the lowest percentages were observed in Boeny, eight percent (8%), and Sofia, 10.4%. Those percentages differed between districts, ranging from 2.1 in Befandriana Nord, to 32.4% in Antsiranana I. The difference was statistically significant (p<0.01) (Table 20, annex D).
The percentage of household heads who know the three core messages of DIORANO-WASH (Indicator 1.40) was low, 13.5%. The proportions differed in regions, Sava (25.3%), Menabe (20.8%), Diana (17%), Sofia (7.5%), Melaky (3.1%), and Boeny (0%). The difference was statistically significant (p<0.01). There was also a significant variation by districts (p<0.01). The highest rate was reported in Ambilobe (33.9%). However, in one third of the districts, such as Soalala, Mitsinjo, Ambatomainty, Antsalova, Maintirano, Morafenobe, and Antsiranana I, the percentage of household heads who know the three core messages was zero percent (0%) (Table 20, annex D). Memory bias (people could not remember or precise exactly the words) might have induced under reporting of this indicator.
The results indicated a decline of percentage of households with at least one ITN (Indicator 1.03), from 91.8% (2012 baseline) to 82.9% (2014 OMS) (p<0.001). The percentages ranged from 78.3% in Sofia, to 88% in Boeny, the difference of percentage was statistically significant among regions (p=0.006). The percentages also differed among districts (p<0.001). Almost all households in Ambatomainty (100%), Antsalova (100%), and Morondava (95.2%) were found with at least one ITN. However, the lowest percentages were reported in Besalampy and Belo
Outcome Monitoring Survey in the MAHEFA Areas - 12 -
Sur Tsiribihina, 52.8% and 66.2 % respectively (Table 21, annex D). Having at least one ITN at home was positively associated with male household head gender (p=0.038).
Less than one fifth, 18.3% of women reported they received one or more visits by CHVs for health-related IPC in the past three months (Indicator 1.13). A significant difference of percentages was found between regions (p<0.001). The highest rates were reported in Melaky and Menabe, 25%; and the lowest in Boeny, 5.7% (Table 24, annex D). The difference of precentages was also statistically significant between districts (p<0.001). CHV visits for health- related IPC were concentrated in the Morondava district, 83.6%. However, the percentages did not exceed 10% in half of districts, including Ambanja (8.9%), Belo Sur Tsiribihina (8.1%), Mitsinjo (6.5%), Port Bergé (6%), Miandrivazo (5.3%), Analalava (5%), Soalala (4.5%), Nosy Be (4.4%), Bealalana (4.1%), Antsiranana II (3.4%), and Morafenobe (0%).
Household heads were asked about their opinion regarding the concept that males and females should have equal access to social, economic, and political opportunities (Indicator 1.08). Their perception is reported in the figure 1 below.
Figure 1: Household head reporting agreement with the concept that males and females should have equal access to social, economic, and political opportunities (Indicator 1.08), MAHEFA Project, 2014 OMS
Figure 1a: Women should have equal rights with men and receive the same treatment as men do. Total Male Female 19,0% 16,7% Strongly agree 26,3% 40,0% 39,4% Agree 41,7% 16,1% Neither agree nor… 16,8% 14,0% 17,8% Disagree 19,5% 12,6% 7,0% Strongly disagree 7,6% 5,4%
Women and men‘s responses significantly differed on the statement in figure 1a: ―Women should have equal rights with men and receive the same treatment as men do‖ (p<0.001).
Outcome Monitoring Survey in the MAHEFA Areas - 13 -
Figure 1b: On the whole, men make better political leaders than women and should be elected rather than women. Total Male Female 14,5% Strongly agree 14,8% 13,3% 29,4% Agree 30,7% 25,6% 16,4% Neither agree nor 17,0% disagree 14,7% 29,9% Disagree 28,4% 9,7% 34,8% 9,1% Strongly disagree 11,6%
Women and men‘s responses significantly differed on the statement in figure 1b: ―On the whole, men make better political leaders than women and should be elected rather than women.‖ (p=0.03).
Figure 1c: When jobs are scarce, men should have more right to a job than women.
Total Male Female
12,8% Strongly agree 13,8% 9,7% 27,4% Agree 29,4% 21,1% 14,0% Neither agree nor disagree 14,0% 14,0% 33,4% Disagree 32,0% 37,8% 12,4% Strongly disagree 10,8% 17,4%
Women and men‘s answers significantly differed on the statement in figure 1c: ―When jobs are scarce, men should have more right to a job than women‖ (p<0.001).
Outcome Monitoring Survey in the MAHEFA Areas - 14 -
The proportion of households having a cell phone (Indicator 1.15) has significantly increased, from 26.3% at baseline, to 32.4% in 2014. The coverage with cell phones differed among regions (p<0.001). The highest coverage was observed in Diana, 46.7%; and the lowest in Sofia, 20.7%. The percentages also differed between districts (p<0.001), which were high in Antsiranana I, 76.3%; and Maintirano, 55.6%. However, they were much lower in the Mahabo and Morafenobe districts, respectively, 7.2% and zero percent (0%) (Table 22, annex D).
The percentage of households willing to participate in a phone interview (indicator 1.16), 62.2% is favorable to further surveys using mobile phones. The percentages of households who are willing to participate were respectively, 80.4%, 78.1%, 69%, 62%, 54.5%, and 44.5% in Boeny, Sava, Diana, Menabe, Sofia, and Melaky. The difference of percentages was statistically significant (p<0.001). A significant difference of percentages was also observed between districts (p<0.001), with the highest percentages in Mitsinjo (86.7%); Ambilobe (87.2%); Antsiranana I (78.4%) and Vohemar, 78.1%; and the lowest in Morafenobe, 22.2% (Table 22, annex D).
Findings indicated an improved accessibility to household electricity connection (Indicator 1.17), 37.7%, compared to only 17% (DHS, 2008). The highest percentage was reported in Diana, 61.7%. However, it did not exceed 50% in the other five regions: Menabe (29.2%), Melaky (25.8%), Boeny (26%), Sava (25.3%), and Sofia (22.1%). The difference of percentage among regions was statistically significant (p<0.001). The proportions also differed between districts (p<0.001), the highest rates were concentrated in Nosy Be, 93.5%; Antsiranana I, 83.3% Morondava, 76.2%, and Ambilobe 73.7%, while the lowest were reported in Antsiranana II and Analalava, 9.1% and zero percent (0%) respectively (Table 22, annex D).
One hundred and seventy four (174) household heads reported that one or more members of their household experienced moderate to severe hunger situations (Indicator 1.18). They represented 6.5% of the samples. The percentages significantly differed among regions (p<0.001). They exceeded 10% in Menabe (12.5%), and Melaky (10.9%) regions. Moreover, it was found that more than one fith of households experienced moderate to severe hunger in the Besalampy and Belo Sur Tsiribihina districts, respectively 22.2% and 18.9%. However, the rates were low (0%) in Soalala, Mitsinjo, Befandriana Nord, Ambatomainty, and Morafenobe; and relatively low in Mahabo, Antsalova, Ambilobe, Bealalana, Vohemar, and Mandritsara: 4.9%, 4.8%, 2.6%, 1.7%, 0.7%, and 0.5% rexpectively. The difference of percentage was also statistically significant between the districts (p<0.001). Those results indicate an emersion of vulnerable households with regard to hunger in the intervention zones.
It was found that open defecation (Indicator 1.06) was a common practice in the surveyed households, 39.9%. The percentages of households practicing open defecation were the highest in the regions of Boeny (82.4%), Melaky (68%) and Menabe (56.1%). The lowest percentage was observed in Sofia (26.9%). The percentages differed significantly among regions (p<0.001). More than half of households reported practice of open defecation in the districts of, Soalala
Outcome Monitoring Survey in the MAHEFA Areas - 15 -
(90%), Antsalova (86.4%), Besalampy (83.3%), Ambatomainty (77.8%), Mitsinjo (76.7%), Analalava (65.7%), Manja (64.7%), Antsiranana II (62.5%), Belo Sur Tsiribihina (62.2%), Mahabo (57.8%), Miandrivazo (54.5%), and Maintirano (50.9%). However, the percentages were relatively low in Antsiranana I (8.1%), and Mandritsara (3.5%). The difference of percentage was statistically significant between the districts (p<0.001).
In general, there was no evidence of increase in practice of effective household water treatment (Indicator 1.07), 23% in 2012 and 24.8% in 2014. The highest percentage was observed in Sava (39.7%). The difference of percentage was statistically significant among regions (p<0.001). Boiling water and using Sur‘eau were the most common practices, reported respectively by 19.1% and 8.4% of households. Only 0.3% of the households used ceramic filtration and 0.1% practiced solar disinfection.
This survey also revealed that a very few households reported correct use of recommended water treatment, 1.8% (Indicator 1.09). The prevailing practices included boiling water and putting it in a clean and covered recipient (1.6%), and correct water filtration (0.2%). However, none of the households (0%) reported correct use of Sur‘eau.
Low insurance covering was observed among the surveyed population. Only 0.1% of the households reported they were covered by a USG-supported community health financing arrangement. Besides, only fifteen (15) of the 2,391 interviewed household heads reported using the MAHEFA emergency transportation system, 0.3%. In fact, few household heads (4.5%) mentioned MAHEFA ambulances as an available emergency transportation for pregnant women and CU5.
The following chart presents trends of some indicators between the two periods.
Figure2: Change of some indicators’ level between the 2012 baseline and the 2014 OMS
1.15 Percentage of households 32,4% having a cell phone 26,3% 1.07 Percentage of households that 24,8% are practicing effective household… 23% 2014 OMS MAHEFA 2012… 1.05 Percentage of households with 15,6% soap and water at hand washing… 11% 82,9% 1.03 Percentage of households with at least one ITN 91,8% 1.02 Percentage of households with 65,2% improved drinking water source 46,8% 1.01 Percentage of households using 9,8% improved sanitation 3,1%
Outcome Monitoring Survey in the MAHEFA Areas - 16 -
TABLE 2: WRA INDICATORS
INDICATORS MAHEFA 2012 2014 OMS Definition Baseline 2.01: Modern contraceptive Prevalence Rate 26.9% 41.3% (MCPR) Female sterilization: Female sterilization: Number of WRA in union currently using a modern method of contraception (Male/Female 0.2% 0.5% sterilization, IUD, Pills, Injection, Implant, Vasectomy: 0% Vasectomy: 0% Male/Female condom, Spermicide, Diaphragm, Pills: 5.5% Pills: 8.7% Exclusive breastfeeding and amenorrhea, Cycle Injection: 15.2% Injection: 26.7% beads) [WHO] IUD: 0.2% IUD: 0.4% Implant: 0.9% Implant: 3% Respondents: WRA in union (married, living with their partner) Condom: 1.6% Male condom: 0.4% Numerator n=756 Female condom: 0% Denominator N=1,686 Diaphragm: 0% Diaphragm: 0% Spermicide: 0% Spermicide: 0% Cycle beads: 0.7% Cycle beads: 0.6% Exclusive Exclusive breastfeeding and breastfeeding and amenorrhea: 1.3% amenorrhea: 1.9%
2.02: % of women with unmet FP need 19% (DHS 2008) 30.6% WRA (married or in a union) who are not using contraception, are fecund, and desire to either stop childbearing or postpone their next birth for at least two years; pregnant women whose current pregnancy was unwanted or mistimed; women in post-partum amenorrhea who are not using contraception and, at the time they became pregnant, had wanted to delay or prevent the pregnancy [WHO] Respondents : WRA in union (married, living with their partner) Numerator n=438 Denominator N=1,686
Outcome Monitoring Survey in the MAHEFA Areas - 17 -
2.03: % of women exposed to IEC/BCC FP 12.9% 80.3% messages CHVs (IPC and local WRA who have heard IEC/BCC FP messages radio stations): 48.3% from CHVs (IPC and information from local radio stations), other health service providers, Other health service TV, radio, events, newspapers, posters and providers: 56.3% books, and other sources. Radio: 36.2% Respondents : WRA Numerator n=1,967 TV: 10.9% Denominator N=2,529 Events: 3.2% Newspapers, posters and books: 1.1% 2.04: % of women who received two doses of 13.7% 26.4% SP for IPTP during last pregnancy within the last two years
WRA who received 2 doses of SP for IPTP during last pregnancy within the last 2 years
Respondents : WRA who stated they were pregnant within the last 2 years Numerator n=165 Denominator N=744 2.05: % of WRA seeking counselling or N/A CHV: 8.9% treatment from CHVs for FP/RH Clinic, physician, WRA who know to go to CHVs for FP counselling/treatment (proxy) and reported nurse, midwife: receiving FP counselling or FP products from 28.5% CHVs or health facilities. Pharmacy, grocery: OR WRA who received counselling/FP 0.5% products from CHVs Respondents: WRA Other: 1.1% CHV: Numerator n=263
Denominator N=2,529 2.06: % of WRA satisfied with CHVs' quality N/A 49% care
WRA achieving over 75 on a standard client satisfaction questionnaire (Scale between 25 and 100)
Respondents: WRA who use FP products provided by CHVs and reported a recent visit by a CHVs at their home. Numerator n=39 Denominator N=84
Outcome Monitoring Survey in the MAHEFA Areas - 18 -
2.07: % of females who report increased self- N/A efficacy at the conclusion of the USG- Average score: 7.14 supported training Number of WRA whose scores on self-efficacy have improved over time (two tests: before and after an USG-supported program)
Respondents: WRA Numerator n=2,529 Denominator N =2,529 2.08: % of women seen at ANC at least four 33.2% 67.3% times during their pregnancy with a live birth Women seen at ANC at least four times by a Doctor, Nurse, Midwife, Medical assistant* during their last pregnancy * Medical assistants (Aide-sanitaires) are healthcare providers in Madagascar‘s public health centres.
Respondents: WRA with live birth in the past 2 years. Numerator n=565 Denominator N=921 2.09: % of women who receive two tetanus 51.3% 67.5% toxoid shots (or equivalent) during their last pregnancy Women who received 2nd TT or 3rd TT or 4th TT or 5th TT
Respondents: WRA with live birth in the past five years Numerator n=1,035 Denominator N=1,600 2.10: % of birth attended by a doctor, nurse, 49.9% 77.7% trained midwife or a medical assistant Birth attended by a doctor, nurse, trained midwife or medical assistant.
Respondents: WRA with live birth in the past two years. Numerator n=656 Denominator N=921
Outcome Monitoring Survey in the MAHEFA Areas - 19 -
2.11: % of women who state they received 51.3% (pregnancy 56.2% iron folate supplement during their last in the past 5 years) pregnancy
WRA who state they received iron folate supplement during their last pregnancy in the past 2 years. (It was considered that women who took the tabs for less than 7 days did not took Iron folate)
Respondents: WRA with live birth in the past 2 years. Numerator n=514 Denominator N=921 2.12: % of mother of children aged less than 78.7% 86% 12 months who stated a desire to wait at least 24 months to have another child Mother of children aged less than 12 months who stated a desire to wait at least 24 months to have another child.
Respondents: WRA who are mothers of children aged less than 12 months Numerator n=351 Denominator N=420 2.14: % of women reporting no myths or N/A 15.7% misconceptions regarding modern FP methods, n=2,529 Use of scales: women answering ―no‖ to statements of myths and misconceptions on modern FP methods.
Respondents: WRA Numerator n=481 Denominator N=2,529 2.15: % of WRA who perceive that their N/A 45.1% partner support them to use modern contraceptives WRA who stated that their partner support them to use modern contraceptives Respondents: WRA with at least one sexual partner, in union or not Numerator n=963 Denominator N=2,007
Outcome Monitoring Survey in the MAHEFA Areas - 20 -
2.16: % of pregnant women who slept under 89.3% 52.5% an ITN the previous night or in a house sprayed with IRS in the last 12 months Pregnant who slept under an ITN the previous night or in a house sprayed with IRS in the last 12 months. Bed nets were considered as ITNs if they were Long lasting insecticide treated nets (LLI) acquired in the past three years, or bed nets soaked in an insecticide product in the last 12 months preceding the survey.
Respondents: All pregnant women in households Numerator n=105 Denominator N=167 2.17: % of pregnant women who know to go N/A 90.0% to CSB (Centre de santé de base) to receive two doses of ItPt during pregnancy Pregnant women who know to go to CSB to receive two doses of ItPt during pregnancy Respondents: pregnant WRA Numerator n=141 Denominator N=162 Missing=5
The global MCPR increased from 26.9% to 41.3% (Indicator 2.01). The percentages differed across regions, with high rates reported in Menabe and Melaky, 53.3% and 52.7% respectively. However, the rate was relatively low in Boeny, 28.2% (Table 25, annex D). The difference of percentage was statistically significant (p<0.001). The prevailing contraceptive use was injection, reported by 26.7% of WRA. However, Long-Acting Permanent Methods (LAPM) users were fewer, 0.5% for female sterilization, zero percent (0%) for vasectomy, 0.4% for intrauterine devices (IUDs), and 3% for implant use.
The percentage of WRA reporting unmet need for FP went up from 19% (2008DHS) to 30.6% (2014 OMS) (Indicator 2.02). We are facing with increased MCPR and unmet need for FP. The percentages of WRA with unmet need for birth limiting and birth spacing ranged from 19.4% in Melaky, to 33.9% in Sofia (p<0.001). The highest percentage was observed in the Analalava district (62%). However, only 12.5% and 13% of the WRA in union reported unmet need for FP in Morafenobe and Manja, respectively. The difference of precentage is statistically significant between districts (p<0.001), as shown in table 25, annex D.
Outcome Monitoring Survey in the MAHEFA Areas - 21 -
An increased percentage of WRA having heard FP messages was observed, from 12.9 at baseline to 80.3% (2014 OMS) (Indicator 2.03). A percentage of 48.3% WRA heard the messages from CHVs from CHVs, 56.3% received messages from other healthcare providers, 10.9% from television, and 1.1% from newspapers, displays and books (Table 2). Data indicate evidences of effective mass and IPC communication that rose general awareness of FP among women. Therefore, there is an opportunity to strength IPC through CHVs in order to individually identify and satisfy the increasing unmet need for FP.
The percentage of women who perceived partner support when using modern contraceptives ranged from 38.3%, in Boeny, to 63.9% in Melaky (Indicator 2.15). The difference of percentage was statistically significant among regions (p<0.001). Table 25 (annex D) shows that the percentages of women percieving partner support significantly differed between districts. They were high in Antsalova, 75%; and Maintirano 69.8%; but low in Analalava, 18.6% (p<0.001).
Myths and misconceptions regarding modern FP methods were quite common among the interviewed women because more than half of them (52.7%) thought that FP was only for married people (Indicator 2.14). Moreover, about 43% of the women believed that contraceptives incited adultery.
The percentage of mothers who stated a desire to wait at least two years to have another child went up from 70% at baseline, to 86% in 2014 (Indicator 2.12). Observed performances were high across regions, ranging from 75% in Boeny, to 98.5% in Diana. In the districts of Antsiranana I, Antsiranana II, Ambilobe and Antsalova, all of the interviewed mothers of CU5 stated the desire to wait at least two years before having another child or to stop childbearing (Table 25, annex D).
The proportion of pregnant women who slept under an ITN or a house sprayed with IRS in the previous night preceding the survey was low, 52.5%; compared to the percentage of pregnant women who slept under ITN observed at baseline survey, 89.3% (Indicator 2.16). The proportions ranged from 47.5% in Sofia, and 66.7% in Boeny, Melaky and Sava (Table 27, annex D). However, the proportions did not differ significantly among regions (p=0.307).
The proportion of women seen at ANC at least four times during their pregnancy with a live birth has increased, from 33.2% to 67.3% (Indicator 2.08). Proportions were high across regions compared to the last DHS results (49.3%), ranging from 56.8% in Sofia to 83.7% in Diana, exceeding the performance objective set by the MAHEFA project in 2014 (54%) [MAHEFA performance monitoring table].
A positive change was also observed with regard to the percentage of birth attended by a trained healthcare provider from 49.9% at baseline to 77.7% in 2014 (Indicator 2.10). Among all births, 49% were attended by a midwife, 25% by a doctor, and 3.7% by a nurse. As shown in table 26 (annex D), the percentages significantly differed among regions, ranging from 57.7% in Boeny, to 88% in Diana (p<0.001).
Outcome Monitoring Survey in the MAHEFA Areas - 22 -
The percentage of women receiveing two (2) tetanus toxoid shots showed an increase, from 51.3% at baseline to 67.5%, 2014 OMS, achieving the MAHEFA program performance benchmark in 2014, 62% (Indicator 2.09). The best performance was noticed in Sava, the percentage increased from 40% at baseline to 77.1% in 2014. Table 26 (annex D) presents the variability in percentage across regions and districts (p<0.01), with observed high rates in Nosy Be (89.7%), Ambanja (83.7%), Antsiranana II (78.1%), Antsiranana I (77.8%), and Vohemar (77.1%).
The MAHEFA performance benchmark (52%) was achieved with regard to the percentage of pregnant women taking iron folate during pregnancy (Indicator 2.11). However, out of the 56.2% women who state they receive iron folate supplement during their last pregnancy, only 27.2% reported they received the recommended doses of 60 days or more. The lowest percentage of women, who took iron folate during 60 days or more, was found in Sofia, 4.7%.
The proportion of women who received two (2) doses of Sulfadoxine-Pyrimethamine (SP) during pregnancy for malaria prevention has increased from 13.7% at baseline to 24.6%, 2014 OMS (Indicator 2.04). The proportions ranged from 13% in Boeny, to 48.7% in Diana (p<0.001). More than half of women interviewed in the Ambilobe district (52.3%) reported they received two (2) doses of SP during last pregnancy in the last two years. This percentage was low (0%) in Antsiranana I, Antsiranana II, Ambatomainty, and Morafenobe though (Table 27, annex D).
The results indicated a high proportion of pregnant women (90%) who know to go to CSBs for intermittent preventive treatment for malaria (Indicator 2.17). The proportions exceeded 80% across regions. However, only 16.6% of the interviewed pregnant women reported they received two doses of SP during their prior pregnancy. Adding a question to measure the percentage of pregnant women who effectively go to CSBs to seek for SP tabs would improve the OMS data collection tool.
The interviewed WRA were asked if any CHV came to visit them for health-related services prior to the survey. Approximately, 23% of the women reported they were visited by a CHV for health-related information or services.
Women satisfaction with regard to CHVs‘ quality care was assessed using scales rated from 25 to 100 (Indicator 2.06). Almost half of women (49%) who were priorly visited by CHVs at their home and who received FP products were considered satisfied with regard to CHV‘s quality care because they achieved scores over 75 (Table 25, annex D).
Outcome Monitoring Survey in the MAHEFA Areas - 23 -
6.2. TABLE 3: CARETAKER AND CHILD INDICATORS
INDICATORS MAHEFA 2012 2014 OMS Definition Baseline 3.01: % of fully immunized children 19% 41.1% Full immunization is defined as having received one dose of BCG, three doses of diphtheria/pertussis/tetanus vaccine and immunization against measles and polio before age one. Respondents were caretakers of CU12-23 months of age. Numerator n=134 Denominator N=414 3.02: % CU5 diarrhea prevalence 5.5% 10.3% Reported occurrence of diarrhea in the past two weeks preceding the survey. Denominators: CU5 Numerator n=225 Denominator N=2,134 3.03: % CU5 pneumonia prevalence 2.4% 4.4% Pneumonia was defined as caretakers‘ perceptions of a child who had a cough, was breathing faster than usual with short, quick breaths or had difficulty breathing, excluding children that had only a blocked nose (symptoms have occurred in the prior two weeks) Denominators: CU5 Numerator n=103 Denominator N=2,134 3.04: % CU5 malaria prevalence 7.7% 0.3% CU5 with fever in two weeks preceding the survey and tested RDT+ Denominators: CU5 Numerator n=8 Denominator N=2,134
Outcome Monitoring Survey in the MAHEFA Areas - 24 -
3.05: % of CU5 with fever treated by CHVs N/A 8.2% CU5 with fever and treated by CHV in the past two weeks preceding the survey. Denominators: CU5 with fever in the past two weeks Numerator n=29 Denominator N=319
3.06: % of CU5 with chest-related cough 2.9% 38.6% and fast and/or difficult breathing in the last two weeks receiving appropriate care CU5 with chest-related cough and fast and/or difficult breathing in the last two weeks Baseline : % receiving antibiotics from CHVs or healthcare reported treatments providers. by antibiotics Denominators: CU5 with cough and fast and/or difficult breathing in the past two weeks Numerator n=44 Denominator N=103 3.07: % of CU5 with diarrhea treated by N/A 5.0% CHVs CU5 with diarrhea in the last two weeks treated by CHVs Denominators: CU5 with diarrhea in the past two weeks Numerator n=11 Denominator N=229 3.08: % of CU5 with diarrhea in the past 2 19.9% 59.9% weeks who were treated with ORS and/or zinc supplement CU5 with diarrhea in the last two weeks treated by ORS and/or zinc supplements Denominators: CU5 with diarrhea in the past two weeks Numerator n=131 Denominator N=225 3.09: % of CU5 testing RDT positive, who N/A 29.6%* receive ACT CU6-59 testing RDT positive, who receive ACT Denominator: CU5 with fever in the past two Average based on very weeks and tested RDT positive limited cases (two out Numerator n=2 of eight) Denominator N=8
Outcome Monitoring Survey in the MAHEFA Areas - 25 -
3.10: % of people exposed to IEC/BCC N/A All channels : 68.2% MCH messages - Radio: 35% People who were exposed to MCH messages through: - TV: 15.5% Radio, TV, IPC with CHVs, Community health - IPC with CHVs: mobilization (events, posters, streamers, 18.7% booklets, secaline, top reseau, Commune, COSAN, Fokontany and local associations), - Community health health facilities and healthcare providers mobilization: 4.5% Respondents: All of the interviewed WRA Numerator n=1,648 Denominator N=2,529
3.11: % of people exposed to IEC/BCC N/A All channels: 69.3% Malaria messages People who were exposed to malaria messages - Radio: 36.4% through: - TV: 14.4% Radio, TV, IPC with CHVs, Community health mobilization (events, posters, streamers, - IPC with CHVs: 21% booklets, secaline, top reseau, Commune, COSAN, Fokontany and local associations), - Community health health facilities and healthcare providers mobilization: 3.3% Respondents: all of the interviewed WRA, Numerator n=1,659 Denominator N=2,529
3.12: % of people exposed to IEC/BCC N/A All channels: 27.6% Nutrition messages Radio, TV, IPC with CHVs, Community health - Radio: 6.8% mobilization (events, posters, streamers, - TV:3.3% booklets, secaline, top reseau, Commune, COSAN, Fokontany and local associations), - IPC with CHVs: 5.4% health facilities and healthcare providers Respondents: all of the interviewed WRA - Community health Numerator n=605 mobilization: 4% Denominator N=2,529
Outcome Monitoring Survey in the MAHEFA Areas - 26 -
3.13: % of CU5 who slept under an ITN the 75% 67.8% previous night or in a house sprayed with IRS in the last 12 months Children 0–59 months of age who, the previous night slept under an ITN and/or in a house sprayed with IRS in the last 12 months Bed nets were considered as ITNs if they were Long lasting insecticide treated nets (LLI) acquired in the past three years, or bed nets soaked in an insecticide product in the last 12 months.
Denominators: CU5 in the target areas Numerator n=1,427 Denominator N=2,063 Missing=125
3.14: % of newborn receiving essential care N/A 24.3% through USG-supported programs Number of newborn infants who receive essential newborn care* (clean cord care, drying and wrapping, immediate breastfeeding) Male: 0% from trained facility, outreach or community health workers through USG-supported Female: 33.3% programs
Denominators: Children 0-28 days of age Numerator n=2 Denominator N=10
* At least two among: clean cord care – drying and wrapping – immediate breastfeeding 3.15: % of CU5 with fever in last 2 weeks 0% 5.5% who received ACT treatment within 24 hours from onset of fever CU5 with fever in last 2 weeks who received ACT treatment within 24 hours from onset of fever Denominators: CU5 with fever in the past two weeks Numerator n=15 Denominator N=319
Outcome Monitoring Survey in the MAHEFA Areas - 27 -
3.16: % of caretakers of CU5 satisfied with N/A 69.8% quality of care of CHVs Satisfied clients achieved 75 or more on a standard client satisfaction questionnaire (25- 100 scales) Respondents: caretakers of CU5 receiving CHV services Numerator n=317 Denominator N=432
3.17: % of caretakers of CU5 who know two N/A 22.1% ways to prevent diarrhea Caretaker of CU5 who knows two ways* to prevent diarrhea * At least two: - Washing hands with water and soap - Using clean drinking water - Using improved sanitation Respondents: Caretakers of CU5 Numerator n=310 Denominator N=1,725 3.18: % of caretakers of CU5 who cite that 0.8% 39% diarrhea treatment with ORS and Zinc is effective Caretakers of CU5 who cited that diarrhea treatment with ORS and Zinc is effective Respondents: Caretakers of CU5 Numerator n=670 Denominator N=1725 3.19: % of caretakers of CU5 who cite cough N/A 26.3% and rapid breathing as that main symptom for ARI/Pneumonia Caretakers of CU5 who cite cough and rapid breathing as that main symptoms for ARI/Pneumonia Respondents : Caretakers of CU5 in households Numerator n=387 Denominator N=1,725
Outcome Monitoring Survey in the MAHEFA Areas - 28 -
3.20: % of caretakers of CU5 who cite that N/A 93.8% sleeping under an ITN every night prevents them from getting malaria Caretakers of CU5 who cite that sleeping under an ITN every night prevents them from getting malaria Respondents : Caretakers of CU5 in households Numerator n=1,605 Denominator N=1,725 3.21: % of children 0 - 6 months exclusively N/A 72.5% breastfed Children under 6 months exclusively breastfed within three days from delivery and in the past 24 hours (proxy) Denominators: Children under 6 months Numerator n=204 Denominator N=282 3.22: % of children 0-6 months exclusively 2008 DHS: 51% 95.9% breastfed in the past 24 hours
Children under 6 months exclusively breastfed in the past 24 hours preceding the survey. Denominators: Children 0 – 6 months Numerator n=270 Denominator N=282 3.23: % of CU2 weighted during GMP in N/A 38.6% the last 2 months
Caretaker reported that CU2 was weighted during GMP in the last two months preceding the survey. Numerator n=301 Denominator N=882 3.24: % of mother of CU1 expressing a N/A 54.4% desire to wait at least 24 months before being pregnant again
Mother of children aged less than 12 months who stated a desire to wait at least 24 months to have another child Respondents: WRA who are mothers of children aged less than 12 months Numerator n=209 Denominator N=420
Outcome Monitoring Survey in the MAHEFA Areas - 29 -
3.26: % of CU6-23 months fed according to Baseline: 0% 58.3% a minimum standard of infant and young child feeding practices
The minimum standard of infant and young child feeding practices used the 2008 DHS definition 2008 DHS: 2.7% Denominators: CU6-23 months of age Numerator n=333 Denominator N=636 3.27: % of children 6-59 months receiving 11.4% 61% vitamin A supplement during the last 6 months Children 6-59 months receiving vitamin A supplement during the last 6 months Denominators: Children 6-59 months of age Numerator n=1,136 Denominator N=1,845 3.28: % of children in the red, yellow, green N/A Red: 0.4% MUAC zones Yellow: 1.7% Children 6-59 months of age in the red, yellow, Green: 97.9% green MUAC zones as indicated by the MUAC
tapes. Cut-off points: Red: 0 – 11.5 cm Yellow: 11.5 Green: from 12.5 cm – 12.5 cm For Children 12-23 Measured children: 6-59 months of age months : Numerators: nred=14 Red: 0.3% nyellow=33 Yellow: 2.7% n =1,844 green Green: 97.0% Denominator N=1,892
3.25: % of children between 12-23 months 69.6% 44% of age who received their 3rd dose of DPT Children between 12-23 months of age who received their 3rd dose of DPT Denominators: Children 12-23 months of age. Numerator n=148 Denominator N=414
Outcome Monitoring Survey in the MAHEFA Areas - 30 -
The percentage of fully immunized children has increased compared with the MAHEFA baseline, from 19% to 41.1% (Indicator 3.01). The findings indicated a significant difference of percentage of fully immunized children among the regions, which ranged from 12.5% in Boeny, to 63.6% in Sava (p<0.001). The highest percentages of fully immunized children were observed in Ambilobe and Vohemar, 79.7% and 63.6%, respectively. However, it was found that none of the children were fully immunized in Soalala Antsohihy, and Belo Sur Tsiribihina (Table 32, annex D).
The rate of CU12-23 having received DPT3 was higher than the fully immunized children percentage but it was much lower compared to the baseline, with a significant decrease from 69.6% (2012 baseline) to 44% (2014 OMS) (Indicator 3.25). While the highest DPT3 coverage rates were observed in Sava (77.3%) and Diana (58.1%), the lowest was seen in Boeny (12.5%). The rates significantly differed across regions (p<0.001).
The CU5 diarrhea prevalence has significantly increased compared to the baseline, from 5.5% to 10.3% (Indicator 3.02). As the 2014 survey was conducted during warm season, wich was not the case for the baseline, this limits the data comparability. The proportion differed significantly among regions, ranging from 8.2% in Diana to 15.1% in Menabe (p<0.05).
The percentage of CU5 with diarrhea treated with ORS/zinc supplement went up from 19.9% to 59.9% (Indicator 3.08). The rates ranged between 40% in Boeny, and 67.9% in Diana. Most of caretakers got medicines either from a pharmacy or a clinic, and 5% received treatment from CHVs (figure 1).
The results indicated an increase of the child nutrition indicator levels. The percentage of children under six months of age exclusively breastfed in the past 24 hours was high, 92.7%
Outcome Monitoring Survey in the MAHEFA Areas - 31 -
(Indicator 3.22). It was higher than the percentage of children exclusively breastfed reported by the DHS in 2008 (51%).The proportions exceeded 85% in all regions (Table 39, annex D).
The percentage of children exclusively breastfed in the past six months reached 72.5% (Indicator 3.21) but was lower than the percentage of children under six months of age exclusively breastfed in the past 24 hours, 95.9% (Indicator 3.22). Even though the children were reported to be fed exclusively with breastmilk in the past 24 hours, almost one third of them were already given liquids other than breastmilk before, for instance at birth.
The findings also indicated an increase of CU6-23 months fed according to a minimum standard of infant and young child practices compared to the 2008 DHS, the percentage went up from 2.7% to 58.3% (Indicator 3.26). This 2014 OMS percentage is not comparable to the baseline data: (0%) for the 2012 baseline and 27% for the 2010 OMS (n=4) [OMS, 2010], which used a different variable definition. Significant differences were found between regions regarding infant and child feeding practices (Indicator 3.26). The proportions of appropriately fed children ranged from 32.6% in Sofia to 81.9% in Diana (p<0.01). However, gender difference was found in child feeding practices in Boeny (Table 28, annex D). Male children were more likely to be fed according to the minimum required standard than females: 66.7% vs 16.7% (p=0.007).
The percentage of children 6-59 months of age receiving vitamin A supplements during the last six months increased from 14.4% to 61% (Indicator 3.27). The percentages differed significantly across regions and the highest rate was found in Diana (70.5%). Receiving vitamine A during the last six months was positively associated with female gender in Sava, and Sofia (p<0.05). A difference of percentage of children receiving vitamin A supplements was also found among districts (p<0.001). The lowest rate was observed in Ambanja (29.4%) and the highest in Besalampy (90.6%).
The results indicated that the percentage of people exposed to nutrition messages was 27.6% (Indicator 3.12). This result was low compared to the percentages of people exposed to MCH (Indicator 3.10) and malaria messages (indicator 3.11), respectively 68.2% and 69.3% (Table3).
Table 3 also presents the results of the Mid-upper arm circumference measures among children 6-59 months of age (Indicator 3.28). Very few children were found in the red MUAC zone (0.4%). The majority of the children were in the green MUAC zone (97.9%).
The percentage of CU5 who slept under an ITN or in a house sprayed with IRS in the last 12 months preceding the survey was 65.9% (Indicator 3.13). Although the 2014 result is not comparable to the baseline (75.4%) which did not consider IRS, it is relatively lower. The percentages significantly differed across regions, ranging from 60.9% in Sofia to 76.4% in Sava (p<0.001). The highest percentages were seen in Antsalova and Morafenobe, respectively 100% and 90.9%; and the lowest in Besalampy and Ambanja, respectively 30.3% and 31% (Table 30, annex D). The difference of percentage was statistically significant among districts (p<0.001).
Outcome Monitoring Survey in the MAHEFA Areas - 32 -
Malaria prevalence among CU5 was only 0.3% (Indicator 3.04). Approximately, 16% of the CU5 were reported with fever in the past two weeks preceding the survey. However, only 4.2% of them were tested with RDT for malaria diagnosis. This might have underestimated the malaria prevalence.
The findings indicated that the proportion of CU5 with fever treated by CHVs (Indicator 3.05) was 8.2%. The highest percentage of CU5 with fever treated by CHVs was seen in Sofia (15.8%), and the lowest was observed in Diana (2.2%).
The proportion of CU5 testing RDT positive and receiving ACT was 29.6% in 2014 (Indicator 3.09). However, it was reported that none of the children with fever received ACT at baseline. CHV intervention is an opportunity to reinforce malaria diagnosis and treatment at community level.
The results indicated a pneumonia prevalence of 4.4% which did not significantly differ from the baseline level, 2.4% (Indicator 3.03). However, the percentage of CU5 with chest-related cough and/or difficult breathing in the last two weeks preceding the survey, and receiving appropriate care went up from 2.9% to 38.6% (Indicator 3.06). The highest proportions of CU5 with pneumonia symptoms receiving appropriate care were found in Melaky (66.7%), Menabe and Sava (50%).
The percentage of newborn receiving essential care through USG-supported programs was 24.3% (Indicator 3.14). The percentages did not differ significantly among males and females (Fisher‘s Exact Test: p=0.467)
The caretaker satisfaction rate with regard to CHV quality care was 69.8% (Indicator 3.16). The highest rate was reported in Melaky, 93.3%; and the lowest in Boeny, 56.3% (Table 40, annexD).
Outcome Monitoring Survey in the MAHEFA Areas - 33 -
TABLE 4: CHV INDICATORS
INDICATOR and MAHEFA 2012 2014 OMS Definition Baseline
4.01: % of CHVs with increased saving N/A Increased savings: 51.6% CHVs had increased savings when a rise was observed between the 2014 quarter 1 No book- account: 29.3% and quarter 2 savings. Respondents: interviewed CHVs Numerator n=115 Denominator N=200 4.02: % of CHVs with access to credit N/A 25.7% provided by COSAN savings and loans CHVs with access to credit were those who reported that they could get credit provided by COSAN. Respondents : all of the interviewed CHVs Numerator n=40 Denominator N=200 4.03: % of CHVs attending monthly N/A Attended monthly meeting: CCDS* meeting 63.7% CHVs who have not missed any in the past 12 months preceding the survey Missed once or twice: 25.6% *CCDS: Commission Communale de Développement de la Santé Missed three to five meetings: Respondents : interviewed CHVs 8% Numerator n=128 Denominator N=200 Missed eight meetings or more: 2.7%
4.04: % of CHVs that have NO stock- N/A ORS/Zinc: 57.8% (n=60) outs of selected commodities (broken Sur‘eau: 87.4% (n=176) down by commodities) ACT : 96.6% (n=190) RDT: 91.8% (n=183) CHVs who had no stock-outs of selected Pneumonia treatment: 94.4% commodities at the moment of the survey (n=185) (broken down by commodities) Contraceptive pills : 93.8% (n=187) Respondents: CHVs Injectable contraceptives: N=200 91.5% (n=180) Cycle beads: 90% (n=180) Protector plus: 53.3% (n=112)
Outcome Monitoring Survey in the MAHEFA Areas - 34 -
4.05: % of CHVs aware of LAPM N/A 57.4% service availability
CHVs aware of LAPM service availability were those who reported that IUD or Implant or sterilization is available in their community.
Respondents: CHVs n=122 N=200 4.06: % of CHVs members of N/A 16.3% microfinance group Microfinance group is a formal microcredit institute n=27 N=200 4.07: % of CHVs achieving minimum N/A 79.4% quality score for community-case management
CHVs who reported that he or she achieved 6 out of 10 or more for community-case management during the last performance test as attested on the community score-card n=152 N=200 4.08: % of CHVs receiving a passing N/A Received a passing score: score on a regular knowledge 85.6% assessment CHVs having succeeded on one regular No regular knowledge knowledge test assessment: 13.9% Numerator n=172 Denominator N=200
Outcome Monitoring Survey in the MAHEFA Areas - 35 -
4.09: % of certified CHVs by type of N/A PF4: 36.1% certification: PF4, Maternal and child Mother and Child health: health, Depo… 26.3% CHVs who reported they were certified in Depo: 29.8% PF4, child health, depo, IEC/Counselling IEC/Counseling: 14.4% or STI. STI: 4.2% Denominator: Sampled CHVs N=200 4.10: % of CHVs receiving supervision N/A 50.9% in the last 2 months
CHVs who reported that they received supervision in the last two months preceding the survey Numerator n=90 Denominator N=200 4.11: % of CHVs practicing adequate N/A 36.7% disposal of hazard materials and equipment CHVs who reported they put used syringes and needles in a special safety box and brought them to CSBs to be incinerated. Numerator n=72 Denominator N=200 ITEM % n N SYRINGES/NEEDLE Brought in safety boxes to the CSBs to be incinerated 14 23 200 Brought in safety boxes and thrown out in the recommended thorough pit to be burried 34,1 77 200 Thrown out in latrines 4,1 8 200 Thrown out in the public garbages 13,9 32 200 Other 34 60 200 WADDINGS/COMPRESSES Brought in safety boxes to the CSBs to be incinerated 4,9 9 200 Brought in safety boxes and thrown out in the recommended thorough pit to be burried 38,6 77 200 Thrown out in latrines 6,8 11 200 Thrown out in the public garbages 26,4 63 200 Other 23,3 40 200
Outcome Monitoring Survey in the MAHEFA Areas - 36 -
4.12: % of CHVs with soap and water N/A 58.1% for hand washing
CHVs with soap and water in hand for hand washing at the moment of the survey Numerator n=120 Denominator N=200 4.13: % of CHVs providing FP/RH N/A 46.9% counselling or services including STI prevention and referral FP: 39% RH: 10.1% CHVs who reported that they visited a STI: 6.5% household in the past month and provided REFERRAL: 18.2% FP/RH counseling or services including STI prevention and referral Numerator n=92 Denominator N=200
A number of 200 of CHVs were selected for interview. Almost half of them, 48.1% reported they received at least one certificate from program training with higher percentages of CHVs having PF4 and DEPO certificates (36.1% and 29.8%, respectively), compared to other CHVs trained for STI (4.2%) or IEC/Counseling (14.4%) (Indicator 4.09). The percentages of qualified CHVs across the regions ranged from 26% (Sofia) to 100% (Sava).
A proportion of 46.9% of CHVs reported that they provided FP/RH counseling or services including STI prevention and referral (Indicator 4.13). However, a very few CHVs (9.1%) reported providing those services in Sava (Table 53, annex D). Most of the interviewed CHVs provided FP services (39%), but a much lower proportion (6.5%) reported having counseled people for STI prevention (Table 4).
About 71% of CHVs had a book-account, which was used to collect data on CHV savings (Indicator 4.01). According to the CHVs‘ book-accounts, more than half of CHVs (56.1%) experienced financial growth as their savings increased from 2014 Q1 to Q2 (Table 4).
The proportions of CHVs with no stock-out of health commodities were high and exceeded 80% for oral and injectable contraceptives, malaria and pneumonia treatment products (reference of figures in table 4) (Indicator 4.04). The percentages of CHVs with no stock-out of ORS/Zinc and condom were lower though, 57.8% and 53.3%, respectively. The proportions of CHVs with no stock-out of ORS/Zinc ranged from 9.1% in Sava, to 89.2% in Boeny. A gender difference was found with regard to the proportion of CHVs with no stock out of condoms. Women were more likely to have no stock out of condoms compared to men: 60.4% vs 37.9% (p=0.028).
Outcome Monitoring Survey in the MAHEFA Areas - 37 -
More than half (57.4%) of CHVs reported that at least one long acting permanent method (LAPM) service is available in their community (Indicator 4.05). As shown in table 53, annex D, the percentages of CHVs aware of the availability of LAPM were 43.3% (Sofia), 63.6% (Sava), 64.1% (Menabe), 64.9% (Diana), 71.4% (Boeny), and 83.3% (Melaky). There were more female than male CHVs who reported that LAPM were available: 65% vs 42% (p<0.01).
Less than half of CHVs (36.7%) reported practice of adequate disposal of hazard materials and equipment (Indicator 4.11). The lowest percentages were found in Melaky and Menabe, 17.6% and 23.1%, respectively (Table 54, annex D). Even though 63.4% of CHVs reported using safety boxes for hurting hazard materials, they were thrown with other hazard materials in public garbage bins or latrines for more than one third of CHVs. Findings also indicated that women were more likely to practice adequate disposal of hazard materials than men: 44.8% vs 20.9% (p<0.01).
Outcome Monitoring Survey in the MAHEFA Areas - 38 -
5.1. TABLE 5: POINT OF SALE INDICATORS
INDICATOR MAHEFA 2012 2014 OMS Definition Baseline 5.01: Duration of stock-out in months N/A for health products during the past Viasur: 1.6 month three months Sur‘eau: 0.6 month Pneumostop: 0.4 month Average duration of stock-out in months Actipal: 0.1 month for each health product in every POS. RDT: 0.1 month Pilplan: 0.3 month N=51 Confiance: 0.5 month Cycle beads: 0.1 month Protector plus (box of 3 pieces): 0.8 month
5.02: Number of days of absence of POS N/A No day of absence: 83.8% during the last three months Percentage of POS with no day of 1-14 days of absence: 13.6% absence, one to 14 days of absence, 15 or more days of absence during the last three 15 days or more: 2.5% months Numerators No day of absence n=42 1-14 days n=8 15 days n=1 Denominator N=51 5.03 Number of CHVs re-supplying N/A 449 from the POS Number of CHVs (CHVs in the sample or not) re-supplying from the POS as reported by the salesperson or checked in the CHV list for POS. Respondents: sampled POS N=51
5.04: Number of CHVs re-supplying N/A Number Average from the POS during the last three Region of number months CHVs Number of CHVs (CHVs in the sample or Boeny 36 5.5 not) re-supplying from the POS in the past Diana 106 7.3 three months as reported by the Melaky 7 4.4 salesperson (The CHVs who are re- Menabe 57 6.6 supplying might not be in the CHV list for Sava 47 15.7 POS). Sofia 204 10.4 Respondents: sampled POS N=51 Total 457 9.19
Outcome Monitoring Survey in the MAHEFA Areas - 39 -
5.05: % of POS who received health N/A 41.6% technical training in the past year Percentage of salespersons who reported they have received health technical training in the past year Numerator n=21 Denominator N=51 5.06: % of POS who received N/A 53% management training in the past three months Percentage of salespersons who reported they received management training in the past three months Numerator n=27 Denominator N=51 5.07: % of POS who attended at least N/A 43.4% one meeting with CHVs in the past three months Percentage of salespersons who reported they attended at least one meeting with CHVs in the past three months preceding the survey Numerator n=20 Denominator N=51 5.08: % of POS regularly receiving N/A 2.2% update on list of FP/Depo certified CHV Percentage of salespersons who reported that they regularly received update on list of FP/Depo certified CHVs Numerator n=1 Denominator N=51
Outcome Monitoring Survey in the MAHEFA Areas - 40 -
5.09: % of POS with adequate health N/A 66% product storage equipment Equipment: POS with adequate health product storage - 75% with a shelf equipment were those found with a shelf - 86.3% with undamaged drug and undamaged boxes to store products; where products were not exposed to containers sunlight or humidity. Protected from sunlights: 92.1% Numerator n=35 Protected from rain water: 88.5% Denominator N=51 ITEM % n N Shelf (Talatalana) 75 41 51 Undamaged box (Baoritra tsara, tsy simba) 86,3 44 51 Protected from sunlight (Voaaro amin'ny taratry ny masoandro ny fanafody/fitaovana) 92,1 48 51 Protected from rainwater (Voaaro amin'ny orana ny fanafody) 88,5 46 51 Roof leak or a mark of roof leak (Mitete na misy faritra nitete ny tafo) 87,8 44 51 Extinguisher (Aroafo) 14,2 7 51 Products are stored by product name (voarindra ny fitoeram- panafody) 46,7 28 51 Products are stored according to the "First expired, first out" principle 43 25 51
5.10: % of POS having expired N/A Viasur: 31.3% products (breakdown by product) Zinc: 13.1% Sur‘eau: 7.7% Percentage of POS having expired Pneumostop: 0% products as observed by enumerators. Actipal: 0% RDT: 0.8% N=51 Pilplan: 0% Confiance: 0% Protector plus (box of 3 pieces): 0% 5.11: % of POS getting promotional N/A 100% items from PSI Percentage of POS getting items from PSI at lower costs than it used to be Numerator n=51 Denominator N=51
Outcome Monitoring Survey in the MAHEFA Areas - 41 -
5.12: Average monthly sales of health N/A Viasur: 33 products (breakdown by product) ORS : 44 Zinc: 32 Average monthly sales of selected Sur‘eau: 95 products during the past semester (from Pneumostop: 66 January through June 2014) by the POS Actipal: 71 RDT: 87 N=51 Pilplan: 194 cycles Confiance : 202 Cycle beads: 3 Protector plus (box of 3 pieces): 44
Data were collected from 51 POS of health commodities providing wholesale services for CHVs, and partners of PSI Madagascar. POS getting promotional item from PSI were 100% of the POS samples (Indicator 5.11).
From January through June 2014, the POS had sold greater quantity of FP products such as contraceptive pills (average sale of 194 pilplan cycles) and injections (average sale of 202 contraceptive injections per month), compared to other products, such as Viasur (33), an Sur‘eau (95) (Indicator 5.11).
The figure 3 below shows the percentages of POS having stock-outs of selected health products. It was found that more than 40% of POS experienced stock-outs of products for diarrheal and water treatment at the moment of the survey, 41.7% and 42.4% for ORS/Zinc and Sur‘eau, respectively. However, the average duration of stock-out in months for health products during the past three months did not exceed one month, except for Viasur (Table 5) (Indicator 5.01).
It was observed that 66% of POS had adequate health product storage equipment. A proportion of 75% of POS had a shelf and 86.3% of POS had undamaged drug containers to store their health products (Indicator 5.09).
Outcome Monitoring Survey in the MAHEFA Areas - 42 -
Figure 3: Percentage of POS having stock-outs of selected health commodities at the moment of the survey, MAHEFA intervention zones, 2014 OMS
Stock-out of Protector plus 29,2%
Stock-out of injectable contraceptives 5,6%
Stock-out of contraceptive pills 11,2%
Stock-out of pneumostop or… 9,9%
Stock-out of RDT 40,5%
Stock-out of ACT 16,9% 42,4% Stock-out of Sur'eau 41,7% Stock-out of ORS/Zinc or ORS 0,0% 10,0% 20,0% 30,0% 40,0% 50,0%
Outcome Monitoring Survey in the MAHEFA Areas - 43 -
ANNEX
Outcome Monitoring Survey in the MAHEFA Areas - 44 -
A. RESULTS OF THE MAIN KEY INDICATORS A.1. FAMILY PLANNING A.1.1. Modern Contraceptive Rate (MCPR) A.1.2. % of WRA reached by Behavior Change Communication (BCC) messages and Use of CHV services
Table 1: Modern contraceptive rate, WRA exposed to IEC/BCC messages from CHVs and use of modern contraceptives provided by CHVs, MAHEFA Project, 2014 OMS
INDICATOR 2.01 SUB-INDICATOR 2.03 SUB-INDICATOR 2.01
MODERN PROPORTION OF PROPORTION OF CONTRACEPTIVE WRA (15-49 y.o.) WRA (15-49 y.o.) RATE AMONG WRA EXPOSED TO USING MODERN IN UNION (%) IEC/BCC FP CONTRACEPTIVES REGION MESSAGES FROM PROVIDED BY CHVs CHVs (%) (%)
n=1686 n=2529 n=2529
BOENY 28.2% 34.0% 7.4%
DIANA 45.8% 54.0% 3.4%
MELAKY 52.7% 51.5% 9.8%
MENABE 53.3% 61.5% 8.9%
SAVA 33.6% 59.6% 7.3%
SOFIA 33.1% 36.4% 4.5%
TOTAL 41.3% 48.3% 5.3%
Outcome Monitoring Survey in the MAHEFA Areas - 45 -
Outcome Monitoring Survey in the MAHEFA Areas - 46 -
A.2. MALARIA A.2.1. % of Households with at least one ITN
Table 2: Households with at least one ITN in Northern and North western Madagascar, MAHEFA Project, 2014 OMS.
INDICATOR 1.03
HOUSEHOLDS
WITH AT REGION LEAST ONE ITN PROVIDED BY DONORS (%)
n=2391
DIANA 87.9
SAVA 87.7
SOFIA 78.3
BOENY 88
MELAKY 79.7
MENABE 80.8
TOTAL 82.9
Outcome Monitoring Survey in the MAHEFA Areas - 47 -
Outcome Monitoring Survey in the MAHEFA Areas - 48 -
WATER AND SANITATION
A.2.2. % of population able to cite the three DIORANO-WASH key Messages A.2.3. % of households that are practicing effective household water treatment A.2.4. % of population having access to Improved drinking water source A.2.5. % of population having access to improved Sanitation facilities
Table 3: Key indicators on water and sanitation by region, MAHEFA project, 2014 OMS
INDICATOR INDICATOR 1.07 INDICATOR 1.02 INDICATOR 1.01 1.40 PROPORTION OF PROPORTION PROPORTION OF PROPORTION HOUSEHOLDS OF HOUSEHOLDS
OF WHO ARE HOUSEHOLDS HAVING ACCESS HOUSEHOLDS PRACTICING WITH TO IMPROVED WHO KNOW EFFECTIVE IMPROVED SANITATION THE THREE HOUSEHOLD DRINKING MESSAGES OF WATER WATER
DIORANO – TREATMENT SOURCE (%) REGION WASH (%) (%) (%) n=2391 n=2391 n=2391 n=2391
DIANA 17.0 32.2 73.6 11.9
SAVA 25.3 39.7 61.6 2.1
SOFIA 7.5 18.3 61.9 10.7
BOENY 0.0 22.0 41.2 5.9
MELAKY 3.1 21.9 39.1 4.7
MENABE 20.8 18.7 68.2 7.9
TOTAL 13.5 24.8 65.2 9.8
Outcome Monitoring Survey in the MAHEFA Areas - 49 -
Outcome Monitoring Survey in the MAHEFA Areas - 50 -
A.3. HEALTH SYSTEM A.3.1. % of households having access to USG- supported emergency transportation system A.3.2. % of households members of Microfinance Institutions and health Mutual A.3.3. % of SDP (Service Delivery Points) that have stock-out of MCH health Products A.3.4. % of SDP with Stock-Out of Malaria health Products A.3.5. % of SDP that have Stock-Out of FP health Products A.3.6. Number of CHVs re-supplying from SDP during the last 3 months A.3.7. % of CHVs receiving supervision in the last 2 months A.3.8. % of CHV members of microfinance group
Table 4: Key indicators on emergency health transportation and financing system MAHEFA project, 2014 OMS
REGION INDICATOR 1.11 INDICATOR 1.10 HOUSEHOLD INDICATOR PROPORTION OF PROPORTION OF HOUSEHOLDS HOUSEHOLDS PROPORTION HAVING ACCESS WITH A MEMBER HOUSHOLDS WITH TO USG- OF MAHEFA’S A PERSON WHO IS SUPPORTED MUTUAL HEALTH MEMBER OF A TRANSPORTATION INSURANCE MICROFINANCE SYSTEM (%) INSTITUTE N=2391 (%)N=2391 (%)N=2391
DIANA 6.6 0.0 2.1 SAVA 2.8 0.7 4.8 SOFIA 3.3 0.1 3.3 BOENY 9.8 0.0 2.0 MELAKY 4.7 0.0 0.8 MENABE 2.3 0.0 2.9 TOTAL 4.5 0.1 2.8
Outcome Monitoring Survey in the MAHEFA Areas - 51 -
Table 5.1.A: SDP having stock-outs of selected child health products: ORS, Viasur, Zinc, Sur’eau, Pneumostop, Cotrimoxazole, Chlorhexidine, Mebendazole, MAHEFA project, 2014 OMS
REGION PROPORTION OF PROPORTION PROPORTION OF SDP HAVING OF SDP HAVING SDP HAVING STOCK-OUTS OF STOCK-OUTS OF STOCK-OUTS OF SELECTED CHILD ORS AND/OR SUR’EAU (%) HEALTH PRODUCTS ZINC (%) (ORS and/or Zinc, N=51 Sur’eau, ACT, RDT, N=51 Pneumostop, Cotrimoxazole) (%)
N=51
DIANA 63.6 54.5 63.6
SAVA 100 100 33.3
SOFIA 69.2 26.9 38.5
BOENY 100 50 0
MELAKY 0 0 0
MENABE 75 42.9 42.9
TOTAL 71.6 41.7 42.4
Outcome Monitoring Survey in the MAHEFA Areas - 52 -
Outcome Monitoring Survey in the MAHEFA Areas - 53 -
Table 5.1.B: SDP having stock-outs of selected Child Health products: Pneumonia products, MAHEFA project, 2014 OMS
REGION PROPORTION OF SDP HAVING STOCK-OUTS OF PNEUMONIA PRODUCTS (%)
N=51
DIANA 0
SAVA 0
SOFIA 19.2
BOENY 0
MELAKY 0
MENABE 0
TOTAL 9.9
Outcome Monitoring Survey in the MAHEFA Areas - 54 -
Outcome Monitoring Survey in the MAHEFA Areas - 55 -
Table 5.2: SDP having stock-outs of selected Maternal Health products: Iron folate, Mebendazole, MAHEFA project, 2014 OMS
REGION PROPORTION OF PROPORTION OF PROPORTION OF SDP HAVING SDP HAVING SDP HAVING STOCK-OUTS OF STOCK-OUTS OF STOCK-OUTS OF SELECTED IRON FOLATE (%) MEBENDAZOLE MATERNAL (%) HEALTH N=51 PRODUCTS: Iron N=51 folate, Mebendazole (%)
N=51
DIANA 54.5 45.5 54.5
SAVA 66.7 66.7 66.7
SOFIA 100 80.8 100
BOENY 100 100 66.7
MELAKY 100 100 100
MENABE 85.7 85.7 85.7
TOTAL 85.5 74.3 84.6
Outcome Monitoring Survey in the MAHEFA Areas - 56 -
Outcome Monitoring Survey in the MAHEFA Areas - 57 -
Table 6: SDP having stock-outs of Malaria products: ACTIPAL, Malaria RDT, MAHEFA Project, 2014 OMS
REGION PROPORTION PROPORTION PROPORTION OF SDP OF SDP OF SDP HAVING HAVING HAVING STOCK-OUTS STOCK-OUTS STOCK-OUTS OF MALARIA OF ACT (%) OF RDT (%) PRODUCTS: N=51 N=51 Actipal, Asaq, RDT (%)
N=51
DIANA 63.6 36.4 63.6
SAVA 66.7 0 66.7
SOFIA 38.5 11.5 30.8
BOENY 50 0 50
MELAKY 0 36.4 0
MENABE 37.5 14.3 25
TOTAL 46.2 16.9 40.5
Outcome Monitoring Survey in the MAHEFA Areas - 58 -
Outcome Monitoring Survey in the MAHEFA Areas - 59 -
Table 7: SDP having stock-outs of Family Planning products: CONFIANCE, PILPLAN, PROTECTOR PLUS, Cycle Beads, MAHEFA project, 2014 OMS
REGION % OF SDP % OF SDP % OF SDP % OF % OF HAVING HAVING HAVING SDP SDP STOCK- STOCK- STOCK- HAVING HAVING OUTS OF OUTS OF OUTS OF STOCK- STOCK- FAMILY PROTECTOR INJECTION OUTS OF OUTS OF PLANNING PLUS (%) PILLS CYCLE PRODUCTS: BEADS Pills, (%) N=51 (%) (%) injection and N=51 N=51 condoms (%) N=51 N=51
DIANA 70 45.5 9.1 0 70
SAVA 100 0 0 0 100
SOFIA 42.3 30.8 3.8 11.5 26.9
BOENY 66.7 50 0 0 50
MELAKY 100 0 0 0 100
MENABE 57.1 14.3 0 28.6 57.1
TOTAL 55.1 29.2 5.6 11.2 47.7
Outcome Monitoring Survey in the MAHEFA Areas - 60 -
Outcome Monitoring Survey in the MAHEFA Areas - 61 -
Table 8: Key indicators on CHVs, MAHEFA project, 2014 OMS
REGION 4.10. PROPORTION OF 4.06. PROPORTION OF CHVs RECEIVING CHVs WHO ARE MEMBERS SUPERVISION IN THE OF A MICROFINANCE LAST TWO MONTHS (%) GROUP (%)
N=200 N=200
DIANA 24.3 18.9
SAVA 63.6 0.0
SOFIA 71.9 23.3
BOENY 14.3 14.3
MELAKY 38.9 0.0
MENABE 35.9 10.5
TOTAL 50.7 16.6
Outcome Monitoring Survey in the MAHEFA Areas - 62 -
Outcome Monitoring Survey in the MAHEFA Areas - 63 -
REFERENCES
WHO (2014) http://www.who.int/
Institut National de la Statistique. Madagascar (2008-2009). DHS
Larsen, D.L., Attkisson, C.C., Hargreaves, W.A., and Nguyen, T.D. (1979). Assessment of client/patient satisfaction: Development of a general scale, Evaluation and Program Planning, 2, 197-207.
PENSER Madagascar (2012). MAHEFA program baseline survey
Terri Ballard & al.Household Hunger Scale: Indicator Definition and Measurement Guide. FANTA project August 2011
MAHEFA Performance Monitoring Table (File)
OMS-FANTA-II, 2010
Judge, Locke, Durham, & Kluger (1998). The Generalized Self-Efficacy or GSE
Outcome Monitoring Survey in the MAHEFA Areas - 64 -
B. ANNEX B
Table 9: Location and map of sites visited during the survey
New Team Arrival Departure Region District Commune (Surveyed) FOKONTANY (Surveyed) Census CHV Refusal CHV POS Refusal POS HH WRA MUAC 1 09-oct 12-oct BOENY MITSINJO MITSINJO MITSINJO 0 2 2 20 22 16 1 12-oct 14-oct BOENY MITSINJO MATSAKABANJA NAMAKIA 0 1 CHV sick 2 20 20 19 temporary 1 19-sept 22-sept BOENY MITSINJO KATSEPY KATSEPY 1 2 1 Closure 20 22 16 temporary 1 17-oct 19-oct BOENY MITSINJO KATSEPY SANKOANY 1 2 0 Closure 20 19 12 1 14-oct 16-oct BOENY MITSINJO ANTONGOMENA BEVARY ANTONGOMENA BEVARY 0 2 1 No POS 20 20 19 temporary 1 23-sept 27-sept BOENY SOALALA SOALALA SOALALA 0 2 1 Closure 20 20 12 CHV unavailable 1 28-sept 01-oct BOENY SOALALA ANDRANOMAVO ANDRANOMAVO 1 1 due to death 2 20 30 8 1 03-oct 05-oct BOENY SOALALA ANDRANOMAVO VILANANDRO 0 2 2 20 18 15 1 06-oct 09-oct BOENY SOALALA AMBOHIPAKY AMBOHIPAKY 0 2 1 Only 1 POS 20 19 14 1 01-oct 03-oct BOENY SOALALA ANDRANOMAVO AMBANJABE 0 1 Only 1 CHV 0 No POS 20 14 18 2 27-sept 29-sept DIANA AMBANJA MAROTOLANA MAROTOLANA 1 2 1 Only 1 POS 20 20 13 BEMANEVIKY HAUT 2 29-sept 01-oct DIANA AMBANJA BEMANEVIKA SAMBIRANO 1 2 2 20 21 11 2 19-sept 22-sept DIANA AMBANJA AMBANJA ANKATAFAHELY 1 2 2 20 18 8 2 22-oct 24-oct DIANA AMBANJA AMBANJA ANTSAHAPANO 1 2 2 20 23 15 2 25-sept 27-sept DIANA AMBANJA AMBANJA TANAMBAO MISSION 1 2 2 20 19 6 2 10-nov 11-oct DIANA NOSY BE DZAMANDZARY AMBATOLOAKA 1 2 2 20 23 9 ANTSIRAMBOZAHA HELL 2 03-oct 06-oct DIANA NOSY BE VILLE ANDAVAKOTOKO 1 1 Only 1 CHV 2 20 20 9 ANTSIRAMBOZAHA HELL 2 07-oct 09-oct DIANA NOSY BE VILLE CAMP VERT 1 1 Only 1 CHV 3 20 23 10 ANTSIRAMBOZAHA HELL 2 08-oct 10-oct DIANA NOSY BE VILLE LA BATTERIE 1 1 Only 1 CHV 1 Only 1 POS 20 22 14 2 12-oct 16-oct DIANA NOSY BE AMBATOZAVAVY AMPASIPOHY 1 2 2 20 20 10 3 22-sept 25-sept DIANA ANTSIRANANA I ANTSIRANANA I BAZARIKELY 1 1 Only 1 CHV 4 20 25 11 3 26-sept 28-sept DIANA ANTSIRANANA I ANTSIRANANA I SCAMA 1 2 0 No POS 20 20 6
Outcome Monitoring Survey in the MAHEFA Areas - 65 -
3 29-sept 01-oct DIANA ANTSIRANANA I ANTSIRANANA ATSINANANA CITE OUVRIERE 1 2 0 No POS 20 26 13 3 02-oct 03-oct DIANA ANTSIRANANA I ANTSIRANANA ATSINANANA LAZARET NORD 0 2 0 No POS 20 23 10 3 04-oct 06-oct DIANA ANTSIRANANA I ANTSIRANANA ATSINANANA PLACE KABARY 1 1 Only 1 CHV 0 No POS 20 25 5 3 12-oct 15-oct DIANA ANTSIRANANA II SADJOAVATO SADJOAVATO 1 2 2 20 20 9 3 19-oct 23-oct DIANA ANTSIRANANA II MAHAVANONA AMBILO 1 2 2 20 21 7 3 23-oct 26-oct DIANA ANTSIRANANA II JOFFREVILLE JOFFREVILLE 1 1 Only 1 CHV 1 Only 1 POS 20 19 8 3 16-oct 19-oct DIANA ANTSIRANANA II ANTSALAKA SUD ANTSALAKA 0 1 Refuse CHV 1 Only 1 POS 20 20 4 3 07-oct 11-oct DIANA ANTSIRANANA II ANIVORANO NORD AMBONDROMIFEHY 1 2 1 Only 1 POS 20 21 8 4 18-oct 22-oct DIANA AMBILOBE ANTSOHIMBONDRONA SIRAMA 0 2 2 20 22 18 4 22-oct 24-oct DIANA AMBILOBE AMPONDRALAVA AMPONDRALAVA 0 2 2 20 26 17 4 12-oct 15-oct DIANA AMBILOBE AMBILOBE ANORONALA 0 1 Only 1 CHV 1 Only 1 POS 20 21 5 4 09-oct 12-oct DIANA AMBILOBE AMBILOBE MATIAKOHO 0 2 2 20 23 19 4 15-oct 18-oct DIANA AMBILOBE AMBILOBE MATSABORILAIDAMA 0 2 0 No POS 20 15 18 4 02-oct 05-oct SAVA VOHEMAR TSARABARIA TSARABARIA 0 2 2 20 20 21 4 05-oct 08-oct SAVA VOHEMAR FANAMBANA FANAMBANA 0 2 2 20 21 14 4 21-sept 25-sept SAVA VOHEMAR ANTSIRABE NORD ANTANAMIKETRAKA 0 2 2 20 21 17 4 25-sept 28-sept SAVA VOHEMAR ANTSIRABE NORD TSARAHITRA 0 2 1 Only 1 POS 20 19 20 4 28-sept 02-oct SAVA VOHEMAR AMPANEFENA AMPANEFENA AVARATRA 0 1 Only 1 CHV 2 20 22 16 5 01-oct 04-oct MELAKY AMBATOMAINTY MAROTSIALEHA AMBAVANINARA 0 1 Only 1 CHV 0 No POS 20 17 26 5 04-oct 06-oct MELAKY AMBATOMAINTY MAROTSIALEHA BEKARARA 0 1 Only 1 CHV 1 Only 1 POS 20 22 19 5 28-sept 30-sept MELAKY AMBATOMAINTY MAROTSIALEHA MAROTSIALEHA 0 2 1 Only 1 POS 20 24 24 CHV POS 5 21-sept 25-sept MELAKY AMBATOMAINTY AMBATOMAINTY AMBATOMAINTY 0 0 unavailable 1 unavailable 20 18 20 5 25-sept 27-sept MELAKY AMBATOMAINTY SARODRANO SARODRANO 0 0 No CHV 0 No POS 20 19 21 5 06-oct 09-oct MELAKY MORAFENOBE MORAFENOBE MORAFENOBE 0 1 Only 1 CHV 1 Only 1 POS 20 23 25 5 15-oct 17-oct MELAKY MORAFENOBE BERAVINA ANDRAMOMAMORERY 0 0 No CHV 0 No POS 20 19 24 5 17-oct 20-oct MELAKY MORAFENOBE BERAVINA BERAVINA 0 0 No CHV 0 No POS 20 21 24 5 09-oct 11-oct MELAKY MORAFENOBE ANDRAMY ANDRAMY 0 0 No CHV 0 No POS 20 20 22 5 11-oct 15-oct MELAKY MORAFENOBE ANDRAMY ANTSINGILITOKA 0 0 No CHV 0 No POS 20 21 26 6 10-oct 13-oct MELAKY ANTSALOVA MASOARIVO AMBALAKAZAHA FENOARIVO 0 2 0 No POS 20 19 28 6 13-oct 15-oct MELAKY ANTSALOVA MASOARIVO BEMAMBA 0 2 0 No POS 20 17 28 6 19-oct 23-oct MELAKY ANTSALOVA BEKOPAKA AMBALAKAZAHA 1 2 0 No POS 20 21 20 6 07-oct 10-oct MELAKY ANTSALOVA ANTSALOVA ANTSALOVA CENTRE 0 2 2 19 18 14 6 16-oct 18-oct MELAKY ANTSALOVA MASOARIVO MASOARIVO 0 1 0 No POS 20 27 22 6 28-sept 30-sept MELAKY MAINTIRANO TAMBOHORANO TSARAMANDROSO 0 1 Only 1 CHV 1 Only 1 POS 20 21 16 6 21-sept 24-sept MELAKY MAINTIRANO MAINTIRANO MARODOKA 0 1 Only 1 CHV 4 20 23 18 6 25-sept 28-sept MELAKY MAINTIRANO MAINTIRANO TANAMBAO SPM 0 2 1 Only 1 POS 20 16 16
Outcome Monitoring Survey in the MAHEFA Areas - 66 -
6 04-oct 06-oct MELAKY MAINTIRANO BETANANTANANA BETANATANANA 0 2 2 18 17 16 6 01-oct 03-oct MELAKY MAINTIRANO ANDRANOVAO ANDRANOVAO 0 1 Only 1 CHV 2 20 22 19 7 13-oct 14-oct MELAKY BESALAMPY MAROVOAY SUD MAROVOAY SUD 0 2 1 Only 1 POS 19 22 18 7 16-oct 17-oct MELAKY BESALAMPY BESALAMPY BESALAMPY AMBANY 0 2 0 No POS 19 22 13 7 16-oct 17-oct MELAKY BESALAMPY BESALAMPY BESALAMPY AMBONY 0 2 1 Only 1 POS 20 22 26 7 21-oct 22-oct MELAKY BESALAMPY ANKASAKASA TSIBIRAY ANKASAKASA TSIBIRAY 1 2 0 No POS 20 20 18 7 14-oct 20-oct MELAKY BESALAMPY SOANENGA SAMBAOKOFA 1 2 0 No POS 20 23 17 BELO SUR 7 21-sept 23-sept MENABE TSIRIBIHINA TSIMAFANA TSIMAFANA 0 2 2 20 21 24 BELO SUR 7 26-sept 27-sept MENABE TSIRIBIHINA BELO SUR TSIRIBIHINA ATSIMONTSENA 0 2 2 20 22 15 BELO SUR 7 28-sept 29-sept MENABE TSIRIBIHINA BELO SUR TSIRIBIHINA AVARADROVA 0 2 2 20 31 9 BELO SUR 7 24-sept 26-sept MENABE TSIRIBIHINA ANKIROROKY BEGIDRO 0 2 1 Only 1 POS 20 20 16 BELO SUR 7 30-sept 02-oct MENABE TSIRIBIHINA BELO SUR TSIRIBIHINA ANDREFATSENA 0 2 0 No POS 20 20 15 8 02-oct 04-oct MENABE MAHABO MALAIMBANDY MALAIMBANDY 0 2 1 Only 1 POS 20 23 21 8 06-oct 08-oct MENABE MAHABO MAHABO MAHABOKELY 0 1 Only 1 CHV 1 Only 1 POS 19 19 13 8 04-oct 06-oct MENABE MAHABO ANKILIZATO ANKILIZATO AVARADRANO 0 1 Only 1 CHV 0 No POS 20 22 22 8 08-oct 10-oct MENABE MAHABO ANKILIVALO ANKILIVALO 0 2 1 Only 1 POS 20 21 17 8 11-oct 13-oct MENABE MAHABO AMPANIHY AMPANIHY 0 1 Only 1 CHV 0 No POS 20 18 14 8 19-sept 21-sept MENABE MIANDRIVAZO MIANDRIVAZO MIANDRIVAZO II 0 2 3 20 23 11 8 27-sept 29-sept MENABE MIANDRIVAZO MANAMBINA MANAMBINA 0 1 Only 1 CHV 1 Only 1 POS 20 21 13 8 22-sept 24-sept MENABE MIANDRIVAZO DABOLAVA DABOLAVA 1 2 1 Only 1 POS 20 22 20 8 29-sept 02-oct MENABE MIANDRIVAZO AMBATOLAHY AMBATOLAHY I 0 2 0 No POS 20 21 20 8 25-sept 27-sept MENABE MIANDRIVAZO ISALO ISALO 1 2 1 Only 1 POS 20 22 17
Outcome Monitoring Survey in the MAHEFA Areas - 67 -
9 27-sept 30-sept SOFIA ANALALAVA MAROVANTAZA ANDREVOREVO 1 2 2 20 22 19 9 20-sept 23-sept SOFIA ANALALAVA MAROMANDIA MAROMANDIA 1 2 2 20 19 15 9 30-sept 03-oct SOFIA ANALALAVA ANTONIBE ANTONIBE 1 2 2 20 19 16 9 23-sept 25-sept SOFIA ANALALAVA AMBALIHA AMBALIHA 1 2 2 20 22 19 9 25-sept 27-sept SOFIA ANALALAVA AMBARIJEBY MAROVATO 1 2 2 20 20 18 9 15-oct 18-oct SOFIA PORT BERGE MAROVATO BELALANDANA 1 2 2 20 22 20 9 10-oct 15-oct SOFIA PORT BERGE MAROVATO MAROVATO 1 2 2 20 23 13 9 03-oct 06-oct SOFIA PORT BERGE BORIZINY CU AMBOHIMALAZA 1 2 1 Only 1 POS 20 21 16 9 06-oct 10-oct SOFIA PORT BERGE BORIZINY CU TSARASAOTRA 1 2 1 Only 1 POS 20 21 9 9 18-oct 23-oct SOFIA PORT BERGE AMPARIHIBE AMPARIHIBE 1 2 2 20 20 16 10 20-oct 23-oct SOFIA ANTSOHIHY MAROALA AMBALAFAMINTY 1 2 2 20 25 7 10 14-oct 16-oct SOFIA ANTSOHIHY ANTSOHIHY ANKIRIRIKY SUD 1 2 1 Refuse POS 20 22 10 10 17-oct 20-oct SOFIA ANTSOHIHY ANTSOHIHY ANTAFIANTSIVAKINA 1 1 Only 1 CHV 2 20 21 11 10 10-oct 14-oct SOFIA ANTSOHIHY ANTSAHABE ANKARANKELY 1 2 2 20 22 16 10 23-oct 26-oct SOFIA ANTSOHIHY ANAHIDRANO ANAHIDRANO 0 2 2 20 22 13 10 19-sept 24-sept SOFIA BEALANANA BEALANANA BEALANANA II 1 2 2 20 20 12 10 01-oct 04-oct SOFIA BEALANANA ANALILA ANALILA 1 2 1 Only 1 POS 20 19 13 POS 10 06-oct 10-oct SOFIA BEALANANA AMBATOSIA AMBATOSIA 1 2 1 unavailable 20 19 11 10 26-sept 01-oct SOFIA BEALANANA AMBATORIA EST AMBATORIHA EST 1 2 2 20 22 11 POS 10 24-sept 26-sept SOFIA BEALANANA AMBARARATABE NORD ANTSATRANA NORD 0 2 1 unavailable 20 21 14 BEFANDRIANA 11 10-oct 12-oct SOFIA NORD MATSOANDAKANA ANTANIBE 1 1 Only 1 CHV 1 Only 1 POS 19 21 18 BEFANDRIANA 11 21-oct 23-oct SOFIA NORD MATSOANDAKANA ANTETEZANTANY 0 2 1 Only 1 POS 20 28 15 BEFANDRIANA 11 18-oct 20-oct SOFIA NORD MATSOANDAKANA BELALONA 0 2 2 20 20 14 BEFANDRIANA 11 14-oct 17-oct SOFIA NORD MATSOANDAKANA NOSIMBENDRANA 0 2 1 Only 1 POS 20 21 10
Outcome Monitoring Survey in the MAHEFA Areas - 68 -
BEFANDRIANA 11 04-oct 07-oct SOFIA NORD BEFANDRIANA AVARATRA MANONGARIVO 0 2 1 Only 1 POS 20 24 11 11 20-sept 22-sept SOFIA MANDRITSARA MANDRITSARA AMBALABE 0 2 2 20 22 8 11 26-sept 28-sept SOFIA MANDRITSARA ANTSIRABE AFOVOANY AMBALAFARIHY 0 2 1 Only 1 POS 20 24 16 11 22-sept 24-sept SOFIA MANDRITSARA ANTSIRABE AFOVOANY ANTSIRABE CENTRE 0 2 2 20 24 15 11 01-oct 04-oct SOFIA MANDRITSARA ANKIABE SALOHY ANKIABE SALOHY 0 2 2 20 21 15 11 28-sept 30-sept SOFIA MANDRITSARA AMBARIOKORANO AMBODISELY 0 1 Only 1 CHV 2 20 24 15 12 04-oct 08-oct MENABE MANJA MANJA ANDROBOTSIABO 1 2 0 No POS 20 19 25 12 01-oct 04-oct MENABE MANJA MANJA MANJA II 1 1 Only 1 CHV 1 Refuse POS 20 30 22 12 28-sept 01-oct MENABE MANJA BEHARONA BEHARONA 1 2 0 No POS 20 22 21 12 21-sept 25-sept MENABE MANJA ANKILIABO ANKILIABO 0 2 1 Only 1 POS 20 21 21 12 26-sept 28-sept MENABE MANJA ANDRANOPASY ANDRANOPASY I 1 1 Only 1 CHV 0 No POS 20 21 25 12 17-oct 20-oct MENABE MORONDAVA MORONDAVA ANDABATOARA 0 2 0 No POS 20 26 24 12 21-oct 24-oct MENABE MORONDAVA MORONDAVA AVARADROVA 0 2 0 Refuse POS 19 22 18 12 27-oct 30-oct MENABE MORONDAVA MORONDAVA NAMAHORA SUD 1 2 0 No POS 19 21 17 12 24-oct 27-oct MENABE MORONDAVA MORONDAVA TSIMAHAVAOKELY 0 2 0 Refuse POS 20 21 19 12 09-oct 12-oct MENABE MORONDAVA BEFASY BEVANTAZA 1 2 0 Refuse POS 20 22 25 TOTAL 51 200 143 2391 2559 1900
Outcome Monitoring Survey in the MAHEFA Areas - 69 -
ANNEXE C: Detailed methodologies and limitations
C.1 Design and target populations
The OMS was carried out from September 18th to October 30th 2014 in Diana, Sava, Sofia, Boeny and Melaky. A cross-sectional design was used to collect data. The survey targeted Women of Reproductive Age (WRA), caretakers of children under five years of age (CU5) dwelling in 2400 households, Community Health Volunteers (CHVs) and Point of Sales in six regions of Madagascar.
C. 2 Sampling We used the same representative samples from the list of Fokontany investigated by the previous baseline survey. A two-stage cluster sampling technique was run to select the households. Five (5) Fokontany were randomly selected within each of the 24 districts of intervention, using probability proportional to size sampling technique. After that, a systematic random sampling technique was used to select 20 households to be interviewed in each selected Fokontany. A total number of households N = 2400 (24 districts x 5 Fokontany x 20 households) was obtained. Samples from households were all caretakers of CU5 and all WRA including pregnant women in each selected household. Two (2) Community Health Volunteers (CHVs) and (1) Point of Sales (POS) providers that covered the selected Fokontany were also selected. Besides, data on household environment that are related to the surveyed outcomes were collected (examples: ITN or Insecticide treated Nets, sanitation facilities, CHVs performances). Additional information on household socio-economic characteristics, on the sampled Commune and Fokontany were also gathered.
C.3 Sample size, participation rate and population characteristics Final sample sizes were HHs=2391, WRA=2529, CHVs=200, POS=51
C.4 Variables We measured levels of the following indicators. The tables below present each indicator reference with regard to data collection tools, definitions and details of calculation methods. Data were entered using computer tablets and the analysis was performed using the STATA software. The Pearson khi-2 test, or if applicable, the Fisher‘s exact test was run in order to compare percentages. The significance level at 5% was considered for p-values.
Outcome Monitoring Survey in the MAHEFA Areas - 70 -
Table 10: Household indicators
N° HOUSEHOLD INDICATORS Question number 1.01 % of houeholds using improved sanitation 114-115- 116 1.02 % of households with improved drinking water source 101 1.03 % of households with at least one ITN provided by USAID 139-139A, 140-141 1.04 % of houses sprayed with IRS in the last 12 months 145A 1.05 % of households with soap and water at hand washing station 146- commonly used by family members 147A,C,D 1.06 % of households practicing open defecation 114 1.07 % of households that are practicing effective household water 105-106 treatment 1.08 % of household head reporting increased agreement with the concept 827 that males and females should have equal access to social, economic, and political opportunities 1.09 % of households practicing correct use of recommended water 106A A-N treatment technologies 1.10 % of households covered by USG-supported community health 133, 133A financing arrangement to C 134, 134A to C 1.11 % of households having access to USG-supported emergency 149BC transportation system 150BC 1.12 % of households having used USG-supported emergency 149E,F transportation system 150E 1.13 % of households visited by CHVs for health-related IPC in the past 3 833D, G, H months 1.40 % of households who know the three message of DIORANO WASH 100-100A 1.15 % of households having a cellphone 117 1.16 % of households willing to participate in a phone interview 117A 1.17 % of households having access to electricity at home 117 1.18 % of households with moderate or severe hunger 828-830A
Outcome Monitoring Survey in the MAHEFA Areas - 71 -
Table 11: WRA indicators
N° WRA INDICATORS Question number 2.01 Modern contraceptive Rate 302, 303A to 303O 2.02 % of women with unmet FP need 301, 301A, 301B 304A, 304B, 831 832 2.03 % of women exposed to IEC/BCC FP message 300A ,300B 2.04 % of women who received 2 doses of SP for IPTp during last 304M, pregnancy within the last two years 304N, 304O 2.05 % of WRA seeking counseling or treatment from CHVs for FP/RH 301C, 304, 300,833H 2.06 % of WRA satisfied of CHVs' quality care 834
2.07 % of females who report increased self-efficacy at the conclusion of 833 USG-supported training 2.08 % of women seen at ANC at least 4 times during their pregnancy 304C, 304D with a live birth 2.09 % of women who receive two tetanus toxoid shot (or equivalent) 304E during their last pregnancy ,304F,G,H,I 2.10 % of birth attended by a doctor, nurse, or trained midwife 304P 2.11 % of women who state they received iron folate supplement during 304J, 304K their last pregnancy 2.12 % of mother and children aged less than 12 months who stated a 304P1, desire to wait at least 24 months to have another children 304Q 2.13 % of WRA who reported increased self-efficacy at the conclusion of 833 an USG-supported training 2.14 % of women reporting no myths or misconceptions regarding modern 301H FP methods % of WRA who perceive that their partner support them to use 301G modern contraceptives 2.16 % of women who slept under ITN the previous night or in a house 139, 138A, sprayed with IRS in the last 12 months 142, 145A, 204A 2.17 % of pregnant women who know to go to CSB to receive two doses 301D of ItPt during pregnancy
Outcome Monitoring Survey in the MAHEFA Areas - 72 -
Table 12: Indicators related to Caretaker of children N° INDICATORS RELATED TO CARETAKER OF CHILDREN Question number 3.01 % of children fully immunized 506A 3.02 CU5 diarrhea prevalence 518A 3.03 CU5 pneumonia prevalence 535 3.04 CU5 malaria prevalence 533A, 537A 3.05 % of CU5 with fever treated by CHVs 523A 3.06 % of CU5 with chest-related cough and fast and/or difficult breathing 306B in the last 2 weeks receiving appropriate care 3.07 % of CU5 with diarrhea treated by CHVs 523A 3.08 % of CU5 with diarrhea in the past 2 weeks who were treated with 518A, 528- ORS and/or zinc supplement 530 3.09 % of CU5 testing RDT positive, who receive ACT 537A,B,C 3.10 % of people exposed to IEC/BCC MCH messages 107C,D 3.11 % of people exposed to IEC/BCC Malaria messages 107E,F 3.12 % of people exposed to IEC/BCC Nutrition messages 107G,H 3.13 % of CU5 who slept under ITN the previous night or in house 517A sprayed with IRS in the last 12 months 3.14 % of newborn receiving essential care through USG-supported 464A programs 3.15 % of CU5 with fever in last 2 weeks who received ACT treatment 537,D within 24 hours from onset of fever 3.16 % of caretaker of CU5 satisfied with quality of care of CHV 834A 3.17 % of caretaker of CU5 who know two ways to prevent diarrhea 530B 3.18 % of caretaker of CU5 who cite that diarrhea treatment with ORS and 530A Zinc is effective 3.19 % of caretaker of CU5 who cite cough and rapid breathing as that 530E main symptoms for ARI/Pneumonia 3.20 % of caretaker of CU5 who cite that sleeping under an ITN every 530D night prevents them from getting malaria 3.21 % of children 0 - 6 months exclusively breastfed for 6 months 463, 468, 471 3.22 % of children 0-6 months exclusively breastfed in past 24 hours 467, 471 3.23 % of CU2 weighted during GMP in the last 2 months 835-836 3.24 % of mother of CU1 expressing a desire to wait at least 24 months 304P,Q before being pregnant again 3.25 % of children between 12-23 months of age who received their 3rd 506A dose of DPT 3.26 % of CU6-23 months fed according to a minimum standard of infant 602 and young child feeding practices 3.27 % of children 6-59 months receiving vitamin A supplement during 515 the last 6 months 3.28 % of children in the red, yellow, green MUAC zones 537E
Outcome Monitoring Survey in the MAHEFA Areas - 73 -
Table 13: Indicators related to individual CHV
N° CHV INDICATORS Question number 4.01 % of CHVs with increased saving 1015 4.02 % of CHVs with access to credit provided by COSAN savings and 1016 loans 4.03 % of CHVs attending monthly CCDS meeting 1014 4.04 % of CHVs that have no stock-outs of selected commodities (broken 1011 down by commodities) 4.05 % of CHVs aware of LAPM service availability 1012 4.06 % of CHVs members of microfinance group 1017 4.07 % of CHVs achieving minimum quality score for community-case 1007, 1008 management 4.08 % of CHVs receiving a passing score on a regular knowledge 1005, 1006 assessment 4.09 % of certified CHVs by type of certification: PF4, IMCI, Depo… 1003-1009 4.10 % of CHVs receiving supervision in the last 2 months 1013 4.11 % of CHVs practicing adequate disposal of hazard materials and 1010 equipment 4.12 % of CHVs with soap and water for hand washing 1009 4.13 % of CHVs providing FP/RH counseling or services including STI 1001B, prevention and referral 1002
Table 14: POS indicators
5.01 Duration of stock-out in months for health products during the past 3 1058 months 5.02 Number of days of absence of POS during last 3 months 1060 5.03 Total number of CHVs re-supplying from the POS 1062 5.04 Number of CHVs re-supplying from the POS during the last 3 1063 months 5.05 % of POS who received health technical training in the past year 1054 5.06 % of POS who received management training in the past 3 months 1053 5.07 % of POS who attended at least one meeting with CHVs in the past 1066 three months 5.08 % of POS regularly receiving update on list of FP/Depo certified 1063A CHV 5.09 % of POS with adequate health product storage equipment 1056 5.10 % of POS having expired products (breakdown by product) 1058 5.11 % of POS getting promotional items from PSI 1052 5.12 Average monthly sales of health products (breakdown by product) 1051
Outcome Monitoring Survey in the MAHEFA Areas - 74 -
Table 15 – Indicators related to HHs
1.01 % of HHs using improved sanitation Def : Improved sanitation facilities with sewer connections, septic system connections, pour-flush latrines, ventilated improved pit latrines (VIPs), composting toilets and pit latrines with a slab or covered pit. Using public or shared sanitation facilities was not considered as having improved sanitation.
Calc : Number of HH with improved sanitation x 100/Total number of observed HH
1.02 % of HHs with improved drinking water source Def : Improved drinking water sources are HH connection; public standpipe; borehole; protected dug well; protected spring; and rainwater collection. On premises piped drinking water connections – running water in dwelling, yard or plot. Calc : Number of HH with improved drinking water source x 100/Total number of observed HH
1.03 % of HHs with at least one ITN Def : Bed nets that are treated with insecticides
Calc : Number of HHs with at least one ITN x 100/Total number of observed HH
1.04 % of houses sprayed with Indoor Residual Spraying in the last 12 months Def : Homes and barns that are sprayed with insecticides in the last 12 months
Calc : Number of houses sprayed with IRS in the last 12 months x 100/Total number of observed houses
1.05 % of HHs with soap and water at hand washing station commonly used by family members Calc : Number of HHs with soap and water at hand washing station commonly used by family members x 100/Total number of observed HHs
Non-functional tap waters were computed as absence of water
Outcome Monitoring Survey in the MAHEFA Areas - 75 -
1.06 % of HHs practicing open defecation Def : HHs reporting open defecation
Calc : Number of HHs practicing open defecation x 100/Total number of observed HHs
1.07 % of HHs that are practicing effective HH water treatment Def : Effective HH water treatment includes: chemical disinfection, solar disinfection, filtration, combined flocculation/chlorination systems and boiling
Calc : Number of HHs that are practicing effective HH water treatment x 100/Total number of observed HHs
1.08 % of HHs head reporting increased agreement with the concept that males and females should have equal access to social, economic, and political opportunities Def : A test using a Likert 5 point scale was run. The HH head should be tested again and at the end of the program. Obtained scores are to be compared
Respondents were asked: ―To what extent do you agree or disagree with the following three statements?‖ (Based on a 5 pt scale: strongly disagree, disagree, neither agree nor disagree, agree and strongly agree). To score the opportunity measure, responses are coded as follows: -2 = Strongly Disagree, -1 = Disagree, 0 = Neither Agree nor Disagree, +1 = Agree, +2 = Strongly Agree. Statements: • Women should have equal rights with men and receive the same treatment as men do. • On the whole, men make better political leaders than women and should be elected rather than women. (r) • When jobs are scarce, men should have more right to a job than women. (r) The items with an (r) would be reverse-scored. In other words, those items followed by an ―r‖ that have a score of -2 will be recoded as a score of +2, -1 as +1, +1 as -1 and +2 as -2. Responses on each item will be added. A higher score indicates greater agreement that men and women should have equal opportunities for household head or more positive feeling of self-efficacy for WRA. The number of persons in the target group whose scores have increased across time and the denominator is the total number of participants in the relevant training/programming.
Calc : Number of persons whose scores on the equal opportunity survey have increased over time x 100/Total number of persons who participated in the program/training
Outcome Monitoring Survey in the MAHEFA Areas - 76 -
1.09 % of HHs practicing correct use of recommended water treatment technologies Def : Correct use includes correct treatment, storage and use Correct treatments: boiling, covering or transferring it in a clean recipient OR using sur‘eau : not expired product, appropriate dosage as indicated by the manufaturer, 30mn pause, covering OR ceramic filtration OR using 1% chlorine: appropriate dosage, 30 mn pause, covering* OR solar disinfection*
Calc : Number of HHs practicing correct use of recommended water treatment technologies x 100/Total number of observed HHs
*WHO: www.who.int/water_sanitation_health/
1.10 % of HHs covered by USG-supported community health financing arrangement Def : Number of HHs covered by MAHEFA health insurance or subsidies (to avoid double counting, HHs receiving both insurance and subsidies are to be counted only once) Calc : Number of HHs covered by MAHEFA community health financing arrangement x 100/ Total number of observed HHs
1.11 % of HHs having access to USG-supported emergency transportation system Def : Access to MAHEFA‘s emergency transportation
Calc : Number of HHs who know that MAHEFA has transportation system available for pregnant women and CU5x 100/ Total number of observed HHs
1.12 % of HHs having used USG-supported emergency transportation system Def : HHs where one or more members used MAHEFA‘s emergency transportation system
Calc : Number of HHs having used MAHEFA‘s transportation system x 100/ Total number of observed HHs
1.13 % of HHs visited by CHVs for health-related interpersonal communication (IPC) in the past 3 months Calc : Number of HHs visited by CHVs for health-related IPC in the past 3 months x 100/ Total number of observed HHs
Outcome Monitoring Survey in the MAHEFA Areas - 77 -
1.14 % of HHs who know the three message of DIORANO WASH Def : The three messages are: Wash your hands with soap / Use hygienic latrines / Transport and store water safely
Calc : Number of HHs who know the three message of DIORANO WASH x 100/ Total number of observed HHs
1.15 % of HHs having a cellphone Calc : Number of HHs having a cellphone x 100/ Total number of observed HHs
1.16 % of HHs willing to participate in a phone interview Calc : Number of HHs willing to participate in a phone interview x 100/ Total number of observed HHs
1.17 % of HHs having access to electricity at home Calc : Number of HHs having access to electricity at home x 100/ Total number of observed HHs
1.18 % of HHs with moderate or severe hunger Def : Use of the HH hunger scale2
The responses to each frequency-of-occurrence question were recoded from three frequency categories (―rarely,‖ ―sometimes,‖ ―often‖) into two frequency categories (―rarely or sometimes‖and ―often‖). Then, for each of the new variables created, a frequency response of ―rarely‖ (originally coded as ―1‖) was coded as ―1‖; a frequency response of ―sometimes‖ (originally coded as ―2‖) was coded as ―1‖; and a frequency response of ―often‖ (originally coded as ―3‖) was coded as ―2‖. After that, code of ―0‖ was added for households that replied ―No‖ to each corresponding occurrence question. Once this step has been completed, all households had a value of 0, 1, or 2. The values of the responses were then summed for each household to calculate the HHS score. Each household had an HHS score between 0 and 6. These values were then used to generate the HHS indicators. A score of 0–1 meant ―Little to no hunger in the household‖, 2-3 meant ―Moderate hunger‖ and 4-6 meant ―Severe hunger‖i. HHs getting scores ranging from 2 to 6 were considered to be with moderate or severe hunger
Calc : Number of HHs with moderate or severe hunger x 100/Total number of HHs
2 Terri Ballard & al.Household Hunger Scale: Indicator Definition and Measurement Guide. FANTA project August 2011
Outcome Monitoring Survey in the MAHEFA Areas - 78 -
Table 16 – Indicators related to Woman of Reproductive Age
2.01 Modern prevalence contraceptive Rate Def : WRA in union using modern contraceptives including cycle beads (other traditional methods were excluded)
Calc : Number of women in union of reproductive age currently using a modern method of contraception x 100/Total number of women of reproductive age in union
2.02 % of women with unmet FP need Def : Women (married or in a union) who are not using contraception, are fecund, and desire to either stop childbearing or postpone their next birth for at least two years; pregnant women whose current pregnancy was unwanted or mistimed; women in post- partum amenorrhea who are not using contraception and, at the time they became pregnant, had wanted to delay or prevent the pregnancy
Calc : Number of women (married or in a union) who have unmet FP need for spacing and limiting birth* x 100/Total number of women of reproductive age (15-49) who are married or in a union *The WHO flow chart below (Figure 4) was used to determine the unmet need for spacing and unmet need for limiting
2.03 % of women exposed to IEC/BCC FP message Def : Women who affirm that they have heard IEC/BCC FP messages from CHVs, health care providers, mass media or other event
Calc : Number of women exposed to IEC/BCC FP message x 100/Total number of WRA
2.04 % of women who received 2 doses of SP for IPTp during last pregnancy within the last two years Calc : Number of women who received 2 doses of SP for IPTp during last pregnancy within the last two years x 100/Total number of woman who have been pregnant within the last two years
2.05 % of WRA seeking counselling or treatment from CHVs for FP/RH Calc : Number of WRA seeking counselling or treatment from CHVs for FP/RH x 100/Total number of WRA
Outcome Monitoring Survey in the MAHEFA Areas - 79 -
2.06 % of WRA satisfied of CHVs' quality care Def : Use of the standard Client Satisfaction Questionnaire (Attkisson, 2004) For the client satisfaction indicator, obtained scores on each response were summed. Then, the results were multiplied by 3.125 in order to have a score distribution between 25 and100. Higher score meant more satisfaction. Participants who rated high scores between 75 and 100 were considered satisfied [Larsen et al., 1979].. Calc : Number of WRA satisfied of CHVs' quality care x 100/Total number of WRA
2.07 % of WRA who reported increased self-efficacy at the conclusion of an USG-supported training Def : Data are collected at baseline and the end of the program. The measure that will be used is the Generalized Self-Efficacy or GSE (Judge, Locke, Durham, &Kluger, 1998)
Calc : Number of WRA whose scores have improved over time x 100/ Total number of WRA who participated in the programming
2.08 % of women seen at ANC at least 4 times during their pregnancy with a live birth Calc : Number of women aged 15 to 49 with live births who ANC four or more times during most recent pregnancy x 100 / Total number of women with live births for their last pregnancy (Pregnancy in the past 2 years)
2.09 % of women who receive two tetanus toxoid shot (or equivalent) during their last pregnancy Def : 2nd TT + 3rd TT + 4th TT + 5th TT
Calc : Number of women who receive two tetanus toxoid shot (or equivalent) during their last pregnancy x 100/ Total number of women with live birth for their last pregnancy in the past 5 years
2.10 % of birth attended by a doctor, nurse, or trained midwife Calc : Number of births attended by a doctor, nurse, or trained midwife during last pregnancy x 100/number of live births for their last pregnancy in the past 2 years
2.11 % of women who state they received iron folate supplement during their last pregnancy Calc : Number of women who state they received iron folate supplement during their last pregnancy x 100/Total number of women who have been pregnant (pregnancy in the past 2 years)
Outcome Monitoring Survey in the MAHEFA Areas - 80 -
2.12 % of mother of children aged less than 12 months who stated a desire to wait at least 24 months to have another children Calc : Number of mother of children aged less than 12 months who stated a desire to wait at least 24 months to have another children x 100/ Total number of mothers of children aged less than 12 months
2.13 % of WRA who reported increased self-efficacy at the conclusion of an USG-supported training Def : Data are collected at baseline and the end of the program. The measure that will be used is the Generalized Self-Efficacy or GSE (Judge, Locke, Durham, &Kluger, 1998)
Calc : Number of WRA whose scores have improved over time x 100/ Total number of WRA who participated in the programming
2.14 % of women reporting no myths or misconceptions regarding modern FP methods Def : Use of scales
Calc : Number of women reporting no myths or misconceptions regarding modern FP methods x 100/Total number of women
2.15 % of WRA who perceive that their partner support them to use modern contraceptives Def: WRA who stated that their partner support them to use modern contraceptives
Calc: Number of women who stated that their partner support them to use modern contraceptives x100/Total number of women with at least one sexual partner (in union or not)
2.16 % of pregnant women who slept under ITN the previous night or in a house sprayed with IRS in the last 12 months Calc : Number of pregnant women who slept under ITN the previous night or in a house sprayed with IRS in the last 12 months x 100/Total number of pregnant women
2.17 % of pregnant women who know to go to CSB to receive two doses of IPTp during pregnancy Calc : Number of pregnant women who know to go to CSB to receive two doses of IPTp during pregnancy x 100/ Total number of pregnant
Outcome Monitoring Survey in the MAHEFA Areas - 81 -
Table 17– Indicators related to Caretaker or Mother of child
3.01 % of children fully immunized Def : Full immunization is defined as having received 1 dose of BCG, three doses of diphtheria/pertussis/tetanus vaccine and immunization against measles and polio before age 1 Calc : Number of children fully immunized x 100/Total number of CU1
3.02 CU5 diarrhea prevalence Def : Diarrhea in the prior two weeks
Calc : Children 0–59 months of age who had diarrhea in the prior 2 weeks x 100/ Total population of children0–59 months of age
3.03 CU5 pneumonia prevalence Def : Pneumonia in the prior two weeks
Calc : Children 0–59 months of age who had pneumonia in the prior 2 weeks x 100/ Total population of children 0–59 months
3.04 CU5 malaria prevalence Def : Fever in the two weeks preceding the survey is used as a proxy
Calc : Children 0–59 months with fever in the two weeks preceding the survey x 100/ Total population of children 0–59 months
Breakdown into: Children 6–59 months of age with fever in the two weeks preceding the survey x 100/ Total population of children 6–59 months of age
3.05 % of CU5 with fever treated by CHVs Calc : Children 6–59 months of age with fever in the two weeks preceding the survey and treated by CHVs x 100/ Children 6–59 months of age with fever in the two weeks preceding the survey
3.06 % of CU5 with chest-related cough and fast and/or difficult breathing in the last 2 weeks receiving appropriate care Calc : Children 0–59 months with chest-related cough and fast and/or difficult breathing in the last 2 weeks and treated by CHVs x 100/ Total population of children 0–59 months with chest-related cough and fast and/or difficult breathing in the last 2 weeks
Outcome Monitoring Survey in the MAHEFA Areas - 82 -
3.07 %of CU5 with diarrhea treated by CHVs Calc : Children 0–59 months of age with diarrhea in the last 2 weeks and treated by CHVs x 100/ Total population of children 0–59 months of age with diarrhea the last 2 weeks
3.08 %of CU5 with diarrhea in the past 2 weeks who were treated with ORS and/or zinc supplement
Calc: Children 0–59 months of age with diarrhea in the last 2 weeks and treated ORS and/or zinc supplement x 100/ Total population of children 0–59 months of age with diarrhea the last 2 weeks 3.09 % of CU5 testing RDT positive, who receive ACT Calc : Children 6–59 months of age testing RDT positive in the past 2 weeks and received ACT x 100/ Children 6–59 months of age with fever in the past 2 weeks
3.10 % of people exposed to IEC/BCC MCH messages Def : Exposed to MCH messages through: Mass media / IPC / Community health mobilization
Calc : People exposed to IEC/BCC MCH messages x 100/ Total population
3.11 % of people exposed to IEC/BCC Malaria messages Def : Exposed to malaria messages through: Mass media / IPC / Community health mobilization
Calc : People exposed to IEC/BCC malaria messages x 100/ Total population
3.12 % of people exposed to IEC/BCC Nutrition messages Def : Exposed to nutrition messages through: Mass media / IPC / Community health mobilization
Calc : People exposed to IEC/BCC nutrition messages x 100/ Total population
3.13 % of CU5 who slept under ITN the previous night or in house sprayed with IRS in the last 12 months Def : Children 0–59 months of age who, the previous night: Slept under ITN and/or in a house sprayed with IRS the last 12months
Calc : Children 0–59 months of age who slept under ITN the previous night or in house sprayed with IRS in the last 12 months x 100/Total population of Children 0–59 months of age
Outcome Monitoring Survey in the MAHEFA Areas - 83 -
3.14 % of newborn receiving essential care through USG-supported programs Def : Number of newborn infants who receive essential newborn care* (clean cord care, drying and wrapping, immediate breastfeeding) from trained facility, outreach or community health workers through USG-supported programs* At least two
Clean cord care = cutting newborn umbilical cord with new or boiled scissors/blade AND tiding it with a new or boiled twine AND putting nothing or at most chlorhexidine ointment on the cord Drying = drying the newborn whole body with a cloth Wrapping = wrapping the newborn with a dry cloth Immediate breastfeeding = breastfeeding the newborn within an hour from delivery † Facility healthcare providers who were trained or not by an USG-supported program †† CHVs of USG-supported programs Calc : Newborn receiving essential care through USG-supported programs x 100/ Total population of newborn (0-31days)
3.15 % of CU5 with fever in last 2 weeks who received ACT treatment within 24 hours from onset of fever Calc : Children 6–59 months of age with fever in last 2 weeks who received ACT treatment within 24 hours from onset of fever x 100/ Children 6–59 months of age with fever in last 2 weeks
3.16 % of caretaker of CU5 satisfied with quality of care of CHV Def : Client satisfaction questionnaire Calc : Caretaker of CU5 satisfied with quality of care of CHV x 100/ Total number of interviewed caretakers
3.17 % of caretaker of CU5 who know two ways to prevent diarrhea Calc : Caretaker of CU5 who knows two ways to prevent diarrhea x 100/ Total number of interviewed caretakers
3.18 % of caretaker of CU5 who cite that diarrhea treatment with ORS and Zinc is effective Calc : Number of caretakers of CU5 who cite that diarrhea treatment with ORS and Zinc is effective x 100/ Total number of interviewed caretakers
Outcome Monitoring Survey in the MAHEFA Areas - 84 -
3.19 % of caretaker of CU5 who cites cough and rapid breathing as that main symptoms for ARI/Pneumonia Calc : Number of caretakers of CU5 who cite cough and rapid breathing as that main symptoms for ARI/Pneumonia x 100/ Total number of interviewed caretakers
MM : Interview of caretaker with Questionnaire
3.20 % of caretaker of CU5 who cites that sleeping under an ITN every night prevents them from getting malaria Calc : Number of caretakers of CU5 who cite that sleeping under an ITN every night prevents them
from getting malaria x 100/ Total number of interviewed caretakers
MM : Interview of caretaker with Questionnaire
3.21 % of children 0 - 6 months exclusively breastfed for 6 months Calc : Children 0 - 6 months exclusively breastfed since birth x 100/ Total population of children 0 - 6 months
3.22 % of children 0-6 months exclusively breastfed in past 24 hours Calc : Children 0 - 6 months exclusively breastfed in past 24 hours x 100/ Total population of children 0 - 6 months
3.23 % of CU2 weighted during GMP in the last 2 months Calc : CU2 weighted during GMP in the last 2 months x 100/ Total population of children under 2
3.24 % of mother of CU1 expressing a desire to wait at least 24 months before being pregnant again Calc : Mother of CU1 expressing a desire to wait at least 24 months before being pregnant again x 100/Total population of mother of CU1
3.25 % of children between 12-23 months of age who received their 3rd dose of DPT Calc : Children between 12-23 months who received their 3rd dose of DPT x 100/Total population of children between 12-23 month
Outcome Monitoring Survey in the MAHEFA Areas - 85 -
3.26 % of CU6-23 months fed according to a minimum standard of infant and young child feeding practices Definition: Def: : CU6-23 months fed according to a minimum standard of infant and young child feeding practices if they are breastfed or if not breastfed, they receive milk (other than breast milk), including commercial preparations for infants/children, animal fresh milk (canned or powdered), cheese, yoghurts or other dairy products. AND they are fed with at least the minimum number of food groups, at an appropriate frequency according to their age:
- At least three (3) groups of foods for breastfed children and four (4) groups of foods for non-breastfed children - At least twice a day for the CU6-8 months of age and at least three (3) times a day for the CU9-23 months of age.
AND they are fed with solid or semi-solid foods, at least twice a day for the CU6-8 months of age, at least three (3) times a day for the other breastfed children, and at least four (4) times a day for the non-breastfed children. Groups of food are : I- Preparations for infants and children, milk other than breast milk, cheese, yoghurt and other dairy products; II-Préparations of cereals, roots and tubercules, including oat porridges or other food preparation with cereals; III.- Fruits and vegetables rich in vitamine A (and red palm oil); IV- Other fruits and vegetables; V- Eggs; VI- Meat, chicken, fish, shells (and giblets); VII Dryed grains and nuts; VIII. Preparations with oil, oil fat or butter. Calc: Children between 6-23 months of age fed according to a minimum standard of infant and young child feeding practices x 100/Total population of children between 6-23 months
3.27 % of children 6-59 months receiving vitamin A supplement during the last 6 months Calc : Children 6-59 months receiving vitamin A supplement during the last 6 months x 100/ Total of children between 6-59 months
3.28 % of children in the red, yellow, green MUAC zones Calc : Children between 6-59 months of age in the red, yellow, green MUAC zones x 100/ Total of children between 6-59 months
Children between 12-23 months of age in the red, yellow, green MUAC zones x 100/ Total of children between 12-23 months
MM : Measure left mid-upper arm circumference using the 2009 version of MUAC tape
Outcome Monitoring Survey in the MAHEFA Areas - 86 -
Table 18– Indicator related to Individual CHV
4.01 % of CHVs with increased saving Def : Compare CHVs over time savings
Calc : Number CHVs with increased savings x 100/Number of interviewed CHVs
4.02 % of CHVs with access to credit provided by COSAN savings and loans Def : CHV that are given the opportunities and can easily get credit provided by COSAN savings and loans
Calc : Number of CHVs with access to credit provided by COSAN savings and loans x 100/ Number of interviewed CHVs
4.03 % of CHVs attending monthly CCDS meeting Def : CHVs attending monthly CCDS meeting in the past year (CCDS : commission communale de développement de la santé)
Calc : Number of CHVs attending monthly CCDS meeting in the past year x 100/Number of interviewed CHVs
4.04 % of CHVs that have no stock-outs of selected commodities (broken down by commodities) Def : CHVs that have no stock-outs of selected commodities at the moment of the survey (broken down by commodities)
Calc : Number of CHVs that have no stock-outs of selected commodities at the moment of the survey x 100/ Number of interviewed CHVs
4.05 % of CHVs aware of LAPM service availability Def : CHVs aware of LAPM (long acting and permanent method)service availability
Calc : Number of CHVs aware of LAPM service availability x 100/ Number of interviewed CHVs
4.06 % of CHVs members of microfinance group Calc : Number of CHVs members of microfinance group x 100/ Number of interviewed CHVs
MM : Interview of CHVs
Outcome Monitoring Survey in the MAHEFA Areas - 87 -
4.07 % of CHVs achieving minimum quality score for community-case management Def : CHVs achieving minimum quality score for community-case management during the last performance tests
Calc : Number of CHVs achieving minimum quality score for community-case management x 100/Number of tested CHVs
4.08 % of CHVs receiving a passing score on a regular knowledge assessment Calc : Number of CHVs receiving a passing score on one regular knowledge assessment x 100/Number of CHVs having done the knowledge test
4.09 % of certified CHVs by type of certification: PF4, IMCI, Depo… Calc : Number of certified CHVs by type of certification: PF4, IMCI, Depo…x100/Number of interviewed CHVs
4.10 % of CHVs receiving supervision in the last 2 months Def : CHVs receiving supervision in the last 2 months
Calc : Number of CHVs receiving supervision in the last 2 months x 100/ Number of interviewed CHVs
4.11 % of CHVs practicing adequate disposal of hazard materials and equipment Def : CHVs practicing adequate disposal of hazard materials and equipment at the moment of the survey
Calc : Number of CHVs practicing adequate disposal of hazard materials and equipment x 100/ Number of CHVs in action
4.12 % of CHVs with soap and water for hand washing Def : CHVs with soap and water in hand for hand washing at the moment of the survey
Calc : Number of CHVs with soap and water for hand washing at the moment of the survey x 100/ Number of CHVs in action
4.13 % of CHVs providing FP/RH counseling or services including STI prevention and referral Def : CHVs providing FP/RH counseling or services including STI prevention and referral during the survey
Calc : Number of CHVs providing FP/RH counseling or services including STI prevention and referral during the survey x 100/ Number of CHVs in action
Outcome Monitoring Survey in the MAHEFA Areas - 88 -
Table 19 – Indicators related to Individual Point of Sales
5.01 Duration of stock-out in months for health products during the past 3 months Def : Duration of stock-out in months for each health product in every POS
Calc : Percentage of POS with no day of absence, one to 14 days of absence, 15 or more days of absence during the last three months Average/median of duration of stock-out in POSs for each health products
5.02 Number of days of absence of POS during last 3 months Def : Number of days of absence of POS during last 3 months
Calc : Percentage of POS with no day of absence, one to 14 days of absence, 15 or more days of absence during the last three months
5.03 Total number of CHVs re-supplying from the POS Def : Total number of CHVs re-supplying from the POS
Calc : Number of CHVs re-supplying from the POS
5.04 Number of CHVs re-supplying from the POS during the last 3 months Calc : Number of CHVs re-supplying from the POS during the last 3 months
5.05 % of POS who received health technical training in the past year Def : POS who received health technical training in the past year
Calc : Number of POS who received health technical training in the past year x 100/Total number of POS
5.06 % of POS who received management training in the past 3 months Def : POS who received management training in the past 3 months
Calc : Number of POS who received management training in the past 3 months x 100/Total number of POS
Outcome Monitoring Survey in the MAHEFA Areas - 89 -
5.07 % of POS who attended at least one meeting with CHVs in the past three months Def : POS who attended at least one meeting with CHVs in the past three months
Calc : Number of POS who attended at least one meeting with CHVs in the past three months x 100/Total number of POS
5.08 % of POS regularly receiving update on list of FP/Depo certified CHV Def : POS regularly receiving update on list of FP/Depo certified CHV
Calc : Number of POS regularly receiving update on list of FP/Depo certified CHV x 100/ Total number of POS
5.09 % of POS with adequate health product storage equipment Def : POS with adequate health product storage equipment are those found with a shelf and undamaged boxes to store products; where products are not exposed to sunlight or humidity.
Calc : Number of POS with adequate health product storage equipment x 100/ Total number of POS
5.10 % of POS having expired products (breakdown by product) Def : POS having expired products (breakdown by product)
Calc : Number of POS having expired products (breakdown by product) x 100/Total number of POS
5.11 % of POS getting promotional items from PSI Calc : Number of POS getting promotional items from PSI (at low cost) x 100/ Total number of POS
5.12 Average monthly sales of health products in the past six months Calc: Average number of products monthly sold in the past six months
Outcome Monitoring Survey in the MAHEFA Areas - 90 -
Figure 4: Unmet need for FP definition and analysis process
Source: www.who.it
Outcome Monitoring Survey in the MAHEFA Areas - 91 -
C.5. Data collection and instruments
. Questionnaire:
A structured, pre-tested questionnaire was used to collect data from household heads, WRA, caretakers of CU5, CHVs and POS. Enumerators were trained to administer questionnaires through direct interview. Each interview could not start without participant‘s informed consent.
. Enumerators brought templates along in order to gather data from households‘ environments (Commune, Fokontany).
. MUAC-tape: the 2009 version was used to identify children in red, yellow and green MUAC
. Data collection fieldworks
• CU5 sample sizes in districts were small. Therefore, data comparison could not be completed between districts. However, comparisons between regions provided relevant evidences. • Some indicators are not available in the MAHEFA baseline. Therefore, their comparison with the OMS results could not be determined at this point. • Under or over reporting has biased some indicator levels. Assurance of confidentiality was assured in order to minimize biased information. Nevertheless, in case of difficulties in remembering the events, the importance of biases remains unknown (example: indicator 5.03, 5.04, number of CHVs re-supplying from the POS) • History biases are inavoidable. Other events might have determined or contributed to changes in the magnitude of indicator levels.
Outcome Monitoring Survey in the MAHEFA Areas - 92 -
ANNEXE D - INDICATOR LEVELS IN REGIONS AND DISTRICTS
I. HOUSEHOLD INDICATORS
Table 20: WATER, HYGIENE AND SANITATION INDICATORS, MAHEFA Project, 2014 OMS
Ind1.01 : Households using Ind1.02: Households with Ind 1.06: Household practicing improved sanitation improved drinking water source open defecation
HH HEAD GENDER 63.6% p=0.002 10.1% p=0.408 40.2% p=0.978 Male n=1810 70.3% 8.8% 38.8% Female n=581 FEMALE MALE TOTAL FEMALE MALE TOTAL FEMALE MALE TOTAL
REGION Boeny 36.4% 41.0% 41.2% 8.3% 5.1% 5.9% 81.8% 82.1% 82.4% Diana 81.5% 70.6% 73.6% 13.7% 11.2% 11.9% 34.5% 40.1% 38.5% Melaky 40.6% 37.9% 39.1% 9.4% 2.1% 4.7% 63.6% 68.8% 68.0% Menabe 68.0% 68.2% 68.2% 4.0% 9.0% 7.9% 65.3% 53.6% 56.1% Sava 82.6% 57.7% 61.6% 4.3% 0.8% 2.1% 30.4% 49.2% 46.6% Sofia 64.1% 61.3% 61.9% 5.3% 12.5% 10.7% 28.2% 26.9% 27.2% DISTRICT BESALAMPY 22.2% 18.5% 19.4% 4.0% 6.3% 5.7% 77.8% 85.2% 83.3% SOALALA 20.0% 6.3% 9.5% 8.0% 14.4% 5.0% 80.0% 87.5% 90.0% MITSINJO 57.1% 65.2% 63.3% 0.0% 0.0% 3.4% 83.3% 75.0% 76.7% PORT BERGE 62.1% 53.1% 55.2% 0.0% 0.0% 7.4% 13.8% 15.5% 14.4% MANDRITSARA 46.8% 53.0% 51.5% 14.3% 2.6% 12.6% 0.0% 4.7% 3.5% ANALALAVA 74.4% 50.0% 57.4% 0.0% 0.0% 4.4% 59.5% 68.0% 65.7% BEFANDRIANA 57.9% 57.9% 57.9% 9.1% 4.3% 15.4% 23.7% 17.9% 18.9% NORD
Outcome Monitoring Survey in the MAHEFA Areas - 93 -
Table 20 (continued): WATER AND SANITATION INDICATORS, MAHEFA Project, 2014 OMS
Ind1.02: Households with Ind1.01 : Households using Ind 1.06: Household practicing improved drinking water improved sanitation open defecation source FEMALE MALE TOTAL FEMALE MALE TOTAL FEMALE MALE TOTAL DISTRICT (continued) ANTSOHIHY 76.9% 82.3% 81.0% 4.0% 6.3% 5.9% 36.0% 34.2% 35.2% BEALANANA 73.1% 81.6% 79.8% 8.0% 14.4% 13.3% 44.0% 39.8% 40.7% AMBATOMAINTY 0.0% 12.5% 11.1% 0.0% 0.0% 0.0% 100.0% 75.0% 77.8% ANTSALOVA 14.3% 20.0% 18.2% 0.0% 0.0% 0.0% 85.7% 86.7% 86.4% MAINTIRANO 60.0% 60.5% 60.4% 14.3% 2.6% 5.8% 46.7% 53.8% 50.9% MORAFENOBE 100.0% 62.5% 66.7% 0.0% 0.0% 0.0% 50.0% 42.9% 44.4% MANJA 70.0% 66.7% 67.6% 9.1% 4.3% 6.1% 63.6% 66.7% 64.7% MORONDAVA 83.3% 86.3% 85.7% 8.3% 15.7% 14.3% 41.7% 43.1% 42.9% MAHABO 33.3% 43.1% 41.0% 0.0% 1.5% 1.2% 66.7% 55.4% 57.8% BELO SUR 77.8% 60.7% 64.9% 5.6% 12.5% 11.1% 72.2% 58.9% 62.2% TSIRIBIHINA MIANDRIVAZO 77.8% 84.3% 83.0% 5.6% 8.5% 7.9% 70.6% 50.7% 54.5% ANTSIRANANA II 73.9% 83.3% 80.9% 0.0% 4.6% 3.4% 78.3% 57.6% 62.5% ANTSIRANANA I 92.9% 95.7% 94.6% 26.7% 27.3% 27.0% 7.1% 4.5% 8.1% VOHEMAR 82.6% 57.7% 61.6% 4.3% 0.8% 1.4% 30.4% 49.2% 46.6% AMBILOBE 82.3% 72.1% 74.4% 16.7% 11.1% 12.5% 23.7% 34.3% 31.9% NOSY BE 89.3% 82.4% 85.5% 3.4% 2.9% 3.2% 31.0% 34.3% 32.3% AMBANJA 78.1% 56.4% 62.6% 16.9% 14.1% 15.2% 43.1% 50.9% 48.5% TOTAL 70.3% 63.6% 65.2% 8.8% 10.1% 9.8% 38.8% 40.2% 39.9%
Outcome Monitoring Survey in the MAHEFA Areas - 94 -
Table 20(continued): WATER AND SANITATION INDICATORS, MAHEFA Project, 2014 OMS
Ind 1.05 : Households with soap Ind 1.09 : Household using correct Ind 1.40 : Household who knows and water at hand washing Ind 1.07 : Household practicing recommended water treatment the three core messages of station commonly used by effective water treatment DIORANO WASH family members HH HEAD GENDER Male n=1810 13.3% p=0.964 15.7% p=0.408 25.5% p=0.487 1.8% p=0.626 Female n=581 14.2% 15.4% 22.8% 2.1% FEMALE MALE TOTAL FEMALE MALE TOTAL FEMALE MALE TOTAL FEMALE MALE TOTAL REGION Boeny 0.0% 0.0% 0.0% 8.3% 10.0% 8.0% 27.3% 20.5% 22.0% 0.0% 2.5% 2.0% Diana 15.9% 17.4% 17.0% 16.7% 21.4% 20.1% 28.3% 33.6% 32.2% 2.7% 1.8% 2.0% Melaky 3.0% 4.2% 3.1% 15.2% 12.5% 13.2% 21.2% 22.1% 21.9% 3.0% 2.1% 2.3% Menabe 26.7% 19.1% 20.8% 25.3% 20.6% 21.6% 13.2% 20.2% 18.7% 0.0% 3.0% 2.3% Sava 25.0% 25.4% 25.3% 30.4% 8.2% 11.7% 50.0% 37.7% 39.7% 20.8% 0.8% 4.1% Sofia 9.1% 7.0% 7.5% 9.6% 10.7% 10.4% 17.3% 18.7% 18.3% 0.0% 1.3% 1.1% DISTRICT BESALAMPY 11.1% 11.1% 11.1% 11.1% 11.1% 11.1% 22.2% 3.8% 11.1% 10.0% 0.0% 2.8% SOALALA 0.0% 0.0% 0.0% 0.0% 12.5% 10.0% 40.0% 13.3% 20.0% 0.0% 0.0% 0.0% MITSINJO 0.0% 0.0% 0.0% 0.0% 8.3% 6.7% 28.6% 25.0% 25.8% 0.0% 4.2% 3.2% PORT BERGE 13.8% 13.6% 13.6% 31.0% 16.5% 20.0% 17.2% 18.6% 18.3% 0.0% 3.1% 2.4% MANDRITSARA 2.1% 4.7% 4.1% 4.2% 15.4% 13.1% 20.8% 26.7% 25.3% 0.0% 0.0% 0.0% ANALALAVA 16.3% 6.1% 9.2% 7.1% 13.3% 11.4% 2.4% 7.2% 5.8% 0.0% 1.0% 0.7% BEFANDRIANA 5.1% 8.6% 7.9% 0.0% 2.6% 2.1% 13.2% 14.6% 14.2% 0.0% 1.3% 1.1% NORD ANTSOHIHY 15.4% 5.1% 7.6% 8.0% 6.3% 6.7% 38.5% 20.3% 24.8% 0.0% 2.6% 1.9% BEALANANA 4.0% 4.1% 4.1% 11.5% 11.2% 11.3% 23.1% 22.4% 22.6% 0.0% 1.0% 0.8% Table 20(the end): WATER, HYGIENE AND SANITATION INDICATORS, MAHEFA Project, 2014 OMS
Outcome Monitoring Survey in the MAHEFA Areas - 95 -
Ind 1.05 : Households with soap Ind 1.40 : Household who knows and water at hand washing Ind 1.07: Household practicing Ind 1.09: Household using correct the 3 core messages of station commonly used by family effective water treatment recommended water treatment DIORANO WASH members FEMALE MALE TOTAL FEMALE MALE TOTAL FEMALE MALE TOTAL FEMALE MALE TOTAL DISTRICT (continued) AMBATOMAINTY 0.0% 0.0% 0.0% 0.0% 12.5% 11.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% ANTSALOVA 0.0% 0.0% 0.0% 0.0% 7.1% 4.8% 14.3% 21.4% 19.0% 0.0% 0.0% 0.0% MAINTIRANO 0.0% 0.0% 0.0% 21.4% 15.8% 17.0% 26.7% 42.1% 37.7% 0.0% 2.6% 1.9% MORAFENOBE 0.0% 0.0% 0.0% 0.0% 0.0% 11.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% MANJA 10.0% 4.3% 8.8% 18.2% 8.3% 11.8% 10.0% 12.5% 11.8% 0.0% 4.3% 3.0% MORONDAVA 0.0% 21.6% 17.5% 8.3% 23.5% 20.6% 8.3% 21.6% 19.0% 0.0% 5.9% 4.8% MAHABO 29.4% 18.2% 20.5% 22.2% 21.2% 20.5% 27.8% 24.6% 25.3% 0.0% 1.5% 1.2% BELO SUR 33.3% 15.8% 18.9% 38.9% 21.4% 25.7% 5.6% 8.9% 8.1% 0.0% 1.8% 1.4% TSIRIBIHINA MIANDRIVAZO 41.2% 25.4% 28.4% 33.3% 21.1% 23.6% 11.1% 26.8% 23.9% 0.0% 1.4% 1.1% ANTSIRANANA II 0.0% 1.5% 1.1% 18.2% 16.9% 17.0% 17.4% 33.3% 29.2% 0.0% 1.5% 1.1% ANTSIRANANA I 0.0% 0.0% 0.0% 35.7% 31.8% 32.4% 42.9% 40.9% 41.7% 6.7% 13.0% 10.5% VOHEMAR 25.0% 25.4% 25.3% 30.4% 8.2% 11.7% 50.0% 37.7% 39.7% 20.8% 0.8% 4.1% AMBILOBE 37.1% 31.6% 33.9% 24.0% 28.5% 27.5% 37.1% 33.4% 34.3% 5.2% 1.8% 2.6% NOSY BE 0.0% 2.9% 1.6% 10.7% 17.1% 14.3% 14.3% 40.0% 28.6% 0.0% 0.0% 0.0% AMBANJA 0.0% 0.0% 0.0% 3.1% 8.6% 7.0% 23.1% 31.9% 29.4% 0.0% 1.2% 0.9% TOTAL 14.2% 13.3% 13.5% 15.4% 15.7% 15.6% 22.8% 25.5% 24.8% 2.1% 1.8% 1.8%
Outcome Monitoring Survey in the MAHEFA Areas - 96 -
Table 21: ITN INDICATOR, MAHEFA Project, 2014 OMS % of households with at least one ITN (Indicator 1.03)
Ind 1.03: % Household with at least ONE ITN HH HEAD GENDER Male n=1810 83.9% p=0.038 Female n=581 79.8% FEMALE MALE TOTAL
REGION Boeny 81.8% 89.7% 88.0% Diana 82.7% 90.4% 87.9% Melaky 78.1% 81.1% 79.7% Menabe 82.4% 79.9% 80.8% Sava 78.3% 89.3% 87.7% Sofia 76.2% 78.9% 78.3% DISTRICT BESALAMPY 33.3% 59.3% 52.8% SOALALA 80.0% 86.7% 85.0% MITSINJO 85.7% 91.3% 90.0% PORT BERGE 89.7% 90.7% 90.5% MANDRITSARA 64.6% 70.0% 68.7% ANALALAVA 92.9% 86.7% 88.6% BEFANDRIANA NORD 74.4% 78.3% 77.9% ANTSOHIHY 84.6% 82.1% 82.7%
Outcome Monitoring Survey in the MAHEFA Areas - 97 -
Table 21 (continued and the end): ITN INDICATOR, MAHEFA Project, 2014 OMS
Ind 1.03 : Household with at least ONE ITN FEMALE MALE TOTAL
DISTRICT (continued) BEALANANA 53.8% 70.4% 66.9% AMBATOMAINTY 100.0% 100.0% 100.0% ANTSALOVA 100.0% 100.0% 100.0% MAINTIRANO 92.9% 84.6% 86.8% MORAFENOBE 100.0% 87.5% 88.9% MANJA 90.9% 83.3% 85.7% MORONDAVA 83.3% 98.0% 95.2% MAHABO 82.4% 78.5% 79.3% BELO SUR TSIRIBIHINA 72.2% 64.3% 66.2% MIANDRIVAZO 88.9% 81.4% 83.0% ANTSIRANANA II 77.3% 84.6% 83.0% ANTSIRANANA I 73.3% 90.9% 83.8% VOHEMAR 78.3% 89.4% 87.7% AMBILOBE 94.8% 92.5% 92.8% NOSY BE 89.3% 94.1% 91.9% AMBANJA 64.1% 86.5% 80.2% TOTAL 79.8% 83.9% 82.9%
Outcome Monitoring Survey in the MAHEFA Areas - 98 -
Table 22: HOUSEHOLDS WITH ACCESS TO ELECTRICITY AND CELLPHONE, HOUSEHOLDS WILLING TO PARTICIPATE IN A PHONE INTERVIEW, MAHEFA Project, 2014 OMS
Ind 1.17 : Households having access Ind 1.15 : Household with cellphone Ind 1.16 : Household willing to to electricity at home participate in a phone interview HH HEAD GENDER Male n=1810 38.1% p=0.169 32.8% p=0.809 63.4% p=0.734 Female n=581 36.6% 30.9% 58.5% FEMALE MALE TOTAL FEMALE MALE TOTAL FEMALE MALE TOTAL REGION Boeny 27.3% 25.0% 26.0% 33.3% 35.0% 34.6% 83.3% 79.5% 80.4% Diana 55.8% 64.5% 61.7% 43.8% 47.8% 46.7% 64.2% 70.9% 69.0% Melaky 25.0% 26.0% 25.8% 30.3% 29.5% 29.7% 45.5% 44.8% 45.0% Menabe 32.9% 28.5% 29.2% 21.3% 25.5% 24.5% 58.7% 62.9% 62.0% Sava 33.3% 23.8% 25.3% 43.5% 38.5% 39.3% 75.0% 78.7% 78.1% Sofia 20.1% 22.7% 22.1% 18.7% 21.3% 20.7% 51.2% 55.5% 54.5% DISTRICT BESALAMPY 22.2% 11.1% 13.9% 22.2% 11.1% 11.1% 37.5% 53.8% 50.0% SOALALA 20.0% 25.0% 23.8% 25.0% 33.3% 31.6% 80.0% 68.8% 71.4% MITSINJO 28.6% 25.0% 25.8% 33.3% 37.5% 36.7% 85.7% 87.5% 86.7% PORT BERGE 24.1% 25.8% 24.8% 13.8% 21.6% 20.0% 59.3% 70.5% 67.2% MANDRITSARA 37.5% 36.9% 37.1% 18.8% 28.9% 26.4% 20.8% 53.1% 46.0% ANALALAVA 0.0% 0.0% 0.0% 19.0% 13.4% 15.7% 75.6% 70.4% 72.9% BEFANDRIANA 10.3% 17.8% 16.3% 15.4% 15.9% 15.8% 67.6% 66.2% 66.8% NORD ANTSOHIHY 12.0% 35.4% 30.5% 19.2% 21.8% 21.2% 38.5% 32.9% 34.3% BEALANANA 38.5% 17.5% 22.0% 26.9% 24.5% 25.2% 37.5% 32.3% 33.3%
Outcome Monitoring Survey in the MAHEFA Areas - 99 -
Table 22 (continued and the end): HOUSEHOLDS WITH ACCESS TO ELECTRICITY AND CELLPHONE, HOUSEHOLDS WILLING TO PARTICIPATE IN A PHONE INTERVIEW, MAHEFA Project, 2014 OMS
Ind 1.17 : Households having access to Ind 1.15 : Household with cellphone Ind 1.16 : Household willing to participate electricity at home in a phone interview DISTRICT (continued) FEMALE MALE TOTAL FEMALE MALE TOTAL FEMALE MALE TOTAL AMBATOMAINTY 0.0% 12.5% 11.1% 0.0% 14.3% 12.5% 0.0% 37.5% 33.3% ANTSALOVA 14.3% 13.3% 13.6% 14.3% 13.3% 13.6% 42.9% 26.7% 31.8% MAINTIRANO 35.7% 46.2% 43.4% 53.3% 56.4% 55.6% 50.0% 51.3% 50.9% MORAFENOBE 0.0% 12.5% 11.1% 0.0% 0.0% 0.0% 0.0% 25.0% 22.2% MANJA 20.0% 12.5% 14.7% 18.2% 20.8% 17.6% 70.0% 75.0% 73.5% MORONDAVA 66.7% 76.5% 76.2% 16.7% 37.3% 33.3% 58.3% 78.4% 74.6% MAHABO 22.2% 10.8% 13.3% 11.8% 6.1% 7.2% 27.8% 40.0% 37.3% BELO SUR 41.2% 32.1% 33.8% 50.0% 35.1% 37.8% 83.3% 75.0% 77.0% TSIRIBIHINA MIANDRIVAZO 16.7% 11.4% 12.5% 5.6% 29.6% 24.7% 55.6% 59.2% 58.4% ANTSIRANANA II 4.3% 10.8% 9.1% 21.7% 41.5% 36.4% 36.4% 51.5% 47.7% ANTSIRANANA I 73.3% 87.0% 83.3% 73.3% 78.3% 76.3% 85.7% 77.3% 78.4% VOHEMAR 33.3% 23.8% 25.3% 43.5% 38.5% 39.3% 75.0% 78.7% 78.1% AMBILOBE 61.9% 77.1% 73.7% 50.5% 55.7% 54.5% 80.2% 89.2% 87.2% NOSY BE 86.2% 97.1% 93.5% 32.1% 48.6% 41.3% 57.1% 57.1% 57.1% AMBANJA 47.7% 50.3% 49.6% 39.1% 30.1% 32.6% 47.7% 43.6% 44.5% TOTAL 36.6% 38.1% 37.7% 30.9% 32.8% 32.4% 58.5% 63.4% 62.2%
Outcome Monitoring Survey in the MAHEFA Areas - 100 -
Table 23: HOUSEHOLDS COVERED BY USG-SUPPORTED COMMUNITY HEALTH FINANCING ARRANGEMENT, ACCESS AND USE OF MAHEFA TRANSPORTATION. MAHEFA Project, 2014 OMS
Ind 1.10 Household covered by IND1.11 Access to the USG-supported community MAHEFA transportation IND1.12 Use of MAHEFA health financing arrangement system emmergency transportation HH HEAD GENDER Male n=1810 0.2% - 4.8% 0.4% - Female n=581 0% 3.6% p=0.477 0.2% Female Male TOTAL Female Male TOTAL Female Male TOTAL REGION Diana 0.0% 0.0% 0.0% 4.8% 7.3% 6.6% 0.0% 0.3% 0.2% Sava 0.0% 0.8% 0.7% 0.0% 3.3% 2.7% 0.0% 0.0% 0.0% Sofia 0.0% 0.1% 0.1% 2.4% 3.6% 3.3% 0.0% 0.1% 0.1% Boeny 0.0% 0.0% 0.0% 16.7% 10.0% 11.5% 0.0% 0.0% 0.0% Melaky 0.0% 0.0% 0.0% 3.1% 5.3% 4.7% 0.0% 1.1% 0.8% Menabe 0.0% 0.0% 0.0% 3.9% 1.9% 2.3% 2.7% 1.3% 1.6% DISTRICT BESALAMPY 0.0% 0.0% 0.0% 11.1% 7.7% 8.6% 0.0% 0.0% 0.0% SOALALA 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% MITSINJO 0.0% 0.0% 0.0% 28.6% 16.7% 19.4% 0.0% 0.0% 0.0% PORT BERGE 0.0% 0.0% 0.0% 0.0% 1.0% 0.8% 0.0% 0.0% 0.0% MANDRITSARA 0.0% 0.0% 0.0% 2.1% 4.0% 3.5% 0.0% 0.7% 0.5% ANALALAVA 0.0% 0.0% 0.0% 0.0% 1.0% 0.7% 0.0% 0.0% 0.0% BEFANDRIANA NORD 0.0% 0.0% 0.0% 10.3% 9.3% 9.5% 0.0% 0.0% 0.0% ANTSOHIHY 0.0% 0.0% 0.0% 0.0% 1.3% 1.0% 0.0% 0.0% 0.0% BEALANANA 0.0% 1.0% 0.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% AMBATOMAINTY 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% ANTSALOVA 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Outcome Monitoring Survey in the MAHEFA Areas - 101 -
Table 23 (continued and the end): HOUSEHOLDS COVERED BY USG-SUPPORTED COMMUNITY HEALTH FINANCING ARRANGEMENT, ACCESS AND USE OF MAHEFA TRANSPORTATION. MAHEFA Project, 2014 OMS
Ind 1.10 Household covered by USG-supported IND1.11 Access to community health MAHEFA IND1.12 Use of MAHEFA financing arrangement TRANSPORTATION emmergency transportation Female Male TOTAL Female Male TOTAL Female Male TOTAL DISTRICT (continued) MAINTIRANO 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 2.6% 1.9% MORAFENOBE 0.0% 0.0% 0.0% 0.0% 14.3% 12.5% 0.0% 0.0% 0.0% MANJA 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 9.1% 4.2% 5.9% MORONDAVA 0.0% 0.0% 0.0% 0.0% 2.0% 1.6% 0.0% 0.0% 0.0% MAHABO 0.0% 0.0% 0.0% 5.6% 0.0% 1.2% 0.0% 0.0% 0.0% BELO SUR TSIRIBIHINA 0.0% 0.0% 0.0% 11.1% 3.6% 5.4% 0.0% 0.0% 0.0% MIANDRIVAZO 0.0% 0.0% 0.0% 0.0% 2.8% 2.2% 0.0% 2.8% 2.3% ANTSIRANANA II 0.0% 0.0% 0.0% 4.3% 3.1% 3.4% 0.0% 1.5% 1.1% ANTSIRANANA I 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 4.5% 2.7% VOHEMAR 0.0% 0.8% 0.7% 0.0% 3.3% 2.8% 0.0% 0.0% 0.0% AMBILOBE 0.0% 0.0% 0.0% 5.2% 8.7% 8.2% 0.0% 0.0% 0.0% NOSY BE 0.0% 0.0% 0.0% 14.3% 11.8% 12.9% 0.0% 0.0% 0.0% AMBANJA 0.0% 0.0% 0.0% 0.0% 5.5% 3.9% 0.0% 0.0% 0.0% TOTAL 0.0% 0.2% 0.1% 3.6% 4.8% 4.5% 0.2% 0.4% 0.3%
Outcome Monitoring Survey in the MAHEFA Areas - 102 -
Table 24: % household with moderate or severe hunger (Indicator 1.18) % household visited by CHVs for health related IPC in the past three months (Indicator 1.13) MAHEFA Project, 2014 OMS
Ind 1.18 Household with moderate or Ind 1.13 Households severe hunger visited by CHVs for HH HEAD GENDER health related IPC Male n=1808 10.6% p=0.000 in the past three Female n=581 5.2% months Missing = 2 N=WRA
Female Male TOTAL REGION Diana 11.9% 4.4% 6.4% 21.7% Sava 0.0% 0.8% 0.7% 23.2% Sofia 9.1% 3.6% 4.9% 11.4% Boeny 0.0% 0.0% 0.0% 5.7% Melaky 9.4% 11.6% 10.9% 24.8% Menabe 15.8% 11.6% 12.5% 25.3% DISTRICTS BESALAMPY 22.2% 22.2% 22.2% 10.0% SOALALA 0.0% 0.0% 0.0% 4.5% MITSINJO 0.0% 0.0% 3.2% 6.5% PORT BERGE 13.8% 8.2% 9.6% 6.0% MANDRITSARA 2.1% 0.0% 0.5% 21.5% ANALALAVA 20.9% 10.2% 12.9% 5.0% BEFANDRIANA NORD 15.4% 6.3% 0.0% 13.9% ANTSOHIHY 4.0% 1.0% 8.6% 10.3% BEALANANA 22.2% 22.2% 2.4% 4.1%
Outcome Monitoring Survey in the MAHEFA Areas - 103 -
Table 24 (continued and the end): % household with moderate or severe hunger (Indicator 1.18) % household visited by CHVs for health related IPC in the past three months (Indicator 1.13) MAHEFA Project, 2014 OMS
Ind 1.13 Households visited by CHVs for Ind 1.18 Household with moderate health related IPC in or severe hunger the past 3 months Female Male TOTAL DISTRICT (continued) AMBATOMAINTY 0.0% 0.0% 0.0% 11.1% ANTSALOVA 14.3% 0.0% 4.8% 36.4% MAINTIRANO 6.7% 10.5% 9.4% 39.2% MORAFENOBE 0.0% 0.0% 0.0% 0.0% MANJA 9.1% 16.7% 11.8% 55.3% MORONDAVA 16.7% 7.8% 9.5% 83.6% MAHABO 11.1% 3.1% 4.9% 1.1% BELO SUR TSIRIBIHINA 27.8% 17.5% 18.9% 8.1% MIANDRIVAZO 11.8% 15.5% 14.8% 5.3% ANTSIRANANA II 22.7% 7.7% 12.5% 3.4% ANTSIRANANA I 20.0% 0.0% 8.3% 11.6% VOHEMAR 0.0% 0.8% 0.7% 23.2% AMBILOBE 7.2% 1.2% 2.6% 35.2% NOSY BE 10.3% 5.7% 6.5% 4.4% AMBANJA 13.8% 9.8% 11.0% 8.9% TOTAL 10.6% 5.2% 6.5% 18.3%
Outcome Monitoring Survey in the MAHEFA Areas - 104 -
II. WRA INDICATORS
Table 25: FAMILY PLANNING INDICATORS, MAHEFA OMS, 2014
Ind 2.01 : Modern Ind 2.12 : Mother of Ind 2.15 : WRA who contraceptive rate Ind 2.02 : Ind 2.03 : Women CU1 who desires to percieve that their including cycle Women with exposed to wait at least 24 partner support them beads and unmet need months to have IEC/BCC FB breastfeeding for FP to use modern another child messages methods contraceptive REGION Boeny 28.2% 30.8% 70.0% 70.4% 38.3% Diana 45.8% 32.3% 98.5% 84.9% 46.6% Melaky 52.7% 19.4% 92.9% 81.8% 63.9% Menabe 53.3% 24.0% 86.7% 89.7% 49.3% Sava 33.6% 27.4% 90.3% 87.4% 51.2% Sofia 33.1% 33.9% 73.6% 71.6% 38.9% DISTRICT
BESALAMPY 48.3% 25.0% 100.0% 92.5% 51.4% SOALALA 18.8% 31.3% 60.0% 72.7% 35.0% MITSINJO 34.8% 31.8% 60.0% 68.8% 39.3% PORT BERGE 26.1% 35.9% 75.0% 64.2% 26.7% MANDRITSARA 47.2% 33.3% 93.1% 83.1% 46.8% ANALALAVA 9.9% 62.0% 51.4% 36.2% 18.6% BEFANDRIANA NORD 50.0% 22.4% 63.2% 83.2% 57.5% ANTSOHIHY 31.1% 23.0% 87.5% 75.0% 40.7% BEALANANA 17.6% 33.0% 86.7% 76.6% 27.6% AMBATOMAINTY 66.7% 16.7% 100.0% 62.5% 57.1%
Outcome Monitoring Survey in the MAHEFA Areas - 105 -
Table 25 (continued): FAMILY PLANNING INDICATORS, MAHEFA OMS, 2014
Ind 2.01 : Modern Ind 2.12 : Mother of Ind 2.15 : WRA who Ind 2.02 : Ind 2.03 : Women contraceptive CU1 who desires to percieve that their Women with exposed to rate including wait at least 24 partner support them unmet need IEC/BCC FP cycle beads and months to have to use modern for FP messages breastfeeding another child contraceptive method DISTRICT (Continued) ANTSALOVA 57.1% 14.3% 100.0% 100.0% 75.0% MAINTIRANO 47.2% 18.9% 92.9% 92.9% 69.8% MORAFENOBE 75.0% 12.5% 100.0% 100.0% 62.5% MANJA 60.9% 13.0% 60.0% 66.7% 62.1% MORONDAVA 58.7% 15.2% 92.3% 93.3% 48.3% MAHABO 50.0% 29.3% 90.0% 91.7% 44.9% BELO SUR TSIRIBIHINA 61.5% 26.9% 75.0% 75.0% 52.9% MIANDRIVAZO 42.4% 25.8% 81.8% 83.3% 45.9% ANTSIRANANA II 51.6% 22.6% 100.0% 100.0% 43.1% ANTSIRANANA I 43.5% 29.2% 100.0% 100.0% 41.7% VOHEMAR 33.6% 27.4% 95.2% 90.3% 51.2% AMBILOBE 40.1% 39.4% 100.0% 100.0% 51.0% NOSY BE 51.4% 20.0% 100.0% 100.0% 41.7% AMBANJA 53.3% 27.2% 95.2% 95.3% 42.7% TOTAL 41.3% 30.6% 88.8% 86% 45.1%
Outcome Monitoring Survey in the MAHEFA Areas - 106 -
Table 25 (continued): FAMILY PLANNING INDICATORS,
WOMAN SATISFACTION WITH CHV’S QUALITY CARE, MAHEFA OMS, 2014
Ind 2.14 : Woman reporting no myths nor Ind 2.05 : WRA seeking Ind 2.06 : Woman misconceptions counseling or teatment satisfied with CHV’s regarding modern FP from CHV for FP/RH FP/RH quality care REGION Boeny 11.3% 9.3% - Diana 6.4% 7.9% 62.5% Melaky 19.7% 14.4% 50.0% Menabe 20.3% 12.6% 44.4% Sava 9.3% 9.3% 37.5% Sofia 23.2% 7.7% 42.9% DISTRICT BESALAMPY 22.5% 26.8% 50.0% SOALALA 9.1% 4.5% - MITSINJO 15.6% 9.7% - PORT BERGE 46.7% 5.2% 0.0% MANDRITSARA 19.2% 15.5% 18.2% ANALALAVA 31.7% 4.9% 100.0% BEFANDRIANA 12.2% 8.4% 0.0% NORD
Outcome Monitoring Survey in the MAHEFA Areas - 107 -
Table 25 (the end): FAMILY PLANNING INDICATORS,
WOMAN SATISFACTION WITH CHV’S QUALITY CARE, MAHEFA OMS, 2014
Ind 2.14 : Woman Subind 2.06 : reporting no myths Ind 2.05 : WRA Woman nor misconceptions seeking counseling or satisfied with regarding modern teatment from CHV CHV’s FP/RH FP for FP/RH quality care DISTRICT (Continued) ANTSOHIHY 23.3% 5.2% 83.3% BEALANANA 13.0% 0.8% 0.0% AMBATOMAINTY 22.2% 12.5% - ANTSALOVA 27.3% 22.7% 75.0% MAINTIRANO 11.5% 3.8% 100.0% MORAFENOBE 33.3% 0.0% - MANJA 47.4% 21.1% 42.9% MORONDAVA 35.6% 26.0% 50.0% MAHABO 12.6% 12.5% 50.0% BELO SUR TSIRIBIHINA 11.6% 6.9% - MIANDRIVAZO 11.7% 4.3% 0.0% ANTSIRANANA II 12.6% 4.6% - ANTSIRANANA I 7.0% 2.3% 100.0% VOHEMAR 9.3% 9.3% 100.0% AMBILOBE 7.8% 13.5% 50.0% NOSY BE 4.4% 1.5% 81.0% AMBANJA 0.9% 1.3% 0.0% TOTAL 15.7% 8.9% 49%
Outcome Monitoring Survey in the MAHEFA Areas - 108 -
Table 26: MATERNAL CARE INDICATORS. MAHEFA OMS, 2014
Ind 2.08 : Woman seen Ind 2.09 : Women by Doctor, Nurse, who receive Two Midwife, Medical tetanos toxoid shots Ind 2.10 : Birth attended Ind 2.11 : Woman who assistant at antenatal during their last by doctor, nurse, trained states she receives iron
care at least 4 times pregnancy (last midwife (Last live birth folate supplement (last pregnancy with pregnancy with live in the past 2 years) during her last live birth in the past 2 birth in the past 5 pregnancy (In the past years) years) 2 years) REGION
Boeny 69.2% 59.5% 57.7% 60.0% Diana 83.7% 74.5% 88.0% 67.2% Melaky 67.2% 67.3% 81.0% 53.4% Menabe 60.8% 65.1% 61.3% 62.0% Sava 69.0% 77.1% 72.4% 60.3% Sofia 56.8% 61.0% 78.8% 44.3% DISTRICTS
BESALAMPY 66.7% 63.0% 83.3% 58.3% SOALALA 55.6% 57.1% 44.4% 66.7% MITSINJO 75.0% 60.9% 66.7% 56.3% PORT BERGE 58.6% 63.3% 67.2% 43.1% MANDRITSARA 66.3% 55.0% 90.8% 51.2% ANALALAVA 44.2% 60.9% 62.7% 38.5% BEFANDRIANA NORD 54.7% 66.7% 78.8% 50.9% ANTSOHIHY 53.3% 50.9% 80.0% 33.3% BEALANANA 55.3% 69.8% 89.5% 40.5% AMBATOMAINTY 40.0% 62.5% 100.0% 60.0% ANTSALOVA 50.0% 64.7% 50.0% 41.7%
Outcome Monitoring Survey in the MAHEFA Areas - 109 -
Table 26 (continued and the end): MATERNAL CARE INDICATORS. MAHEFA OMS. 2014
Ind 2.08 : Woman seen Ind 2.09 : Women by Doctor, Nurse, who receive Two Midwife, Medical tetanos toxoid shots Ind 2.10 : Birth attended Ind 2.11 : Women who assistant at antenatal during their last by doctor, nurse, trained state they recieved iron
care at least 4 times pregnancy (last midwife (Last live birth folate supplement (last pregnancy with pregnancy with live in the past 2 years) during her last live birth in the past 2 birth in the past 5 pregnancy (In the past years) years) 2 years) DISTRICT (Continued) MAINTIRANO 80.8% 74.4% 92.0% 52.0% MORAFENOBE 50.0% 66.7% 75.0% 75.0% MANJA 55.6% 65.5% 61.1% 72.2% MORONDAVA 64.3% 62.5% 71.4% 82.1% MAHABO 67.9% 63.2% 57.1% 39.3% BELO SUR TSIRIBIHINA 47.1% 59.6% 55.6% 64.7% MIANDRIVAZO 63.5% 72.1% 58.8% 58.8% ANTSIRANANA II 68.8% 78.1% 75.0% 62.5% ANTSIRANANA I 88.9% 77.8% 100.0% 88.9% VOHEMAR 69.0% 77.1% 72.4% 60.3% AMBILOBE 91.0% 67.7% 86.5% 53.4% NOSY BE 81.3% 89.7% 100.0% 93.3% AMBANJA 73.7% 83.7% 90.8% 85.5% TOTAL 67.3% 67.5% 77.7% 56.2%
Outcome Monitoring Survey in the MAHEFA Areas - 110 -
Table 27: MALARIA INDICATORS AMONG WRA, MAHEFA OMS, 2014.
Ind 2.16 : Pregnant Ind 2.04 : Women women who slept Ind 2.17 : Pregnant who recieved 2 under ITN or in a woman who knows doses of SP for house sprayed with to go to CSB to IPTq during last IRS in the last 12 receive 2 doses of pregnancy in the months SP past 2 years
REGION
Boeny 66.7% 85.7% 13.0% Diana 50.0% 92.6% 48.7% Melaky 66.7% 83.3% 30.8% Menabe 53.1% 88.5% 18.0% Sava 66.7% 88.9% 22.5% Sofia 47.5% 90.3% 18.1% DISTRICT
BESALAMPY 50.0% 100.0% 36.4% SOALALA 66.7% 100.0% 11.1% MITSINJO 66.7% 100.0% 15.4% PORT BERGE 85.7% 100.0% 22.4% MANDRITSARA 7.1% 91.7% 18.2% ANALALAVA 57.1% 71.4% 8.0% BEFANDRIANA 61.5% 100.0% 13.3% NORD ANTSOHIHY 50.0% 62.5% 31.3% BEALANANA 63.6% 92.9% 20.6% AMBATOMAINTY 0.0% - 0.0%
Outcome Monitoring Survey in the MAHEFA Areas - 111 -
Table 27 (continued and the end): MALARIA INDICATORS AMONG WRA AND PREGNANT WOMEN,
MAHEFA OMS, 2014.
Ind 2.16 : Pregnant women who slept Ind 2.04 : Women under ITN or in a Ind 2.17 : Pregnant who recieved 2 doses woman who knows of SP for IPTq
house sprayed with to go to CSB to during last IRS in the last 12 receive 2 doses of SP pregnancy in the months past 2 years
DISTRICT (Continued) ANTSALOVA 100.0% 100.0% 38.5% MAINTIRANO 33.3% 50.0% 31.8% MORAFENOBE 0.0% - 0.0% MANJA 60.0% 100.0% 18.2% MORONDAVA 71.4% 100.0% 11.4% MAHABO 25.0% 66.7% 20.0% BELO SUR 50.0% 100.0% 38.5% TSIRIBIHINA MIANDRIVAZO 37.5% 85.7% 15.0% ANTSIRANANA II 50.0% 100.0% 0.0% ANTSIRANANA I 50.0% 33.3% 0.0% VOHEMAR 66.7% 88.9% 22.5% AMBILOBE 62.5% 100.0% 53.2% NOSY BE 100.0% 50.0% 41.7% AMBANJA 0.0% 100.0% 48.2% TOTAL 52.5% 90.0% 26.4%
Outcome Monitoring Survey in the MAHEFA Areas - 112 -
III. CHILD AND CARETAKER INDICATORS
Table 28 : % of CU6-23 months fed according to a minimum standard of infant and young and MUAC zones
3.26 % of CU6-23 months fed according 3.28 % children 6-59 months in the red, yellow, green MUAC to a minimum standard of infant and zones n=1892 young n=633 Male Female Male Female n=334 n=302 n=951 n=941
% % % % REGION p N Red Yellow Green Red Yellow Green N DIANA 81.8% 81.9% 0.303 100 0.0% 0.0% 100.0% 0.0% 2.4% 97.6% 263 SAVA 78.9% 100.0% 0.220* 26 0.0% 0.0% 100% 0.0% 0.0% 100% 88 SOFIA 38.1% 26.5% 0.614 150 0.0% 1.5% 98.5% 0.3% 1.9% 97.7% 411 BOENY 66.7% 16.7% 0.007 48 0.0% 0.0% 100% 0.0% 0.0% 100% 149 MELAKY 69.6% 61.1% 0.202 158 4.5% 1.5% 94.0% 1.8% 0.0% 98.2% 517 MENABE 63.3% 44.7% 0.102 154 1.3% 2.7% 96.0% 0.0% 4.3% 95.7% 464 TOTAL 60.7% 55.8% 0.108 636 0.6% 1.1% 98.4% 0.3% 2.4% 97.2% 1892 Fisher‘s exact test
Outcome Monitoring Survey in the MAHEFA Areas - 113 -
Table 28 (continued and the end) : % of CU6-23 months fed according to a minimum standard of infant and young and MUAC zones
3.26 % of CU6-23 months fed according to a 3.28 % children 6-59 months in the red. yellow. green MUAC minimum standard of zones infant and young n=1892 n=636 Male Female Male n=951 Female n=941 n=334 n=302 % % % % red yellow green red yellow green DISTRICT BESALAMPY 83.3% 100.0% 5.3% 0.0% 94.7% 7.7% 0.0% 92.3% SOALALA 50.0% 0.0% 0.0% 0.0% 100.0% 0.0% 0.0% 100.0% MITSINJO 60.0% 33.3% 0.0% 0.0% 100.0% 0.0% 0.0% 100.0% PORT BERGE 25.0% 19.0% 0.0% 0.0% 100.0% 0.0% 0.0% 100.0% MANDRITSARA 40.7% 16.7% 0.0% 7.5% 92.5% 1.5% 6.2% 92.3% ANALALAVA 13.6% 40.0% 0.0% 0.0% 100.0% 0.0% 0.0% 100.0% BEFANDRIANA NORD 61.1% 13.3% 0.0% 0.0% 100.0% 0.0% 3.3% 96.7% ANTSOHIHY 44.4% 42.9% 0.0% 0.0% 100.0% 0.0% 0.0% 100.0% BEALANANA 50.0% 30.8% 0.0% 0.0% 100.0% 0.0% 0.0% 100.0% AMBATOMAINTY 0.0% 0.0% 0.0% 0.0% 100.0% 0.0% 0.0% 100.0% ANTSALOVA 80.0% 75.0% 0.0% 0.0% 100.0% 0.0% 0.0% 100.0% MAINTIRANO 66.7% 62.5% 8.7% 0.0% 91.3% 0.0% 0.0% 100.0% MORAFENOBE 0.0% 0.0% 0.0% 0.0% 100.0% 0.0% 0.0% 100.0% MANJA 57.1% 33.3% 0.0% 0.0% 100.0% 0.0% 0.0% 100.0% MORONDAVA 57.1% 72.7% 3.4% 0.0% 96.6% 0.0% 0.0% 100.0% MAHABO 57.1% 44.4% 0.0% 6.3% 93.8% 0.0% 15.0% 85.0% BELO SUR TSIRIBIHINA 87.5% 75.0% 3.1% 3.1% 93.8% 0.0% 0.0% 100.0% MIANDRIVAZO 61.1% 18.8% 0.0% 0.0% 100.0% 0.0% 2.4% 97.6% ANTSIRANANA II 66.7% 100.0% 0.0% 0.0% 100.0% 0.0% 0.0% 100.0%
Outcome Monitoring Survey in the MAHEFA Areas - 114 -
Table 28 (the end) : % of CU6-23 months fed according to a minimum standard of infant and young and MUAC zones
3.26 % of CU6-23 months 3.28 % children 6-59 months in the red. yellow. green MUAC fed according to a zones minimum standard of n=1892 infant and young n=636 Male Female Male n=951 Female n=941 n=334 n=302 % % % % red yellow green red yellow green DISTRICT (Continued) ANTSIRANANA I 78.9% 100.0% 0.0% 0.0% 100.0% 0.0% 14.3% 85.7% VOHEMAR 100.0% 91.8% 0.0% 0.0% 100.0% 0.0% 0.0% 100.0% AMBILOBE 80.0% 77.8% 0.0% 0.0% 100.0% 0.0% 3.0% 97.0% NOSY BE 52.4% 61.5% 0.0% 0.0% 100.0% 0.0% 0.0% 100.0% AMBANJA 78.9% 100.0% 0.0% 0.0% 100.0% 0.0% 0.0% 100.0% TOTAL 60.7% 55.8% 0.6% 1.1% 98.4% 0.2% 2.2% 97.6%
Outcome Monitoring Survey in the MAHEFA Areas - 115 -
Table 29 : % of children 6-59 months receiving vitamin A supplement during the last 6 months and children 0 - 6 months exclusively breastfed
3.27: % of children 6-59 months receiving 3.21: % of children 0 - 6 months exclusively vitamin A supplement during the last 6 breastfed for 6 months months N= 282 N= 1845 Male Female Male Female n= 926 n= 919 n= 127 n= 155 % %
REGION p N p N
DIANA 70.5% 72.0% 0.781 274 88.5% 78.2% - 36 SAVA 54.1% 75.5% 0.037 86 75.0% 62.5% - 15
SOFIA 56.3% 46.4% 0.048 401 76.3% 63.6% 0.502 67 BOENY 60.0% 67.9% 0.304 156 50.0% 100.0% 0.114* 29 MELAKY 61.6% 64.8% 0.466 491 57.1% 77.8% - 62 MENABE 61.8% 61.4% 0.934 437 63.2% 74.1% 0.684 73 TOTAL 60.9% 61.1% 0.906 1845 73.1% 72.0% 0.442 282 *Fisher‘s exact test
Outcome Monitoring Survey in the MAHEFA Areas - 116 -
Table 29 (continued and the end): % of children 6-59 months receiving vitamin A supplement during the last 6 months and children 0 - 6 months exclusively breastfed 3.27: % of children 6-59 months receiving vitamin A supplement during the last 6 3.21: % of children 0 - 6 months months exclusively breastfed N=1845 n= 282 Male Female Male Female N= 926 N=919 N= 127 N= 155 DISTRICT % % BESALAMPY 42.1% 25.0% 100.0% 66.7% SOALALA 66.7% 75.0% 0.0% 100.0% MITSINJO 57.1% 66.7% 66.7% 100.0% PORT BERGE 56.4% 49.0% 88.9% 66.7% MANDRITSARA 60.9% 60.0% 85.7% 71.4% ANALALAVA 51.0% 25.8% 62.5% 85.7% BEFANDRIANA NORD 34.3% 24.6% 100.0% 100.0% ANTSOHIHY 87.5% 62.2% 0.0% 44.4% BEALANANA 70.7% 80.0% 75.0% 50.0% AMBATOMAINTY 100.0% 100.0% 100.0% 0.0% ANTSALOVA 50.0% 40.0% 100.0% 100.0% MAINTIRANO 57.9% 68.4% 60.0% 66.7% MORAFENOBE 80.0% 80.0% 0.0% 100.0% MANJA 57.9% 50.0% 66.7% 50.0% MORONDAVA 52.2% 67.7% 83.3% 55.6% MAHABO 57.6% 65.9% 100.0% 85.7% BELO SUR 65.6% 64.0% 100.0% 100.0% TSIRIBIHINA MIANDRIVAZO 80.0% 72.1% 50.0% 70.0% ANTSIRANANA II 64.3% 57.1% 0.0% 66.7%
Outcome Monitoring Survey in the MAHEFA Areas - 117 -
Table 29 (the end): % of children 6-59 months receiving vitamin A supplement during the last 6 months and children 0 - 6 months exclusively breastfed
3.27: % of children 6-59 3.21: % of children 0 - 6 months receiving vitamin A months exclusively breastfed supplement during the last 6 n= 282 months
Male Female
N= 127 N= 155 DISTRICT (Continued) ANTSIRANANA I 72.7% 71.4% 75.0% 62.5% VOHEMAR 53.7% 74.6% 100.0% 72.2% AMBILOBE 75.7% 78.0% - 100.0% NOSY BE 81.3% 100.0% 80.0% 100.0% AMBANJA 48.7% 54.8% 75.0% 62.5% TOTAL 60.9% 61.1% 73.1% 72.0%
Table 30: Malaria indicators
3.20 : Caretakers who cite that 3.13: % of CU5 who slept under ITN sleeping under an ITN every night the previous night or in a house prevents them from getting sprayed with IRS in the last12 months malaria n= 2063 n= 1725 Male Female n= 1033 n= 1030
% % REGION p N % N Boeny 66.7% 65.2% 0.617 174 94.70% 148 Diana 67.1% 75.0% 0.085 310 96.50% 283 Melaky 71.4% 76.3% 0.489 545 90.00% 448 Menabe 70.3% 69.7% 0.658 476 90.80% 394 Sava 76.5% 76.4% 0.519 97 94.50% 75 Sofia 61.0% 60.9% 0.791 461 93.00% 377 TOTAL 66.6% 69.1% 0.736 2063 93.70% 1725
Outcome Monitoring Survey in the MAHEFA Areas - 118 -
Table 30 (continued): Malaria indicators
3.13: % of CU5 who slept under ITN the previous night or in a house sprayed with IRS in the last12 months n= 2063 Male Female n= 1033 n= 1030 % % DISTRICT BESALAMPY 35.0% 21.4% SOALALA 85.7% 60.0% MITSINJO 57.1% 69.2% PORT BERGE 90.7% 81.7% MANDRITSARA 46.9% 54.4% ANALALAVA 61.0% 48.5% BEFANDRIANA NORD 56.8% 65.8% ANTSOHIHY 54.5% 65.3% BEALANANA 55.3% 46.7% AMBATOMAINTY 80.0% 80.0% ANTSALOVA 100.0% 100.0% MAINTIRANO 72.0% 91.7% MORAFENOBE 100.0% 100.0% MANJA 70.0% 68.8% MORONDAVA 82.1% 89.5% MAHABO 72.2% 76.6% BELO SUR TSIRIBIHINA 42.4% 19.0%
Outcome Monitoring Survey in the MAHEFA Areas - 119 -
Table 30 (continued): Malaria indicators
3.13: % of CU5 who slept under ITN the previous night or in a house sprayed with IRS in the last12 months N= 2063
Male Female n= 1033 n= 1030 % %
DISTRICT (Continued) MIANDRIVAZO 81.0% 69.0% ANTSIRANANA II 46.7% 70.8% ANTSIRANANA I 36.4% 62.5% VOHEMAR 77.6% 76.4% AMBILOBE 88.6% 91.9% NOSY BE 56.3% 52.9% AMBANJA 36.6% 21.8% TOTAL 66.6% 69.1%
Outcome Monitoring Survey in the MAHEFA Areas - 120 -
Table 30 (continued): Malaria indicators
3.05: % of CU5 with fever treated by 3.15: % of CU5 with fever in last 2 3.04: % CU5 malaria prevalence CHVs n=319 weeks who received ACT treatment N=2134 within 24 hours from onset of fever. N=319 Male Female Male Female Male Female Average n=1049 n= 1085 p N Average n=155 n= 164 p N Average n=155 n= 164 p N REGION Boeny 0.0% 100% 0.0% 0.498* 184 15.4% 14.30% 16.7% - 45 0.0% 0.0% 0.0% - 45 Diana 0.0% 0.0% 0.0% - 318 1.2% 0% 2.1% 0.478 46 8.6% 0.0% 15.2% 0.101* 46 Melaky 0.0% 0.0% 0.0% - 558 6.7% 0.00% 11.1% - 54 0.0% 0.0% 0.0% - 54 Menabe 1.5% 1.2% 1.7% - 508 8.2% 6.30% 10.3% - 80 6.5% 12.1% 0.0% 0.123* 80 Sava 0.0% 0.0% 0.0% - 104 7.4% 15.40% 0.0% - 18 0.0% 0.0% 0.0% - 18 Sofia 0.0% 0.0% 0.0% - 462 12.9% 16.00% 10.6% - 76 5.2% 8.0% 3.0% 0.657* 76 0.3% 0.2% 0.3% 0.726* 2134 8.2% 9.0% 7.1% 0.972 319 5.5% 5.6% 5.3% 0.706 319 TOTAL * Fisher‘s exact test
Outcome Monitoring Survey in the MAHEFA Areas - 121 -
Tableau 31: Pneumonia indicators
3.19: % of caretakers of CU5 who cite 3.06: % of CU5 with chest-related cough and cough and rapid fast and/or difficult breathing in the last 2 3.03: % CU5 pneumonia prevalence breathing as that weeks receiving appropriate care N=2134 main symptom N=103 for ARI/Pneumonia N=1725 N Male Female p N Male Female p N REGION N=1049 N=1085 N=45 N=58 21.1% 184 8.9% 7.4% 0.721 184 0.0% 50.0% - 15 Boeny 33.8% 318 3.1% 3.2% - 318 33.3% 11.1% - 10 Diana 21.8% 554 1% 3.7% 0.038 558 0.0% 50.0% - 13 Melaky 29.5% 506 6% 7.3% 0.554 508 50.0% 46.2% - 34 Menabe 58.2% 104 4.2% 7.1% 0.684 104 50.0% 50.0% - 6 Sava 12.0% 458 5.6% 5.2% 0.845 462 50.0% 23.5% - 25 Sofia 26.3% 2124 4.3% 5.4% 0.255 0.0% 50.0% 0.476 TOTAL 2134 103
Outcome Monitoring Survey in the MAHEFA Areas - 122 -
Tableau 31(continued and the end): Pneumonia indicators
3.19: % of caretakers of CU5 who cite cough and rapid breathing as that 3.03: % CU5 pneumonia prevalence main symptom for N=2134 ARI/Pneumonia N=1725 N Male Female p N DISTRICT N=1049 N=1085 BESALAMPY 28.6% 78 0.0% 0.0% 0.441* 102 SOALALA 14.3% 71 12.5% 10.0% 0.724* 85 MITSINJO 25.0% 77 6.3% 7.1% - 99 PORT BERGE 7.4% 64 9.8% 15.0% 0.494 87 MANDRITSARA 6.0% 64 4.9% 0.0% 0.494* 73 ANALALAVA 7.9% 74 1.7% 0.0% 0.469* 96 BEFANDRIANA NORD 8.5% 61 0.0% 3.0% - 67 ANTSOHIHY 25.9% 56 9.1% 8.7% - 70 BEALANANA 28.4% 58 9.1% 2.7% 0.356* 69 AMBATOMAINTY 22.2% 100 0.0% 0.0% 0.374* 114 ANTSALOVA 21.1% 86 0.0% 9.1% 0.072* 119 MAINTIRANO 17.4% 86 0.0% 3.8% - 95
Outcome Monitoring Survey in the MAHEFA Areas - 123 -
3.19: % of caretakers of CU5 who cite cough and rapid 3.03: % CU5 pneumonia prevalence breathing as that main N=2134 symptom for ARI/Pneumonia N=1725 N Male Female p N DISTRICT (continued and the end) N=1049 N=1085 MORAFENOBE 22.2% 98 0.0% 0.0% 0.492* 128 MANJA 24.1% 86 4.3% 5.6% 0.702* 122 MORONDAVA 28.8% 81 0.0% 7.3% 0.397* 109 MAHABO 23.1% 78 0.0% 2.2% 0.498* 100 BELO SUR TSIRIBIHINA 43.1% 71 16.1% 11.5% 0.509 79 MIANDRIVAZO 27.8% 78 6.8% 6.4% - 98 ANTSIRANANA II 15.8% 43 11.8% 12.0% - 46 ANTSIRANANA I 11.1% 49 0.0% 0.0% 58 VOHEMAR 58.2% 75 4.2% 7.3% 0.684* 104 AMBILOBE 52.5% 73 3.3% 2.8% - 90 NOSY BE 11.8% 54 0.0% 0.0% - 58 AMBANJA 5.6% 64 0.0% 0.0% - 66 TOTAL 26.3% 1725 4.0% 4.7% 0.255 2134
Outcome Monitoring Survey in the MAHEFA Areas - 124 -
Table 32: % immunized CU12-23 months of age (Indicators 3.01, 3.25), Northern and North western Madagascar, 2014 OMS
3.01% of CU 12-23 months fully immunized 3.25 % of CU 12-23 months of age who received DPT3 N=414 N=414 REGION Average Male Female p N Average Male Female p N n=219 n=195 n=219 n=195 DIANA 57.4% 50.7% 64.5% 0.332 67 58.1% 52.2% 64.5% 0.389 67 SAVA 63.6% 66.7% 61.5% - 16 77.3% 66.7% 78.6% 0.604* 16 SOFIA 31.1% 31.6% 30.5% 0.344 92 34.1% 33.3% 35.6% 0.503 92 BOENY 12.5% 20.0% 0.0% - 31 12.5% 20.0% 0.0% 0.835 31 MELAKY 36.0% 35.7% 36.4% 0.837 101 42.3% 42.9% 36.4% 0.653 101 MENABE 28.8% 30.0% 27.3% 0.960 107 31.5% 33.3% 30.3% 0.845 107 TOTAL 41.1% 38.8% 46.3% 0.692 414 44.0% 41.1% 47.3% 0.791 414
*Fisher‘s exact test
Outcome Monitoring Survey in the MAHEFA Areas - 125 -
Table 32 (continued and the end): % immunized CU12-23 months of age (Indicators 3.01, 3.25), Northern and North western Madagascar, 2014 OMS
3.25 % of CU 12-23 months of 3.01% of CU 12-23 months fully age who received DPT3 immunized
Male Female Male Female N n=219 n=195 n=219 n=195 DISTRICT BESALAMPY 25.0% 50.0% 25.0% 50.0% 17 SOALALA 0.0% 0.0% 0.0% 0.0% 12 MITSINJO 25.0% 0.0% 25.0% 0.0% 19 PORT BERGE 22.2% 0.0% 44.4% 0.0% 20 MANDRITSARA 33.3% 56.3% 33.3% 56.3% 18 ANALALAVA 37.5% 60.0% 37.5% 60.0% 11 BEFANDRIANA NORD 47.1% 50.0% 47.1% 75.0% 13 ANTSOHIHY 0.0% 0.0% - 25.0% 9 BEALANANA 25.0% 12.5% 25.0% 12.5% 21 AMBATOMAINTY - 50.0% - 50.0% 23 ANTSALOVA 25.0% 0% 25.0% 0.0% 26 MAINTIRANO 40.0% 50% 60.0% 50.0% 17 MORAFENOBE 100.0% - 100.0% - 18 MANJA 25.0% 0.0% 25.0% 20.0% 26 MORONDAVA 20.0% 28.6% 20.0% 28.6% 27 MAHABO 30.0% 25.0% 40.0% 25.0% 22 BELO SUR TSIRIBIHINA 0.0% 0.0% 0.0% 0.0% 11 MIANDRIVAZO 66.7% 50.0% 66.7% 50.0% 21
Outcome Monitoring Survey in the MAHEFA Areas - 126 -
Table 32 (the end): % Immunized CU12-23 months of age (Indicators 3.01, 3.25), Northern and North western Madagascar, 2014 OMS N=454
3.01% of CU 12-23 months fully 3.25 % of CU 12-23 months of immunized age who received DPT3 Male Female Male Female N=219 N=195 N=219 N=195 N DISTRICT (Continued) ANTSIRANANA II 33.3% 100.0% 50.0% 100.0% 6 ANTSIRANANA I 33.3% 100.0% 33.3% 100.0% 14 VOHEMAR 66.7% 61.5% 66.7% 78.6% 16 AMBILOBE 64.4% 100.0% 64.4% 100.0% 21 NOSY BE 75.0% 16.7% 75.0% 16.7% 13 AMBANJA 0.0% 11.1% 0.0% 11.1% 13 TOTAL 38.8% 46.3% 41.4% 47.3% 414
Outcome Monitoring Survey in the MAHEFA Areas - 127 -
Table 33: 3.02 CU5 diarrhea prevalence, Northern and North western Madagascar, MAHEFA project 2014 OMS
N=2134
Average Male Female p n region REGION
District DIANA 8.2% 8.2% 8.2% 0.815 318 ANTSIRANANA II 14.6% 17.6% 12.5% - 46 ANTSIRANANA I 9.5% 9.1% 10% - 58 AMBILOBE 5.3% 6% 4.7% - 90 NOSY BE 25.7% 29.4% 22.2% 0.641 58 AMBANJA 10.5% 6.8% 16.4% 0.426* 66 SAVA 11.1% 11.1% 11.1% 0.961 104 VOHEMAR 11.1% 11.1% 11.1% 0.961 104 SOFIA 9.6% 8.7% 10.4% 0.338 462 PORT BERGE 11.7% 15.4% 8.5% 0.502* 87 MANDRITSARA 2.9% 1.7% 3.9% 0.604* 73 ANALALAVA 18.5% 11.7% 24.3% 0.17 96 BEFANDRIANA NORD 1.6% 3% - 67 ANTSOHIHY 12.9% 17.4% 10.6% - 70 BEALANANA 14.5% 15.6% 13.2% - 69
Outcome Monitoring Survey in the MAHEFA Areas - 128 -
Table 33 (continued and the end): 3.02 CU5 diarrhea prevalence, Northern and North western Madagascar, MAHEFA 2014 OMS N=2134
Average Male Female p N REGION N=1049 N=1085 District BOENY 10.4% 8.3% 12.5% 0.110 184 SOALALA 11.8% 0% 20.0% 0.071* 85 MITSINJO 10.0% 11.8% 7.7% - 99 MELAKY 9.0% 10.0% 7.9% 0.535 558 BESALAMPY 5.7% 5.0% 6.7% 0.401* 102 AMBATOMAINTY 0% 0% 0% 0.591* 114 ANTSALOVA 15.4% 13.3% 18.2% - 119 MAINTIRANO 10.2% 12.5% 8.0% 0.516* 95 MORAFENOBE 0% 0% 0% 0.361* 128 MENABE 15.5% 19.1% 12.3% 0.143 508 MANJA 7.3% 4.5% 10.5% 0.731* 122 MORONDAVA 11.4% 10.7% 11.9% - 109 MAHABO 9.6% 13.5% 6.5% 0.295* 100 BELO SUR TSIRIBIHINA 19.6% 23.3% 15.4% 0.29 79 MIANDRIVAZO 25.3% 31.8% 19.1% 0.247 98 TOTAL 10.3% 10.7% 10.0% 0.844 2134 *Fisher‘s exact test
Outcome Monitoring Survey in the MAHEFA Areas - 129 -
Table 34: CU5 with diarrhea in the past 2 weeks who were treated with ORS and/or zinc supplement (Indicator 3.08), and CU5 with diarrhea managed by CHVs (Indicator 3.07), Northern and North western Madagascar, MAHEFA 2014 OMS,
N=225
3.08 % CU5 with diarrhea in the past 2 weeks who 3.07 % of CU with diarrhea treated by CHVs were treated with ORS and/or zinc supplement N=225 N=225 Male Female p N Male Female p N REGION Average Average N=112 N=113 N=112 N=113 Boeny 40% 50.0% 33.3% - 19 20% 0% 33.3% - 19 Diana 67.9% 77.8% 57.7% - 36 0% 0% 0% - 36 Melaky 58.3% 62.5% 40.0% 0.567 41 0% 0% 0% - 41 Menabe 52.8% 58.1% 45.5% 0.533 70 7.5% 6.5% 9.1% - 70 Sava 47.1% 25.0% 66.7% 0.242* 11 6.3% 0% 12.5% - 11 Sofia 64.1% 69.2% 59.5% 0.548 48 7.9% 0% 13.5% - 48 TOTAL 59.9% 63.7% 54.9% 0.831 225 5.0% 2% 8.9% 0.006 225
Outcome Monitoring Survey in the MAHEFA Areas - 130 -
Table 35: caretakers of CU5 who know two ways to prevent diarrhea, N=1725 and caretakers of CU5 who cite that diarrhea treatment with ORS and Zinc is effective
3.18: % of caretakers of 3.17: % of CU5 who cite caretakers of CU5 that diarrhea who know two ways treatment with to prevent diarrhea, ORS and Zinc is N=1725 effective N=1725 N REGION Boeny 10.5% 13.20% 148 Diana 30.0% 45.70% 283 Melaky 14.5% 47.30% 448 Menabe 22.6% 27.70% 394 Sava 31.8% 47.30% 75 Sofia 14.2% 36.30% 377 TOTAL 22.1% 39.0% 1725
Outcome Monitoring Survey in the MAHEFA Areas - 131 -
Table 35 (continued and the end): caretakers of CU5 who know two ways to prevent diarrhea, n=1720 and caretakers of CU5 who cite that diarrhea treatment with ORS and Zinc is effective
3.18: % of caretakers of CU5 3.17: % of who cite that caretakers of CU5 diarrhea treatment who know two with ORS and Zinc ways to prevent is effective diarrhea, n=1725 n=1725 DISTRICT BESALAMPY 21.4% 39.3% SOALALA 7.1% 7.1% MITSINJO 8.7% 17.4% PORT BERGE 25.9% 49.4% MANDRITSARA 9.4% 46.6% ANALALAVA 22.5% 37.6% BEFANDRIANA NORD 3.4% 16.2% ANTSOHIHY 15.5% 46.6% BEALANANA 13.6% 26.9% AMBATOMAINTY 22.2% 75.0% ANTSALOVA 5.6% 38.9% MAINTIRANO 10.9% 47.8% MORAFENOBE 25.0% 62.5% MANJA 13.8% 58.6% MORONDAVA 21.2% 59.6%
Outcome Monitoring Survey in the MAHEFA Areas - 132 -
Table 35 (the end): caretakers of CU5 who know two ways to prevent diarrhea, n=1725 and caretakers of CU5 who cite that diarrhea treatment with ORS and Zinc is effective
3.18: % of caretakers of CU5 who cite 3.17: % of that diarrhea caretakers of CU5 treatment with who know two ORS and Zinc is ways to prevent effective diarrhea, n=1725 n=1725 DISTRICT MAHABO 18.2% 6.20% BELO SUR TSIRIBIHINA 23.5% 27.5% MIANDRIVAZO 30.6% 11.0% ANTSIRANANA II 2.6% 31.6% ANTSIRANANA I 5.6% 38.9% VOHEMAR 31.8% 47.3% AMBILOBE 40.8% 58.9% NOSY BE 32.4% 38.2% AMBANJA 16.3% 23.4% TOTAL 22.1% 39.0%
Outcome Monitoring Survey in the MAHEFA Areas - 133 -
Table 36 : People exposed to IEC/BCC MCH messages (Indicator 3.10)
3.10 people exposed to Community IEC/BCC Mass IPC with health MCH media: CHVs mobilization: messages REGION Boeny 9.3% 20.7% 1.9% 46.1% Diana 53.3% 14.8% 2.2% 74.0% Melaky 30.1% 24.6% 7.7% 71.2% Menabe 44.1% 39.8% 7.3% 82.0% Sava 55.9% 15.7% 4.3% 74.3% Sofia 21.4% 13.4% 5.3% 57.3% DISTRICT BESALAMPY 51.9% 21.5% 9.8% 72.3% SOALALA 5.5% 15.6% 1.6% 45.5% MITSINJO 11.9% 24.3% 2.2% 46.5% PORT BERGE 31.1% 6.7% 0.0% 51.3% MANDRITSARA 27.6% 25.3% 6.6% 71.0% ANALALAVA 14.9% 5.8% 1.5% 30.6% BEFANDRIANA NORD 13.3% 13.5% 6.1% 64.3% ANTSOHIHY 24.7% 11.6% 9.5% 58.6% BEALANANA 18.4% 9.7% 7.5% 56.2% AMBATOMAINTY 3.0% 25.1% 0.0% 42.2% ANTSALOVA 15.6% 34.2% 2.3% 79.5% MAINTIRANO 28.2% 27.1% 10.9% 77.8% MORAFENOBE 3.1% .8% 1.0% 36.6% MANJA 35.8% 52.7% .9% 79.4% MORONDAVA 48.9% 92.1% 1.9% 98.7%
Outcome Monitoring Survey in the MAHEFA Areas - 134 -
Table 36 (continued and the end): People exposed to IEC/BCC MCH messages (Indicator 3.10)
3.10 people exposed to Community IEC/BCC Mass IPC with health MCH media: CHVs mobilization: messages DISTRICT (Continued) MAHABO 24.5% 26.5% 7.9% 70.3% BELO SUR TSIRIBIHINA 55.8% 22.6% 11.8% 83.0% MIANDRIVAZO 51.1% 21.9% 9.5% 79.9% ANTSIRANANA II 36.2% 8.7% 0.0% 55.3% ANTSIRANANA I 51.5% 7.9% 2.8% 68.4% VOHEMAR 55.9% 15.7% 4.3% 74.3% AMBILOBE 66.1% 22.8% 2.5% 85.2% NOSY BE 61.9% 4.7% 0.0% 70.5% AMBANJA 32.4% 5.9% 3.0% 61.3% TOTAL 38.0% 18.7% 4.5% 68.2%
Outcome Monitoring Survey in the MAHEFA Areas - 135 -
Table 37: People exposed to IEC/BCC malaria message (Indicator 3.11)
3.11 people Community exposed to Mass IPC with health IEC/BCC media: CHVs mobilization: malaria message REGION Boeny 11.0% 23.0% 1.1% 44.4% Diana 53.5% 16.3% .7% 75.4% Melaky 34.4% 24.2% 7.4% 68.9% Menabe 46.0% 39.0% 7.7% 83.2% Sava 53.2% 19.2% 3.6% 74.2% Sofia 22.0% 17.8% 3.3% 58.7% DISTRICT BESALAMPY 47.6% 19.0% 5.9% 61.0% SOALALA 7.5% 18.2% 1.1% 40.9% MITSINJO 13.4% 26.4% 1.1% 45.2% PORT BERGE 37.4% 5.7% 1.1% 53.0% MANDRITSARA 24.1% 25.1% 1.2% 67.3% ANALALAVA 17.8% 10.1% 1.5% 35.9% BEFANDRIANA NORD 18.2% 16.1% 4.2% 56.8% ANTSOHIHY 22.5% 27.4% 9.8% 69.0% BEALANANA 12.5% 20.9% 4.0% 69.1% AMBATOMAINTY 4.1% 22.0% 0.0% 37.5% ANTSALOVA 18.9% 32.2% 2.5% 72.7% MAINTIRANO 40.6% 29.4% 12.3% 84.6% MORAFENOBE 5.8% .8% 4.6% 30.0% MANJA 38.3% 50.9% 2.1% 76.9% MORONDAVA 55.2% 85.7% 1.9% 94.5% MAHABO 28.2% 33.8% 17.0% 84.1% BELO SUR TSIRIBIHINA 48.8% 13.8% 3.6% 67.4%
Outcome Monitoring Survey in the MAHEFA Areas - 136 -
Table 37(continued and the end): People exposed to IEC/BCC malaria message (Indicator 3.11)
3.11 people Community exposed to Mass IPC with health IEC/BCC media: CHVs mobilization: malaria message DISTRICT (Continued) MIANDRIVAZO 56.1% 25.6% 9.5% 89.5% ANTSIRANANA II 41.0% 10.3% 2.7% 65.5% ANTSIRANANA I 41.8% 2.2% 3.6% 68.2% VOHEMAR 53.2% 19.2% 3.6% 74.2% AMBILOBE 63.7% 26.6% .3% 84.8% NOSY BE 66.3% 3.7% 1.0% 82.4% AMBANJA 36.4% 4.7% 0.0% 60.0% TOTAL 38.7% 21.0% 3.3% 69.3%
Outcome Monitoring Survey in the MAHEFA Areas - 137 -
Table 38: People exposed to IEC/BCC Nutrition messages (Indicator 3.12)
3.12: % of people Community Mass IPC with exposed to health media: CHVs IEC/BCC mobilization: Nutrition messages REGION Boeny 5.8% .5% .4% 11.0% Diana 14.0% 5.4% 4.0% 33.9% Melaky 6.3% 6.7% 0.0% 24.9% Menabe 11.4% 14.2% 1.5% 32.7% Sava 9.8% 6.9% 26.5% 48.5% Sofia 6.8% 1.7% 2.1% 17.7% DISTRICT BESALAMPY 7.0% .4% 0.0% 9.0% SOALALA 5.2% 0.0% 1.1% 9.5% MITSINJO 6.3% .8% 0.0% 12.0% PORT BERGE 13.0% 0.0% 1.1% 17.1% MANDRITSARA 9.4% 5.0% 2.7% 24.7% ANALALAVA 2.9% 1.7% 0.0% 5.4% BEFANDRIANA NORD 1.7% .8% .8% 21.3% ANTSOHIHY 11.6% .8% 2.1% 17.9% BEALANANA 4.8% 0.0% 6.4% 13.0% AMBATOMAINTY 0.0% 6.4% 0.0% 8.5% ANTSALOVA 4.1% 4.7% 0.0% 28.0% MAINTIRANO 8.9% 13.6% 0.0% 42.4% MORAFENOBE 0.0% 0.0% 0.0% 5.2% MANJA 10.4% 24.2% .9% 41.7% MORONDAVA 25.2% 40.6% 0.0% 71.8%
Outcome Monitoring Survey in the MAHEFA Areas - 138 -
Table 38 (continued and the end): People exposed to IEC/BCC Nutrition messages (Indicator 3.12)
3.12: % of people Community Mass IPC with exposed to health media: CHVs IEC/BCC mobilization: Nutrition messages DISTRICT (Continued) MAHABO 6.7% 5.2% 3.4% 17.2% BELO SUR TSIRIBIHINA 3.3% 2.5% 1.2% 11.0% MIANDRIVAZO 12.7% 8.6% 1.6% 32.7% ANTSIRANANA II 12.6% 2.6% 0.0% 22.4% ANTSIRANANA I 19.0% 1.0% 1.0% 31.5% VOHEMAR 9.8% 6.9% 26.5% 48.5% AMBILOBE 10.1% 9.8% 7.7% 44.4% NOSY BE 23.9% 1.0% 0.0% 24.9% AMBANJA 18.3% 0.0% 0.0% 20.9% TOTAL 10.2% 5.4% 4.0% 27.6%
Outcome Monitoring Survey in the MAHEFA Areas - 139 -
Table 39: children 0-6 months exclusively breastfed in the past 24 hours and CU2 weighted during GMP in the last 2 months
3.22: % of children 0-6 months exclusively breastfed in 3.23: % of CU2 weighted during GMP in the last 2 the past 24 hours months, n = 295 n=870 Male Female Male Female Average n= 125 n= 155 p N Average n= 422 n= 448 p N REGION Boeny 87.5% 80.0% 100.0% - 29 42.1% 44.4% 40.0% 0.814 77 Diana 92.0% 100.0% 100.0% - 36 53.9% 59.5% 49.7% 0.690 129 Melaky 90.0% 75.0% 90.0% - 62 35.2% 30.8% 39.3% 0.360 208 Menabe 96.0% 100.0% 100.0% - 73 34.9% 39.2% 30.6% 0.179 218 Sava 85.7% 84.6% 87.5% - 15 32.7% 24.1% 42.3% 0.257 39 Sofia 94.9% 100.0% 92.7% - 67 29.2% 29.2% 29.2% 0.706 199 TOTAL 95.9% 95.4% 96.2% 0.344 282 38.9% 40.1% 38% 0.726 870
Outcome Monitoring Survey in the MAHEFA Areas - 140 -
Table 39 (continued and the end): children 0-6 months exclusively breastfed in the past 24 hours and CU2 weighted during GMP in the last 2 months
3.23: % of CU2 weighted during GMP in the last 2 months, n=870 Male Female n= 422 n= 448 DISTRICT BESALAMPY 50.0% 50.0% SOALALA 33.3% 33.3% MITSINJO 50.0% 50.0% PORT BERGE 30.0% 13.3% MANDRITSARA 25.0% 33.3% ANALALAVA 47.6% 37.0% BEFANDRIANA NORD 19.0% 28.6% ANTSOHIHY 25.0% 50.0% BEALANANA 27.3% 18.8% AMBATOMAINTY 50.0% 50.0% ANTSALOVA 14.3% 0.0% MAINTIRANO 40.0% 42.9% MORAFENOBE 0.0% 50.0% MANJA 30.0% 14.3% MORONDAVA 50.0% 50.0% MAHABO 0.0% 5.9% BELO SUR TSIRIBIHINA 33.3% 33.3% MIANDRIVAZO 60.0% 35.0% ANTSIRANANA II 66.7% 37.5% ANTSIRANANA I 20.0% 40.0% VOHEMAR 24.1% 42.3%
Table 39 (the end): children 0-6 months exclusively breastfed in the past 24 hours and CU2 weighted during GMP in the last 2 months
3.23: % of CU2 weighted during GMP in the last 2 months, n=870 Male Female n= 422 n= 448 AMBILOBE 62.3% 47.7% NOSY BE 60.0% 66.7% AMBANJA 57.1% 55.3% TOTAL 40.1% 38.0%
Outcome Monitoring Survey in the MAHEFA Areas - 141 -
Table 40: Caretakers of CU5 satisfied with quality of care of CHV
3.16: % of caretakers of CU5 satisfied with quality of care of CHVs N=432 REGION n Boeny 66.7% 12 Diana 74.1% 69 Melaky 93.3% 89 Menabe 69.9% 151 Sava 71.0% 21 Sofia 56.3% 90 TOTAL 69.8% 432
Table 40 (continued and the end): Caretakers of CU5 satisfied with quality of care of CHV
3.16: % of caretakers of DISTRICT CU5 satisfied with quality of care of CHVs n N=432 BESALAMPY 80.0% 12 SOALALA 100.0% 5 MITSINJO 50.0% 7 PORT BERGE 73.7% 16 MANDRITSARA 43.6% 27 ANALALAVA 100.0% 6 BEFANDRIANA NORD 41.7% 13 ANTSOHIHY 61.5% 17 BEALANANA 80.0% 11 AMBATOMAINTY 100.0% 10 ANTSALOVA 85.7% 30 MAINTIRANO 94.7% 37 MORAFENOBE - 0
Outcome Monitoring Survey in the MAHEFA Areas - 142 -
Table 40 (the end): Caretakers of CU5 satisfied with quality of care of CHV
3.16: % of caretakers of CU5 satisfied with quality of n care of CHVs DISTRICT (continued) N=432 MANJA 76.5% 51 MORONDAVA 74.5% 74 MAHABO 83.3% 8 BELO SUR TSIRIBIHINA 50.0% 6 MIANDRIVAZO 33.3% 12
ANTSIRANANA II 100.0% 2 ANTSIRANANA I 50.0% 21 VOHEMAR 71.0% 21 AMBILOBE 79.7% 33 NOSY BE 66.7% 7 AMBANJA 26.7% 6 TOTAL 69.8% 432
Outcome Monitoring Survey in the MAHEFA Areas - 143 -
COMMUNITY HEALTH VOLUNTEER INDICATORS
Table 50 : % CHVs who have NO Stock-outs of products for malaria and pneumonia treatment (Indicator 4.04), Northern and North Western Madagascar, OMS 2014,
CHV who have NO CHV who have CHV who have NO stock-out of NO stock-out of stock-out of ACT PNEUMOSTOP or RDT COTRIM N=200 N=200 N=200 % p % p % p GENDER 98.5% Male n≈ 59 93.9% 93.9%
0.429 0.478 - Female n≈ 141 95.5% 91% 94%
REGION
DIANA n=42 81.1% 78.4% 89.2%
SAVA n=9 100% 45.5% 81.8% SOFIA n=57 100% 97.8% 95.6% BOENY n=17 100% 100% 100%
MELAKY n=31 100% 100% 100%
MENABE n=44 100% 97.4% 97.4% TOTAL 96.6% 91.8% 94.4%
Outcome Monitoring Survey in the MAHEFA Areas - 144 -
Table 51: % CHVs who have NO Stock-outs of Family Planning products (Indicator 4.03), Northern and North Western Madagascar, OMS 2014
CHVs who have NO CHVs who have NO CHVs who have NO CHVs who have NO stock-out of stock-out of stock-out of CYCLE stock-out of PILPLAN INJECTION (confiance PROTECTOR PLUS BEADS or depo) N=200 N=200 N=200 N=200 % p % p % p % p GENDER 100% Male n= 59 87.9% 37.9% 89.6% - 0.004 - 0.022 Female n= 141 97.0% 98.9% 60.4% 90.3% REGION DIANA n≈42 91.9% 89.5% 32.4% 78.4% SAVA n≈9 100% 90.9% 81.8% 100%
SOFIA n≈57 96.6% 94.4% 51.1% 93.3%
BOENY n≈17 100% 83.3% 66.7% 100% MELAKY n≈31 88.9% 94.1% 76.5% 88.2% MENABE n≈44 89.5% 87.2% 59% 92.3% TOTAL 94% 91.5% 53.3% 90.0%
Outcome Monitoring Survey in the MAHEFA Areas - 145 -
Table 52: Percentages of certified CHVs: PF4, DEPO, Child health, IEC/Counselling, STI (Indicator 4.09), Northern and North Western Madagascar, OMS 2014
% CHVs with % CHVs with % CHVs with PF4 % CHVs with child CHVs with STI DEPO IEC/Counseling certificate health certificate certificate certificate certificate N≈200 N≈200 N≈200 N≈200 N≈200 % p % p % p % p % p GENDER 31.8% Male n= 59 26.9% 18.2% 16.7% 3.0% 0.523 0.160 0.279 0.759 - Female n= 141 38.3% 31.3% 30.6% 12.8% 4.5% REGION DIANA n≈42 64.9% 59.5% 59.5% 5.4% 5.40% SAVA n≈9 63.6% 9.1% 100% 63.6% 0.0% SOFIA n≈57 13.3% 8.9% 6.7% 6.7% 0.0% BOENY n≈17 42.9% 71.4% 16.7% 0.0% 14.30% MELAKY n≈31 47.1% 38.9% 29.4% 27.8% 23.50% MENABE n≈44 46.2% 43.6% 20.5% 21.1% 5.10% TOTAL 36.1% 29.8% 26.3% 14.4% 4.2%
Outcome Monitoring Survey in the MAHEFA Areas - 146 -
Table 53: Percentages of CHVs who are aware of LAPM service availability (Indicator 4.05);who provide FP/RH counseling, services including STI prevention and referral (Indicator 4.13), Northern and North Western Madagascar, 2014 OMS
4.05 CHV aware of LAPM 4.13 CHV providing FP/RH service availability counseling and STI referral N=200 N=200 % p % p GENDER Male n= 59 42.4% 39.4% 0.004* 0.198 Female n= 141 64.9% 50.7% REGION DIANA n=42 64.9% 51.4% SAVA n=9 63.6% 9.1% SOFIA n=57 43.3% 51.7% BOENY n=17 71.4% 57.1% MELAKY n=31 83.3% 41.2% MENABE n=44 64.1% 43.6% TOTAL 57.4% 46.9% *Fisher’s exact test
Outcome Monitoring Survey in the MAHEFA Areas - 147 -
Table 54: Percentages of CHVs having soap and water for hand washing (Indicator 4.12) ; practicing adequate disposal of hazard materials and equipment (Indicator 4.11), Northern and North Western Madagascar, OMS 2014.
4.11 CHV practicing 4.12 CHVs having soap ITEM % n N adequate disposal of and water for hand SYRINGES NEEDLE hazard materials and washing equipment Brought in safety boxes to the CSBs to be incinerated 14 23 200 N=200 N=200 % p % p Brought in safety boxes and thrown GENDER out in the recommended thorough Male n= 59 50.0% 20.9% pit to be burried 34,1 77 200 0.282 0.008 Female n= 141 61.9% 44.8% Thrown out in latrines 4,1 8 200 REGION Thrown out in the public garbages 13,9 32 200 DIANA n=42 67.6% 62.2% Other 34 60 200 SAVA n=9 63.6% 45.5% WADDINGS/COMPRESSES SOFIA n=57 54.4% 34.4% Brought in safety boxes to the CSBs BOENY n=17 83.3% 42.9% to be incinerated 4,9 9 200 MELAKY n=31 82.4% 17.6% Brought in safety boxes and thrown MENABE n≈=4 41.0% 23.1% out in the recommended thorough TOTAL 58.1% 36.7% pit to be burried 38,6 77 200 Thrown out in latrines 6,8 11 200 Thrown out in the public garbages 26,4 63 200 Other 23,3 40 200
Outcome Monitoring Survey in the MAHEFA Areas - 148 -
Table 55: Indicators on CHV capacity building (Indicators 4.07, 4.08, 4.10 and 4.03), Northern and North Western Madagascar, OMS 2014.
4.07 CHVs achieving 4.08 CHVs achieving a 4.10 CHVs 4.03 CHVs minimum quality passing score on a receiving attending monthly score for community- regular knowledge supervision in the CCDS meeting case management assessment last 2 months N=200 N=200 N=200 N=200 % p % p % p % p GENDER Male n= 59 76.1% 77.3% 66.7% 60.6% 0.674 - 0.003* 0.505 Female n= 141 81.2% 90.2% 43.3% 57.7% REGION DIANA n=42 70.3% 94.6% 24.3% 47.4% SAVA n=9 81.8% 90.9% 63.6% 54.5% SOFIA n=57 81.1% 81.1% 71.9% 68.5% BOENY n=17 85.7% 85.7% 14.3% 71.4% MELAKY n=31 70.6% 16.7% 38.9% 70.6% MENABE n=44 87.2% 10.5% 35.9% 66.7% TOTAL 79.4% 85.6% 50.9% 63.7% * Fisher‘s Exact test
Outcome Monitoring Survey in the MAHEFA Areas - 149 -
Table 56: Indicators on CHV financial development (Indicators 4.01, 4.02 and 4.06), Northern and North Western Madagascar, OMS 2014.
4.02 CHVs with access to credit 4.06 CHVs members 4.01 CHVs with provided by of microfinance increased saving COSAN savings group and loans N=200 N=200 N=200 % p % p % p GENDER Male n= 59 43.0% 24.2% 18.2% 0.402 0.642 0.366 Female n≈ 141 60.9% 26.9% 15.2% REGION DIANA n≈42 59.5% 2.7% 18.9% SAVA n≈9 70.0% 18.2% 0.0% SOFIA n≈57 52.2% 43.8% 23.3% BOENY n≈17 100.0% 0.0% 14.3% MELAKY n≈31 61.1% 11.1% 0.0% MENABE n≈44 51.3% 15.8% 10.5% TOTAL 56.5% 25.7% 16.3%
Outcome Monitoring Survey in the MAHEFA Areas - 150 -
POS INDICATORS
Table 57: Average monthly sales of diarrheal management and prevention products by POS (Indicators 5.12), MAHEFA project, Northern and North Western Madagascar, 2014 OMS
Average monthly Average monthly Average monthly sales of VIASUR sales of ZINC sales of SUREAU
N=51 N=51 N=51 Average Average Average REGION BOENY 36.8 36.8 62.9 DIANA 9.6 37.9 84.5 MELAKY 358.1 365.6 779.6 MENABE 20.2 25.1 88.2 SAVA 0.0 0.7 86.7 SOFIA 32.6 17.7 70.0 TOTAL 32.7 31.9 95.2
Table 58 : Average monthly sales of malaria diagnostic and treatment ptoducts by POS, MAHEFA project, Northern and North Western Madagascar, 2014 OMS (Indicators 5.12)
Average monthly Average monthly sales of ACTIPAL sales of RDT N=51 N=51 Average Average REGION 135,7 150,5 BOENY 41,7 62,2 DIANA 1629,6 329,0 MELAKY 25,3 28,5 MENABE 6,7 0,0 SAVA 18,5 106,8 SOFIA TOTAL 71.4 86.7
Outcome Monitoring Survey in the MAHEFA Areas - 151 -
Table 59: Average monthly sales of pneumonia treatment products by POS (Indicators 5.12), MAHEFA project, in Northern and North Western Madagascar, 2014 OMS
Average monthly Average monthly sales of sales of COTRIM PNEUMOSTOP N=51 N=51 Average Average REGION BOENY 82.6 236.5 DIANA 54.7 112.2 MELAKY 554.6 85.0 MENABE 14.6 36.8 SAVA 32.0 33.3 SOFIA 63.0 16.8 TOTAL 65.9 52.2
Table 60 : Average monthly sales of Family Planning products by POS (Indicators 5.12), MAHEFA project, Northern and North Western Madagascar, 2014 OMS.
Average monthly Average Average monthly Average sales of monthly sales of sales of monthly sales of PROTECTOR PILPLAN CONFIANCE CYCLE BEADS PLUS
N=51 N=51 N=51 N=51 Average Average Average Average REGION BOENY 86.3 309.8 0.0 38.8 DIANA 209.4 148.7 0.8 5.2 MELAKY 44.4 1662.1 0.0 406.8 MENABE 201.9 225.7 0.3 32.5 SAVA 72.7 74.3 0.7 1.7 SOFIA 217.8 442.1 4.8 49.3 TOTAL 193.6 351.3 2.7 43.5
Outcome Monitoring Survey in the MAHEFA Areas - 152 -
Table 61: Average monthly sales of pregnant women and newborn care products by POS (Indicators 5.12), MAHEFA project, Northern and North Western Madagascar, 2014 OMS.
Average monthly Average Average sales of monthly sales of monthly sales of MEBENDAZOL CHLORHEXID IRON FOLATE E INE N=51 N=51 N=51 Average Average Average REGION BOENY 131.4 103.2 0 DIANA 21.1 47.1 0 MELAKY 7.5 0.4 0 MENABE 3 7.4 0 SAVA 1.7 66.7 0 SOFIA 22.7 0 0 TOTAL 22.5 19.9 0
Outcome Monitoring Survey in the MAHEFA Areas - 153 -
Table 62 : Duration of stock-out in months for diarrhea and water treatment products experienced by POS (Indicator 5.01), Northern and North Western Madagascar, OMS 2014
Duration of stock-out in Duration of stock-out in Duration of stock-out in months for VIASUR months for ZINC months for SUREAU N=51 N=51 N=51
Average Median Average Median Average Median REGIONS BOENY 2.6 0.0 2.6 0.0 2.2 0.0 DIANA 0.4 0.0 0.1 0.0 0.2 0.0 MELAKY 1.3 2.0 1.2 0.0 0.0 0.0 MENABE 0.5 0.0 0.1 0.0 0.2 0.0 SAVA 0.0 0.0 0.0 0.0 0.0 0.0 SOFIA 2.6 0.0 0.3 0.0 0.9 0.0 DISTRICTS BESALAMPY SOALALA 1.5 1.5 1.5 1.5 0.0 0.0 MITSINJO 3.0 0.0 3.0 0.0 3.0 0.0 PORT BERGE 1.0 1.0 1.0 1.0 0.5 0.5 MANDRITSARA 0.0 0.0 0.0 0.0 0.0 0.0 ANALALAVA 1.0 0.0 0.4 0.0 0.1 0.0 BEFANDRIANA NORD 4.0 0.0 0.0 0.0 4.0 0.0 ANTSOHIHY 5.0 5.5 0.0 0.0 0.3 0.0 BEALANANA 4.5 4.5 0.0 0.0 0.0 0.0 AMBATOMAINTY 0.0 0.0 4.5 4.5 0.0 0.0 ANTSALOVA MAINTIRANO 2.0 2.0 0.0 0.0 0.0 0.0 MORAFENOBE 0.0 0.0 1.0 1.0 0.0 0.0
Outcome Monitoring Survey in the MAHEFA Areas - 154 -
Table 62 (continued and the end): Duration of stock-out in months for diarrhea and water treatment products experienced by POS (Indicator 5.01), Northern and North Western Madagascar, OMS 2014
Duration of stock- Duration of stock- Duration of stock- out in months for out in months for out in months for VIASUR ZINC SUREAU N=51 N=51 Average Median Average Median Average Median DISTRICT (Continued) MANJA 1.0 1.0 0.0 0.0 0.0 0.0
MORONDAVA
MAHABO 0.5 0.5 0.5 0.5 0.5 0.5 BELO SUR 0.4 0.0 0.0 0.0 0.2 0.0 TSIRIBIHINA MIANDRIVAZO
ANTSIRANANA II 0.0 0.0 0.3 0.0 0.0 0.0
ANTSIRANANA I 3.0 3.0 0.0 0.0 0.0 0.0
VOHEMAR 0.0 0.0 0.0 0.0 0.0 0.0
AMBILOBE 1.0 0.0 0.0 0.0 0.3 0.0
NOSY BE 0.0 0.0 0.0 0.0 2.0 2.0
AMBANJA 0.0 0.0 0.0 0.0 0.0 0.0
TOTAL 1.6 0.0 0.3 0.0 0.6 0.0
Outcome Monitoring Survey in the MAHEFA Areas - 155 -
Table 63: Duration of stock-out in months for malaria diagnostic and treatment, experienced by POS (Indicator 5.01), MAHEFA project, Northern and North Western Madagascar, 2014 OMS
Duration of stock-out in Duration of stock-out in months Duration of stock-out in months for ACTIPAL for PNEUMOSTOP months for RDT N=51 N=51 N=51 Average Median Average Median Average Median REGION BOENY 0 0 0.2 0 0.1 0 DIANA 0.1 0 0 0 0 0 MELAKY 0 0 0 0 0 0 MENABE 0 0 1.1 0 0 0 SAVA 0 0 0 0 0 0 SOFIA 0.1 0 0.4 0 0.1 0 DISTRICT BESALAMPY SOALALA 0 0 0 0 0.5 0.5 MITSINJO 0 0 0.3 0 0 0 PORT BERGE 0 0 0.5 0.5 0 0 MANDRITSARA 1 1 0 0 0 0 ANALALAVA 0 0 0 0 0.1 0 BEFANDRIANA NORD 0 0 0 0 0.3 0 ANTSOHIHY 0 0 2 1.5 0 0 BEALANANA 0 0 0 0 0 0 AMBATOMAINTY 0 0 0 0 0 0 ANTSALOVA MAINTIRANO 0 0 0 0 0 0 MORAFENOBE 0 0 0 0 0 0
Outcome Monitoring Survey in the MAHEFA Areas - 156 -
Table 63(continued and the end): Duration of stock-out in months for malaria diagnostic and treatment, experienced by POS (Indicator 5.01), MAHEFA project, Northern and North Western Madagascar, 2014 OMS
Duration of stock- Duration of stock- Duration of stock- out in months for out in months for out in months for ACTIPAL PNEUMOSTOP RDT N=51 N=51 N=51 Average Median Average Median Average Median DISTRICT (Continued) MANJA 0 0 1 1 0 0 MORONDAVA MAHABO 0 0 0.5 0.5 0 0 BELO SUR 0 0 1.2 0 0 0 TSIRIBIHINA MIANDRIVAZO ANTSIRANANA II 0.3 0 0 0 0 0 ANTSIRANANA I 0 0 0 0 0 0 VOHEMAR 0 0 0 0 0 0 AMBILOBE 0 0 0 0 0 0 NOSY BE 0 0 0 0 0 0 AMBANJA 0 0 0 0 0 0 TOTAL 0.1 0.0 0.4 0.0 0.1 0.0
Outcome Monitoring Survey in the MAHEFA Areas - 157 -
Table 64: Duration of stock-out in months for Family Planning products, experienced by POS (Indicator 5.01), MAHEFA project, Northern and North Western Madagascar, 2014 OMS.
Duration of stock-out in Duration of stock-out Duration of stock-out in Duration of stock-out in months for in months for CYCLE months for months for PILPLAN CONFIANCE BEADS PROTECTOR PLUS N=51 N=51 N=51 N=51 Average Median Average Median Average Median Average Median
months months months months months months months months REGION BOENY 2.2 0 2.2 0 0 0 2.2 0 DIANA 0.1 0 0.2 0 0 0 0 0 MELAKY 0.0 0 0.1 0 0 0 0 0 MENABE 0.4 0 0.4 0 0.3 0 0.4 0 SAVA 0.0 0 0.0 0 0 0 0 0 SOFIA 0.3 0 0.7 0 0.1 0 1.2 0 DISTRICT BESALAMPY SOALALA 0 0 0 0 0 0 0 0 MITSINJO 3 0 3 0 0 0 3 0 PORT BERGE 0 0 2.5 2.5 0 0 1.5 1.5 MANDRITSARA 0 0 1 1 0 0 1 1 ANALALAVA 0.1 0 0.3 0 0 0 0 0 BEFANDRIANA NORD 0.7 0 0.7 0 0.7 0 5 3 ANTSOHIHY 0.3 0 0 0 0 0 0 0 BEALANANA 0.5 0.5 0.5 0.5 0 0 0 0 AMBATOMAINTY 0 0 0 0 0 0 0 0 ANTSALOVA ------
Outcome Monitoring Survey in the MAHEFA Areas - 158 -
Table 64 (continued and the end): Duration of stock-out in months for Family Planning products, experienced by POS (Indicator 5.01), MAHEFA project, Northern and North Western Madagascar, 2014 OMS.
Duration of stock-out Duration of stock-out Duration of stock-out Duration of stock-out in in months for in months for in months for months for PILPLAN CONFIANCE CYCLE BEADS PROTECTOR PLUS N=51 N=51 N=51 N=51 Average Median Average Median Average Median Average Median
months months months months months months months months DISTRICT (Continued) MAINTIRANO 0 0 0 0 0 0 0 0 MORAFENOBE 0 0 1 1 0 0 0 0 MANJA 0 0 0 0 0 0 0 0 MORONDAVA MAHABO 0 0 0.5 0.5 0 0 0.5 0.5 BELO SUR 0.6 0 0.4 0 0.4 0 0.4 0 TSIRIBIHINA MIANDRIVAZO ANTSIRANANA II 0 0 0 0 0 0 0 0 ANTSIRANANA I 0 0 0 0 0 0 0 0 VOHEMAR 0 0 0 0 0 0 0 0 AMBILOBE 0.3 0 0.3 0 0 0 0 0 NOSY BE 0 0 2 2 0 0 0 0 AMBANJA 0 0 0 0 0 0 0 0 TOTAL 0.3 0.0 0.5 0.0 0.1 0.0 0.8 0.0
Outcome Monitoring Survey in the MAHEFA Areas - 159 -
Table 66: % POS having adequate product storage equipment (Indicator 5.09), MAHEFA Project, 2014 OMS.
5.09 POS having adequate product storage equipment N=51 % DIANA 63.6%
SAVA 100.0%
SOFIA 57.7%
BOENY 66.7%
MELAKY 100.0%
MENABE 75.0% TOTAL 66.0%
Additionnal information (not part of equipment, so not used to compute the indicator 5.09)
ITEM weighted % n N Products are stored by product name (voarindra) 46,7 28 51 Products are stored according to the "First expired, first out" principle 43 25 51
Outcome Monitoring Survey in the MAHEFA Areas - 160 -
Table 67: Percentage of POS having expired products for diarrhea and water treatment (Indicator 5.10), Northern and North Western Madagascar, 2014 OMS
POS having POS having POS having expired expired ZINC expired SUREAU VIASUR N=51 N=51 N=51 REGION % % % DIANA 10.0% 9.1% 0.0%
SAVA 0.0% 0.0% 33.3%
SOFIA 46.2% 11.5% 11.5%
BOENY 33.3% 33.3% 0.0%
MELAKY 0.0% 100.0% 0.0%
MENABE 28.6% 12.5% 0.0% TOTAL 31.3% 13.1% 7.7%
Table 68: Percentage of POS having expired products for malaria diagnostic and treatment (Indicator 5.10), MAHEFA project, Northern and North Western Madagascar, 2014 OMS
POS having POS having expired expired RDT ACTIPAL N=51 N=51 REGION % % BOENY 0.0% 0.0%
DIANA 0.0% 0.0%
MELAKY 0.0% 0.0%
MENABE 0.0% 0.0%
SAVA 0.0% 0.0%
SOFIA 0.0% 0.0%
TOTAL 0.0% 0.8%
Outcome Monitoring Survey in the MAHEFA Areas - 161 -
Table 69: Percentage of POS having expired products for pneumonia treatment (Indicator 5.10), Northern and North Western Madagascar, 2014 OMS
POS having expired PNEUMOSTOP N=51 REGION % BOENY 0.0%
DIANA 0.0%
MELAKY 0.0%
MENABE 0.0%
SAVA 0.0%
SOFIA 0.0%
TOTAL 0.0%
Table 71 : : Percentage of POS having expired products for Family Planning, Northern and North Western Madagascar, 2014OMS
POS having POS having POS having expired expired expired PROTECTOR PILPLAN CONFIANCE PLUS N=51 N=51 N=51 REGION % % BOENY 0.0% 0.0% 0.0%
DIANA 0.0% 0.0% 0.0%
MELAKY 0.0% 0.0% 0.0%
MENABE 0.0% 0.0% 0.0%
SAVA 0.0% 0.0% 0.0%
SOFIA 0.0% 0.0% 0.0%
TOTAL 0.0% 0.0% 0.0%
Outcome Monitoring Survey in the MAHEFA Areas - 162 -
Table 72: CHVs re-supplying from the POS (Indicators 5.03 and 5.04) and number of days of absence of POS (Indicator 5.02), Northern and North Western Madagascar, 2014 OMS
5.04 Number of CHVs re- 5.02 Number of 5.03 Number of supplying from days of absence CHVs re-supplying the POS during of POS during
from the POS the last three the last three months months (Frequency) N=51 N=51 N=51
REGION n n Average DIANA 126 106 6.0 SAVA 51 47 6.3 SOFIA 174 24 0.3 BOENY 26 36 0.1 MELAKY 16 7 1.6 MENABE 56 57 0.8 TOTAL 449 457 1.9
Outcome Monitoring Survey in the MAHEFA Areas - 163 -
Table 73: POS training (Indicators 5.05 and 5.06), MAHEFA project, 2014 OMS
5.05 % POS who 5.06 % POS who received health received management technical training in the training in the past 3 past year N=51 months N=51 % % REGION DIANA 54.5% 10.0%
SAVA 66.7% 66.7% SOFIA 57.7% 57.7% BOENY 50.0% 66.7% MELAKY 0.0% 100.0% MENABE 75.0% 37.5% TOTAL 41.3% 53.0%
Outcome Monitoring Survey in the MAHEFA Areas - 164 -
Table 74: Percentage of POS who attended at least one meeting with CHVs in the past 3 months (Indicator 5.07), and percentage of POS receiving regularly update on list of FP/DEPO certified CHV (Indicator 5.08), MAHEFA project, Norhern and North Western Madagascar, 2014 OMS.
5.07 % POS who 5.08 % POS attended at least one receiving regularly meeting with CHVs in update on list of
the past three months FP/DEPO certified N=51 CHV N=51
DIANA 30.0% 0.0 SAVA 33.3% 0.0 SOFIA 53.8% 0.0 BOENY 33.3% 0.0 MELAKY 100.0% 0.0 MENABE 28.6% 14.3 TOTAL 43.4% 2.2%
Outcome Monitoring Survey in the MAHEFA Areas - 165 -
ANNEXES E: Data collection instruments
E.1 HH Questionnaire
FANEKENA HANDRAY ANJARA AMIN’NY FANADIHADIANA
Miarahaba anao tompoko. ______no anarako, miasa amin‘ny ______aho.
Manao fanadihadiana momba ny fahasalamana izahay, ka maniry ny handraisanao anjara amin‘izany. Maharitra adiny iray na adiny iray sy sasany eo ny fanadihadiana. Mandritra izany dia hisy andiam-panontaniana hapetrakay aminao momba ny tokantrano misy anao, ny fahasalamanao, sy ny fahasalaman‘ny zaza ato an-tokantranonao. Ao anatin‘io fanadihadiana momba ny fahasalaman‘ny zaza io, dia handrefy ny manodidina ny sandrin‘ny ankizikely ato aminareo izahay amin‘ny alalan‘ity metatra fandrefesana ity. Ny fanadihadiana dia atao ao anatin‘ny tsiambaratelo tanteraka. Tsy hisy anarana, na adiresy trano hivoaka ampahimebaso na oviana na oviana. Noho izany, miangavy anao izahay hilaza ny tena marina An-tsitrapo ny fandraisana anjara. Raha misy fanontaniana tsy tianao valiana dia ilazao aho fa avy hatrany dia hiroso amin‘ny fanontaniana manaraka isika. Azonao atao tsara koa ny manapaka ny fanadihadiana na oviana na oviana, eny na dia mbola tsy mifarana aza izany. Ny fanirianay anefa dia ny mba handraisanao sy ny zaza latsaky ny 5 taona anjara amin‘ny fandrefesan-tsandry satria zava-dehibe aminay ny hevitrao sy ny fahafantarana izany refy izany. Manana fanontaniana momba ny fanadihadiana ve ianao? Azontsika atomboka ve ny fanadihadiana? Sonian‘ny mpanadihady ______Sonian‘ny mpandray anjara ______Daty ______NANDA TSY HANDRAY ANJARA AMIN‘NY FANADIHADIANA VE NY TOKANTRANO? RAHA ENY, TOHIZO
RAHA TSIA, ANONTANIO:
- TAONA: |__|__| - MPAMALY: L V - MANAMBADY – MPITOVO – EFA NISARA-PANAMBADIANA – MATY VADY - ISAN‘NY ZAZA : |__|__| - ANTON‘ASA : ______- ANTONY NANDAVANA : ______
Outcome Monitoring Survey in the MAHEFA Areas - 166 -
MAHAKASIKA NY TOKANTRANO
ANARAN‘NY TOERANA/FOKONTANY NUMERO DE GRAPPE NUMÉRO DU MÉNAGE : 01 - 20 FARITRA DISTRIKA KAOMININA AN-DRENIVOHITRA=1 / AMBANIVOHITRA=2 LAHARANA FINDAY RAHA MISY
CSB AKAIKY INDRINDRA:
CHV/ MPANENTANA ARA-PAHASALAMANA AKAIKY INDRINDRA: ANARANA ………………. HALAVIRANA: ………………KM
MISY OLONA ATO AN-TRANO VE AFAKA MIHINDRAM-BOLA ANY AMIN‘NY ENY TSIA TSY BANKY? FANTATRA
MISY OLONA ATO AN-TRANO VE AFAKA MIHINDRAM-BOLA ANY AMIN‘NY ENY TSIA TSY TAHIRY FAMPINDRAMAM-BOLA? FANTATRA
MISY OLONA ATO AN-TRANO VE AFAKA MIHINDRAM-BOLA ANY AMINA ENY TSIA TSY TETIK‘ASA NA FAMPINDRAMAM-BOLA HAFA? FANTATRA
ASA FIVELOMANA MAMPIDI-BOLA HO AN‘NY TOKANTRANO : A-FAMBOLENA B-FIOMPIANA
C-JONO D-MITRANDRAKA HARENA AN-KIBON‘NY TANY E-ASA TANANA
F-MANAO SARIBAO G-VAROTRA H-ASA ISAN‘ANDRO I-ASA SARAKA AN-TSAHA J-KARAMA RAIKITRA
K-HAFA (LAZAO)
FITAMBARAN‘NY VOLA MIDITRA ISAM-BOLANA: 1-latsaky ny 100 000Ar 2-100 000At-200 000Ar 3-200 000Ar-300 000Ar
4-300 000Ar-400 000Ar 5-400 000Ar-500 000Ar 6-500 000Ar-750 000Ar 7-750 000Ar-1 000 000Ar 8-1 000 000Ar-1 500 000Ar
9-1 5000 000Ar -2 000 000Ar 10-Mihoatra ny 2 000 000Ar
NITROSA VOLA VE NY TOKANTRANONAREO, TAMIN‘NY TAONA LASA? ENY TSIA
Outcome Monitoring Survey in the MAHEFA Areas - 167 -
RAHA ENY, IZA NO NINDRAMANA VOLA? A- HAVANA/ NAMANA B- MPANAO ASA SOA C- MPANJANA-BOLA
D- MPAMPINDRAM-BOLA MADINIKA E- BANKY F- MPIVAROTRA G – HAFA (LAZAO)
INONA NO NAMPIASANAO IZANY? A-SAKAFO B-FAHASALAMANA C-FAMPIANARANA D-FITAFIANA
E-TRANO IPETRAHANA F-SOSIALY/ KOLONTSAINA G-FAMPIASAM-BOLA H-FANEFANA TROSA
HAFA I-HAFA LAZAO FANANANA (TAFIDITRA AO NY FANANAN-TANY) :
ISAN‘NY TRANO …………………………………………….
VELARAN‘NY TANY MITAMBATRA………… ARA
TOMPON-TRANO VE IANAO SA MPANOFA? 1-TOMPON-TRANO 2-TSY TOMPONY NEFA TSY MANDOA HOFAN- TRANO 3-MPANOFA
NANDRAY TOMBONTSOA TAMIN‘NY TETIK‘ASA MAHEFA VE NY TOKANTRANO? ENY TSIA
RAHA ENY, MOMBA NY INONA IZANY? A-TAZOMOKA B-FITATERANA MARARY C-FAHASALAMAN‘NY RENY SY NY ZAZA D-IST E-RANO, FANADIOVANA SY FIDIOVANA F-SAKAFO ARA- PAHASALAMANA F-FAHASALAMANA ENY AMIN‘NY FIARAHA- MONINA G-PLANNING FAMILIAL H-FANDEFASANA ENY AMIN‘NY CSBII
Outcome Monitoring Survey in the MAHEFA Areas - 168 -
FITSIDIHAN‘NY MPANADIHADY
1 2 3 FITSIDIHANA NATAO
______ANDRO DATY ______VOLANA ANARAN‘NY TAONA MPANADIHADY MARIKY NY MPANADIHADY ______VALINY
VALINY
FITSIDIHANA MANARAKA ______
DATY ______FITAMBARAN‘NY ORA ISAN‘NY FITSIDIHANA
*MARIKY NY VOKATRA : FITAMBARAN‘NY ISAN‘NY OLONA AO 1 FENO AMIN‘ILAY 2 TSY MISY OLONA TENA MIPETRAKA AO AMIN‘ILAY TRANO NA TSY TOKANTRANO MISY OLONA AZO HADIHADIANA TAMIN‘NY FOTOANA NANDALOVANA 3 TSY MISY OLONA MIHITSY AO AN-TRANO MANDRITRA NY FOTOANA FITAMBARAN‘NY MAHARITRA TSY VOAFETRA ISAN‘NY VEHIVAVY AZO 4 NANDA HADIHADIANA 5 TRANO FOANA NA TSY MISY TRANO AMIN‘ILAY ADIRESY VOATONDRO FITAMBARAN‘NY 6 EFA NORAVAINA ILAY TRANO ISAN‘NY MPITAIZA ZAZA 7 TSY HITA ILAY TRANO AZO HADIHADIANA 96 HAFA (LAZAO) LAHARAN‘NY ANDININ‘NY FANADIHADIANA AMIN‘NY FANONTANIANA HO AN‘NY TOKANTRANO
Outcome Monitoring Survey in the MAHEFA Areas - 169 -
ANDIAM-PANONTANIANA MOMBA NY TOKANTRANO
Ankehitriny dia hanontany anareo aho momba ny olona mipetraka ato amin‘ity tokan-trano ity
RAHA 15 TAONA NA MIHOATRA OLONA FIFANDR LAHY FONENANA TAONA FIANAR ASA NA VADY VOHOK TOETRA NISAFIDIANANA AZY MONINA SY AISANY SA ANA ZAVATRA A MPAMANGY AMIN‘NY VAVY ATAO LEHIBEM- PIANAKA VIANA L Azafady, iza avy Inona no Lahy sa vavy (ANARAN Natory tato Firy taona i Kilasy faha- Inona no ataon‘i Manamba Mitondra MARIHO MARIHO MARIHO MARIH AH ireo olona monina ifandraisan‘i i A ve i (ANARAN firy izao i (ANARANA dy ve i vohoka ve i X NY X NY X NY O X NY ARA ato amin‘ny (ANARANA (ANARANA FIANTSO (ANARAN A (ANARANA FIANTSOANA) (ANARA (ANARAN LAHARA LAHARA LAHARA LAHAR N‘ andavanandro sy FIANTSOANA FIANTSOA ANA) ve A FIANTSO FIANTSOA izao? NA A N‘ANDAL N‘ANDAL N‘ANDA AN‘AN AN ireo olona nivahiny ) amin‘ny NA)? monina eto FIANTSO ANA)? NA)? FIANTSO FIANTSO AN‘NY AN‘NY LAN‘NY DALAN‘ D ka natory tato lehiben‘ny rehefa ANA) ANA) sa ANA) VEHIVAV ANKIZY ANKIZY NY A alina? Atomboy fianakaviana? andavanand alina? Mariho ny mpitovo ankehitriny Y LATSAKY LATSAK ANKIZY LAN amin‘ny lehibem- ro? taona Raha tsy sa hafa? ? REHETRA NY 1 Y NY 2 LATSA A pianakaviana, ary |__|__|, mianatra 15-49 TAONA TAONA KY NY 5 ny anarana Sy ny intsony i TAONA REHETRA REHETR TAONA fiantsoana azy no volana (ANARANA KA A REHETR soratana nitsahiny FIANTSOA MANAMB A |__|__| NA) dia ADY (EN kilasy UNION) fahafiry no niala nianatra?
Valiny: T0— T25 (fa tsy asiana T ao anaty tablette)
ENY = 1 L: 1 ENY = 1 TSIA = 0 V: 0 TSIA = 0 (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (10a) (12) (13) (14) (15) 01 |__|__| , |__|__| 02 |__|__| , |__|__| 03 |__|__| ,
Outcome Monitoring Survey in the MAHEFA Areas - 170 -
|__|__| 04 |__|__| , |__|__| 05 |__|__| , |__|__| 06 |__|__| , |__|__| 07 |__|__| , |__|__| 08 |__|__| , |__|__| 09 |__|__| , |__|__| 10 |__|__| , |__|__|
1. MARIKA SORATANA F.3: FIFANDRAISANA AMIN‘NY LEHIBEM- 3. MARIKA SORATANA F.10: VADY PIANAKAVIANA 01 = LEHIBEN‘NY FIANAKAVIANA IHANY 09 = ZANAKY NY IRAY TAMPO 1 = MANAMBADY ARA-DALANA NA MANAO TOKANTRANO MASO 02 = VADY AMINY 2 = MISARAKA VITA TRIBONALY/MISARA-TOERANA 03 = ZANAKA LAHY NA VAVY 10 = HAVANA HAFA 3 = MATY VADY 04 = VINANTO LAHY NA VAVY 11 = ZAZA NATSANGANA 4 = MPITOVO/MBOLA TSY NANAMBADY NA TSY MBOLA NANAO 05 = ZAFIKELY 12 = ZANA-BADY TOKANTRANO MASO MIHITSY 06 = RAINY NA RENINY 12 = TSY MISY RA IRAISANA 07 = RAIKELY NA RENIKELINY 96 = TSY FANTATRA 08 = RAHALAHY, ANADAHY, RAHAVAVY, ANABAVY 7.ASA ATAO 01 = MPIASA 02 = TSY MIASA 03 = VAO MITADY ASA VOALOHANY 04 = MIKARAKARA TOKANTRANO 05 = MISOTRO RONONO 06 = TSY AFAKA MIASA 07 = MPIANATRA 08 = MPAMBOLY/ MPIOMPY 09 = MIASA TENA 10 = HAFA (lazao)
Outcome Monitoring Survey in the MAHEFA Areas - 171 -
RAHA 15 TAONA NA MIHOATRA OLONA FIFANDR LAHY FONENANA TAONA FIANAR ASA NA VADY VOHOK TOETRA NISAFIDIANANA AZY MONINA SY AISANY SA ANA ZAVATRA A MPAMANGY AMIN‘N VAVY ATAO Y LEHIBE M- PIANAK AVIANA L Azafady, iza avy ireo Inona no Lahy sa vavy (ANARAN Natory tato Firy taona i Kilasy faha- Inona no ataon‘i Manamba Mitondra MARIHO MARIHO MARIHO MARIH AH olona monina ato ifandraisan‘i i A ve i (ANARAN firy izao i (ANARANA dy ve i vohoka ve i X NY X NY X NY O X NY ARA amin‘ny (ANARANA (ANARANA FIANTSO (ANARAN A (ANARANA FIANTSOANA) (ANARA (ANARAN LAHARA LAHARA LAHARA LAHAR N‘ andavanandro sy ireo FIANTSOA FIANTSOA ANA) ve A FIANTSO FIANTSOA izao? NA A N‘ANDAL N‘ANDAL N‘ANDA AN‘AN AN olona nivahiny ka NA) amin‘ny NA)? monina eto FIANTSO ANA)? NA)? FIANTSO FIANTSO AN‘NY AN‘NY LAN‘NY DALAN‘ D natory tato alina? lehiben‘ny rehefa ANA) ANA) sa ANA) VEHIVAV ANKIZY ANKIZY NY A Atomboy amin‘ny fianakaviana andavanand alina? Mariho ny mpitovo ankehitriny Y LATSAKY LATSAK ANKIZY LAN lehibem- ? ro? taona Raha tsy sa hafa? ? REHETRA NY 1 Y NY 2 LATSA A pianakaviana, ary ny |__|__|, mianatra 15-49 TAONA TAONA KY NY 5 anarana fiantsoana Sy ny intsony i TAONA REHETRA REHETR TAONA azy no soratana volana (ANARANA KA A REHETR nitsahiny FIANTSOA MANAMB A REHEFA AZO SY |__|__| NA) dia ADY (EN VOASORATRA NY kilasy UNION) LISITRY NY fahafiry no OLONA , FENO niala VALINTENY NY nianatra? TSANGANANA 3 SY 4, APETRAHO Valiny: T0— IREO T25 (fa tsy FANONTANIANA asiana T ao 3 ETSY AMIN‘NY anaty FARAN‘NY tablette) TABILAO MBA HAHAZOANA ANTOKA FA FENO NY LISITRY NY OLONA AO AMIN‘NY TOKANTRANO. APETRAHO ENY = 1 AMIN‘IZAY IREO L: 1 ENY = 1 TSIA = 0 FANONTANIANA V: 0 TSIA = 0 AMIN‘NY TSANGANANA 5 KA HATRAMIN‘NY 15 (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (10a) (12) (13) (14) (15) 01 |__|__| , |__|__| 02 |__|__| , |__|__| 03 |__|__| ,
Outcome Monitoring Survey in the MAHEFA Areas - 172 -
|__|__| 04 |__|__| , |__|__| 05 |__|__| , |__|__| 06 |__|__| , |__|__| 07 |__|__| , |__|__| 08 |__|__| , |__|__| 09 |__|__| , |__|__| 10 |__|__| , |__|__| Mba hahazoana antoka fa manana lisitra feno isika: 1. MARIKA SORATANA F.7: FIFANDRAISANA AMIN‘NY LEHIBEM- PIANAKAVIANA Mbola misy ankizikely na zaza menavava Raha ENY, soraty tsirairay amin‘ny 01 = LEHIBEN‘NY FIANAKAVIANA 09 = ZANAKY NY IRAY TAMPO hafa tsy voalaza ve? tabilao IHANY AMINY 02 = VADY 10 = HAVANA HAFA Mbola misy olon-kafa tsy voasoratra ao 03 = ZANAKA LAHY NA VAVY 11 = ZAZA NATSANGANA anaty lisitra ve kanefa monina ato? Toy Raha ENY, soraty tsirairay amin‘ny 04 = VINANTO LAHY NA VAVY 12 = ZANA-BADY ny mpanampy, ny namana, na mpanofa tabilao 05 = ZAFIKELY 12 = TSY MISY RA IRAISANA trano 06 = RAINY NA RENINY 96 = TSY FANTATRA 07 = RAIKELY NA RENIKELINY Misa namana na havana namangy anareo Raha ENY, soraty amin‘ny tabilao 08 = RAHALAHY, ANADAHY, ve ka natory tato alina, kanefa mbola tsy RAHAVAVY, ANABAVY ao anaty lisitra?
Outcome Monitoring Survey in the MAHEFA Areas - 173 -
TOETOETRY NY TOKANTRANO
N° FANONTANIANA SY SIVANA Mandeh ana any amin’ny 100 Efa nahare momba ny DIORANO- ENY 1 WASH na momba ny fanadiovana sy TSIA 2 101 ny fidiovana ve ianareo? TSY FANTATRO 96 101 100A Inona ireo hafatra fototra (message MANASÀ TANANA AMIN‘NY RANO SY SAVONY 1 clés) DIORANO WASH efa renareo? KAJIO NY FAHADIOVAN‘NY RANO FISOTRO HADIO AVY 2 ANY AMPANTSAKANA KA HATRANY AMIN‘NY TSY TONONINA FAMPIASANA AZY MAMPIASA LAVAPIRINGA AZO SASANA SY VOADIO 3 HAFA………………………….. 96
101 Avy aiza ny fiavian‘ny rano sotroin‘ny RANO AMIN’NY PAOMPY olona matetika indrindra ao amin‘ity tokantrano ity? - AO ANATY TRANO FONENANA 11 - AO AN-TOKONTANY 12 - PAOMPIM-POKONOLONA 13 LAVA-DRANO MISY PAOMPY NA FANTSON-DRANO 21 LAVA-DRANO NOHADIANA - MISARONA 31 - TSY MISARONA 32 LOHARANO - VOAARO 41 - TSY VOAARO 42 RANONORANA 51 KAMIAO MISY SINIBE (CITERNE) 61 RANO AVY AMIN‘NY 81 RENIRANO/FEFILOHA/ONY/FARIHY/KAMORY/TATATRA RANO AMIN‘NY TAVOAHANGY 91 RANO AMIN‘NY TAVOAHANGY VOADIO TAMIN‘NY 92 TARATRY NY MASOANDRO HAFA (LAZAO)……………… 96
Outcome Monitoring Survey in the MAHEFA Areas - 174 -
102 Avy aiza ny rano handrahoan-tsakafo na hanasan‘ny olona tanana ato RANO AMIN’NY PAOMPY amin‘ity tokantrano ity? - AO ANATY TRANO FONENANA 11
- AO AN-TOKONTANY 12 - PAOMPIM-POKONOLONA 13 LAVA-DRANO MISY PAOMPY NA TABIKA 21 LAVA-DRANO NOHADIANA - MISARONA 31 - TSY MISARONA 32 LOHARANO - VOAARO 41 - TSY VOAARO 42 RANONORANA 51 105 KAMIAO FITOERAN-DRANO (citerne) 61 RANO AVY AMIN‘NY 81 RENIRANO/FEFILOHA/ONY/FARIHY/KAMORY/TATATRA RANO AMIN‘NY TAVOAHANGY 91 RANO AMIN‘NY TAVOAHANGY VOADIO TAMIN‘NY 92 TARATRY NY MASOANDRO HAFA (lazao): …………………………….... 96 103 Aiza no misy io toerana - AO ANATY TRANO FONENANA 1 104A fangalanareo rano io? - AO AN-TOKONTANY 2 104A - ANY AN-KAFA 3
104 Hafiriana no ahatongavana MINITRA …. any amin‘io toerana fangalana rano io? (ALLER) TSY FANTATRA 9999 104A Iza no namatsy ny MAHEFA 1 fanamboarana io fantsakana TETIKASA HAFA VATSIAN‘NY USAID 2 io? TSY MISY 3 HAFA (Lazao): …………………………... 96 105 Misy zavatra ataonareo ve ENY 1 hampadio ny rano TSIA 2 107 fisotronareo? TSY FANTATRO 96 107 106 Inona no ataonareo AMPANGOTRAHANA A hampadio ny rano sotroinareo? ASIANA « EAU DE JAVEL/CHLORE » B
ASIANA « SUR‘EAU » C
TATAVANINA AMIN‘NY LAMBA D
TATAVANINA AMIN‘NY FANATATAVANANA E SERAMIKA/FASIKA/VATOKELY/SARIBAO SNS
Outcome Monitoring Survey in the MAHEFA Areas - 175 -
ATAO ANATY TAVOAHANGY MADIO ARY ATANINA F MASOANDRO MBA HO FATY NY OTRIKARETINA
AVELA HIPETRAKA ELAELA G
HAFA (lazao) 96 TSY FANTATRA Z 106A Ahoana ny fampiasanareo MAHAY MAMPANGOTRAKA RANO SY MITAHIRY (VALIN‘NY AZY FANONTANIANA 106) NANGOTRA-TOKANA NA MIHOATRA A hanadiovana rano?
Henoina ny fanazavany na jerena ny ataony dia NOSAROMANA B marihana ENY na TSIA mifanandrify amin‘ny valiny
NAFINDRA TAMIN’NY FITOERAN-DRANO MADIO C (NOSASANA RANO SY SAVONY ISAN’ANDRO)
MAHAY MAMPIASA RANON-JAVELY NA « CHLORE » HANADIOVANA RANO FISOTRO VOAHAJA NY FATRA NAHAZOANA RANONA D « CHLORINE 1% » HANADIOVANA NY RANO FISOTRO
FANTATRA/VOAHAJA NY FATRAN’NY RANONA E « CHLORINE 1% » NA RANON-JAVELY NANAMPOHANA SY NY RANO FISOTRO NOTAPOHINA
NOHAROHAROINA NY RANO AVY NONTAMPOHANA F « CHLORINE 1% » NA RANON-JAVELY
NOSAROMANA ARY NAVELA HILONA 30mn NY G FANGARO AZO
NOSOLOINA ISAN’ANDRO NY RANO FISOTRO H NODIOVINA TAMIN’NY « CHLORINE 1% » NA RANON- JAVELY
MAHAY MAMPIASA « SUR’EAU » « SUR’EAU » TSY LANY DATY NO AMPIASAINY I (JERENA)
VOAHAJA NY FATRAN’NY RANONA « SUR’EAU » J NANAMPOHANA SY NY RANO FISOTRO NOTAPOHINA
Outcome Monitoring Survey in the MAHEFA Areas - 176 -
NOHAROHAROINA NY RANO AVY NOTAMPOHANA K « SUR’EAU »
NOSAROMANA ARY NAVELA HILONA 30mn NY L FANGARO AZO
MAHAY MANALA OTRIKARETINA AMIN’NY RANO AMIN’NY ALALAN’NY MASOANDRO TAVOAHANGY VOAFANTINA (MISY SORATRA “PET”: M polyéthylène thérephtalate), VOADIO, MANGARAHARA (TSY MATROKA), MISARONA, TSY MISY FONO TARATASY, TSY MISY KIAKA ARY TSY SIMBA NO NAMPIASAINA
VOAHAJA NY FOTOANA NIPETRAHAN’NY N TAVOAHANGY MISY RANO TEO AMIN’NY TARATRY NY MASOANDRO
107 Mitahiry rano fisotro ve ENY 1 ianareo? TSIA 2 108 Azoko jerena ve ireo ENY 1 fitoeran-drano ampiasainareo itehirizana rano fisotro ao an- TSIA 2 trano ireo? 109 ARAKA NY HITA MASO, IREO FITOERAN-DRANO DIA: 110 Lehibe vava LEHIBE VAVA NY FITOERAN-DRANO REHETRA 1
JEREN‘NY MPANADIHADY LEHIBE VAVA NY FITOERAN-DRANO SASANY 2
TERY VAVA DAHOLO NY FITOERAN-DRANO 3 REHETRA
111 Misy paompy MISY PAOMPY NY FITOERAN-DRANO REHETRA 1
JEREN‘NY MISY PAOMPY NY FITOERAN-DRANO SASANY 2 MPANADIHADY
TSY MISY PAOMPY DAHOLO NY FITOERAN-DRANO 3 REHETRA
Outcome Monitoring Survey in the MAHEFA Areas - 177 -
112 Misy sarony misy visy na MISY SARONY VISY NA AFAKA MIRAIKITRA AMINY 1 sarony sahafa na sarony NY FITOERAN-DRANO REHETRA afaka miraikitra aminy ny fitoeran-drano MISY SARONY VISY NA AFAKA MIRAIKITRA AMINY 2 JEREN‘NY NY FITOERAN-DRANO SASANY MPANADIHADY
TSY MISY SARONY VISY NA AFAKA MIRAIKITRA 3 AMINY NY FITOERAN-DRANO REHETRA
MISY SARONY SAHAFA VE NY FITOERAN-DRANO 4
113 Misy siny misy fitatavanana, MISY SINY MISY FITATAVAVANA, SARONY ARY 1 sarony ary paompy PAOMPY NY FITOERAN-DRANO REHETRA
JEREN‘NY MPANADIHADY MISY SINY MISY FITATAVAVANA, SARONY ARY 2 PAOMPY NY FITOERAN-DRANO SASANY
MISY SINY MISY FITATAVAVANA, FA TSY MISY 3 SARONY SY/NA PAOMPY NY FITOERAN-DRANO REHETRA
146 Aiza ny olona ato amin‘ity ANATIN‘NY TRANO/NA ANY AN-TOKONTANY 1 tokantrano ity no manasa AN‘NY AMIN‘NY TOERANA HAFA ANY 2 tanana matetika? ENY REHETRA ENY 3
147 MIANGAVIA MBA PAOMPY MANDEHA (andramo raha mandeha) A HOENTINA ANY SAVONY, LAVENONA NA AKORA HAFA SOLON- B AMIN‘ILAY TOERANA TSAVONY FANASAN‘NY OLONA KOVETA NA SIO MISY RANO C TANANA MATETIKA AO AN-TOKANTRANO, KA TSY MISY AN‘IREO ZAVATRA VOALAZA EO D JEREO RAHA MISY AMBONY IRETO ZAVATRA IRETO EO AMIN‘IZANY TOERANA IZANY
Outcome Monitoring Survey in the MAHEFA Areas - 178 -
114 Inona ny karazana trano MISY FANDEFASAN-DRANO NA TONDRAHANA fivoahana (fanaovana MANARY AMIN‘NY ZOHINDRIAKA 11 maloto) ampiasain‘ny olona MANARY AMIN‘NY ―FOSSE SEPTIQUE‖ 12 ao an-tokantranonareo? MANARY AMIN‘NY LAVAPIRINGA 13 MANARY AMIN‘NY ZAVATRA HAFA 14 TSY FANTATRA MANKAIZA NY RANO 15 JEREN‘NY LAVAKA NA LAVAPIRINGA MPANADIHADY LAVAPIRINGA NOHATSARAINA MISY 21 FIVEZIVEZEN‘NY RIVOTRA LAVAPIRINGA MISY GORODONA AZO SASANA 22 LAVAPIRINGA MISY GORODONA TSY AZO SASANA 23 LAVAPIRINGA TSY MISY GORODONA/LAVAKA TSY 24 MISARONA LAVAPIRINGA SADY FANAOVANA ―COMPOST‖ 31 SIÔ/TINETY 41 LAVAPIRINGA MIHANTONA 51 TSY MISY LAVAPIRINGA FA MANAO MALOTO ENY 61 REHETRA ENY HAFA (Lazao): ……………….. 96 114A Aiza no anarianao ny ANY ANATY LAVAPIRINGA maloton‘ny zanakao, izay MANDAVAKA, ATAO ANATY LAVAKA, TOTOFANA mbola tsy mahay ka mbola AVY EO manao ―couche‖ na taty? ANATY LAVAKA TSY VOATOTOTRA ENY REHETRA ENY HAFA (Lazao): ……………….. 115 Itambarana amin‘ny olon- ENY 1 kafa ve ny trano fivoahana TSIA 2 116A ampiasainareo?
116 Tokantrano firy no ISANY ….. mampiasa ny trano fivoahana TSY FANTATRA 96 ampiasainareo?
116A Iza no namatsy ny MAHEFA 1 fananganana io trano TETIKASA HAFA VATSIAN‘NY USAID 2 fivoahana ampiasainareo io? TSY MISY 3 HAFA (Lazao):…………………. 96 117 Misy herin‘aratra, radio, HERIN’ARATRA fahitalavitra, finday, ENY 1 telefaona ve ao an- TSIA 2 tokantranonareo? RADIO ENY 1 JEREN‘NY TSIA 2 MPANADIHADY FAHITALAVITRA ENY 1 TSIA 2 FINDAY ENY 1 TSIA 2 TELEFAONA ENY 1 TSIA 2 VATA FAMPANGATSIAHANA ENY 1 TSIA 2
Outcome Monitoring Survey in the MAHEFA Areas - 179 -
118 Inona no fampiasanareo HERINARATRA 1 handrahoina sakafo? GAZ PROPANE LIQUEFIE 2 ENTONA VOAJANAHARY/ GAZ NATUREL 3 BIOGAZ 4 KEROSENE 5 CHARBON, LIGNITE 6 SARIBAO VITA @ HAZO 7 HAZO/ KITAY 8 BOZAKA/ TAPA-KAZO/ RAVIN-KAZO 9 AMBIM-PAKO @ VOLY 10 BOUSE (TAIN‘OMBY) 11 TSY MAHANDRO SAKAFO 95 HAFA (LAZAO)…………………. 96 119 Mahandro sakafo amin‘ny AFO 1 121 afo na amin‘ny lafaoro ve LAFAORO MIVOHA 2 ianareo ao an-trano? LAFAORO MIHIDY MISY FIVOAHAN‘ETONA 3 HAFA (LAZAO)…………………… 96 120 Misy fivoahan‘entona sa tsy FIVOAHAN‘ENTONA (CHEMINEE) 1 misy ny lafaoro FANTSONA MITROKA ENTONA (HOTTE) 2 ampiasainareo? SAMY TSY MISY 3 121 Ao anaty trano fipetrahana sa AO AN-TRANO 1 anaty trano mitokana sa any TRANO HAFA MITOKANA 2 ivelan‘ny trano no hanaovanareo lakozia? ANY IVELANY 3 HAFA (LAZAO)…………………………. 96 122 Manana trano mitokana 1 hampiasainareo hatao lakozia ve ianareo? ENY TSIA 2
Outcome Monitoring Survey in the MAHEFA Areas - 180 -
123 VITA AMIN‘NY INONA AKORA NATORALY NY TANY HITSAHINA AO AN-TRANO, MARIHO TANY/ FASIKA 11 ATO BOUSE 12 AKORA TSOTRA GORODONA HAZO 21 PALMES/ BAMBOU 22 TSIHY (NATTE) 23 AKORA VOAHODINA HAZO EFA VOAASA SY NASIANA SAVOKA NA 31 VERNIS BANDES DE VINYLE/ ASPHALTE (GOUDRON) 32 CARREAUX 33 CIMENT 34 MOQUETTE 35 HAFA (LAZAO) ……………… 96 124 VITA AMIN‘NY INONA AKORA NATORALY NY TAFON-TRANO? MARIHO ATO TSY MISY TAFO 11 CHAUME/ PALME/ RAVINA 12 MOTTE D‘HERBE (BOZAKA) 13 AKORA TSOTRA PLANCHES EN BOIS 23 PALMES/ BAMBOU 22 TSIHY (NATTE) 21 BAORITRA (CARTON) 24 AKORA VOAHODINA TOLE 31 HAZO (BOIS) 32 ZINC/ FIBRE DE CIMENT 33 TUILES 34 SIMENITRA (CIMENT) 35 SHINGLES 36 HAFA (LAZAO) 96
Outcome Monitoring Survey in the MAHEFA Areas - 181 -
125 VITA AMIN‘NY INONA AKORA NATORALY NY RINDRINA AO AN- TRANO? MARIHO ATO TSY MISY RINDRINA 11
BAMBOU/ CANE/ PALME/ TRONC 12 TANY 13 AKORA TSOTRA BAMBOU AVEC BOUE 21 PIERRE AVEC BOUE 22 ADOBE NON RECOUVERT 23 CONTRE PLAQUE 24 CARTON 25 BOIS DE RECUPERATION 26 AKORA VOAHODINA SIMENITRA (CIMENT) 31 PIERRE AVEC CHAUX/ CIMENT 32 BIRIKY 33 BLOCS DE CIMENT 34 ADOBE RECOUVERT 35 PLANCHE EN BOIS/ SHINGLES 36 HAFA (LAZAO) 96 126 Firy ny efitra fatorianareo ao ISAN‘NY EFITRA an-trano? 127 Misy olona mipetraka ato ENY TSIA aminareo ve manana: Famataranandro? 1 2
Bisikileta? 1 2 Motocyclette: Scooter? 1 2 Saretin‘omby? 1 2 Fiara/ Kamiao 1 2 Bateau à moteur 1 2 128 Misy manana tanimboly na ENY 1 tany ve ny olona mipetraka ato aminareo? TSIA 2 130 129 Firy ara no haben‘ny ARA tanimboly na tany ve olona mipetraka ato aminareo? 9500 ARA NA MIHOATRA 95 TSY HAIKO 96 130 Misy manana biby fiompy ENY 1 toy ny omby, akoho sy vorona sns ve ny olona ato TSIA 2 132 aminareo?
Outcome Monitoring Survey in the MAHEFA Areas - 182 -
131 Firy amin‘ireto no ananan‘ny Omby olona mipetraka ato aminareo? Soavaly/ Apondra/ Boriky (Mules)
Ondry
Osy
Akoho
Gana/ Gisa
Kisoa
132 Misy manana kaonty any ENY 1 amin‘ny banky ve ny olona ato aminareo? TSIA 2
117A Mazoto ve ianareo raha toa ENY 1 ka hanaovana fanadihadiana amin‘ny telefaonina indray TSIA 2 androany?
148 Raha misy ny voina mahazo, ENY 1 misy fitaovam-pitaterana azonareo antsoina/ TSIA 2 149B ampiasaina ve?
149 Inona ireo karazam- TAXI/TAXI BOROSY A pitaovam-pitaterana FIARAN‘OLON-TSOTRA B ampiasaina raha mila vonjy BISIKILETA C maika ianareo monina ato BISIKILETA AMBULANCE (MAHEFA) D amin‘ity tokantrano ity? MOTO E SARETY TARIHIN‘OMBY F OMBY/AMPONDRA G TRAKITERA H KAMIAO I POSY J POSY AMBULANCE (MAHEFA) K LAKANA L BAKA/SAMBO/KANOTY M CANOE AMBULANCE (MAHEFA) N FIARAMANIDINA O FITSOROA (BRANCARD) P BRANCARD A ROUE (MAHEFA) Q AEROGLISSEUR R HAFA (lazao) 96 149B Misy fitaterana tohanana ENY 1 tetikasa ve azonao antsoina hitondra ny olona ato TSIA 2 150 amin‘ny tokantranonao any amin‘ny toeram-pitsaboana LAZAO NY KARAZANY RAHA MISY: 96 raha mila fitsaboana maika izy?
Outcome Monitoring Survey in the MAHEFA Areas - 183 -
149C Raha misy izany, iza no MAHEFA 1 mamatsy ny fitaovam- TETIKASA HAFA VATSIAN‘NY USAID 2 pitaterana? TSY MISY HAFA (lazao): 96 149D Raha araka ny hevitrareo, SAROTRA 1 mora ve no ahazoana izany MORA 2 fitaterana vatsian‘ny tetikasa ANTONONY 3 izany? TSY FANTATRO 4 149E Efa nisy olona ve tato an- ENY 1 tokantranonao nila fitsaboana maika ka nentina tany amin‘ny toeram-pitsaboana TSIA 2 150 tamin‘ny alalan‘ny fitaovam- pitanterana tohanana tetikasa? TSY FANTATRO 3 150
149F Raha nisy izany, iza no MAHEFA 1 nanome fitaovam-pitanterana TETIKASA HAFA VATSIAN‘NY USAID 2 nitondrana ny marary HAFA (Lazao): 96 nankany amin‘ny toeram- pitsaboana? 150 Raha mila fitsaboana maika ENY 1 ny vehivavy bevohoka sy ny zaza latsaky ny 5 taona, misy TSIA 2 150B fitaovana ve azo itaterana azy ho amin‘ny toeram- pitsaboana? 150A Inona ny fitaovam-pitaterana TAXI/TAXI BOROSY A ampiasaina raha mila FIARAN‘OLON-TSOTRA B fitsaboana maika ny BISIKILETA C vehivavy bevohoka sy ny BISIKILETA AMBULANCE (MAHEFA) D zaza latsaky ny 5 taona MOTO E monina ato an- SARETY TARIHIN‘OMBY F tokantranonareo? OMBY/AMPONDRA G TRAKITERA H KAMIAO I POSY J POSY BICYCLETTE AMBULANCE (MAHEFA) K LAKANA L BAKA/SAMBO/KANOTY M CANOE AMBULANCE (MAHEFA) N FIARAMANIDINA O FITSOROA (BRANCARD) P BRANCARD A ROUE (MAHEFA) Q AEROGLISSEUR R HAFA (lazao) 96
Outcome Monitoring Survey in the MAHEFA Areas - 184 -
150B Misy fitaterana tohanana ENY 1 tetikasa ve azonao antsoina hitondra ny vehivavy TSIA 2 150E bevohoka sy zaza latsaky ny 5 taona ato amin‘ny LAZAO NY KARAZANY RAHA MISY: 96 tokantranonao raha mila fitsaboana maika izy? 150C Iza no tetikasa manohana MAHEFA 1 izany? TETIKASA HAFA VATSIAN‘NY USAID 2 HAFA (Lazao): 96 150D Raha araka ny hevitrareo, SAROTRA 1 mora ve no ahazoanareo io MORA 2 fitaovana io raha itaterana ANTONONY 3 vehivavy bevohoka na zaza latsaky ny 5 taona mila TSY FANTATRO 4 fitsaboana maika? 150E Efa nisy vehivavy bevohoka ENY 1 na zaza latsaky ny 5 taona ve tato an-tokantranonao nila TSIA 2 fitsaboana maika ka nentina tany amin‘ny toeram- TSY FANTATRA 3 pitsaboana tamin‘ny alalan‘ny fitaovam- pitanterana tohanana tetikasa?
150F Raha nisy izany, iza no MAHEFA 1 nanome ny fitaovam- TETIKASA HAFA VATSIAN‘NY USAID 2 pitaterana? TSY MISY HAFA (Lazao): 96 150G Ahoana no fahitanareo ny LAFO, TSY TAKATRY NY FAHEFA-MIVIDIKO ALOHA 1 saran‘ny fitaovam-pitaterana AMIN‘IZAO FOTOANA IZAO ho an‘ny vehivavy sy ankizy marary toy ny bicyclette ANTONONY IHANY SAINGY TSY MBOLA TAKATRO 2 ambulance, ny pousse ambulance ary ny brancard à TAKATRY NY FAHEFA MIVIDIKO 3 roue et le canoe ambulance vatsian‘ny USAID ireo? TSY MISY AN‘IZANY ANY AMINAY 4
Outcome Monitoring Survey in the MAHEFA Areas - 185 -
154 Ohatrinona ny saram- TOTALIN‘NY VOLA NALOANAREO (Ar) - ALLER pitaterana aloanareo matetika rehefa mankany amin‘ny tobim- Mandeha an-tongotra mankany amin‘ny tobim-pahasalamana 1 pahasalamana akaiky anareo Tsy mbola nandoa mihitsy 2 indrindra? Tsy fantatra 3
133 Misy mpikambana amina ENY 1 fikambanam-piantohana ara- TSIA 2→134 pahasalamana (mutuelle de santé) ve ato aminareo?
ANARAN‘NY FIKAMBANANA______
133A Iza no mpikambana amin‘io ANARANA ANARANA ANARANA fikambanam-piantohana io ato amin‘ity tokantrano ity? ANDALANA FAHA ANDALANA FAHA ANDALANA FAHA
133B Iza no nanentana/nandresy MPANENTANA ARA- MPANENTANA ARA- MPANENTANA ARA- lahatra azy hiditra ho PAHASALAMANA PAHASALAMANA PAHASALAMANA mpikambana amin‘io fikambanam-piantohana io? HAFA (lazao) HAFA (lazao) HAFA (lazao) 133C Iza no tetikasa nanamora sy MAHEFA MAHEFA MAHEFA nanampy tamin‘ny nananganana ny TETIKASA HAFA TETIKASA HAFA TETIKASA HAFA fikambanam-piantohana? VATSIAN'NY USAID VATSIAN'NY USAID VATSIAN'NY USAID
HAFA (lazao) HAFA (lazao) HAFA (lazao) 134 Misy mpikambana amina ENY 1 fikambanana TSIA 2→135 mpampindram-bola madinika ve ato aminareo?
ANARAN‘NY FIKAMBANANA 134A Iza no mpikambana amin‘io ANARANA ANARANA ANARANA fikambanan mpampindram- bola madinika io ato ANDALANA FAHA ANDALANA FAHA ANDALANA FAHA amin‘ity tokantrano ity?
134B Iza no nanentana/nandresy MPANENTANA ARA- MPANENTANA ARA- MPANENTANA ARA- lahatra azy hiditra ho PAHASALAMANA PAHASALAMANA PAHASALAMANA mpikambana mpampindram-bola HAFA (lazao) HAFA (lazao) HAFA (lazao) madinika io? 134C Iza ny tetikasa nanamora sy MAHEFA…………1 MAHEFA…………1 MAHEFA…………1 nanampy tamin‘ny nananganana ny TETIKASA HAFA TETIKASA HAFA TETIKASA HAFA fikambanana VATSIAN'NY VATSIAN'NY VATSIAN'NY mpampindram-bola USAID…………….2 USAID…………….2 USAID…………….2 madinika? HAFA (lazao)…….96 HAFA (lazao)…….96 HAFA (lazao)…….96 135 Manana lay fampiasa rehefa ENY 1 matory ve ianareo? TSIA 2→145A
Outcome Monitoring Survey in the MAHEFA Areas - 186 -
136 Firy ny isan‘ny lay ISANY……………………….. anananareo ato amin‘ity tokantrano ity? RAISO AN-TSORATRA ETSY AMIN‘NY 137, 137A NY MOMBA NY LAY TSIRAIRAY LAY#1 LAY#2 LAY#3
137 RAHA TSY MAHADISO, MBA ASEHOY AHY NY NOJERENA SY NOJERENA SY NOJERENA SY LAY FIAROVANA HITA HITA HITA AMIN‘NY KAIKITRY NY → 138A → 138A → 138A MOKA REHETRA AO AN- TOKANTRANONAREO TSY HITA TSY HITA TSY HITA
RAHA MIHOATRA NY 3 NY ISAN‘NY LAY DIA MANAMPIA TAKELAM- PANONTANIANA
138A FIRY VOLANA IZAY NO ISAN‘NY ISAN‘NY ISAN‘NY VOLANA NANANAREO NY LAY? VOLANA VOLANA
(atao hoe 0 raha (atao hoe 0 raha (atao hoe 0 raha latsaky ny 1 latsaky ny 1 volana) latsaky ny 1 volana) volana) 37 volana na 37 volana na mihoatra 37 volana na mihoatra mihoatra
TSY TADIDY TSY TADIDY TSY TADIDY 139 ANONTANIO NA JEREO LAY MISY ODY LAY MISY ODY LAY MISY ODY NY MARIKY NY LAY MOKA MOKA MOKA MAHARITRA MAHARITRA MAHARITRA
1 1 1 OLYSET OLYSET OLYSET
2 2 2 SUPERMANET SUPERMANET SUPERMANET
3 3 3 SUPER SUPER SUPER
MOUSTIQUAIRE MOUSTIQUAIRE MOUSTIQUAIRE
4 4 4 MILAY MILAY MILAY
5 5 5 HAFA MARIKA HAFA MARIKA HAFA MARIKA
96 96 96 TSY FANTATRA TSY FANTATRA TSY FANTATRA
(lazao) (lazao) (lazao)
LAY NASIANA LAY NASIANA LAY NASIANA ODY MOKA ODY MOKA ODY MOKA MIALOHA MIALOHA MIALOHA
MARIKA 7 MARIKA 7 MARIKA REHETRA 7 REHETRA REHETRA
96 96 HAFA (lazao) 96 HAFA (lazao) HAFA (lazao) TSY MISY MARIKA TSY MISY 9 TSY MISY 9 9 MARIKA MARIKA
Outcome Monitoring Survey in the MAHEFA Areas - 187 -
139A FIAVIAN‘NY LAY RAHA TETIKASA TETIKASA TETIKASA HITA VATSIAN‘NY VATSIAN‘NY VATSIAN‘NY USAID USAID USAID
HAFA (Lazao): 96 HAFA (Lazao): 96 HAFA (Lazao): 96
140 FONY NAHAZOANAREO ENY……….…1 ENY……….…1 ENY……….…1 NY LAY, NASIANA ODY TSIA…………2 TSIA…………2 TSIA…………2 MAMONO SY → 143 → 143 → 143 MAMPANDOSITRA TSY VOA- TSY VOA- TSY VOA- MOKA VE IZY IO? FARITRA……3 FARITRA……3 FARITRA……3 → 143 → 143 → 143 141 HATRAMIN‘NY ENY……….…1 ENY……….…1 ENY……….…1 NAHAZOANA NY LAY, TSIA…………2 TSIA…………2 TSIA…………2 NATSOBOKA TAO → 143 → 143 → 143 ANATY RANO MAMONO TSY VOA- TSY VOA- TSY VOA- SY MAMPANDOSITRA FARITRA……3 FARITRA……3 FARITRA……3 MOKA VE IZY IO? → 143 → 143 → 143
142 FIRY VOLANA IZAY NY ISAN‘NY ISAN‘NY ISAN‘NY VOLANA LAY NO NATSOBOKA VOLANA VOLANA TAO ANATY RANO MAMONO SY (atao hoe 00 raha (atao hoe 00 raha (atao hoe 00 raha MAMPANDOSITRA latsaky ny 1 latsaky ny 1 volana) latsaky ny 1 volana) MOKA? volana) Tato anatin‘ny 8 Tato anatin‘ny 8 Tato anatin‘ny 8 volana volana volana Tato anatin‘ny 12 Tato anatin‘ny 12 Tato anatin‘ny 12 volana volana volana TSY TSY VOAFARITRA TSY VOAFARITRA VOAFARITRA 143 Nisy natory ve tao anatin‘io ENY……….…1 ENY……….…1 ENY……….…1 lay io alina? TSIA…………2 TSIA…………2 TSIA…………2 →145A →145A →145A TSY VOA- TSY VOA- TSY VOA- FARITRA……3 FARITRA……3 FARITRA……3 →145A →145A →145A
144 Iza avy no natory tao ANARANA ANARANA ANARANA anatin‘io lay io alina? ANDALANA ANDALANA ANDALANA FAHA FAHA FAHA ANARANA ANARANA ANARANA ANDALANA FAHA ANDALANA ANDALANA FAHA FAHA ANARANA ANDALANA FAHA ANARANA ANARANA ANDALANA ANDALANA ANARANA FAHA FAHA ANDALANA FAHA
ANARANA ANARANA ANDALANA ANDALANA FAHA FAHA
Outcome Monitoring Survey in the MAHEFA Areas - 188 -
145 RAHA MBOLA RAHA MBOLA RAHA MBOLA MISY LAY MISY LAY HAFA MISY LAY HAFA HAFA DIA DIA DIA MANDEHANA MANDEHANA MANDEHANA ANY AMIN‘NY ANY AMIN‘NY ANY AMIN‘NY F137 F137 F137 RAHA TSY MISY RAHA TSY RAHA TSY MISY INTSONY DIA MISY INTSONY INTSONY DIA TOHIZO AO DIA TOHIZO AO TOHIZO AO AMIN‘NY F145A AMIN‘NY AMIN‘NY F145A F145A
145A TSIAHIVO NY DATY ANDROANY. KAJIO NY DATY TAMIN‘NY 12 VOLANA LASA. ENY 1 Tamin‘ny (DATIN‘NY 12 VOLANA LASA) no TSIA 2 mankaty, namendrahana ody moka ve ny ati-tranonareo TSY VOAFARITRA 3 mba hiarovana amin‘ny tazomoka?
145B TSIAHIVO NY DATY ANDROANY. KAJIO NY DATY TAMIN‘NY TELO VOLANA LASA
Tamin‘ny (DATIN‘NY TELO VOLANA LASA) no ENY 1 mankaty, novangian‘ny mpanentana ara- TSIA 2→827 pahasalamana eo anivon‘ny fiaraha-monina ve ny TSY VOAFARITRA 3→827 tokantranonareo?
145C Inona ny resaka FISAFOANA SY FITERAHANA…………………………………….. A nifanaovanareo SOINS NEONATALS………………………………………………….B tamin‘izany? SOINS APRES ACCOUCCHEMENT…………………………………C SOINS APRES AVORTEMENT………………………………………D FANDRINDRAM-PITERAHANA……………………………………. E FIAROVANA AMIN‘NY VOHOKA TSY NIRIANA……………….. F FANAOVANA VAKSINY NY ZAZA NA NY RENY……………… G NY SAKAFON‘NY ZAZA SY NY FAMPINONOAN-DRENY…….. H FANARAHA-MASO NY FITOMBON‘NY ZAZA……………………I TAZO NA TAZOMOKA……………………………………………….J ARETIM-PIVALANANA……………………………………………. K KOHAKA SY ARETIN-TRATRA…………………………………… L HAFA (lazao)…………………………………………………………. 96
Outcome Monitoring Survey in the MAHEFA Areas - 189 -
827 FANONTANIANA APETRAKA AMIN‘NY LEHIBEN‘NY FIANAKAVIANA IHANY
Hatraiza ny fanekenao na fandavanao ireto tsangan- MARIKA kevitra ireto
1.Ny vehivavy dia tokony hitovy zo sy ho mira lenta -2= Laviko tanteraka izany amin‘ny lehilahy. -1= Laviko izany 0 = Ekeko tsy ekeko ihany +1= Ekeko izany +2= Ekeko tanteraka izany
2. Rehefa dinihina, ny lehilahy no tena mety mpitarika +2= Laviko tanteraka izany politika tsara noho ny vehivavy, ny lehilahy no tokony +1= Laviko izany fidiana amin‘ny fifidianana fa tsy ny vehivavy ® 0= Ekeko tsy ekeko ihany -1= Ekeko izany -2= Ekeko tanteraka izany
3. Rehefa vitsy ny asa, ny lehilahy no tokony hanan-jo +2= Laviko tanteraka izany omena asa alohan‘ny vehivavy ® +1= Laviko izany 0= Ekeko tsy ekeko ihany -1= Ekeko izany -2= Ekeko tanteraka izany
828 MIANGAVY ANAO AHO MBA HAMALY AMIM- PAHATSORANA IRETO FANONTANIANA IRETO MARIKA FA TENA HANAMPY AHY HAHALALA BEBE KOKOA NY OLANA MISY IZANY
TSIAHIVO NY DATIN‘NY 30 ANDRO LASA
Nandritra ny 4 herinandro, izany hoe tamin‘ny (DATIN‘NY 30 ANDRO LASA) hatramin‘ny anio, 1=TSIA→829 nisy fotoana ve tsy nisy nohanina mihitsy tato an-trano 2=ENY na dia vary iray venty aza noho ny tsy fahampian‘ny vola na ny hoenti-manana na ny tsy fiakaran‘ny vokatra eny an-tsaha/tanimbary?
828A Impiry niseho izany nandritra izay 1 volana izay, izany MARIKA hoe tamin‘ny (DATIN‘NY 30 ANDRO LASA) 1= MAHALANA (In-1 ka hatramin‘ny hatramin‘ny anio? indroa) 2= INDRAINDRAY (Intelo ka hatramin‘ny impolo) 3= MATETIKA (In-11 na mihoatra) 829 Nandritra ny 4 herinandro, izany hoe tamin‘ny MARIKA (DATIN‘NY 30 ANDRO LASA) hatramin‘ny anio, nisy fotoana ve ianao na ny olona tato amin‘ity 1= TSIA→830 tokantrano ity, nahatsiaro noana nony hatory ny hariva 2= ENY satria zara raha nisakafo nandritra ny andro?
(FANAMARIHANA: tsy ampy ny sakafo noho ny tsy fisiana na ny tsy fahampian‘ny hoenti-manana ny tsy fiakaran‘ny vokatra eny an-tsaha/tanimbary) 829A Impiry niseho izany hanoanana izany nandritra izay 1 MARIKA volana izay, izany hoe tamin‘ny (DATIN‘NY 30 1= MAHALANA (In-1 ka hatramin‘ny ANDRO LASA) hatramin‘ny anio? indroa) 2= INDRAINDRAY (Intelo ka hatramin‘ny impolo) 3= MATETIKA (In-11 na mihoatra)
Outcome Monitoring Survey in the MAHEFA Areas - 190 -
830 Nandritra ny 4 herinandro, izany hoe tamin‘ny (DATIN‘NY 30 ANDRO LASA) hatramin‘ny anio, RAHA nisy fotoana ve ianao na ny olona tato amin‘ity 1= TSIA (TSIA) DIA tokantrano ity, tsy nihinana sakafo mihitsy na kely aza 2= ENY TAPITRA nandritra ny andro ary nandry fotsy noho ny tsy NY fahampian‘ny sakafo na ny hoenti-manana na ny tsy FANADIHA fisian‘ny vokatra miakatra? DIANA
830A Impiry niseho izany tsy fihinanana sakafo izany MARIKA nandritra izay 1 volana izay, izany hoe tamin‘ny 1= MAHALANA (In-1 ka hatramin‘ny (DATIN‘NY 30 ANDRO LASA) hatramin‘ny anio? indroa) 2= INDRAINDRAY (Intelo ka hatramin‘ny impolo) 3= MATETIKA (In-11 na mihoatra) 155 ISAN‘NY TOKANTRANO VOAFANTINA HANAOVANA NY FANADIHADIANA G
ENY (1) ------ TOHIZO AMIN‘NY FANADIHADIANA MAHAKASIKA NY VEHIVAVY HO AN‘IZAY VEHIVAVY MAHAFENO NY FEPETRA
TSIA (2) ------ TAPITRA NY FANADIHADIANA MOMBA NY TOKANTRANO
Outcome Monitoring Survey in the MAHEFA Areas - 191 -
E.2 WRA Questionnaire
FANEKEN’NY VEHIVAVY 15-49 TAONA SY NY MPITAIZA HANDRAY ANJARA
Miarahaba anao. ______no anarako ary miasa amin‘ny ______aho.
Manao fanadihadiana momba ny fahasalamana izahay ary maniry ny handraisanao anjara amin‘izany. Maharitra 1 ora ka hatramin‘ny 1 ora sy sasany eo ny fanadihadiana. Mandritra izany dia hanontany fanontaniana maromaro anao izahay momba ny fahasalamanao sy ny fahasalaman‘ny zanakao na ny zaza tezainao. Raha 6 volana ka hatramin‘ny 5 taona ny zanakao dia dia horefesiko amin‘ny alalan‘ity metatra kely ity ny manodidina ny sandriny. Izay zavatra holazainao eto dia hijanona ho tsiambaratelo tanteraka. An-tsitrapo tanteraka ny fandraisana anjara amin‘izao fanadihadiana izao. Raha misy fanontaniana napetrako ka tsy tianao ho valiana dia ilazao aho fa tonga dia hotohizantsika amin‘ny fanontaniana manaraka yny resatsika. Azonao atao koa ny miato tsy handray anjara na oviana na oviana. Maniry ny handraisanao anjara amin‘izao fanadihadiana izao izahay satria zava-dehibe aminay ny hevitrao. Tsy ho lazaina ampahabemaso ny anaranao ka miangavy anao izahay, izay tena marina lazaina. Manana fanontaniana momba ny fanadihadiana ve ianao? Azontsika atomboka ny resantsika?
Sonian‘ny mpanadihady: ______
Sonian‘ny hadihadiana : ______
Daty : ______
MANAIKY NY HANDRAY ANJARA AMIN‘NY MANDA TSY METY HANDRAY ANJARA AMIN‘NY FANADIHADIANA IZY FANADIHADIANA IZY
TOHIZO TAONA: FANAMBADIANA : MANAMBADY – MPITOVO – MATY VADY - MISARAKA ISAN‘NY ZANAKA : ANTONY NANDAVANA:
Outcome Monitoring Survey in the MAHEFA Areas - 192 -
TOETOETRY NY TOKANTRANON‘NY VEHIVAVY 15-49 TAONA
ANARAN-TOERANA ANARAN‘NY RAIM-PIANAKAVIANA LAHARAN‘NY « GRAPPE » LOT TRANO FARITRA KAOMININA RENIVOHITRA=1 / AMBANIVOHITRA=2
LAHARAN‘NY FINDAY RAHA MISY
CSB AKAIKY INDRINDRA:
CHV/ MPANENTANA ARA-PAHASALAMANA AKAIKY INDRINDRA: ANARANA ………………. HALAVIRANA: ………………KM
MISY OLONA ATO AN-TRANO VE AFAKA MIHINDRAM-BOLA ANY ENY TSIA TSY FANTATRA AMIN‘NY TAHIRY FAMPINDRAMAM-BOLA?
MISY OLONA ATO AN-TRANO VE AFAKA MIHINDRAM-BOLA ANY ENY TSIA TSY FANTATRA AMIN‘NY TAHIRY FAMPINDRAMAM-BOLA?
MISY OLONA ATO AN-TRANO VE AFAKA MIHINDRAM-BOLA ANY ENY TSIA TSY FANTATRA AMINA TETIK‘ASA NA FAMPINDRAMAM-BOLA HAFA?
ASA FIVELOMANA MAMPIDI-BOLA HO AN‘NY TOKANTRANO : A-FAMBOLENA B-FIOMPIANA C-JONO D-MITRANDRAKA HARENA AN- KIBON‘NY TANY E-ASA TANANA F-MANAO SARIBAO G-VAROTRA H-ASA ISAN‘ANDRO I-ASA SARAKA AN-TSAHA J-KARAMA RAIKITRA K-HAFA (LAZAO)
NITROSA VOLA VE NY TOKANTRANONAREO, TAMIN‘NY TAONA LASA? ENY TSIA
A- HAVANA/ NAMANA RAHA ENY, IZA NO NINDRAMANA VOLA? B- MPANAO ASA SOA C- MPANJANA-BOLA D- MPAMPINDRAM-BOLA MADINIKA
E- BANKY F- MPIVAROTRA G – HAFA (LAZAO)
Outcome Monitoring Survey in the MAHEFA Areas - 193 -
INONA NO NAMPIASANAO IZANY? A-SAKAFO B-FAHASALAMANA
C-FAMPIANARANA D-FITAFIANA E-TRANO IPETRAHANA F-SOSIALY/ KOLONTSAINA G-FAMPIASAM-BOLA H-FANEFANA TROSA HAFA I-HAFA LAZAO
FANANANA (TAFIDITRA AO NY FANANAN-TANY) :
ISAN‘NY TRANO …………………………………………….
VELARAN‘NY TANY MITAMBATRA………… ARA
Outcome Monitoring Survey in the MAHEFA Areas - 194 -
FITSIDIHAN‘NY MPANADIHADY NY VEHIVAVY 15-49 TAONA
1 2 3 FITSIDIHANA NATAO
______ANDRO DATY ______VOLANA ANARAN‘NY MPANADIHADY TAONA
______MARIKY NY MPANADIHADY
VOKATRA* VOKATRA
FITSIDIHANA MANARAKA ______TOTALIN‘ISAN‘NY FITSIDIHANA DATY ______ORA
*MARIKY NY VOKATRA : TOTALIN‘ISAN‘NY VEHIVEVY 15-49 TAONA 1 FENO AO AN-TOKANTRANO 2 TSY MISY OLONA NY TRANO NA OLONA TSY AFAKA MAMALY NY ANDIAM-PANONTANIANA NY TAO TAMIN‘NY FITSIDIHANA TOTALIN‘ISAN‘NY 3 TOKANTRANO TSY EO ARY TSY HOE EO MANDRITRA NY FOTOANA VEHIVAVY AZO MAHARITRA HADIHADIANA 4 NANDA TSY HANDRAY ANJARA 5 TRANO TSY MISY OLONA NA TSY MISY TRANO AMIN‘NY ADIRESY TOTALIN‘ISAN‘NY 6 TRANO SIMBA MPITAIZA AZO 7 TRANO TSY HITA HADIHADIANA 96 HAFA (LAZAO) LAHARAN‘NY ANDALANA
MARIKY NY MPANARAMASO BIRAO MPITANTANA ANTONTAN‘ISA ANARANA ANARANA
DATY DATY
Outcome Monitoring Survey in the MAHEFA Areas - 195 -
N° FANONTANIANA SY SIVANA MARIKA MANDEHANA ANY AMIN’NY 101 SORATY NY ORA ORA |__|__|
MINITRA |__|__|
102 Nanomboka oviana ianao no nipetraka TAONA………… tato (ANARAN‘NY TRANO IPETRAHANY, IZAY ANAOVANA HATRIZAY NY FANADIHADIANA) VAHINY MPAMANGY RAHA LATSAKY NY 1 TAONA, SORATY 00 103 Oviana ianao no teraka? Omeo ny daty VOLANA……………... misy ny volana sy ny taona TSY TADIDY NY VOLANA nahaterahanao TAONA………………… TSY TADIDY NY TAONA 104 Firy taona ianao tamin‘ny tsingerintaona nahaterahanao farany?
AMPITOVIO ARY AHITSIO 103 SY/NA 104 RAHA TSY MITOVY
105 Efa nandia sekoly ve ianao? ENY 1 TSIA 2 107A
106 Hatraiza ny dingana farany vitanao teo AMBARATONGA FOTOTRA amin‘ny fianarana? AMBARATONGA FAHAROA
AMBARATONGA AMBONY 107 Kilasy fahafiry ianao no niala tamin‘izay dingana izay? T……………… TO T25 107A Manambady ve ianao? - MANAMBADY ARA-DALANA 1 - MANAO TOKANTRANO MASO 2 - MISARA-TOERANA 3 107B - MISARAKA VITA TRIBONALY 4 - MISARAKA TSY NANDALO 5 TRIBONALY - TSY MANAMBADY NA MPITOVO 6
107A1 Hatry ny oviana ianareo no niara- VOLANA……………... nipetraka? TSY TADIDY NY VOLANA
TAONA…………………
TSY TADIDY NY TAONA
107B1 - MIARA-MIPETRAKA 1 Miara-mipetraka ve ianareo roa izao sa mipetraka any an-kafa izy? - MIPETRAKA TOERAN-KAFA ILAY 2 LEHILAHY
Outcome Monitoring Survey in the MAHEFA Areas - 196 -
107B Inona no asa ataonao andavanandro? A-FAMBOLENA A B-FIOMPIANA B C-JONO C D-MITRANDRAKA HARENA AN- D KIBON‘NY TANY E-ASA TANANA E F-MANAO SARIBAO F G-VAROTRA G H-ASA ISAN‘ANDRO H I-ASA SARAKA AN-TSAHA I J-KARAMA RAIKITRA J K-HAFA (LAZAO) K
107C Efa nahare hafatra fampianarana ENY 1 momba ny fahasalaman‘ny reny sy ny TSIA 2 107E zaza ve ianao?
107D Raha ENY, taiza na iza no - MPIASAN‘NY FAHASALAMANA A nandrenesanao izany hafatra - MPANENTANA ARA- B fampianarana momba ny PAHASALAMANA fahasalaman‘ny reny sy ny zaza izany? - RADIO C - FAHITALAVITRA D - FETY NA SEHO E - HAFA 96
107E Efa nahare hafatra fampianarana ENY 1 momba ny tazomoka ve ianao? TSIA 2 107G
107F Raha ENY, taiza na iza no - MPIASAN‘NY FAHASALAMANA A nandrenesanao izany hafatra - MPANENTANA ARA- B fampianarana momba ny tazo moka PAHASALAMANA izany? - RADIO C - FAHITALAVITRA D - FETY NA SEHO E - HAFA 96
107G Efa nahare hafatra fampianarana ENY 1 momba ny sakafo ve ianao? TSIA 2 107I
107H Raha ENY, taiza na iza no - MPIASAN‘NY FAHASALAMANA A nandrenesanao izany hafatra - MPANENTANA ARA- B fampianarana momba ny sakafo izany? PAHASALAMANA - RADIO C - FAHITALAVITRA D - FETY NA SEHO E - HAFA 96
107I Manana zanaka latsaky ny 5 taona ENY 1 miaraka mipetraka aminao ve ianao? TSIA 2
Mitaiza zaza na mandray an-tanana ENY zaza latsaky ny 5 taona ve ianao? 1 TSIA 2
Outcome Monitoring Survey in the MAHEFA Areas - 197 -
ANDIAM-PANONTANIANA MOMBA NY FANANAHANA
N° FANONTANIANA SY SIVANA MARIKA MANDEHANA ANY AMIN‘NY 201 Ankehitriny dia hanontany anao aho momba ny ENY 1 zaza naterakao hatramin‘izay.
Efa niteraka ve ianao? TSIA 2 204A
202 Zaza firy no nateraky ny kibonao nandritra ny ISAN‘NY ZANAKA LAHY…… fiainanao? Isao ny zanaka lahy (ao anatin‘izay ireo tsy miaraka mipetraka aminao ankehitriny sy ireo izay teraka velona nefa tsy azo na efa maty)
Zazavavy firy no nateraky ny kibonano nandritra ISAN‘NY ZANAKA VAVY…… ny fiainanao? Isao ny zanaka vavy (ao anatin‘izay izay tsy miaraka mipetraka aminao ankehitriny sy ireo izay teraka velona nefa tsy azo na efa maty
203 HAMARINO NY TOTALINY HITA TAO AMIN‘NY 202
Tiako hamarinina fa azoko tsara any tianao lazaina. Raha totaliana izany dia______(isan‘ny zanaka lahy + isan‘ny zanaka vavy) ny isan‘ny zanaka nateraky ny kibonao nandritra ny fiainanao.
RAHA ENY RAHA TSIA→ HAMARINO TSARA ↓ KA AHITSIO 201-203 204 HAMARINO NY ↓ TSY MISY……………………. 224 TOTALINY EO AMIN‘NY 202
RAHA ZAZA IRAY RAHA ZAZA 2 NA TOTALIN‘NY ZAZA NATERANY MIHOATRA TATO ANATIN‘NY 6 TAONA
Teraka tato anatin‘ny 6 Firy amin‘ireo no taona ve izy teraka tato anatin‘ny 6 taona RAHA TSY MISY DIA ATAOVY HOE 00
Outcome Monitoring Survey in the MAHEFA Areas - 198 -
Tiako raisina an-tsoratra izao ny anaran‘ny zaza naterakao tato anatin‘ny 5 taona na velona na tsia. Andao hatomboka amin‘ilay zaza naterakao farany.
SORATY AO AMIN‘NY 212 NY ZAZA REHATRA NATERANY TATO ANATIN‘NY 6 TAONA, KA ANDALANA IRAY, ZAZA IRAY NA MISY KAMBANA AZA 212 213 214 215 216 217 218 219 220 Iza no anaran‘ny (ANARAN (ANAR Firy taona, sy isan‘ny Mbola velona RAHA MBOLA RAHA MBOLA RAHA MBOLA VELONA, Mbola misy zaza zanakao? Y) ve ANY) ve volana nitsahina i ve i VELONA I VELONA I SORATY NY LAHARAN- teraka velona ve (atomboka kambana lahy sa (ANARANY)? (ANARANY)? (ANARANY), firy (ANARANY), DAHARANY TAO AMIN‘NY teo anelanelan‘i amin‘izay teraka fony teraka? vavy? taona izy tamin‘ny miara-mipetraka LISITRY NY TOKANTRANO (ANARANY) sy farany) fitsingerenan‘ny aminao ve izy? (ANARANY taona nahaterahany (SORATY 00 RAHA TSY AO ZAZA ETAKA farany teo? ANATY LISITRY NY TEO TOKANTRANO IZY) ALOHANY)? 01 TAONA |__|__| ENY Tsy fantatra ny taona TSIA Tokana Lahy ↓ TAONA ENY LAHARAN‘ANDALANA VOLANA |__|__| Zaza manaraka ↓ Kambana Vavy Tsy fantatra ny volana TSIA Zaza manaraka
02 TAONA |__|__| ENY TAONA ENY LAHARAN‘ANDALANA ENY Tokana Lahy TSIA ↓ VOLANA |__|__| ↓ TSIA Zaza manaraka Kambana Vavy Zaza manaraka TSIA 03 TAONA |__|__| ENY TAONA ENY LAHARAN‘ANDALANA ENY Tokana Lahy TSIA ↓ VOLANA |__|__| ↓ TSIA Zaza manaraka Kambana Vavy Zaza manaraka TSIA 04 TAONA |__|__| ENY TAONA ENY LAHARAN‘ANDALANA ENY Tokana Lahy TSIA ↓ VOLANA |__|__| ↓ TSIA Zaza manaraka Kambana Vavy Zaza manaraka ENY 05 Tokana Lahy TAONA |__|__| TSIA TAONA ENY LAHARAN‘ANDALANA ↓ ↓ Kambana Vavy VOLANA |__|__| Zaza manaraka TSIA Zaza manaraka
06 TAONA |__|__| ENY TAONA ENY LAHARAN‘ANDALANA Tokana Lahy TSIA ↓ VOLANA |__|__| ↓ TSIA Zaza manaraka Kambana Vavy Zaza manaraka 07 TAONA |__|__| ENY TAONA ENY LAHARAN‘ANDALANA TSIA Tokana Lahy ↓ VOLANA |__|__| TSIA TSIA Zaza manaraka Kambana Vavy ↓ Zaza manaraka
Outcome Monitoring Survey in the MAHEFA Areas - 199 -
204A Natory tao anaty lay ve ianao alina? ENY 1 TSIA 2 833
HAMARINO AO AMIN‘NY F137 139 145A NY #LAY NATORIANY
F137 LAY#
F138 lay misy ody moka maharitra ka 5 taona na ENY 1 latsaka no nananana azy TSIA 2
F139 lay nasiana ody moka mialoha ka 2 taona ENY 1 latsaka no nananana azy TSIA 2
F140 lay nasiana ody moka mialoha ka 2 taona ENY mahery no nananana azy kanefa natsoboka tao TSIA 1 anaty ody moka tato anatin‘ny 12 volana 2
F141 namendrahana ody moka ny ati-trano tato ENY 1 anatin‘ny 12 volana TSIA 2
833 Izao dia hanontany ny hevitrao manokana aho momba ny fahitanao ny fiainana amin‘ny ankapobeny: MARIKA Hatraiza ny fanekenao na ny fandavanao ireto filazàna ireto:
1. Izaho dia olona manana fahatanjahana izay -2= LAVIKO TANTERAKA IZANY ampy hitolomako amin‘ny fiainana/ J’ai la force -1= LAVIKO IZANY nécessaire pour affronter la vie 0= EKEKO TSY EKEKO IHANY +1= EKEKO IZANY +2= EKEKO TANTERAKA IZANY
2. Raha ny ato anatiko ato dia olona marefo aho +2=LAVIKO TANTERAKA IZANY (r)/ En mon fort intérieur, je pense être +1=LAVIKO IZANY quelqu’un de faible 0=EKEKO TSY EKEKO IHANY -1=EKEKO IZANY -2=EKEKO TANTERAKA IZANY
3. Raisiko an-tanana ny zava-misy entin‘ny -2=LAVIKO TANTERAKA IZANY fiainana/ Je prends en main les situations de la -1= LAVIKO IZANY vie 0=EKEKO TSY EKEKO IHANY +1=EKEKO IZANY +2= EKEKO TANTERAKA IZANY
4. Mahatsapa aho mazàna fa izaho dia olona tsy +2=LAVIKO TANTERAKA IZANY mahomby (r)/ J’ai souvent l’impression d’être +1=LAVIKO IZANY une personne qui ne réussit pas 0=EKEKO TSY EKEKO IHANY -1=EKEKO IZANY -2=EKEKO TANTERAKA IZANY
Outcome Monitoring Survey in the MAHEFA Areas - 200 -
5. Tsapako matetika fa tsy misy ataoko mba tsara +2=LAVIKO TANTERAKA IZANY (r)/ J’ai souvent l’impression de ne jamais faire +1=LAVIKO IZANY rien de bien 0=EKEKO TSY EKEKO IHANY -1=EKEKO IZANY -2=EKEKO TANTERAKA IZANY
6. Tsapako fa haiko sady mandaitra ny -2=LAVIKO TANTERAKA IZANY fifandraisako amin‘ny tontolo tena izy/ Je sais -1= LAVIKO IZANY comment communiquer efficacement avec le 0=EKEKO TSY EKEKO IHANY monde réel +1=EKEKO IZANY +2= EKEKO TANTERAKA IZANY
7. Mahatsapa ny tenako ho toy ny tsy +2=LAVIKO TANTERAKA IZANY fahombiazana aho (r)/ Je me considère comme +1=LAVIKO IZANY une faille/ perte 0=EKEKO TSY EKEKO IHANY -1=EKEKO IZANY -2=EKEKO TANTERAKA IZANY
8. Matetika aho mahatsapa fa vitako ny mandray -2=LAVIKO TANTERAKA IZANY an-tanana ny olana mpitranga amin‘ny fiainana/ -1= LAVIKO IZANY Souvent, je sens que je sais prendre en main les 0=EKEKO TSY EKEKO IHANY problèmes de la vie +1=EKEKO IZANY +2= EKEKO TANTERAKA IZANY
300A Efa nahare hafatra na fampianarana momba ny ENY………………………………………………….1 fandrindram-piterahana ve ianao? TSIA…………………………………………………2 221 A
300B Iza na taiza na tamin‘inona no nandrenesanao - MPIASAN‘NY FAHASALAMANA……………….A hafatra na fampianarana momba ny fandrindram- - MPANENTANA ARA-PAHASALAMANA …...….B piterahana na ny fanabeazana aizana? - RADIO………………………………………………C - FAHITALAVITRA………………………………….D - FETY NA SEHO……………………………………E - HAFA……………………………………………….96
Outcome Monitoring Survey in the MAHEFA Areas - 201 -
N° FANONTANIANA SY SIVANA MARIKA
221A Efa niteraka ve ianao? NITERAKA………………………………………. 1
TSY NITERAKA. ...…………………….……….. 2 224
221B Efa niverina ve ny fadimbolana taorian‘ny ENY…………………..1 niterahanao an‘i (ANARAN‘NY ZANANY TSIA………………….2 FARANY) |__|__|, |__|__|, |__|__| (DATY NIVERENAN‘NY FADIMBOLANA Andro, Volana, Taona)
EFA NITSAHATRA VE NY FADIMBOLANAO? ENY…………………1 221C (menopause) TSIA………………...2
|__|__|, |__|__|, |__|__| (DATY NIVERENAN‘NY FADIMBOLANA Andro, Volana, Taona)
224 ENY ……………………………………..1 Bevohoka ve ianao ankehitriny ? TSIA ……………………………………...2 225A TSY AZOKO ANTOKA ……………………… 3 225A 225 Nanomboka oviana ianao no bevohoka?
SORATY NY ISAN‘NY VOLANA EFA ………………. ………….. VOLANA NODIAVIN‘NY VOHOKA
225A Oviana ianao no nanao firaisana ara-nofo farany? EFA NISY ……… … ANDRO IZAY RAHA LATSAKY NY 12 VOLANA, SORATY EFA NISY ……………HERINANDRO IZAY HOE NISY FIRY ANDRO NA FIRY EFA NISY ……………VOLANA IZAY HERINANDRO NA FIRY VOLANA IZAY EFA NISY ……………TAONA IZAY MBOLA TSY NANAO FIRAISANA ARA-NOFO RAHA 12 VOLANA NA MIHOATRA, VALIO MIHITSY AMIN‘NY ALALAN‘NY TAONA
301A Efa nodidiana tranon-jaza ve ianao? ENY…………………………………….1 TSIA……………………………………2 301C
301B Raha ENY, inona ny fandidiana natao taminao? NALANA NY FANTSONA ROA…….…1 NALANA NY FANTSONA IRAY..…..…2 NALANA NY TRANON-JAZA……..…..3 NALANA NY TRANON‘ATODY ROA...4 NALANA NY TRANON‘ATODY IRAY.5 HAFA (lazao):…………………………..96
301C Fantatrao ve aiza no aleha na iza no hatonina raha mila toro TOBIM-PAHASALAMANA…………….1 hevitra izay hanampy anao hanapa-kevitra, na fitsaboana MPIASAN‘NY FAHASALAMANA…….2 mikasika ny fanabeazana aizana sy ny fahasalamana ara- MPANENTANA ARA- pananahana ianao? PAHASALAMANA ………………..3 HAFA(lazao):……………………………96
Outcome Monitoring Survey in the MAHEFA Areas - 202 -
301D Raha bevohoka ianao izao, fanatatrao ve aiza no aleha na iza no TOBIM-PAHASALAMAM- Raha hatonina raha haka fanafody/ pilina hiarovanao ny tenanao tsy ho PANJAKANA tsy voan‘ny tazomoka? HOPITALY CHD II……………………...1 bevoho HOPITALY CHD I………………………2 ka dia CSB II…………………………………….3 TOHIZ CSB I……………………………………..4 O 301H
TOBIM-PAHASALAMANA TSY MIANKINA HOPITALY TSY MIANKINA………….5 DISPANSERA TSY MIANKINA………6 RAHA TSY FANTATRA NA FANJAKANA NA TSIA DIA FARMASIA/TOBIM-PIVAROTAM- SORATY NY ANARAN‘NY TOBIM-PAHASALAMANA PANAFODY……………………….…….7 DOKOTERA LIBRA…………...... …….8 TOBIN‘NY FANDRINDRAM- PITERAHANA/FISA……..……..……….9 HAFA……………………………...….…96
MPANENTANA ARA- PAHASALAMANA………..………….11 LABOTIKA/MPIVAROTRA TSOTRA……………………….……...... 12 KIOSKA…….…………………..……….13 FIANGONANA……………….…..…….14 NAMANA/HAVANA…………..….…. .15 HAFA (lazao):…………………………...96
TSY FANTATRO…………...…...…….16
301E Inona ny fanafody ilainao amin‘izany fiarovana ny vehivavy NIVAQUINE/CHLOROQUINE……..…1 bevohoka tsy ho voan‘ny tazomoka izany? SULFADOXINE PYRIMETHAMINE/ FANSIDAR………………………….….2 QUININE………………………..………3 HAFA (lazao):…………………………..96
301F Impiry moa ianao no tokony hihinanana ny SP/FANSIDAR IN-…………………. mandritra ny vohoka? IN-2 NA MIHOATRA
TSY FANTATRA……………………….96
301G Mandrisika sy manampy anao ve ny vadinao na ny olona miaraka ENY……….……………………….……1 aminao hampiasa fomba fanabeazana aizana? TSIA…………………………….………2
301H Ahoana ny eritreritrao na ny finoanao momba ny fanabeazana aizana? Mahomby ny fomba fandrindram-piterahana maoderina ENY……………………………….……1 TSIA……………………………………2 TSY FANTATRO………………………3
Natao ho an‘ny olona manambady ihany ny fanabeazana aizana ENY……………………………….……1 TSIA……………………………………2 TSY FANTATRO………………………3
Misy fiantraikany ratsy amin‘ny fanaovana firaisana ara-nofo ny fanaovana fanabeazana aizana ENY……………………………….……1 TSIA……………………………………2 TSY FANTATRO………………………3
Outcome Monitoring Survey in the MAHEFA Areas - 203 -
―Miaro amin‘ny vohoka tsy niriana ny fanabeazana aizana ENY……………………………….……1 TSIA……………………………………2 TSY FANTATRO………………………3
Mampaditra ny fanaovana fanabeazana aizana raha mbola tsy ENY……………………………….……1 manambady na mpitovo TSIA……………………………………2 TSY FANTATRO………………………3
Andraikitry ny vehivavy samirery ny fanabeazana aizana fa tsy misy ENY……………………………….……1 idiran‘ny lehilahy TSIA……………………………………2 TSY FANTATRO………………………3
Amin‘ny lehilahy dia mitovy amin‘ny vosirina ihany ny ENY……………………………….……1 ―vasectomie‖ TSIA……………………………………2 TSY FANTATRO………………………3
Mahatonga homamiadana sy aretina samihafa ny fanabeazana aizana ENY……………………………….……1 TSIA……………………………………2 TSY FANTATRO………………………3 Mahamomba ny vehivavy ny fanabeazana aizana ENY……………………………….……1 TSIA……………………………………2 TSY FANTATRO………………………3 Ny fampiasan‘ny vehivavy fomba fanabeazana aizana dia mamporisika ny vadiny hampirafy ENY……………………………….……1 TSIA……………………………………2 TSY FANTATRO………………………3 302 Amin‘izao fotoana izao, mampiasa fomba fanabeazana aizana ve ENY……………………………….……1 ianao? TSIA……………………………………2 304A
Outcome Monitoring Survey in the MAHEFA Areas - 204 -
303 Inona ny fomba ampiasainao amin‘izao fotoana izao? ENY(1) TSIA(2) - NOFATORANA NY FANTSONA
- NANAO ―VASECTOMIE‖ RAHA VOAFARITRA DIA LAZAO NY ANARAN‘NY NY VADIKO FOMBA FANABEAZANA AIZANA AMPIASAINY - PILINA HOHANINA
- DIU
- TSINDRONA
- ―IMPLANT‖ ASISIKA EO AMIN‘NY SANDRY
- FIMAILO
- FIMAILOM-BEHIVAVY
- DIAFRAGMA
- ―SPERMICIDE‖ (pilina na tsiranoka asisika amin‘ny lalan- jaza)
- VAKANA FANISANA ANDRO
- MANISA ANDRO (fa tsy vakana)
- MAMA (fampinonoan-dreny ihany)
- FIALANA ALOHAN‘NY FIVOAHAN‘NY TSIRANOKA
- HAFA (lazao):……………..………….96
Outcome Monitoring Survey in the MAHEFA Areas - 205 -
304 Taiza no nangalanao farany io fomba fanabeazana aizana TOBIM-PAHASALAMAM- ampiasainao io? PANJAKANA HOPITALY CHD II……………………...1 HOPITALY CHD I………………………2 CSB II…………………………………….3 VOHIZO NY FANONTANIANA MBA HAHAZOANA NY CSB I……………………………………..4 FOMBA FANABEAZANA AIZANA NAMPIASAINY TOBIM-PAHASALAMANA TSY RAHA TSY FANTATRA NA FANJAKANA NA TSIA DIA MIANKINA SORATY NY ANARAN‘NY TOBIM-PAHASALAMANA HOPITALY TSY MIANKINA………….5 DISPANSERA TSY MIANKINA………6 FARMASIA/TOBIM-PIVAROTAM- ______PANAFODY……………………………..7 (ANARAN‘NY TOBIM-PAHASALAMANA) DOKOTERA LIBRA…………………….8 TOBIN‘NY FANDRINDRAM- PITERAHANA/FISA…………………….9 HAFA……………………………………10
MPANENTANA ARA- PAHASALAMANA ………………...….11 LABOTIKA/MPIVAROTRA TSOTRA..12 KIOSKA…………………………………13 FIANGONANA……………………...….14 NAMANA/HAVANA……………..….. .15 HAFA (lazao):…………………………..96
TSY FANTATRO…………………...... 16
304A Maniry na mbola maniry ny hiteraka ve ianao any aoriana na ENY……………………………….……1 aorian‘izao vohoka izao? TSIA……………………………………2 304B TSY FANTATRO………………...……3 304B
304A Raha ENY, rahoviana ianao no mieritreritra ny hiteraka indray TSY MIANDRY 2 TAONA AORIAN‘NY 1 any aoriana any na ao aorian‘izao vohoka izao? NAHATERAHANY……………………1
2 TAONA AORIAN‘NY NAHATERAHANA…………………….2
304B Raha tsy bevohoka ianao, inona no manakana anao tsy hanao - MBOLA MIANDRY ROA TAONA NA bevohoka amin‘izao fotoana izao? MIHOATRA (TAORIAN‘NY NAHATERAHAN‘NY ZANAKO FARANY)…………………………...…..1
- TSY METY MAHAZO ZAZA……….2
- HAFA (lazao)………………………..96
Outcome Monitoring Survey in the MAHEFA Areas - 206 -
Izao dia hiresaka aminao momba ny nitondranao vohoka farany aho
RAHA BEVOHOKA IZY IZAO DIA TSY IZAO VOHOKA IZAO AKORY NO RESAHANA FA ILAY VOHOKA TALOHAN‘IZAO KA NITERAHANA ZAZA VELONA
304C Nandritra ny fotoana nitondranao vohoka farany ka MPIASAN’NY FAHASALAMANA niterahanao zaza ary mbola velona io zaza io, nahazo DOKOTERA……………………………..A fanaraha-maso ara-pahasalamana ve ianao? INFIRIMERA…………………………….B MPAMPIVELONA………………………C MPITSABO MPANAMPY…………...…D
VOHIZO NY FANONTANIANA MBA OLON-KAFA HAHAFANTARANA NY OLONA REHETRA NANARA- RENIN-JAZA VOAOFANA…………….E MASO AZY RENIN-JAZA MBOLA TSY NAHAZO FIOFANANA……..……………………...F
TSY NISAFO……………………………G 408
304D Nandritra ny fotoana nitondranao vohoka farany ka ISAN‘NY FISAFOANA NATAO………… niterahanao zaza ary mbola velona io zaza io, impiry nisafo ianao? TSY TADIDY……………………………
408 Manana karinem-pahasalamana ve ianao? ENY……………………………….……1 Mba alaivo hoe ho jereko azafady. TSIA……………………………………2
Izao indray isika dia hiresadresaka momba ny vohoka farany nentinao.
304E Nandritra ny fotoana nitondranao vohoka farany, nanao ENY……………………………….……1 vaksiny hiarovana ny zaza tsy ho voan‘ny tetanosy (miaro azy TSIA……………………………………2 304G tsy ho voan‘ny fanintona rehefa teraka) ve ianao? Vaksiny TSY FANTATRO………………...……3 304G atao amin‘ny sandry izy io.
JEREO MIARAKA AMINY NY KARINE KA RAHA NAHAVITA VAKSINY TETANOSY IZY DIA ENY NY VALINY
304F Raha nanao vaksiny fiarovana ny zaza ao am-bohoka amin‘ny ISANY ………………………. tetanosy (miaro azy tsy ho voan‘ny fanintona rehefa teraka) ianao, impiry izany no natao nandritra io vohoka io? IN-2 NA MIHOATRA JEREO MIARAKA AMINY NY KARINE KA ISAO NY VAKSINY TETANOSY NATAO AZY
304G Talohan‘ny nitondranao vohoka farany, efa nanao vaksiny ENY……………………………….……1 fanefitry ny tetanosy ve ianao hiarovana tena na hiarovana ny TSIA……………………………………2 304I zaza hateraka any aoriana? TSY FANTATRO………………...……3 304I 304H Raha ENY, impiry izany vaksiny izany no natao? ISANY…………………………..
304I Talohan‘ny vohoka farany, oviana ianao no nanao vaksiny DATY…………………………... fanefitry ny tetanosy farany? TSY TADIDY…………………..
304J Nandritra ny fotoana nitondranao vohoka farany, nomen‘ny ENY……………………………….……1 mpiasan‘ny fahasalamana, na nividy pilifera ve ianao? TSIA……………………………………2 304L TSY FANTATRO………………...……3 304L ASEHOY AZY NY PILIFERA 304K Raha ENY, hafiriana no nihinananao izany pilifera na izany ANDRO………………………. ranom-panafody izany?
VOHIZO MBA HAHAZOANA TOMBATOMBANY
Outcome Monitoring Survey in the MAHEFA Areas - 207 -
304L TSIAHIVO NY DATY ANIO ARY KAJIO NY DATY TAMIN‘NY ROA TAONA LASA ENY……………………………….……1 Tamin‘ny (DATY TAMIN‘NY ROA TAONA LASA) ka TSIA……………………………………2 304P mandrak‘androany, nitondra vohoka ve ianao? 304M Raha ENY, nandritra ny nitondranao vohoka farany tato ENY……………………………….……1 anatin‘ny roa taona, nihinana fanafody miaro amin‘ny TSIA……………………………………2 304P tazomoka ve ianao? TSY FANTATRO………………………3 304P
304N Inona ny fanafody tazomoka nohaninao nandritra ny vohoka - SULFADOXINE PYRIMETHAMINE farany tato anatin‘ny roa taona? (FANSIDAR) …………..……………..….1 - CHLOROQUINE……………………….2 - QUININE……………………………….3 - HAFA (Lazao):………………………...96 TSY FANTATRO………………………..4 IN-……………….. 304O Raha nihinana SP (FANSIDAR) ianao hiarovana amin‘ny tazomoka, impiry no nihinananao izany? IN-2 NA MIHOATRA
TSY FANTATRO……………………….96 304P Tamin‘ny ianao niteraka an‘i (ANARAN‘NY ZANANY MPIASAN’NY FAHASALAMANA FARANY), iza no nampiteraka anao? DOKOTERA……………………………1 INFIRIMERA…………………….……..2 MPAMPIVELONA………………..…....3 MPAMPIVELONA VOAOFANA……..4 MPITSABO MPANAMPY…………….5
OLON-KAFA RENIN-JAZA VOAOFANA……………..6 RENIN-JAZA MBOLA TSY NAHAZO FIOFANANA……………………….…….7 NAMANA/HAVANA……………………8
TSY NISY NAMPITERAKA…...... …..9
TSY MBOLA NITERAKA
304P HAMARINO 212, 215, 217 JEREO RAHA MANA- 1 JANAKA TERAKA TATO ANATIN‘N 12 VOLANA IZY ENY……………………………….……1
Maniry ny hiteraka ve ianao aorian‘i (ANARANA)? TSIA……………………………………2 304R
304Q Raha ENY, rahoviana ianao no mieritreritra ny hiteraka ao AFAKA 2 TAONA RAHA ALOHA aorian‘i (ANARANA)? INDRINDRA……………………………..1
HAFA (LAZAO) ………………………..96
304R Taloha kelin‘ny nanananao an‘i (ANARAN‘NY ZAZA ENY……………………………….……1 831 FARANY) tao am-bohoka, naniry ny hanan-janaka ve ianao? TSIA……………………………………2
304S Raha TSIA, tamin‘ny ianao vao bevohoka an‘i NIRIKO NY HITERAKA AZY FA TATY (ANARAN‘NY ZAZA FARANY), naniry ny hanana azy ho AORIANA KOKOA………………..….1 amin‘ny any aoriana ve ianao sa tsy naniry ny ho bevohoka mihitsy aloha? TSY NILA ZAZA INTSONY AHO KANEFA BEVOHOKA AZY IHANY…2
Outcome Monitoring Survey in the MAHEFA Areas - 208 -
HAMARINO 301 RAHA BEVOHOKA IZY IZAO 831 ENY……………………………….……1 Naniry ny mbola hiteraka ve ianao talohan‘ny nipetrahan‘ity TSIA……………………………………2 zanakao ity? TSY FANTATRO………………...……3 832 Naniry ny hiteraka ve ianao tamin‘ny fotoana nipetrahan‘ity ENY……………………………….……1 zanakao ity, kanefa mbola tsy vonona fa nieritreritra hoe aleo TSIA……………………………………2 aoriana kely? TSY FANTATRO………………...……3
833 Oviana ianao no tonga fadimbolana farany? EFA NISY ……………. ANDRO EFA NISY ……………. HERINANDRO LAZAO NY ANDRO VOALOHANY EFA NISY …………….. VOLANA NAHATONGAVA‘NY FADIMBOLANA EFA NISY ……………..TAONA
NITSAHATRA FADIMBOLANA NA NESORINA TRANON-JAZA ………...994 TALOHAN‘NY NITERAHANA FARANY……………………………....995 TSY MBOLA TONGA FADIMBOLANA MIHITSY …………………………..….996
833A HAMARINO 301A1 RAHA TSY BEVOHOKA IZY ENY, AMIN‘IZAO…………………….1 Mbola te hanan-janaka ve ianao? TSIA, NY AORIANA………………….2 833B TSIA, TSY TE-HITERAKA INTSONY AHO...... 3 TSY AFAKA MAHAZO ZAZA AHO…………………………………....4 TSY FANTATRO……………………..96
833B AFAKA………. VOLANA Raha tsy te-hiteraka izao ianao, rahoviana indray no maniry AFAKA……….TAONA ny hiteraka? (833 A - TSY HO ELA……………………………1 TSY AFAKA MAHAZO ZAZA AHO……………………………………..2 HAFA (LAZAO)…..…………………...96 TSY FANTATRO……………………….3 833 C TSY MANAMBADY………………...... A Raha tsy maniry ny hiteraka ato ho ato ianao, na tsy maniry zaza any aoriana any, maninona ianao no tsy mampiasa fomba EFA MAMPIASA IZY………………….B fanabeazana aizana? MANIRY HITERAKA IZY……………..C
ANTONY MIFANDRAIKA AMIN’NY FAHALONAHANA TSY MISY FIRAISANA ARA-NOFO . ..D
FIRAISANA ARA-NOFO MAHALANA ………………………………………….. E
NITSAHATRA FADIMBOLANA/NESORINA TRANON- JAZA …………………………………... F
TSY AFAKA MITERAKA . …...... G
MBOLA TSY NIVERINA NY FADIMBOLANA ………………..… . . .H
MAMPINONO ...... …………… ... I
SITRAPON‘ADRIAMANITRA/ FATALISMA . ……………………… . . J
Outcome Monitoring Survey in the MAHEFA Areas - 209 -
MANDA NY FAMPIASANA IZANY TSY EKEKO NY FANABEAZANA AIZANA…………………………………K
TSY AVELAN‘NY VADY …………… L
TSY AVELAN‘NY OLON-KAFA ANKOATRA NY VADY……………… M
SAKANA ARA-PINOANA . …………. N
TSY FAHAMPIAN’NY FAHALALANA TSY MAHALALA FOMBA FANABEAZANA AIZANA MAODERINA .………………………. . O
TSY NAHALALA NY TOERANA FANGALANA IZANY ...... …… . . . P
ANTONY MIFANDRAIKA AMIN‘NY FOMBA FANABEAZANA AIZANA FIANTRAIKANY/FAHASALAMANA .Q
SAROTRA NY FAHAZOANA AZY…...R
LAVITRA LOATRA …………..……... . S
LAFO NY VIDINY ...... ………….. . . T
TSY NISY ILAY FOMBA FANABEAZANA AIZANA NOSAFIDIANA . . . . ……………. ….. . U
TSY MAHITA FOMBA FANABEAZANA AIZANA ……………………………….. V
NY INDRO KELY AMIN‘NY FAMPIASANA AZY DIA MANIMBA NY FIASA VOA-JANAHARIN‘NY VATANA. . . . …. ………………………W
HAFA (LAZAO) ……………………….96
TSY FANTATRA...... …. X 833D Efa novangian‘ny mpanentana ara-pahasalamana ve ianao? ENY……………………………………..1 TSIA…………………………………….2 TAPIT RA NY WRA 833 E Raha ENY, impiry izy no namangy anareo tato anatin‘ny 3 ISA………………………………. volana?
833 F Isaky ny inona izy no mamangy anareo? ISAN-KERINANDRO……………………1 ISAN-TAPA-BOLANA…………………..2 ISAM-BOLANA……………………….…3 ISAN-TELO VOLANA………………..…4 MAHALANA NOHO IREO………….….5 TSY TADIDY…………………………...96 TSY NISY……………………………...…6
Outcome Monitoring Survey in the MAHEFA Areas - 210 -
833 G Oviana izy no tonga farany namangy anao? TATO ANATIN‘NY HERINANDRO….. 1 TATO ANATIN‘NY TAPA-BOLANA …2 TATO ANATIN‘NY 1 VOLANA ………3 TATO ANATIN‘NY 2 VOLANA ………4 TATO ANATIN‘NY 3 VOLANA ……....5 EFA MIHOATRA NOHO IREO VOALAZA……………………………….6 TSY TADIDY ………….……………….96
833 H Inona ny resaka nifanaovanareo nandritra izay telo volana FISAFOANA SY FITERAHANA…..…..A izay? FIKARAKARANA NY ZAZA VAO TERAKA……………………………..….B FIKARAKARANA NY VEHIVAVY AVY TERAKA ……………….……………..…C FITSABOANA NY VEHIVAVY AFA- JAZA NA NANALA ZAZA….………....D FANDRINDRAM-PITERAHANA……...E FIAROVANA AMIN‘NY VOHOKA TSY NIRIANA………………………..………..F FANAOVANA VAKSINY NY ZAZA NA NY RENY…………………………..…... G NY SAKAFON‘NY ZAZA SY NY FAMPINONOAN-DRENY…………….. H FANARAHA-MASO NY FITOMBON‘NY ZAZA………………………….……….…I TAZO NA TAZOMOKA……….….…….J ARETIM-PIVALANANA……………….K KOHAKA SY ARETIN-TRATRA………L HAFA (lazao)……………………………96
834 Hanampy ireo mpanentana ara-pahasalamana hanatsara ny asany ny famalianao ireto fanontaniana manaraka ireto:
Ahoana ny fahitanao ny fikarakaran‘ ny mpanentana ara- 4=LAFATRA pahasalamana anao? 3=TSARA 2=TSY DIA TSARA 1=RATSY
Azonao ve ny torohevitra/fitsaboana nilainao? 1=TSIA, TSY AZOKO VELIVELY 2=TSIA, TSY TENA AZOKO 3=ENY, AMIN‘NY ANKAPOBENY 4=ENY, AZOKO TOKOA
Mifandraika amin‘izay nilainao ve ny tolotra nomeny? 4=SAIKA NIFANDRAIKA TAMIN‘IZAY Hatraiza? NILAIKO REHETRA NY TOLOTRA 3=NIFANDRAIKA TAMIN‘NY ANKAMAROAN‘IZAY NILAIKO NY TOLOTRA 2=SASANTSASANY AMIN‘IZAY NILAIKO IHANY NO NAHAZO VALINY 1=TSY NAHAZO VALINY DAHOLO IZAY NILAM-BALINY
Raha misy namanao nila fanampiana toa anao, hatoronao azy 1=TSIA, TSY HANDEFA AZY ANY ve ireo mpanentana ara-pahasalamana ireo? AHO 2=TSIA, TSY IZAY LOATRA 3=ENY, HATOROKO AZY 4=ENY, TENA HATOROKO AZY TOKOA
Outcome Monitoring Survey in the MAHEFA Areas - 211 -
Manao ahoana ny fahafam-ponao manoloana ny fanampiana 1=TSY AFA-PO MIHITSY azonao? 2=TSY AFA-PO LOATRA 3=AFA-PO 4=TENA AFA-PO TOKOA
Nanampy anao nisedra ny olanao ve ny tolotra azonao? 4=ENY, TENA NANAMPY BE TOKOA 3=ENY, NANAMPY 2=TSIA, TSY DIA TENA NANAMPY 1=TSIA, VAO MAINKA AZA NANAMPY TROTRAKA NY OLAKO
Raha atao bango tokana, afa-po tamin‘ny toro hevitra sy 4=TENA AFA-PO TOKOA fikarakarana azonao ve ianao? 3= AFA-PO 2=TSY DIA AFA-PO LOATRA 1=TSY AFA-PO MIHITSY
Raha mila fanampiana indray ianao any aoriana any dia 1=TSIA, TSY HIVERINA MIHITSY hiverina haka toro hevitra sy fitsaboana any amin‘ny 2=TSIA, TSY HIVERINA ANGAMBA mpanentana ara-pahasalamana ve? 3=ENY, HIVERINA 4=ENY, HIVERINA TOKOA
Outcome Monitoring Survey in the MAHEFA Areas - 212 -
E.3 CARETAKER Questionnaire
FANONTANIANA HO AN’NY OLONA MITAIZA ZAZA LATSAKA NY 5 TAONA NA CARETAKERS
ATAO REHEFA MAHAZO ALALANA AVY AMIN‘NY OLONA HADIHADIANA
FANAOVAM-BAKSINY: ZAZA EO ANELANELAN’NY 12-23 VOLANA
N° APETRAKA NY LAHARANY, NY ANARANY SY NY MARI-PAHAVELOMAN‘NY ZAZA TERAKA TAO ANELANELAN‘NY (23 VOLANA MIALOHA NY FANADIHADIANA) SY (12 VOLANA MIALOHA NY FANADIHADIANA). APETRAHO NY 501 FANONTANIANA AMIN‘IREO FAHATERAHANA REHETRA NISY ARY ATOMBOY AMIN‘NY FAHATERAHANA FARANY INDRINDRA IZANY. (RAHA MISY MIHOATRA NY 3 DIA AMPIASAO NY FAFANA 2 FARANY AMIN‘NY TAKELAM-PANONTANIANA FANAMPINY). 502 LAHARANA AO FAHATERAHANA FARANY FAHATERAHANA FAHATERAHANA AMIN‘NY 212 LAHARANY ALOHAN‘NY FARANY ALOHAN‘NY ALOHAN‘NY LAHARANY FARANY LAHARANY
503 ANARANA ANARANA ANARANA LAHARANA 212 SY 216 VELONA MATY VELONA MATY VELONA MATY ↓ → ZAZA ↓ → ZAZA MANARAKA ↓ → ZAZA MANARAKA MANARAKA RAHA TSY MISY RAHA TSY ZAZA RAHA TSY MISY ZAZA INTSONY MISY ZAZA INTSONY ↓ INTSONY ↓ ↓ 504 Manana karine misy ny HITA (KARNEM- HITA (KARNEM- HITA (KARNEM- vaksiny natao taminy ve PAHASALAMANA) PAHASALAMANA) PAHASALAMANA) i (ANARANA)? ………………………………1 …………………………1 →506A ………………………………1 212 SY 216 →506A →506A HITA (KARINE HAFA) ……2. Raha ENY, azoko →506 HITA (KARINE HAFA) ……2. HITA (KARINE HAFA) →506 jerena ve azafady? ENT FA TSY ……2. →506 MANANA FA TSY HITA…………..3.→508 ENT FA TSY HITA…………..3.→508 HITA…………..3.→508 TSY MISY KARINE ………..4 TSY MISY KARINE TSY MISY KARINE ………..4 ………..4 ↓ ↓ ↓ 505 Efa nanana karinem- ENY, KARINEM- ENY, KARINEM- ENY, KARINEM- baksiny ve PAHASALAMANA .1 PAHASALAMANA .1 PAHASALAMANA .1 (ANARANA) taloha? ENY ENY ENY Karinem-pahasalamana ……………………………… …………………………………… ………………………………… ve ilay izy? ……2 2 …2
TSIA, TSY MISY KARINE TSIA, TSY MISY KARINE TSIA, TSY MISY KARINE ...... 3 →508 ...... 3 →508 ...... 3 →508
Outcome Monitoring Survey in the MAHEFA Areas - 213 -
(1) ADIKAO NY DATY NANAOVANA NY VAKSINY AO AMIN‘NY KARINE HO AN‘NY VAKSINY TSIRAIRAY (2) MARIHO ‗44' TANDRIFY NY 'ANDRO' RAHA VOALAZA AO ANATY KARINE FA NATAO VAKISINY SAINGY TSY VOARAKITRA NY DATY
FAHATERAHANA FARANY FAHATERAHANA FAHATERAHANA 506A ALOHAN‘NY FARANY ALOHAN‘NY ALOHAN‘NY AN VO TAO AN VO TAO FARANY AN VO TAO DR LA NA DR LA NA DR LA NA O NA O NA O NA BC BC BC G G G P0 P0 P0 P1 P1 P1 P2 P2 P2 P3 P3 P3 DT DT DT C1 C1 C1 DT DT DT C2 C2 C2 DT DT DT C3 C3 C3 AT AT AT R R R
506B HAMARINO 506A BCG ka hatramin‘ny ATR BCG ka hatramin‘ny ATR BCG ka hatramin‘ny ATR HAFA→ HAFA→ HAFA→
↓ ↓ ↓
VOARAKITRA DAHOLO VOARAKITRA DAHOLO VOARAKITRA DAHOLO ↓ ↓ ↓ 510 510 510
Outcome Monitoring Survey in the MAHEFA Areas - 214 -
N° FANONTANIANA SY FAHATERAHANA FARANY FAHATERAHANA FAHATERAHANA SIVANA ALOHAN‘NY FARANY ALOHAN‘NY ALOHAN‘NY FARANY
ANARANA ANARANA LAHARANY ANARANA LAHARANY LAHARANY
507 Natao vaksiny hafa ENY …………………….. 1 ENY …………………….. 1 ENY …………………….. 1 ankoatra ny ao amin‘ny ↓ ↓ ↓ karine ve i (ANARANA)? Eny fa AVERENO ANONTANIANA AVERENO ANONTANIANA AVERENO ANONTANIANA na vaksiny natao TSARA ARY MARIHO ‗66‘ TSARA ARY MARIHO ‗66‘ TSARA ARY MARIHO ‗66‘ nandritra ny hetsika TANDRIFY AMIN‘ NY TANDRIFY AMIN‘ NY TANDRIFY AMIN‘ NY faobe ho an‘ny « ANDRO » AO AMIN‘NY 506 « ANDRO » AO AMIN‘NY 506 « ANDRO » AO AMIN‘NY 506 fanaovam-baksiny ary ↓ ↓ AN VO TAO ATAO HOE ‗ENY' TOHIZO 510 TOHIZO 510 RAHA BCG, NA POLIO 0-3, NA DTCoq DR LA NA TSIA …………………..2 → TSIA …………………..2 → 1-3, SY/NA NY TOHIZO 510 TOHIZO 510 KITROTRO.NY O NA TSY FANTATRA …….99→ TSY FANTATRA …….99→ VAKSINY NOTONONIN‘NY P TOHIZO 510 TOHIZO 510 OLONA HADIHADIANA AT
R
DT
C
BC
G
↓ TOHIZO 508 TSIA …………………..2 → TOHIZO 510 TSY FANTATRA …….99→ TOHIZO 510
508 Natao vaksiny ENY ENY …………………………..1 ENY …………………………..1 …………………………..1 hiarovana azy amin‘ny aretina ve i (ANARANA)? Eny fa TSIA→ TOHIZO 510 na vaksiny natao TSIA→ TOHIZO 510 TSIA→ TOHIZO 510 nandritra ny hetsika TSY FANTATRA → TOHIZO faobe ho an‘ny vaksiny TSY FANTATRA → TOHIZO 510 TSY FANTATRA → TOHIZO aza. 510 510
Outcome Monitoring Survey in the MAHEFA Areas - 215 -
509A Natao ireto vaksiny manaraka ireto ve i (ANARANA)?
Ny BCG miaro amin‘ny raboka, tsindrona natao ENY…………………………… ENY…………………………… ENY…………………………… teo amin‘ny tanana na …….1 …….1 …….1 sandry mamela diany TSIA TSIA TSIA matetika ………………………………...2 ………………………………...2 ………………………………...2
TSY TSY TSY FANTATRA…………………... FANTATRA…………………...3 FANTATRA…………………... 3 3
509B Ny fanefitry ny Polio, ENY ENY ENY ranom-panafody natete TSIA → TOHIZO 509E TSIA → TOHIZO 509E TSIA → TOHIZO 509E tao am-bava TSY FANTATRA → TOHIZO TSY FANTATRA → TOHIZO TSY FANTATRA → TOHIZO 509E 509E 509E Natao tamin‘ny 509C tapabolana voalohany TAPA-BOLANA TAPA-BOLANA TAPA-BOLANA taorian‘ny nahaterahana VOALOHANY…….. 1 VOALOHANY 1 VOALOHANY 1 sa taoriana ny fanefitry TAORIANA ...... ny Polio voalohany TAORIANA ...... ……….. . TAORIANA ...... ……….. . …………………. 2 2 2
509D Impiry nanao fanefitry ISA ISA ISA ny Polio i (ANARANA)?
509E Ary efa natao vaksiny ENY ………………….. 1 ENY ………………….. 1 ENY ………………….. 1 DTC ve i TSIA ……..……………2→ TSIA ……..……………2→ TSIA ……..……………2→ (ANARANA)? Ilay 509G 509G 509G tsindrona atao amin‘ny fitombenana na ny fe, TSY FANTATRA ……..3 → TSY FANTATRA ……..3 → TSY FANTATRA ……..3 → ilay ampiarahana 509G 509G 509G amin‘ny fanefitry ny Polio matetika
509F HAMARINO 506, 507, ISA ISA ISA 508
Impiry nanao ny vaksiny DTC i (ANARANA)?
509G Natao vaksiny fanefitry ENY…………………………… ENY…………………………… ENY…………………………… ny …….1 …….1 …….1 Kitrotro (ATR na ROR) TSIA TSIA TSIA ve i (ANARANA)? ilay ………………………………...2 ………………………………...2 ………………………………...2 tsindrona atao amin‘ny sandry rehefa feno 9 TSY TSY TSY volana na mihoatra mba FANTATRA…………………... FANTATRA…………………...3 FANTATRA…………………... hiarovana azy tsy ho 3 3 voan‘ny kitrotro
510 HAMARINO 506 NA VAKISINY NATAO 1 NA VAKISINY NATAO 1 NA VAKISINY NATAO 1 NA 508: MIHOATRA MIHOATRA MIHOATRA NATAO VAKISINY ENY …1 ENY …1 ENY …1 VE I (ANARANA)? TSIA…..2 TSIA…..2 TSIA…..2
FAHASALAMAN’NY ZAZA 0 KA HATRAMIN’NY 59 VOLANA
Outcome Monitoring Survey in the MAHEFA Areas - 216 -
Hiresadresaka momba ny fahasalamana isika izao dia hametraka fanontaniana vitsivitsy aminao aho.
Aorian‘izay dia hiresaka momba ny fahasalaman‘ny zanakao izay teraka tamin‘ny 2009 sy taorian‘izay isika ka ho an‘izay mihoatry ny 6-bolana na mihoatra dia horefesintsika ny sandrin- tanany havia amin‘ny alalan‘ity metatra fandrefesana voatokana ity. (ASEHO AZY NY METATRA).
N° Te hanontany ny hevitrao aho. 530A
ANTIBIOTIKA………………………………….A Raha aminao, inona no fanafody mahomby FANAFODY TSY MAMPANDOA ……………B hitsaboana ny aretim-pivalanana? SRO/ZINC……………………………………….C
FANAFODY VITA AO AN-TRANO/ RAVIN- KAZO MAHASITRANA………………………..D AVELA HAMALY MALALAKA NY OLONA HADIHADIANA FA TSY HAFA……………………………………………X AMPISEHO MIALOHA NY VALINY
530B Raha aminao, inona no fiarovana mahomby FANASAN-TANANA AMIN‘NY RANO SY hisorohana ny aretim-pivalanana? SAVONY……………………………………….A FAMPIASANA RANO FISOTRO MADIO …………………………………………………..B
AVELA HAMALY MALALAKA NY FAMPIASANA LAVAPIRINGA VOADIO SY OLONA HADIHADIANA FA TSY AZO SASANA …………………………………C AMPISEO MIALOHA NY VALINY HAFA……………………………………………X HAMARINO 530B 530C IRETO AVY NO NOVALIAN‘NY OLONA HADIHADIANA :
FANASAN-TANANA AMIN‘NY RANO SY ENY…………………………1 SAVONY TSIA…………………………2
FAMPIASANA RANO FISOTRO MADIO ENY…………………………1 TSIA…………………………2
FAMPIASANA LAVAPIRINGA VOADIO ENY…………………………1 SY AZO SASANA TSIA…………………………2
530D FAMONOANA MOKA ……………………….A Raha aminao, inona no fiarovana mahomby
Outcome Monitoring Survey in the MAHEFA Areas - 217 -
hisorohana ny tazo moka? MATORY ANATY LAY MISY ODY MOKA ISAN‘ALINA ………………………………….B
AMENDRAHANA FANAFODY MAMONO SY MAMPANDOSITRA MOKA NY ATIN- TRANO………………………………. ………C
HAFA (LAZAO) ……………………………… D
TSY FANTATRA ……………………………………….. ……… E
530E Raha aminao, inona ireo fambaran‘aretin‘ny KOHAKA………………………………………A fitaovam-pisefoana na pneumonie tena hita maso mivaingana amin‘ny ankizy? TAZO……………………………………………B
HAINGANA NY FISEFOANY …………………C
HAFA (LAZAO) ………………………………D
TSY FANTATRA ……………………………… E
Izao aho dia hanontany anao momba ny hevitrao amin‘ireo mpanentana ara-fahasalamana eny anivon‘ny fiaraha-monina?
Efa novangian‘ny mpanentana ara- 530F pahasalamana ve ianao? ENY …………. 1 TSIA ………….2→516
530G Isaky ny inona ianao no vangian‘ny ISAN-KERINANDRO ……………………...1 mpanentana ara-pahasalamana? ISAN-TAPABOLANA……………………...2 ISAM-BOLANA ……………………………3 ISAKY NY ROA VOLANA .………………4 ISAN-TELO VOLANA……………………..5 MAHALANA NOHO IREO VOALAZA ….6
530H Impiry ianao no novangian‘ny mpanentana IN- ………. ara-pahasalamana tato anatin‘ny 6 volana?
530I Oviana ny mpanentana ara-pahasalamana no TATO ANATIN‘NY HERINANDRO ………… 1 tonga namangy anao farany? TATO ANATIN‘NY TAPA-BOLANA ………...2 TATO ANATIN‘NY 1 VOLANA ……………...3 TATO ANATIN‘NY 2 VOLANA ……………...4 TATO ANATIN‘NY 3 VOLANA ………………5 EFA MIHOATRA NOHO IREO VOALAZA ….6 TSY TADIDY ………………………………….96
Outcome Monitoring Survey in the MAHEFA Areas - 218 -
FISAFOANA SY FITERAHANA ………………A 530J Inona ny votoatin-dresakareo rehefa tonga FITSABOANA NY ZAZA VAO TERAKA ……B mamangy anao ny mpanentana ara- FITSABOANA NY VEHIVAVY AVY pahasalamana? TERAKA ….………..……………………………C FITSABOANA NY VEHIVAVY AFA-JAZA NA NANALA ZAZA ….…………………………….D FANDRINDRAM-PITERAHANA ……………..E FIAROVANA AMIN‘NY VOHOKA TSY NIRIANA ………………………..………………F FANAOVANA VAKSINY NY ZAZA NA NY RENY…………………………..………………..G NY SAKAFON‘NY ZAZA SY NY FAMPINONOAN-DRENY …………………….H FANARAHA-MASO NY FITOMBON‘NY ZAZA……………………………………..………I TAZO NA TAZOMOKA ………………………..J ARETIM-PIVALANANA ………………………K KOHAKA SY ARETIN-TRATRA ……………..L HAFA (lazao) …………………………………..96
Ny valim-panontaniana izay omenao dia 834 hanampy betsaka ireo mpanentana ara- pahasalamana hanatsara ny tolotra sy
fikarakarana omeny:
Ahoana no fahitanao ny fikarakaran‘ireo 4= LAFATRA mpanentana ara-pahasalamana? 3= TSARA 2= TSY DIA TSARA 1= RATSY
Azonao tsara ve ireo torohevitra sy fitsaboana 1= TSY MISY AZOKO MIHITSY nomeny? 2= TSY DIA AZOKO TSARA 3= ENY AMIN‘NY ANKAPOBENY 4= ENY, AZOKO TSARA
Namaly ny filànao ve ireo fanampiana 4= SAIKA IZY REHETRA 3= NY ANKABETSAHANY azonao? Voavaly avokoa ve? 2= NY ANTSASANY TEO HO EO 1= TSY NISY MIHITSY
Handrisika ireo namanao ve ianao hanatona 1= TSIA VELIVELY azy ireo raha toa mety ilain‘ny namanao 2= TSY DIA IZAY LOATRA izany? 3= ENY, HAMPORISIHIKO IZY 4= MAZAVA HO AZY
Ohatry ny ahoana ny fahafaham-ponao 1= TSY AFA-PO MIHITSY tamin‘ny fikarakarana azonao? 2= TSY DIA AFA-PO LOATRA 3= AFA-PO 4= TENA AFA-PO
Nanampy anao namaha ny olana nosedrainao 4= NANAMPY BETSAKA ve ireo fikarakarana nomeny anao? 3= ENY 2= TSY DIA NANAMPY LOATRA 1= VAO MAIKA NAMPITOMBO NY OLAKO
Outcome Monitoring Survey in the MAHEFA Areas - 219 -
Amin‘ny ankapobeny, afa-po ve ianao 4= TENA AFA-PO tamin‘ny fikarakarana sy torohevitra azonao? 3= AFA-PO 2= TSY DIA AFA-PO LOATRA 1= TSY AFA-PO MIHITSY
1= SANATRIA Raha toa mbola mila fikarakarana/ torohevitra 2= METY HO TSIA ianao any aoriana, mbola hanatona ireo 3= ENY mpanentana ara-pahasalamana ireny ve ianao? 4= MAZAVA HO AZY
HAMARINO 215: N° FAHATERAHANA INDRAY MANDEHA TSY NISY FAHATERAHANA HATRAMIN‘NY 516 NA MIHOATRA HATRAMIN‘NY (DATY : (DATY : 59 VOLANA MIALOHAN‘NY 59 VOLANA MIALOHAN‘NY DATIN‘NY DATIN‘NY FANADIHADIANA) FANADIHADIANA) NA TAORIAN‘IZAY NA TAORIAN‘IZAY ↓ →
517 APETRAKA NY LAHARANY, NY ANARANY SY NY MARI-PAHAVELOMAN‘NY ZAZA TERAKA HATRAMIN‘NY (59 VOLANA MIALOHA NY FANADIHADIANA) NA MIHOATRA. APETRAHO NY FANONTANIANA AMIN‘IREO FAHATERAHANA REHETRA NISY ARY ATOMBOHYY AMIN‘NY FAHATERAHANA FARANY INDRINDRA IZANY. (RAHA MISY MIHOATRA NY 3 DIA AMPIASAO NY FAFANA 2 FARANY AMIN‘NY TAKELAM-PANONTANIANA FANAMPINY).
Izao isika dia hiresaka momba ny fahasalaman‘ireo zanakao teraka tao anatin‘izay 5 taona farany izay. (Resahintsika mitokana ny momba ny zaza tsirairay).
N° FANONTANIANA SY FAHATERAHANA FARANY FAHATERAHANA FAHATERAHANA SIVANA ALOHAN‘NY FARANY ALOHAN‘NY ALOHAN‘NY FARANY LAHARANY LAHARANY LAHARANY
ANARANA ANARANA ANARANA LAHARANA 212 SY 216 518 VELONA MATY VELONA MATY VELONA MATY ↓ → ZAZA ↓ → ZAZA ↓ → ZAZA MANARAKA MANARAKA MANARAKA
RAHA TSY MISY RAHA TSY RAHA TSY ZAZA MISY ZAZA INTSONY MISY ZAZA INTSONY INTSONY ↓ ↓ ↓
Outcome Monitoring Survey in the MAHEFA Areas - 220 -
517A I (ANARANA) ve natory tao anaty lay tamin‘ny alina?
HAMARINO 137, 139, 145A MOMBAMOMBA NY LAY NATORIANY
137 #LAY
F138 LAY AZO TAO ANATIN‘NY 36 VOLANA ENY……………………………1 ENY…………………………1 ENY…………………………1 TSIA……………………………2 TSIA………………………...2 TSIA…………………………2
F139 LAY MISY ODY ENY……………………………1 ENY…………………………1 ENY…………………………1 MOKA MAHARITRA NA LAY EFA NASIAM- TSIA……………………………2 TSIA………………………...2 TSIA…………………………2 PANAFODY ENY……………………………1 ENY…………………………1 ENY…………………………1 F142 RAHA TOA KA TSIA……………………………2 TSIA………………………...2 TSIA…………………………2 LAY MISY ODY MOKA KA NATSOBOKA TANATY FANAFODY (MAMONO NA MAMPADOSITRA NY MOKA) TAO ANATIN‘NY 12 VOLANA
F145A ENY……………………………1 ENY…………………………1 ENY…………………………1 NAMENDRAHANA RANO TSIA……………………………2 TSIA………………………...2 TSIA…………………………2 FAMONOAM-BIBIKELY NY ATIN-TRANO (MAMONO NA MAMPADOSITRA NY MOKA) TAO ANATIN‘NY 12 VOLANA
518A Nararin‘ny aretim-pivalanana ENY …..1 ENY …..1 ENY …..1 ve i (ANARANA) tao TSIA …..2→ 531 TSIA …..2→ 531 TSIA …..2→ 531 anatin‘ny 2 herinando? TSY FANTATRA …..96→ 531 TSY FANTATRA …..96→ TSY FANTATRA …..96→ 531 531
519 Nisy rà ve ny fivalanan‘ i ENY …………..1 ENY …………..1 ENY …………..1 (ANARANA) tamin‘izy TSIA ………….2 TSIA ………….2 TSIA ………….2 nivalana tato anatin‘ny 2 herinandro? TSY FANTATRA ……3 TSY FANTATRA ……3 TSY FANTATRA ……3
528 Nanome ny 1 na mihoatra tamin‘ireto lazaiko manaraka VOVOKA SRO + RANO VOVOKA SRO + RANO VOVOKA SRO + RANO ireto azy ve ianao FISOTRO FISOTRO FISOTRO hatramin‘ny nanombohan‘ny MADIO…………………………… MADIO……………………… MADIO……………………… fivalanan‘i (ANARANA)? …A ………A ………A
SRO RANONY SRO RANONY SRO RANONY ……………………..B ……………………..B ……………………..B RANON-JAVATRA RANON-JAVATRA RANON-JAVATRA NAMBOARINA TAO AN- NAMBOARINA TAO AN- NAMBOARINA TAO AN- TRANO …………………….…..C TRANO TRANO …………………….…..C …………………….…..C ZINC ……………………………….. D ZINC ZINC ……………………………….. ……………………………….. D D
Outcome Monitoring Survey in the MAHEFA Areas - 221 -
522 Nitady fitsaboana na ENY …………….. 1 ENY …………….. 1 ENY …………….. 1 torohevitra mahakasika ny TSIA …………….2→527 TSIA …………….2→527 TSIA …………….2→527 aretim-pivalanana ve ianao?
523A Iza no nanome anao ny MPIASAN‘NY MPIASAN‘NY MPIASAN‘NY fanafody nitsaboana ny FAHASALAMANA AO FAHASALAMANA AO FAHASALAMANA AO aretim-pivalanana? AMIN‘NY CSB AM- AMIN‘NY CSB AM- AMIN‘NY CSB AM- PANJAKANA ………………….A PANJAKANA ……………A PANJAKANA ……………A MPIASAN‘NY MPIASAN‘NY MPIASAN‘NY Taiza ihany koa? FAHASALAMANA AO FAHASALAMANA AO FAHASALAMANA AO AMIN‘NY TOBIM- AMIN‘NY TOBIM- AMIN‘NY TOBIM- MARIHO ATO NY PAHASALAMANA TSY PAHASALAMANA TSY PAHASALAMANA TSY ANARAN‘NY TOERANA MIANKINA …………………….B MIANKINA ……………….B MIANKINA ……………….B
DOKOTERA LIBRA …………..C DOKOTERA LIBRA ………C DOKOTERA LIBRA ………C
MPITSABO NETIM- MPITSABO NETIM- MPITSABO NETIM- ______PAHARAZANA ………………D PAHARAZANA …………D PAHARAZANA …………D MPIASAN‘NY MPIASAN‘NY MPIASAN‘NY (ANARAN‘NY TOERANA) FAHASALAMANA AO FAHASALAMANA AO FAHASALAMANA AO AMIN‘NY HOPITALIM- AMIN‘NY HOPITALIM- AMIN‘NY HOPITALIM- PANJAKANA………………….E PANJAKANA………………E PANJAKANA………………E
MPIASAN‘NY MPIASAN‘NY MPIASAN‘NY FAHASALAMANA AO FAHASALAMANA AO FAHASALAMANA AO AMIN‘NY HOPITALY TSY AMIN‘NY HOPITALY TSY AMIN‘NY HOPITALY TSY MIANKINA…………………….F MIANKINA………………F MIANKINA………………F MPANENTANA ARA- MPANENTANA ARA- MPANENTANA ARA- PAHASALAMANA ...... G PAHASALAMANA ...... G PAHASALAMANA ...... G FARMASIA/ TOERAM- FARMASIA/ TOERAM- FARMASIA/ TOERAM- PITEHIRIZANA FANAFODY ...H PITEHIRIZANA FANAFODY PITEHIRIZANA FANAFODY ….H ….H HAFA (LAZAO) …………………… I HAFA HAFA (LAZAO) ……………… …I (LAZAO) ……………… …I
527 Mbola mivalana ihany ve i ENY …………..1 ENY …………..1 ENY …………..1 (ANARANA) amin‘izao TSIA ………….2 TSIA ………….2 TSIA ………….2 fotoana izao? TSY FANTATRA ……3 TSY FANTATRA ……3 TSY FANTATRA ……3
529 Nisy zavatra hafa nomena ENY …..1 ENY …..1 ENY …..1 an‘i (ANARANA) ve TSIA …..2→ TOHIZO 533A TSIA …..2→ TOHIZO 533A TSIA …..2→ TOHIZO 533A hitsaboana ny aretim- pivalanana amin‘izao? TSY FANTATRA ….. 96→ TSY FANTATRA .96→ TSY FANTATRA …96→ TOHIZO 533A TOHIZO 533A TOHIZO 533A
530 Inona no fanafody hafa ANTIBIOTIKA PILINA/ ANTIBIOTIKA PILINA/ ANTIBIOTIKA PILINA/ nomena hitsaboana ny aretim- SIROP…………. ……………….A SIROP……………………. A SIROP……………………. A pivalanana? TSY MAMPANDOA TSY MAMPANDOA TSY MAMPANDOA PILINA/SIROP ...... B PILINA/SIROP …………...B PILINA/SIROP …………...B Sao nisy zavatra hafa? ZINC …………………………..C ZINC ………………………C ZINC ………………………C MARIHO AVOKOA NY FANAFODY VOATONONA TSINDRONA ANTIBIOTIKA .D TSINDRONA ANTIBIOTIKA TSINDRONA ANTIBIOTIKA ……..D ……..D TSINDRONA AMIN‘NY LALAN-DRA (INTRA- TSINDRONA AMIN‘NY TSINDRONA AMIN‘NY VEINEUSE) …………………..E LALAN-DRA (INTRA- LALAN-DRA (INTRA- VEINEUSE) ………………E VEINEUSE) ………………E TSINDRONA HAFA …………F TSINDRONA HAFA ………F TSINDRONA HAFA ………F FANAFODY VITA AO AN- TRANO/TAMBAVY …………G FANAFODY VITA AO AN- FANAFODY VITA AO AN- TRANO/TAMBAVY ……G TRANO/TAMBAVY ……G HAFA(LAZAO) ………………X HAFA HAFA (LAZAO) …………………X (LAZAO) …………………X
Outcome Monitoring Survey in the MAHEFA Areas - 222 -
531 HAMARINO 530 : ENY ……………………………1 ENY ………………………1 ENY ………………………1 TSIA……………………………..2 TSIA ………………………2 TSIA ………………………2 NOMENA ZINC VE ? TSY FANTATRA …………… 96 TSY FANTATRA ………96 TSY FANTATRA ………96
533A Nisy fotoana ve tato anatin‘ny ENY ………………………1 ENY ………………………1 ENY ………………………1 2 herinandro, nanavy na TSIA ………………………2 TSIA ………………………2 TSIA ………………………2 nafana hoditra i (ANARANA)? TSY FANTATRA ………96 TSY FANTATRA ………96 TSY FANTATRA ………96
534 Nisy fotoana ve tato anatin‘ny ENY ………………………1 ENY ………………………1 ENY ………………………1 2 herinandro nikohaka i TSIA ………………………2 TSIA ………………………2 TSIA ………………………2 (ANARANA)? 537 537 537 TSY FANTATRA …………….96 TSY FANTATRA ………96 TSY FANTATRA ………96 537 537 537
535 Tato anatin‘ny 2 herinandro, ENY ………………………1 ENY ………………………1 ENY ………………………1 raha nikohaka i TSIA ………………………2 TSIA ………………………2 TSIA ………………………2 (ANARANA), nisy fotoana ve izy tsy avy miaina na 537 537 537 sempotra, haingana kokoa noho ny mahazatra ny TSY FANTATRA …………….96 TSY FANTATRA ………96 TSY FANTATRA ………96 fisefoana ? 537 537 537
536 Raha ny fahitanao azy avy AO AMIN‘NY TRATRA AO AMIN‘NY TRATRA AO AMIN‘NY TRATRA IHANY ……………………..1 IHANY ……………………..1 amin‘ny orona tsentsina/be IHANY …………………………1 lelo ve sa avy any anaty tratra NY ORONA IHANY ………2 NY ORONA IHANY ………2 no nahatonga azy tsy avy NY ORONA IHANY ………….2 miaina na sempotra ? IZY ROA MITAMBATRA ..3 IZY ROA MITAMBATRA ..3 IZY ROA MITAMBATRA ……3 HAFA (LAZAO) …………96 HAFA (LAZAO) …………96 HAFA (LAZAO) ………………96 TSY FANTATRA ………97 TSY FANTATRA ………97 TSY FANTATRA ……………97
536A Inona no nomena an‘i ANTIBIOTIKA ……………… 1 ANTIBIOTIKA …………… 1 ANTIBIOTIKA …………… 1 (ANARANA) rehefa FANAFODY TSY FANAFODY TSY FANAFODY TSY mikohaka izy ka sempotra sy MAMPIKOHAKA…………….2 MAMPIKOHAKA………….2 MAMPIKOHAKA………….2 tsy avy miaina tato anatin‘ny 2 herinandro? FANAFODY VITA AO AN- FANAFODY VITA AO AN- FANAFODY VITA AO AN- TRANO/ TAMBAVY …………3 TRANO/ TAMBAVY …….3 TRANO/ TAMBAVY …….3 HAFA (LAZAO) ………………96 HAFA (LAZAO) …………96 HAFA (LAZAO) …………96
Outcome Monitoring Survey in the MAHEFA Areas - 223 -
536B Iza no nanome anao ny MPIASAN‘NY MPIASAN‘NY MPIASAN‘NY fanafody nitsaboana ny FAHASALAMANA AO FAHASALAMANA AO FAHASALAMANA AO kohaka sy aretin-tratra? AMIN‘NY CSB AM- AMIN‘NY CSB AM- AMIN‘NY CSB AM- PANJAKANA…………………A PANJAKANA……………...A PANJAKANA……………...A MPIASAN‘NY MPIASAN‘NY MPIASAN‘NY Taiza ihany koa? FAHASALAMANA AO FAHASALAMANA AO FAHASALAMANA AO AMIN‘NY TOBIM- AMIN‘NY TOBIM- AMIN‘NY TOBIM- MARIHO ATO NY PAHASALAMANA TSY PAHASALAMANA TSY PAHASALAMANA TSY ANARAN‘NY TOERANA MIANKINA……………………B MIANKINA………………..B MIANKINA………………..B
DOKOTERA DOKOTERA DOKOTERA LIBRA………………………...C LIBRA………………………C LIBRA………………………C
______MPITSABO NETIM- MPITSABO NETIM- MPITSABO NETIM- PAHARAZANA………………D PAHARAZANA……………D PAHARAZANA……………D (ANARAN‘NY TOERANA) MPIASAN‘NY MPIASAN‘NY MPIASAN‘NY FAHASALAMANA AO FAHASALAMANA AO FAHASALAMANA AO AMIN‘NY HOPITALIM- AMIN‘NY HOPITALIM- AMIN‘NY HOPITALIM- PANJAKANA………………….E PANJAKANA………………E PANJAKANA………………E
MPIASAN‘NY MPIASAN‘NY MPIASAN‘NY FAHASALAMANA AO FAHASALAMANA AO FAHASALAMANA AO AMIN‘NY HOPITALY TSY AMIN‘NY HOPITALY TSY AMIN‘NY HOPITALY TSY MIANKINA…………………….F MIANKINA………………F MIANKINA………………F MPANENTANA ARA- MPANENTANA ARA- MPANENTANA ARA- PAHASALAMANA...... G PAHASALAMANA...... G PAHASALAMANA...... G FARMASIA/ TOERAM- FARMASIA/ TOERAM- FARMASIA/ TOERAM- PITEHIRIZANA PITEHIRIZANA PITEHIRIZANA FANAFODY……………………H FANAFODY………………H FANAFODY………………H HAFA HAFA HAFA (LAZAO) ………………………I (LAZAO) …………………I (LAZAO) …………………I
537 HAMARINO 533A ENY 1 ENY 1 TSIA 2 TSIA 2 NANAVY VE ILAY ZAZA TATO ANATIN‘NY 2 HERINANDRO LASA FARANY?
537A Nandritra ny fotoana ENY …………………. 1 ENY …………………. 1 ENY …………………. 1 nanavian‘i (ANARANA), nisy fotoana ve nangalana ra TSIA …………………..2 → 537F TSIA …………………..2 → TSIA …………………..2 → teo amin‘ny tanany na ny 537C 537C faladiany mba hizahana raha TSY FANTATRA …….3→ 537F misy tazomoka izy? TSY FANTATRA …….3→ TSY FANTATRA …….3→ 537C 537C
537B Raha ENY, inona no MISY ARETINA TAZO MOKA MISY ARETINA TAZO MISY ARETINA TAZO vokatr‘ilay fizahana natao? ……………2 MOKA ……2 MOKA ……2 TSY MISY ARETINA TAZO TSY MISY ARETINA TAZO TSY MISY ARETINA TAZO MOKA ……..3 MOKA..3 MOKA..3 TSY TSY TSY FANTATRA……………………… FANTATRA………………… FANTATRA………………… ….96 ….96 ….96
Outcome Monitoring Survey in the MAHEFA Areas - 224 -
537C Inona no fanafody nomena CHLOROQUINE / NIVAQUINE CHLOROQUINE / CHLOROQUINE / an‘i (ANARANA) tamin‘izy …….. …………………………..A NIVAQUINE …….. ……….A NIVAQUINE …….. ……….A nanavy? AMODIAQUINE ………………B AMODIAQUINE ………….B AMODIAQUINE ………….B JEREO ILAY BOATY MISY QUININE ………………………C QUININE ………………….C QUININE ………………….C NY FANAFODY ACTIPAL (ACT) ……………….D ACTIPAL (ACT) …………D ACTIPAL (ACT) …………D LARIMAL (ACT) ………………E LARIMAL (ACT) …………E LARIMAL (ACT) …………E ARTEMODI (ACT) ……………F ARTEMODI (ACT) ………F ARTEMODI (ACT) ………F ARSUMOON (ACT) …………G ARSUMOON (ACT) ………G ARSUMOON (ACT) ………G FALCIMON (ACT) ……………H FALCIMON (ACT) ………H FALCIMON (ACT) ………H COARTEM (ACT) ………………I COARTEM (ACT) …………I COARTEM (ACT) …………I FANGARO HAFA AZO FANGARO HAFA AZO FANGARO HAFA AZO TAMIN‘NY : ARTEMISININE J TAMIN‘NY : TAMIN‘NY : ARTEMISININE ODY TAZO MOKA HAFA …K ARTEMISININE …………. J …………. J FANAFODY HAFA ……………L ODY TAZO MOKA HAFA ODY TAZO MOKA HAFA FANAFODY NAMBOARINA …K …K TAO AN-TRANO FANAFODY HAFA ………L FANAFODY HAFA ………L / TAMBAVY ……………….M FANAFODY NAMBOARINA FANAFODY NAMBOARINA TSY FANTATRA ……………N TAO AN-TRANO TAO AN-TRANO / TAMBAVY …………….M / TAMBAVY …………….M TSY FANTATRA …………N TSY FANTATRA …………N
537D HAMARINO 537C ENY ENY ENY TSIA →544A TSIA →544A TSIA →544A Nomena ACT ve ilay zaza? DATY: DATY: Oviana i (ANARANA) no DATY: nanomboka nanavy?
Hafiriana taorian‘ny ANDROTR‘INY IHANY ………1 ANDROTR‘INY IHANY …1 ANDROTR‘INY IHANY …1 nanombohan‘i (ANARANA) ANDRO MANARAKA ………..2 ANDRO MANARAKA ……2 ANDRO MANARAKA ……2 nanavy no nanomezana azy 2 ANDRO NA MIHOATRA 2 ANDRO NA MIHOATRA 2 ANDRO NA MIHOATRA ACT? (ACT VOALAZA TAORIAN‘IZAY……………….3 TAORIAN‘IZAY……………3 TAORIAN‘IZAY……………3 537A)
537E Iza no nanome anareo ny MPIASAN‘NY MPIASAN‘NY MPIASAN‘NY fanafody nitsaboana ny tazo? FAHASALAMANA AO FAHASALAMANA AO FAHASALAMANA AO AMIN‘NY CSB AM- AMIN‘NY CSB AM- AMIN‘NY CSB AM- PANJAKANA…………………A PANJAKANA……………...A PANJAKANA……………...A Taiza ihany koa? MPIASAN‘NY MPIASAN‘NY MPIASAN‘NY FAHASALAMANA AO FAHASALAMANA AO FAHASALAMANA AO MARIHO ATO NY AMIN‘NY TOBIM- AMIN‘NY TOBIM- AMIN‘NY TOBIM- ANARAN‘NY TOERANA PAHASALAMANA TSY PAHASALAMANA TSY PAHASALAMANA TSY MIANKINA……………………B MIANKINA………………..B MIANKINA………………..B
DOKOTERA DOKOTERA DOKOTERA LIBRA………………………...C LIBRA………………………C LIBRA………………………C ______MPITSABO NETIM- MPITSABO NETIM- MPITSABO NETIM- (ANARAN‘NY TOERANA) PAHARAZANA………………D PAHARAZANA……………D PAHARAZANA……………D MPIASAN‘NY MPIASAN‘NY MPIASAN‘NY FAHASALAMANA AO FAHASALAMANA AO FAHASALAMANA AO AMIN‘NY HOPITALIM- AMIN‘NY HOPITALIM- AMIN‘NY HOPITALIM- PANJAKANA………………….E PANJAKANA………………E PANJAKANA………………E MPIASAN‘NY MPIASAN‘NY MPIASAN‘NY FAHASALAMANA AO FAHASALAMANA AO FAHASALAMANA AO AMIN‘NY HOPITALY TSY AMIN‘NY HOPITALY TSY AMIN‘NY HOPITALY TSY MIANKINA…………………….F MIANKINA………………F MIANKINA………………F MPANENTANA ARA- MPANENTANA ARA- MPANENTANA ARA- PAHASALAMANA...... G PAHASALAMANA...... G PAHASALAMANA...... G FARMASIA/ TOERAM- FARMASIA/ TOERAM- FARMASIA/ TOERAM- PITEHIRIZANA PITEHIRIZANA PITEHIRIZANA FANAFODY……………………H FANAFODY………………H FANAFODY………………H HAFA HAFA HAFA (LAZAO) ………………………I (LAZAO) …………………I (LAZAO) …………………I
Outcome Monitoring Survey in the MAHEFA Areas - 225 -
537F HAMARINO 212, 216, RAHA FENO ENIM-BOLANA NA MIHOATRA NY ZAZA ENY .….. 1 TSIA ………….3
Raha ENY ↓
515 Nomena vitamine A ve i ENY ……………. 1 ENY ……………. 1 ENY ……………. 1 (ANARANA) tao anatin‘izay enim-bolana izay? TSIA ……………...2 TSIA ……………...2 TSIA ……………...2
HAMARINO NY KARINEM- TSY FANTATRA ….3 TSY FANTATRA ….3 TSY FANTATRA ….3 PAHASALAMANA
537D Andeha ary halaiko refy ny manodidina ny sandrin‘i (ANARANA).
TADIAVINA NY TOERANA HO REFESINA (EO ANELANELAN‘NY TENDRON‘NY TENDRON‘NY SAHAFAN-DAMOSINA SY NY TENDRON‘NY KIHO), ARY MARIHANA IZANY REHEFA HITA IZANY TOERANA HO REFESINA IZANY DIA ASAINA MIJORO TSARA NY ZAZA ARY AHITSY HILATSAKA NY TANANY HAVIA IZAY VAO ALAINA NY REFY EZAHANA TSY HIHINJITRA BE LOATRA ILAY ZAZA,
537E MENA …………… 1 MAVO …………….2 MAITSO …………..3 REFY AMIN‘NY SM = |__|__| sm TSY AFAKA NALAINA REFY ….96 TSY NANAIKY ALAINA REFY…..99
Outcome Monitoring Survey in the MAHEFA Areas - 226 -
ZAZA 0-23 VOLANA
N° FANONTANIANA SY FAHATERAHANA FARANY SIVANA
LAHARANY
DATY NAHATERAHANA DATY NAHATERAHANA DATY NAHATERAHANA HAMARINO 212, 215 SY 216 TAONA : 0 – 23 VOLANA TAONA : 0 – 23 VOLANA TAONA : 0 – 23 VOLANA
FANONTANIANA VELONA MATY VELONA MATY VELONA MATY MAHAKASIKA NY ↓ ↓ ↓ ZAZA VELONA 0 – 23 VOLANA → → → AMPIANA PEJY HAFA RAHA AMPIANA PEJY HAFA RAHA AMPIANA PEJY HAFA RAHA MISY ZAZA 0 – 23 VOLANA MISY ZAZA 0 – 23 VOLANA MISY ZAZA 0 – 23 VOLANA
RAHA TSY MISY RAHA TSY MISY RAHA TSY MISY ZAZA INTSONY ZAZA INTSONY ZAZA INTSONY ↓ ↓ ↓
449 IZAO ISIKA DIA HIRESAKA MOMBA IREO FIKARAKARANA NATAO NY ZANAKAO VANTANY VAO TERAKA IZY
450 Notapahana ve ny ENY 1 ENY 1 ENY 1 tadim-poitran‘i TSIA 2 TSIA 2 TSIA 2 (ANARANA) talohan‘ny nahafahan‘ny tavony?
451 Nisy Kit ENY 1 ENY 1 ENY 1 d'accouchement TSIA 2 TSIA 2 TSIA 2 nampiasainao ve tamin‘ny ianao niteraka an‘i (ANARANA) ?
452 LAME VAOVAO 1 LAME VAOVAO 1 LAME VAOVAO 1 Inona no fitaovana nanapahana ny tadim- LAME EFA 2 LAME EFA 2 LAME EFA 2 poitra an‘i NAMPANGOTRAHANA. NAMPANGOTRAHANA. NAMPANGOTRAHA (ANARANA) tamin‘izy . 3 . 3 NA.. 3 teraka? LAME EFA NIASA LAME EFA NIASA LAME EFA NIASA 4 4 4 HETY VAOVAO HETY VAOVAO HETY VAOVAO
HETY EFA 5 HETY EFA 5 HETY EFA 5 NAMPANGOTRAHANA NAMPANGOTRAHANA NAMPANGOTRAHA NA ANTSY 6 ANTSY 6 6 ANTSY ANTSIM-BILONA 7 ANTSIM-BILONA 7 7 ANTSIM-BILONA HAFA (LAZAO) : HAFA (LAZAO) : 96 96 96 HAFA (LAZAO) : TSY FANTATRO TSY FANTATRO 99 99 TSY FANTATRO 99
Outcome Monitoring Survey in the MAHEFA Areas - 227 -
453 Inona no tady TADY KELY VAOVAO …1 TADY KELY VAOVAO …1 TADY KELY VAOVAO …1 namatorana ny tadim- poitran‘i TADY KELY EFA TADY KELY EFA TADY KELY EFA (ANARANA)? NAMPANGOTRAHANA…2 NAMPANGOTRAHANA…2 NAMPANGOTRAHANA…2 TADY KELY EFA NIASA 3 TADY KELY EFA NIASA 3 TADY KELY EFA NIASA 3 HAFA (LAZAO) : ………96 HAFA (LAZAO) : ………96 HAFA (LAZAO) : ………96 TSY FANTATRO …………99 TSY FANTATRO …………99 TSY FANTATRO ………99
454 Nisy zavatra ENY ……………….1 ENY ……………….1 ENY ……………….1 nosorana ve teo TSIA………………..2→456 TSIA………………..2→456 TSIA………………..2→456 amin‘ny foitran‘i TSY FANTATRO …96→456 TSY FANTATRO …96→456 TSY FANTATRO …96→456 (ANARANA) taorian‘ny nanapahana azy?
454A Raha ENY, Inona no POMADY POMADY POMADY no nosorana tamin‘ny « AROFOITRA » ………….1 « AROFOITRA » ………….1 « AROFOITRA » ………….1 foitran‘i HAFA (LAZAO) : ……….96 HAFA (LAZAO) : ……….96 HAFA (LAZAO) : ……….96 (ANARANA)? TSY NISY …………………2 TSY NISY …………………2 TSY NISY …………………2 TSY FANTATRO …………99 TSY FANTATRO …………99 TSY FANTATRO ………99
Efa nofafana ve i ENY ………………………..1 ENY ………………………..1 ENY ……………………..1 456 (ANARANA) TSIA………………………..2 TSIA………………………..2 TSIA………………………..2 talohan‘ny TSY FANTATRO …………3 TSY FANTATRO …………3 TSY FANTATRO …………3 nahafahan‘ny tavony?
456A Faritra inona tamin‘i NY VATANA ………………1 NY VATANA ………………1 NY VATANA ……………1 (ANARANA) no HATRANY AN-TAMPON- HATRANY AN-TAMPON- HATRANY AN-TAMPON- nofafana? DOHA KA HATRANY AM- DOHA KA HATRANY AM- DOHA KA HATRANY AM- PALADIA…………………2 PALADIA…………………2 PALADIA…………………2 HAFA (LAZAO) : ……….96 HAFA (LAZAO) : ……….96 HAFA (LAZAO) : ……….96 TSY FANTATRO …………99 TSY FANTATRO …………99 TSY FANTATRO ………99
457 Norakofana lamba ve ENY …………………1 ENY …………………1 ENY …………………1 i (ANARANA) TSIA …………………2→458 TSIA …………………2→458 TSIA ………………2→458 talohan‘ny TSY FANTATRO … 96→458 TSY FANTATRO … 96→458 TSY FANTATRO 96→458 nahafahan‘ny tavony?
457A Raha ENY, inona no LAMBA MAINA LAMBA MAINA LAMBA MAINA nandrakofana an‘i SY MADIO …………….….1 SY MADIO …………….….1 SY MADIO ………….….1 (ANARANA)? LAMBA MAINA ………….2 LAMBA MAINA ………….2 LAMBA MAINA ………….2 HAFA ……………………96 HAFA ……………………96 HAFA ……………………96 TSY FANTATRO ……….99 TSY FANTATRO ……….99 TSY FANTATRO ……….99
458 Taiza no AMBONY TANY …………..1 AMBONY TANY …………..1 AMBONY TANY ………..1 nametrahana an‘i AMBONY TSIHY ………….2 AMBONY TSIHY ………….2 AMBONY TSIHY ……….2 (ANARANA) AMBONY AMBONY AMBONY talohan‘ny FANDRIAN-JAZA ………...3 FANDRIAN-JAZA ………...3 FANDRIAN-JAZA ……….3 nahafahan‘ny AN-TRATRAN‘NY RENY ..4 AN-TRATRAN‘NY RENY ..4 AN-TRATRAN‘NY RENY .4 tavony? AKAIKY NY RENY ………5 AKAIKY NY RENY ………5 AKAIKY NY RENY ……5 TANY TANY TANY AMIN‘OLON-KAFA ………6 AMIN‘OLON-KAFA ………6 AMIN‘OLON-KAFA ……6 HAFA (LAZAO) …………..96 HAFA (LAZAO) …………..96 HAFA (LAZAO) …………96 TSY FANTATRO …………99 TSY FANTATRO …………99 TSY FANTATRO ………99
Outcome Monitoring Survey in the MAHEFA Areas - 228 -
Hafiriana taorian‘ny 459 nahaterahany i ORA … ORA … ORA … (ANARANA) no nampandroana ANDRO …. ANDRO …. ANDRO …. voalohany? HERINANDRO …. HERINANDRO …. HERINANDRO …. RAHA LATSAKY NY 1 ANDRO DIA TSY FANTATRA TSY FANTATRA TSY FANTATRA MARIHO AMIN‘NY ………….99 ………….99 ………….99 ORA; RAHA LATSAKY NY HERINANDRO DIA MARIHO AMIN‘NY ANDRO.
I (ANARANA) ve 463 efa ninono? ENY 1 ENY 1 ENY 1 TSIA 2 TSIA 2 TSIA 2
Hafiriana taorian‘ny 464 nahaterahan‘i TEO NOHO EO 000 TEO NOHO EO 000 TEO NOHO EO 000 (ANARANA) no nanomezana nono ORA______ORA______ORA______azy voalohany? ANDRO______ANDRO______ANDRO______RAHA LATSAKY NY ADINY 1 DIA MARIHO '00' TSY FANTATRA TSY FANTATRA TSY FANTATRA
RAHA LATSAKY NY 24 ORA, MARIHO AMIN‘NY ORA. NY ANKOATR‘IZAY MARIHO AMIN‘NY ANDRO
Outcome Monitoring Survey in the MAHEFA Areas - 229 -
464A Vantany vao latsaka i MPIASAN‘NY MPIASAN‘NY MPIASAN‘NY (ANARANA), iza no FAHASALAMANA AO FAHASALAMANA AO FAHASALAMANA AO nikarakara ny zaza? AMIN‘NY CSB AM- AMIN‘NY CSB AM- AMIN‘NY CSB AM- PANJAKANA…………………A PANJAKANA…………………A PANJAKANA…………………A
MPIASAN‘NY MPIASAN‘NY MPIASAN‘NY FAHASALAMANA AO FAHASALAMANA AO FAHASALAMANA AO MARIHO NY AMIN‘NY TOBIM- AMIN‘NY TOBIM- AMIN‘NY TOBIM- ANARAN‘NY PAHASALAMANA TSY PAHASALAMANA TSY PAHASALAMANA TSY TOERANA MIANKINA……………………B MIANKINA……………………B MIANKINA……………………B NITERAHANA DOKOTERA DOKOTERA DOKOTERA LIBRA………………………...C LIBRA………………………...C LIBRA………………………...C MPITSABO NETIM- MPITSABO NETIM- MPITSABO NETIM- PAHARAZANA………………D PAHARAZANA………………D PAHARAZANA………………D MPIASAN‘NY MPIASAN‘NY MPIASAN‘NY FAHASALAMANA AO FAHASALAMANA AO FAHASALAMANA AO AMIN‘NY HOPITALIM- AMIN‘NY HOPITALIM- AMIN‘NY HOPITALIM- PANJAKANA………………….E PANJAKANA………………….E PANJAKANA……………….E MPIASAN‘NY MPIASAN‘NY MPIASAN‘NY FAHASALAMANA AO FAHASALAMANA AO FAHASALAMANA AO AMIN‘NY HOPITALY TSY AMIN‘NY HOPITALY TSY AMIN‘NY HOPITALY TSY MIANKINA…………………….F MIANKINA…………………….F MIANKINA………………….F MPANENTANA ARA- MPANENTANA ARA- MPANENTANA ARA- PAHASALAMANA...... G PAHASALAMANA...... G PAHASALAMANA...... G FARMASIA/ TOERAM- FARMASIA/ TOERAM- FARMASIA/ TOERAM- PITEHIRIZANA PITEHIRIZANA PITEHIRIZANA FANAFODY……………………H FANAFODY……………………H FANAFODY…………………H HAFA HAFA HAFA (LAZAO) ………………………I (LAZAO) ………………………I (LAZAO) ……………………I
464B Efa nahazo fiofanana ENY 1 ENY 1 ENY 1 manokana tamina TSIA 2 → 463 TSIA 2 → 463 TSIA 2 → 463 tetikasa ve io olona nikarakara an‘i (ANARANA) io vantan‘izy vao latsaka?
464C Raha ENY, tetikasa MAHEFA ……………….…..1 MAHEFA ………………….1 MAHEFA …………………1 inona? TETIK‘ASA HAFA TETIK‘ASA HAFA TETIK‘ASA HAFA TOHANAN‘NY TOHANAN‘NY TOHANAN‘NY FANJAKANA AMERIKANA FANJAKANA AMERIKANA FANJAKANA (USAID)……………………..2 (USAID)…...... 2 AMERIKANA (USAID)…..2
TSY MISY …………………3 TSY MISY …………………3 TSY MISY ……………….3
TSY FANTATRO ………….9 TSY FANTATRO …………99 TSY FANTATRO ……….99
Outcome Monitoring Survey in the MAHEFA Areas - 230 -
ZAZA 0-6 VOLANA
N° FANONTANIANA FAHATERAHANA FARANY FAHATERAHANA FAHATERAHANA SY SIVANA ALOHAN‘NY FARANY ALOHAN‘NY ALOHAN‘NY FARANY LAHARANY LAHARANY LAHARANY
HAMARINO 212, 215 SY 216 VELONA MATY VELONA MATY VELONA MATY ↓ ↓ ↓ FANONTANIANA → → MAHAKASIKA NY AMPIANA PEJY HAFA AMPIANA PEJY HAFA → ZAZA VELONA 0 – RAHA MISY ZAZA 0 – 6 RAHA MISY ZAZA 0 – 6 AMPIANA PEJY HAFA 6 VOLANA VOLANA VOLANA RAHA MISY ZAZA 0 – 6 VOLANA
RAHA TSY RAHA TSY MISY ZAZA INTSONY MISY ZAZA INTSONY RAHA TSY ↓ ↓ MISY ZAZA INTSONY ↓
463 I (ANARANA) ve ENY 1 ENY 1 ENY 1 efa ninono? TSIA 2 TSIA 2 TSIA 2
Hafiriana taorian‘ny 464 nahaterahany i TEO NOHO EO 000 TEO NOHO EO 000 TEO NOHO EO 000 (ANARANA) no ninono voalohany?
RAHA LATSAKY NY ADINY 1 DIA ORA ORA ORA MARIHO '00' ANDRO ANDRO ANDRO RAHA LATSAKY NY 24 ORA, MARIHO AMIN‘NY ORA.
NY ANKOATR‘IZAY MARIHO AMIN‘NY ANDRO
465 Nomena ranon- javatra hafa ankoatry ENY 1 ENY 1 ENY 1 ny nonon-dreny ve i (ANARANA) TSIA 2 TSIA 2 TSIA 2 nandritra ny 3 andro taorian‘ny nahaterahany?
Outcome Monitoring Survey in the MAHEFA Areas - 231 -
466 Inona no RONONO (ANKOATRY NY RONONO (ANKOATRY NY RONONO (ANKOATRY NY nampisotroana an‘I NONON-DRENY) NONON-DRENY) NONON-DRENY) (ANARANA)? ……………………………… ……………………………… ……………………………… …A …A …A Sao nisy zavatra RANO……………………… RANO……………………… RANO……………………… hafa? …….……...B …….……...B …….……...B RANON-TSIRAMAMY / RANON-TSIRAMAMY / RANON-TSIRAMAMY / SORATY AVOKOA NASIANA GLUCOSE NASIANA GLUCOSE NASIANA GLUCOSE IZAY RANON- ………………………………C ………………………………C ……………………………… JAVATRA DITE MAFANA MANALA DITE MAFANA MANALA C VOATONONA MANGOTIKA MANGOTIKA DITE MAFANA MANALA ……………………………… ……………………………… MANGOTIKA …………….D …………….D ……………………………… RANON-JAVATRA RANON-JAVATRA …………….D MASIRA/MAMY…E MASIRA/MAMY…E RANON-JAVATRA RANOM-BOANKAZO RANOM-BOANKAZO MASIRA/MAMY…E ………………….F ………………….F RANOM-BOANKAZO FANGARO VOATOKANA FANGARO VOATOKANA ………………….F HO AN‘NY ZAZA HO AN‘NY ZAZA FANGARO VOATOKANA ……………………………… ……………………………… HO AN‘NY ZAZA ……G ……G ……………………………… DITÉ DITÉ ……G ……………………………… ……………………………… DITÉ …….H …….H ……………………………… TANTELY TANTELY …….H ……………………………….I ……………………………….I TANTELY HAFA HAFA ………………………………. (LAZAO)…………………… (LAZAO)…………………… I ……X ……X HAFA (LAZAO)…………………… ……X
467 Mbola minono ve i ENY 1 ENY 1 ENY 1 (ANARANA) izao? TSIA 2 → 471 TSIA 2 → 471 TSIA 2 → 471
468 Nandritra ny firy VOLANA ……………….. VOLANA VOLANA volana no nampinonoana an‘i TSY FANTATRA ……….96 TSY FANTATRA TSY FANTATRA (ANARANA)? ……………. 96 …………….. 96
Outcome Monitoring Survey in the MAHEFA Areas - 232 -
469 Impiry i (anarana) no ISAN‘NY FAMPINONOANA ISAN‘NY FAMPINONOANA ISAN‘NY minono @ alina, AMIN‘NY ALINA AMIN‘NY ALINA FAMPINONOANA izany hoe teo AMIN‘NY ALINA anelanelan‘ny nilentehan‘ny masoandro ka hatramin‘ny niposahany indray?
RAHA TSY MANOME ISA MAZAVA NY OLONA HADIHADIANA DIA ANONTANIO IHANY MBA AHAZOANAO NA ISA MANAKAIKIKAIK Y NY TENA IZY ARY.
470 Impiry i (anarana) no ISAN‘NY FAMPINONOANA ISAN‘NY FAMPINONOANA ISAN‘NY ninono omaly MANDRITRA NY ANDRO MANDRITRA NY ANDRO FAMPINONOANA tontolon‘ny andro? |__|__| MANDRITRA NY ANDRO
471 Nomena ranon- ENY 1 ENY 1 ENY 1 javatra tamin‘ny TSIA 2 TSIA 2 TSIA 2 biberon ve i (ANARANA) omaly na tamin‘ny alina?
Outcome Monitoring Survey in the MAHEFA Areas - 233 -
FAHASALAMAN’NY ZAZA 0-23 VOLANA
N° FANONTANIANA FAHATERAHANA FARANY FAHATERAHANA FAHATERAHANA SY SIVANA ALOHAN‘NY FARANY ALOHAN‘NY ALOHAN‘NY FARANY LAHARANY LAHARANY LAHARANY
HAMARINO 212, 215 SY 216 VELONA MATY VELONA MATY VELONA MATY ↓ ↓ ↓ FANONTANIANA RAHA RAHA MAHAKASIKA NY TSY MISY TSY MISY RAHA TSY MISY ZAZA VELONA 0 – ZAZA ZAZA 23 VOLANA INTSONY INTSONY ZAZA ↓ ↓ INTSONY ↓
835 Firy kilao i ……. Kg, g ……. Kg, g ……. Kg, g (ANARANA)?
TSY FANTATRA 96 TSY FANTATRA 96 TSY FANTATRA 96 Oviana no nizaha fahasalamana sy nolanjaina farany i DATY DATY DATY (ANARANA) ? |__|__| |__|__| |__|__|
HAMARINO NY |__|__| |__|__| |__|__| KARINEM- PAHASALAMAN‘I (ANARANA) ARY JEREO MIARAKA AMIN‘NY OLONA HADIHADIANA NY FIVOARAN‘NY LANJA
836 Nanao fizaham- ENY 1 ENY 1 ENY 1 pahasalamana sy TSIA 2 TSIA 2 TSIA 2 nilanja ve (ANARANA) tato anatin‘ny 2 volana ?
Outcome Monitoring Survey in the MAHEFA Areas - 234 -
FAHASALAMAN’NY ZAZA EO ANELANELAN’NY 6 - 23 VOLANA
601 HAMARINO 215 SY 218, IREO ANDININY REHETRA :
ISAN‘NY ZAZA NATERAKA TAO ANELANELAN‘NY (DATIN‘NY 23 VOLANA LASA) sy (DATY AMIN‘IZAO) KA VELONA ARY MIARAKA AMIN‘NY OLONA HADIHADIANA
RAHA MISY 1 NA MIHOATRA, DIA FANONTANIANA 1 ISAKY NY ZAZA 1
SORATY NY ANARAN‘NY ZAZA ZANDRINY INDRINDRA : ______
(ANARANA)
N° FANONTANIANA SY SIVANA
602 Inona no sakafo na ranon-javatra nohanina/ nosotroin‘i (ANARANA AO AMIN‘NY 601) omaly nandritra ny ENY TSIA(2) TSY andro na tamin‘ny alina? (1) VOAMARIKA (3) RANO
FANGARO VOAOMANA MIALOHA amidy eny @ mpivarotra
KOBAM-BARY HO AN‘NY ZAZA
KOBA MARIHITRAKOBAM- BARIM-BAZAHA HAFA
FARILAC NA CERELAC
Outcome Monitoring Survey in the MAHEFA Areas - 235 -
603 Inona koa ny sakafo na ranon-javatra nomena an‘i (ANARANA AO ENY(1) TSIA(2) TSY AMIN‘NY 601) nandritra ny andro na VOAMARIKA(3) tamin‘ny alina, na dia hoe nafangaro tamin‘ny zavatra hafa aza. 1. Ronono toy ny ronono amin‘ny boaty, vovony na ronono avy amin‘ny biby? (Oh: Omby na osy) 2. Dite na kafe? 3. Ranon-javatra hafa? 4. Mofo, vary, paty na sakafo hafa vita avy amin‘ny kobam- bary na Tapioca? 5. Voatavo, karaoty, courgette na ovy izay somary mavo na volom-boasary ny ao anatiny? 6. Ovy, oviala fotsy, saonjo, mangahazo, sakafo hafa azo avy amin‘ny fakan-javamaniry,? 7. Legioma maitso ravina? 8. Manga na papay? 9. Voankazo na legioma hafa ? 10. Atinkena,haranany, voankena na fon-kena na vorivorin- kenan‘ny biby fihinana (Abats)? 11. Hen‘omby na hena-kisoa, ondry na osy, akoho na gana ? 12. Atody? 13. Trondro lena na maina na hazan-dranomasina ? 14. Sakafo avy amin‘ny voamaina toy ny tsaramaso, voanjobory, tsiasisa na noix ? 15. Fromazy, yaourt na vokatra hafa azo avy amin‘ny ronono? 16. Menaka, tavy na dibera, na sakafo voakarakara avy amin‘ireo singa ireo ? 17. Sakafo mamy toy ny chocolat, vatomamy sy zava-mamy, karazana mofomamy sy bisky ? 18. Vaingan-kanina hafa na sakafo ranondranony ?
HAMARINO 602 (KARAZAN-TSAKAFO 2 FARANY: 604 KOBAM-BARIN-JAZA NA KOBAM-BARIM- IRAY TAMIN‘IREO BAZAHA/KOBA MARIHITRA) RAHA KELY INDRINDRA
ENY …………………….1
TSY NISY TAMIN‘IREO NA DIA IRAY AZA …………….. 2
467A Mbola minono ve i (ANARANA AO AMIN‘NY 601) izao?
605 Impiry i (ANARANA AO AMIN‘NY 601) no nihinana vaingan-kanina, na sakafo marihidrihitra na koba marihitra ankoatra ny ranon-javatra (liquide) omaly tontolo andro (maraina sy hariva) na nandritra ny alina?
RAHA MIHOATRA NY IM-7 DIA MARIHO HOE ‗7'.
Outcome Monitoring Survey in the MAHEFA Areas - 236 -
E4. CHV Questionnaire
MPANENTANA ARA-PAHASALAMANA Manao ahoana tompoko, izaho no ……………………., miasa ao amin‘ny ……………………… ary manatanteraka fanadihadiana momba ny fomba fiasan‘ny mpanentana ara-pahasalamana na ny CHV izahay. (Marihina fa ny fanadihadiana dia ho an‘ny USAID Madagascar). Manam-potoana kely iresahana amiko ve ianao?
Hametraka fanontaniana momba ny asa ataonao, ny fanafody izay amidinao ary ireo fahombiazana ao anatin‘ny asanao aho. Manampy betsaka ahy ary isaorako indrindra anao ny filazanao ny zava-misy marina mahakasika ireo ao anatin‘ny valim-panontanianao. Marihiko fa ao anatin‘ny tsiambaratelo avokoa izany rehetra izany.
Misaotra indrindra.
Anarana:
Fanampiny:
Taona: |__|__|
Ny mpamaly: Lahy Vavy
Daty nanombohana amin‘ny maha mpanentana : Andro |__|__| Volana |__|__| Taona |__|__|
Kilasy fahafiry ianao no nijanona nianatra?
-T0 25
- Tsy nianatra
Fokontany Kaominina Distrika Faritra
______
Outcome Monitoring Survey in the MAHEFA Areas - 237 -
N° FANONTANIANA SY SIVANA
1001A Isaky ny inona ianao no mamangy ISAN‘ANDRO 1 tokantrano iray ka manome ISAN-KERINANDRO 2 fampianarana, fampahalalana sy torohevitra momba ny fahasalamana ny ISAN-TAPA-BOLANA 3 mponina ao aminy? ISAM-BOLANA 4 ISAKY NY ROA VOLANA 5 ISAN-TELO VOLANA 6 MAHALANA NOHO IZANY 7 1001B Oviana ianao no nanome fampianarana, TAMIN‘ITY VOLANA ITY 1 fampahalalana sy torohevitra momba ny fahasalamana tany an-tranon‘olona iray TALOHAN‘IZANY 2 farany?
1002 Raha ENY, inona avy ireo lohahevitra FANDRINDRANA FIAINAM- voaresaka tao anatin‘izay fitsidihana PIANAKAVIANA/ PLANNING farany izay? FAMILIAL…………… ………….… A
FAHASALAMANA ARA- PANANAHANA/ SANTE DE LA REPRODUCTION…. ………….……B
FIAROVANA AMIN‘NY ARETI- MIFINDRA VY @ FIRAISANA ARA- NOFO/ MST….……………………….C
FANDEFASANA ANY @ TOBIM- PAHASALAMANA/ REFERENCE AU CENTRE DE SANTE….. ………….. D
FAHASALAMAN‘NY ZAZA VAO TERAKA/ SANTE DES NOUVEAUX- NES…………. ……………………….E
FAHASALAMAN‘NY RENY SY NY ZAZA/ SANTE MATERNELLE ET INFANTILE…………………………..F
HAFA (Lazao) ………..…………….. G
Outcome Monitoring Survey in the MAHEFA Areas - 238 -
1003 Efa nahazo mari-pankasitrahana/ mari- ENY ………………………. 1 pahaizana momba ny fanentanana ara- pahasalamana ve ianao? TSIA …………………….. 2 1005
1004 Raha ENY, inona avy izany? PF4 …………………………… A
Azonao aseho ahy ve ny mari- PCIME ……………………….. B pankasitrahana azonao? DEPO …………………………C
IEC/COUNSELING ………….D
IST …………………………….E
HAFA (Lazao) ………………..F
1005 Mandalo fitsapam-pahaizana matetika ENY ………………………. 1 ve ianao? TSIA …………………….. 2
1006 Impiry afaka ianao tamin‘izany IN |__|__| fitsapam-pahaizana izany? TSY MBOLA AFAKA MIHITSY NA TAMINA FITSAPAM-PAHAIZANA IRAY AZA
1008 Firy ny naoty azonao tamin‘ny __ /10 tomban‘ezaka natao tamin‘ny alalan‘ny karatry ny naoty ? __ /10
__/10
LAZAO IREO NAOTY TELO TSY NANAO TOMBAN‘EZAKA FARANY TAMIN‘NY ALALAN‘NY KARATRY NY NAOTY …………………………………2
1009 Mitondra rano sy savony hanasana ENY ………………………. 1 tanana ve ianao izao? TSIA …………………….. 2 HAMARINO
Outcome Monitoring Survey in the MAHEFA Areas - 239 -
1010 Ahoana ny fomba nikarakaranao ireo ARIANA ANY @ FAKO ……....……A fitaovana toy ny seraingy sy fanjaitra rehefa avy nampiasaina ? ARIANA ANY @ AVELAO HAMALY NY HADIHADIANA FA TSY VAKIANA LAVA-PIRINGA ……………...... B AMINY NY VALINY ATAO ANATY HARONA PLASTIKA (MAFY) VOATOKANA ARY ALEVINA ANATY LAVAKA VOATOKANA ………………………..C HAFA(Lazao) …………………………X 1010A Ahoana ny fomba nikarakaranao ireo ARIANA ANY @ FAKO ……....……A fitaovana toy ny vovo rehefa avy nampiasaina ? ARIANA ANY @ AVELAO HAMALY NY HADIHADIANA FA TSY VAKIANA LAVA-PIRINGA ……………...... B AMINY NY VALINY ATAO ANATY HARONA PLASTIKA (MAFY) VOATOKANA ARY ALEVINA ANATY LAVAKA VOATOKANA ………………………..C HAFA(Lazao) …………………………X 1011 Azonao aseho ahy ve izao ny toeram- pitehirizanao fanafody?
HAMARINO IRETO VOALAZA MANARAKA IRETO ARY ALAIVO SARY NY TAKELAKA SY NY TOERAM-PITEHIRIZANA FANAFODY
Outcome Monitoring Survey in the MAHEFA Areas - 240 -
LISITRA 1. JERENA NY FANAFODY AO AMIN‘NY TAHIRY UNITE ISA RAHA ISA=0, DIA MARIHO DATIN‘NY RAHA TOA KA NISY FA NAHALANIAN‘NY LANY NA TSY TAHIRY RAHA NISY NAHATONGA MIHITSY IZANY
ARETIN-KIBO
VIASUR
ZINC
SRO
SUR‘EAU
ARETIN-TRATRA
PNEUMOSTOP
COTRIM
CHLORHEXIDINE/ AROFOITRA
HO AN’NY VEHIVAVY BEVOHOKA
FER ACIDE FOLIQUE/ PILIFERA
FANAFODY KANKANA
MEBENDAZOLE
TAZOMOKA
TEST DU PALUDISME
ACTIPAL (ACT)
ASAQ
FANABEAZANA AIZANA
PILPLAN
LOFEMENAL
Outcome Monitoring Survey in the MAHEFA Areas - 241 -
MICROGYNON
OVRETTE
CONFIANCE
Depocom/ Depoprovera ou DEPO
COLLIER DU CYCLE
ARETINA AZO AVY AMIN’NY FIRAISANA ARA-NOFO
PROTECTOR PLUS
CONDOM
SPERMICIDE NEO SAMPOON
Outcome Monitoring Survey in the MAHEFA Areas - 242 -
LISITRA 2. LISITRY NY FANAFODY MISY AO AMINY NA KOA TOKONY AMIDINY KANEFA TSY HITA TAO ANATY LISITRA 1
UNITE ISA MARIHO (1) RAHA TOA KA DATY NISY FA LANY NAHALANIAN‘NY TAHIRY
ARETIN-KIBO
ARETIN-TRATRA
HO AN’NY VEHIVAVY BEVOHOKA
FANAFODY KANKANA
TAZOMOKA
FANABEAZANA AIZANA
Outcome Monitoring Survey in the MAHEFA Areas - 243 -
ARETINA AZO AVY AMIN’NY FIRAISANA ARA- NOFO
1012 Misy ary anisan‘ny tolotra any amin‘ny fiaraha- monina misy anao ve ireto fomba fandrindram- piterahana manaraka ireto ?
MISY TSY MISY TSY FANTATRA
DIU
IMPLANT
STERILISATION
1012 Misy manara-maso na manao supervision ve ENY ………… 1 ianao manao ity asa fanentanana ara- pahasalamana ity? TSIA ………… 2
1013 Oviana ianao no naraha-maso na natao VAO HAINGANA, supervision farany? LATSAKY NY 2 VOLANA
TALOHAN‘NY 2 VOLANA
1014 Tao anatin‘ny 12 volana farany, nisy fotoana ve ENY ………… 1 tsy nahafahanao nivory niaraka tamin‘ny CCDS ? TSIA ………… 2
1014A Raha ENY, impiry ianao no tsy afaka nivory IN-|__|__| tamin‘ny CCDS tato anatin‘ny 12 volana?
Outcome Monitoring Survey in the MAHEFA Areas - 244 -
1015 Izao isika dia hiresaka momba ny tahirim-bola voaangonao tamin‘ny alalan‘ny fivarotana ireto fanafody ireto any amin‘ny fiaraha-monona
JERENA MIARAKA AMIN‘NY HADIHADIANA NY BOKIM-BOLANY
RAHA MISY
ADIKA IREO VOLA VOAANGONY TAO ANATIN‘IRETO TELO VOLANA ROA IRETO: ENY……………..1 VOLA VOAANGONA: JANOARY - MARTSA 2014 TSIA ……………2
VOLA VOAANGONA: APRILY - JONA TSY MANANA 2014 BOKIM- BOLA…..3 Manao lanja miakatra ve ny vola voaangony?
1016 Manana fahafahana mindram-bola amin‘ny ENY ………… 1 alalan‘ny tolotra COSAN ve ianao? TSIA ………… 2
1017 Mpikambana amin‘ny ombon-tahiry ENY ………… 1 fampindramam-bola ve ianao? TSIA ………… 2
Outcome Monitoring Survey in the MAHEFA Areas - 245 -
E.5 POS Questionnaire
TOERAM-BAROTRA Manao ahoana tompoko, izaho no ……………………., miasa ao amin‘ny ……………………… ary manatanteraka fanadihadiana mikasika ny fanafody sy ny fizarana fanafody izahay. (Marihina fa ho an‘ny USAID ny fanadihadiana atao). Manam-potoana kely iresahana amiko ve ianao?
Hametraka fanontaniana momba ny asa ataonao, ny fanafody izay amidinao ary ireo fahombiazana ao anatin‘ny asanao aho. Manampy betsaka ahy ary isaorako indrindra anao ny filazanao ny zava-misy marina mahakasika ireo ao anatin‘ny valim-panontanianao. Marihiko fa ao anatin‘ny tsiambaratelo avokoa izany rehetra izany.
N° Fanontaniana sy sivana
1051 Azonao omena andinindininy fanampiny ve aho mahakasika ny fanafody/ fitaovana izay amidinareo? JEREO NY FANAFODY/ FITAOVANA TSIRAIRAY VOALAZA ETSY AMBANY
Firy ny salan‘isan‘ny fanafody/ fitaovana lafonareo isam-bolana?
TOMBANANA ISAKY NY FANAFODY/ FITAOVANA NY SALANISA KA SORATANA AMIN‘NY TABILAO ETSY AMBANY
BOKIM-BAROTRA, NA NY TATITRA ISAN-TELO (3) VOLANA, NA TAKELAKA MIRAKITRA NY TAHIRIM-PANAFODY NO AHITANA IZANY
FENOY NY FAFANA
Outcome Monitoring Survey in the MAHEFA Areas - 246 -
LISITRA 1. FANAFODY/ FITAOVANA
UNITE (Présentation : ISA LAFO LAZAO RAHA MISY AO Boite, comprimé, (SALANISA) AMINY NA TSIA NY plaquette, flacon, sns/ JANOARY - JONA FANAFODY/ FITAOVANA Mariho eo aloha ny 2014 (Oh: mivarotra izy saingy tsy isany) misy lafo na tsy misy tahiry) Oh: 6 sachets ENY = 1 TSIA =2
ARETIN-KIBO
VIASUR (boite/ sachet)
ZINC (boite/ plaquette)
SRO (sachet/ liquide/ boite)
SUR‘EAU (flacon)
ARETIN-TRATRA
PNEUMOSTOP (flacon)
COTRIM (boite/ plaquette)
CHLORHEXIDINE/ AROFOITRA (pommade, tube)
HO AN’NY VEHIVAVY BEVOHOKA
FER ACIDE FOLIQUE/ PILIFERA (plaquette, boite)
FANAFODY KANKANA
MEBENDAZOLE (plaquette, boite)
Outcome Monitoring Survey in the MAHEFA Areas - 247 -
TAZOMOKA
TEST DU PALUDISME (boite kely/ sachet)
ACTIPAL (ACT)
ASAQ (plaquette/ boite fisaka)
FANABEAZANA AIZANA
PILPLAN (pilule/ plaquette)
LOFEMENAL (plaquette)
MICROGYNON (plaquette)
OVRETTE (plaquette)
CONFIANCE (boite, flacon)
Depocom/ Depoprovera ou DEPO (boite, flacon)
COLLIER DU CYCLE
PROTECTOR PLUS (boite de 3)
CONDOM (pièce)
SPERMICIDE NEO SAMPOON (boite)
ARETINA AVY AMIN’NY FIRAISANA ARA-NOFO
GENICURE
Outcome Monitoring Survey in the MAHEFA Areas - 248 -
LISITRA 2. FANAFODY/ FITAOVANA AMIDIN‘NY TOERAM-PIVAROTANA KANEFA TSY VOARAKITRA TAO ANATY LISITRA 1
UNITE (Présentation : Boite, ISA LAFO (SALANISA) comprimé, plaquette, flacon, sns/ JANOARY - JONA 2014 Mariho eo aloha ny isany) Oh: 6 sachets
ARETIN-KIBO
ARETIN-TRATRA
VEHIVAVY BEVOHOKA
FANAFODY KANKANA
TAZOMOKA
FANABEAZANA AIZANA
ARETINA AVY AMIN’NY FIRAISANA ARA-NOFO
Outcome Monitoring Survey in the MAHEFA Areas - 249 -
1052 Efa nisy fotoana ve ianareo nahazo fanafody/ fitaovanatamin‘ny vidiny ENY mirary (latsaka noho ny vidiny fivarotana azy/ en promotion) avy tamin‘ny TSIA PSI?
1053 Nahazo fiofanana momba ny fitantanana ve ianao tato anatin‘ny 3 volana ENY farany teo? TSIA
1054 Nahazo fiofanana momba ny teknika eo amin‘ny lafiny fahasalamana tato ENY anatin‘ny 12 volana farany teo? TSIA
1055 Te hahafantatra bebe kokoa momba ny toeram-pitehirizana fanafody aho, - Azonao aseho ahy ve ilay toeram-pitehirizana fanafody? - Azonao omena ahy hojereko koa ve ireo takelaka mirakitra ny tahirim- panafody/ pitaovana tsirairay?
1056 JEREO TSARA ARY ALAIVO SARY NY TOERAM-PITEHIRIZANA FANAFODY JEREO IRETO MANARAKA IRETO Eny Tsia
AROAFO
TALATALANA (Etagère)
VOAARO AMIN‘NY TARATRY NY MASOANDRO NY FANAFODY/ FITAOVANA
VOAARO AMIN‘NY ORANA NY FANAFODY
MITETE VE NY TAFO NA MISY FARITRA NITETE VE?
BAORITRA TSARA, TSY SIMBA (BON ETAT)
VOARINDRA NY FITOERAM-PANAFODY
MILAHATRA « PREMIER PERIME, PREMIER SORTI »
1057 Firy ny isan‘ny fanafody voatahiry? |__|__|__|_ FENOY NY FAFANA _|
Outcome Monitoring Survey in the MAHEFA Areas - 250 -
LISITRA 3 :
1058 Presentation Isa Raha isa=0, Efa nisy fotoana Raha ENY, Isan‘ny dia mariho raha ve lany ny nandritra ny firy fanafody/ nisy fa lany (1) tahirin‘io volana no tsy fitaovana lany na tsy anisan‘ny fanafody/ nisy io fanafody daty fitaovana io tao fanafody amidy io? anatin‘ny 3 (2) volana farany Eny=1/ Tsia=2 VIASUR ZINC SRO PNEUMOSTOP COTRIM CHLORHEXIDINE FER ACIDE FOLIQUE MEBENDAZOLE ACTIPAL (ACT) ASAQ SUR‘EAU TEST DU PALUDISME PILPLAN LOFEMENAL MICROGYNON OVRETTE CONFIANCE DEPOCOM COLLIER DU CYCLE PROTECTOR PLUS CONDOM SPERMICIDE NEO SAMPOON
Outcome Monitoring Survey in the MAHEFA Areas - 251 -
1059 Efa nisy fotoana ve ianareo nihidy tao anatin‘izay 3 volana farany izay? ENY …………1 TSIA ………….2
TSY FANTATRO… 3 1061 1060 Raha ENY, firy andro teo ny fitambarany? |__|__| andro Manana ny lisitry ny mpanentana ara-pahasalamana tonga mividy fanafody ato amin‘ity 1061 ENY ………….1 toeram-pivarotana ity ve ianao? TSIA ………….2 1063 1062 Raha ENY, firy ny isan‘izy ireo? ISA Tao anatin‘izay 3 volana izay, firy ny isan‘ny ny mpanentana ara-pahasalamana tonga 1063 |__|__| ISA nividy fanafody tato aminareo? Isaky ny inona ianao no mahazo ny lisitra manaraka ny toetrandro momba ny mpanentana 1063A ISAN-KERINANDRO ara-pahasalamana voaofana momba ny fandrindram-piterahana sy DEPO? ISAM-BOLANA ISAN-TELO VOLANA HAFA (LAZAO) Oviana ianao no nahazo ny lisitry ny mpanentana ara-phasalamana voaofana momba by 1064 DATY fandrindram-piterahana sy DEPO farany? LISITRA LANY DATY (PAS A JOUR) NY ALAINA SARY NY LISITRA FARANY ARY HAMARININA NY FIAVIANY LISITRY NY TOERAM-PIVAROTANA………1 HAMARININA RAHA MITOVY AMIN‘NY LISITRY NY MPANENTANA ARA- LISITRA MANARAKA NY TOERTRANDRO (A PAHASALAMANA VOAOFANA MOMBA NY FANDRINDRAM-PITERAHANA/ JOUR) NY LISITRA EO AMIN‘NY TOERAM- DEPO FARANY INDRINDRA (IZAY EFA NALAINA MIALOHA TAO AMIN‘NY PIVAROTANA………2 FOKONTANY) ISAM-BOLANA 1065A Isaky ny inona ianareo no mivory miaraka amin‘ny mpanentana ara-pahasalamana? ISAN-TELO VOLANA HAFA (LAZAO) Oviana ianao no nanatrika fivoriana farany niaraka tamin‘ireo mpanentana ara- VAO HAINGANA, TAO ANATIN‘NY 3 1064 pahasalamana? VOLANA FARANY TEO ……. 1 EFA MIHOATRA NY 3 VOLANA LASA………2 HAFA (LAZAO) ………3
Outcome Monitoring Survey in the MAHEFA Areas - 252 -
U.S. Agency for International Development American Embassy Lot 207 A, Point Liberty Andranoro, Antehiroka Antananarivo 105 MADAGASCAR
Outcome Monitoring Survey in the MAHEFA Areas - 253 -